{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>authors</th>\n",
       "      <th>title</th>\n",
       "      <th>journal</th>\n",
       "      <th>abstract_summary</th>\n",
       "      <th>language</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1632</td>\n",
       "      <td>005891341c5478c028356dac60945667e6ad77ea</td>\n",
       "      <td>10.1186/s13037-020-00235-9</td>\n",
       "      <td></td>\n",
       "      <td>On March 11, 2020, the World Health Organizati...</td>\n",
       "      <td>Stahel, Philip F.</td>\n",
       "      <td>How to risk-stratify elective surgery during&lt;...</td>\n",
       "      <td>Patient Saf Surg</td>\n",
       "      <td>Not provided.</td>\n",
       "      <td>en</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1663</td>\n",
       "      <td>01213aa45eeb8088eea6f64614ccc066e2321f73</td>\n",
       "      <td>10.1371/journal.pone.0230548</td>\n",
       "      <td>Radiologic characteristics of 2019 novel coron...</td>\n",
       "      <td>In December, 2019, a series of pneumonia cases...</td>\n",
       "      <td>Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,&lt;...</td>\n",
       "      <td>Association of radiologic findings with&lt;br&gt;mo...</td>\n",
       "      <td>PLoS One</td>\n",
       "      <td>Radiologic characteristics of 2019 novel&lt;br&gt;c...</td>\n",
       "      <td>en</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1671</td>\n",
       "      <td>0146de390eb6bdb814a5bd33459ce2c74176a72d</td>\n",
       "      <td>10.1186/s13643-020-01343-4</td>\n",
       "      <td>Background: A new type of coronavirus, novel c...</td>\n",
       "      <td>Recently, a new type of coronavirus was identi...</td>\n",
       "      <td>Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...</td>\n",
       "      <td>Traditional Chinese herbal medicine for&lt;br&gt;tr...</td>\n",
       "      <td>Syst Rev</td>\n",
       "      <td>Background: A new type of coronavirus, novel&lt;...</td>\n",
       "      <td>en</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1679</td>\n",
       "      <td>018269476cd191365d6b8bed046078aea07c8c01</td>\n",
       "      <td>10.1186/s40249-020-00640-3</td>\n",
       "      <td>Background: As reported by the World Health Or...</td>\n",
       "      <td>On 31 December 2019, the World Health Organiza...</td>\n",
       "      <td>Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...</td>\n",
       "      <td>A mathematical model for simulating the&lt;br&gt;ph...</td>\n",
       "      <td>Infectious Diseases of Poverty</td>\n",
       "      <td>Background: As reported by the World Health&lt;b...</td>\n",
       "      <td>en</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1693</td>\n",
       "      <td>021144f6c1945b9bff9ea9e4b04b24dcf53330b4</td>\n",
       "      <td>10.3390/v8030055</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a memb...</td>\n",
       "      <td>Coronaviruses are enveloped, single-stranded, ...</td>\n",
       "      <td>Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...</td>\n",
       "      <td>Identification and Comparison of Receptor&lt;br&gt;...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a&lt;br&gt;...</td>\n",
       "      <td>en</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      paper_id                           doi  \\\n",
       "1632  005891341c5478c028356dac60945667e6ad77ea    10.1186/s13037-020-00235-9   \n",
       "1663  01213aa45eeb8088eea6f64614ccc066e2321f73  10.1371/journal.pone.0230548   \n",
       "1671  0146de390eb6bdb814a5bd33459ce2c74176a72d    10.1186/s13643-020-01343-4   \n",
       "1679  018269476cd191365d6b8bed046078aea07c8c01    10.1186/s40249-020-00640-3   \n",
       "1693  021144f6c1945b9bff9ea9e4b04b24dcf53330b4              10.3390/v8030055   \n",
       "\n",
       "                                               abstract  \\\n",
       "1632                                                      \n",
       "1663  Radiologic characteristics of 2019 novel coron...   \n",
       "1671  Background: A new type of coronavirus, novel c...   \n",
       "1679  Background: As reported by the World Health Or...   \n",
       "1693  Porcine epidemic diarrhea virus (PEDV), a memb...   \n",
       "\n",
       "                                              body_text  \\\n",
       "1632  On March 11, 2020, the World Health Organizati...   \n",
       "1663  In December, 2019, a series of pneumonia cases...   \n",
       "1671  Recently, a new type of coronavirus was identi...   \n",
       "1679  On 31 December 2019, the World Health Organiza...   \n",
       "1693  Coronaviruses are enveloped, single-stranded, ...   \n",
       "\n",
       "                                                authors  \\\n",
       "1632                                  Stahel, Philip F.   \n",
       "1663   Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,<...   \n",
       "1671   Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...   \n",
       "1679   Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...   \n",
       "1693   Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...   \n",
       "\n",
       "                                                  title  \\\n",
       "1632   How to risk-stratify elective surgery during<...   \n",
       "1663   Association of radiologic findings with<br>mo...   \n",
       "1671   Traditional Chinese herbal medicine for<br>tr...   \n",
       "1679   A mathematical model for simulating the<br>ph...   \n",
       "1693   Identification and Comparison of Receptor<br>...   \n",
       "\n",
       "                             journal  \\\n",
       "1632                Patient Saf Surg   \n",
       "1663                        PLoS One   \n",
       "1671                        Syst Rev   \n",
       "1679  Infectious Diseases of Poverty   \n",
       "1693                         Viruses   \n",
       "\n",
       "                                       abstract_summary language  \n",
       "1632                                      Not provided.       en  \n",
       "1663   Radiologic characteristics of 2019 novel<br>c...       en  \n",
       "1671   Background: A new type of coronavirus, novel<...       en  \n",
       "1679   Background: As reported by the World Health<b...       en  \n",
       "1693   Porcine epidemic diarrhea virus (PEDV), a<br>...       en  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pickle\n",
    "import pandas as pd\n",
    "df_covid = pd.read_pickle('covid_keyword_filtered_articles.pkl')\n",
    "df_covid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 1669 entries, 1632 to 35874\n",
      "Data columns (total 9 columns):\n",
      "paper_id            1669 non-null object\n",
      "doi                 1669 non-null object\n",
      "abstract            1669 non-null object\n",
      "body_text           1669 non-null object\n",
      "authors             1669 non-null object\n",
      "title               1669 non-null object\n",
      "journal             1669 non-null object\n",
      "abstract_summary    1669 non-null object\n",
      "language            1669 non-null object\n",
      "dtypes: object(9)\n",
      "memory usage: 130.4+ KB\n"
     ]
    }
   ],
   "source": [
    "df_covid.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.tokenize import sent_tokenize\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.probability import FreqDist\n",
    "from nltk.corpus import stopwords\n",
    "import string\n",
    "import re\n",
    "def tokenizer_function(text):\n",
    "    tokenized_text=sent_tokenize(text)\n",
    "    tokenized_word=word_tokenize(text)\n",
    "    stop_words=set(stopwords.words(\"english\"))\n",
    "    filtered_sent=[]\n",
    "    for w in tokenized_word:\n",
    "        if w not in stop_words:\n",
    "            filtered_sent.append(w)\n",
    "\n",
    "    filtered_punc = [x for x in filtered_sent if not re.fullmatch('[' + string.punctuation + ']+', x)]\n",
    "\n",
    "    filtered_punc=list(set(filtered_punc))\n",
    "    remove_list=['i.e.','might','also','unknown','make','would','like','report','developing', 'need', 'needed','new','use','speed','including','one','understanding','terms','able','onto','pathogen','large','people','e.g.','could']\n",
    "    for i in remove_list: \n",
    "        try: \n",
    "            filtered_punc.remove(i) \n",
    "        except ValueError: \n",
    "            pass\n",
    "    return filtered_punc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def listToString(s):\n",
    "    sep = ' '\n",
    "    return (sep.join(s))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = 'how widespread current exposure is to be able to make immediate policy recommendations on mitigation measures. denominators for testing and a mechanism for rapidly sharing that information, including demographics, to the extent possible. sampling methods to determine asymptomatic disease (e.g., use of serosurveys (such as convalescent samples) and early detection of disease (e.g., use of screening of neutralizing antibodies such as elisas). efforts to increase capacity on existing diagnostic platforms and tap into existing surveillance platforms. recruitment, support, and coordination of local expertise and capacity (public, private—commercial, and non-profit, including academic), including legal, ethical, communications, and operational issues. national guidance and guidelines about best practices to states (e.g., how states might leverage universities and private laboratories for testing purposes, communications to public health officials and the public). development of a point-of-care test (like a rapid influenza test) and rapid bed-side tests, recognizing the tradeoffs between speed, accessibility, and accuracy. rapid design and execution of targeted surveillance experiments calling for all potential testers using pcr in a defined area to start testing and report to a specific entity. these experiments could aid in collecting longitudinal samples, which are critical to understanding the impact of ad hoc local interventions (which also need to be recorded). separation of assay development issues from instruments, and the role of the private sector to help quickly migrate assays onto those devices. efforts to track the evolution of the virus (i.e., genetic drift or mutations) and avoid locking into specific reagents and surveillance/detection schemes. latency issues and when there is sufficient viral load to detect the pathogen, and understanding of what is needed in terms of biological and environmental sampling. use of diagnostics such as host response markers (e.g., cytokines) to detect early disease or predict severe disease progression, which would be important to understanding best clinical practice and efficacy of therapeutic interventions. policies and protocols for screening and testing. policies to mitigate the effects on supplies associated with mass testing, including swabs and reagents. technology roadmap for diagnostics. barriers to developing and scaling up new diagnostic tests (e.g., market forces), how future coalition and accelerator models (e.g., coalition for epidemic preparedness innovations) could provide critical funding for diagnostics, and opportunities for a streamlined regulatory environment. new platforms and technology (e.g., crispr) to improve response times and employ more holistic approaches to covid-19 and future diseases. coupling genomics and diagnostic testing on a large scale. enhance capabilities for rapid sequencing and bioinformatics to target regions of the genome that will allow specificity for a particular variant. enhance capacity (people, technology, data) for sequencing with advanced analytics for unknown pathogens, and explore capabilities for distinguishing naturally-occurring pathogens from intentional. one health surveillance of humans and potential sources of future spillover or ongoing exposure for this organism and future pathogens, including both evolutionary hosts (e.g., bats) and transmission hosts (e.g., heavily trafficked and farmed wildlife and domestic food and companion species), inclusive of environmental, demographic, and occupational risk factors.'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "from spacy.lang.en.stop_words import STOP_WORDS\n",
    "import en_core_sci_lg  # model downloaded in previous step\n",
    "import string\n",
    "\n",
    "punctuations = string.punctuation\n",
    "stopwords = list(STOP_WORDS)\n",
    "custom_stop_words = [\n",
    "    'doi', 'preprint', 'copyright', 'peer', 'reviewed', 'org', 'https', 'et', 'al', 'author', 'figure', \n",
    "    'rights', 'reserved', 'permission', 'used', 'using', 'biorxiv', 'medrxiv', 'license', 'fig', 'fig.', \n",
    "    'al.', 'Elsevier', 'PMC', 'CZI', 'www'\n",
    "]\n",
    "for w in custom_stop_words:\n",
    "    if w not in stopwords:\n",
    "        stopwords.append(w)\n",
    "\n",
    "parser = en_core_sci_lg.load(disable=[\"tagger\", \"ner\"])\n",
    "parser.max_length = 7000000\n",
    "\n",
    "def spacy_tokenizer(sentence):\n",
    "    mytokens = parser(sentence)\n",
    "    mytokens = [ word.lemma_.lower().strip() if word.lemma_ != \"-PRON-\" else word.lower_ for word in mytokens ]\n",
    "    mytokens = [ word for word in mytokens if word not in stopwords and word not in punctuations ]\n",
    "    mytokens = \" \".join([i for i in mytokens])\n",
    "    mytokens = mytokens.split()\n",
    "    remove_list=['i.e.','—','might','also','unknown','make','would','like','report','developing', 'need', 'needed','new','use','speed','including','one','understanding','terms','able','onto','pathogen','large','people','e.g.','could']\n",
    "    for i in remove_list: \n",
    "        try: \n",
    "            mytokens.remove(i) \n",
    "        except ValueError: \n",
    "            pass\n",
    "    mytokens = listToString(mytokens)\n",
    "    return mytokens"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "keywords = ['severe', 'virus', 'environment', 'wildlife', 'surveillance', 'operational', 'opportunity', 'define', 'approach', 'occupational', 'swab', 'screen', 'enhance', 'rapid', 'serosurveys', 'tap', 'bat', 'roadmap', 'traffic', 'variant', 'intentional', 'non-profit', 'develope', 'help', 'food', 'associate', 'laboratory', 'biological', 'companion', 'entity', 'purpose', 'local', 'bed-side', 'accuracy', 'genetic', 'environmental', 'execution', 'sample', 'support', 'ad', 'term', 'assay', 'surveillance/detection', 'hoc', 'region', 'expertise', 'scale', 'covid-19', 'force', 'response', 'determine', 'technology', 'mechanism', 'avoid', 'collect', 'convalescent', 'denominator', 'recommendation', 'datum', 'practice', 'coalition', 'drift', 'heavily', 'risk', 'genome', 'spillover', 'intervention', 'mass', 'tradeoff', 'possible', 'recognize', 'market', 'sector', 'design', 'mutation', 'exposure', 'record', 'pcr', 'explore', 'rapidly', 'capacity', 'preparedness', 'critical', 'load', 'improve', 'share', 'epidemic', 'inclusive', 'recruitment', 'university', 'official', 'aid', 'holistic', 'advance', 'neutralize', 'barrier', 'demographic', 'protocol', 'streamline', 'couple', 'current', 'start', 'fund', 'platform', 'effect', 'allow', 'analytics', 'legal', 'farm', 'longitudinal', 'coordination', 'naturally-occurring', 'accelerator', 'accessibility', 'tester', 'measure', 'specific', 'sequence', 'increase', 'health', 'clinical', 'crispr', 'host', 'ethical', 'time', 'species', 'academic', 'potential', 'information', 'organism', 'point-of-care', 'sufficient', 'policy', 'evolution', 'disease', 'mitigation', 'device', 'exist', 'track', 'supply', 'state', 'ongoing', 'issue', 'progression', 'widespread', 'national', 'guidance', 'efficacy', 'regulatory', 'lock', 'public', 'experiment', 'detect', 'future', 'important', 'mitigate', 'area', 'cytokine', 'specificity', 'therapeutic', 'bioinformatics', 'migrate', 'immediate', 'early', 'understand', 'employ', 'leverage', 'genomics', 'include', 'source', 'distinguish', 'factor', 'human', 'model', 'communication', 'separation', 'commercial', 'impact', 'marker', 'quickly', 'detection', 'innovation', 'elisas', 'latency', 'test', 'diagnostics', 'development', 'transmission', 'evolutionary', 'asymptomatic', 'predict', 'particular', 'viral', 'influenza', 'antibody', 'extent', 'effort', 'private', 'guideline', 'instrument', 'diagnostic', 'reagent', 'capability', 'domestic', 'target', 'method', 'demographics', 'provide', 'role', 'scheme']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\abhin\\Anaconda3\\lib\\site-packages\\tqdm\\std.py:666: FutureWarning: The Panel class is removed from pandas. Accessing it from the top-level namespace will also be removed in the next version\n",
      "  from pandas import Panel\n",
      "100%|██████████| 1669/1669 [00:36<00:00, 46.13it/s]\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "tqdm.pandas()\n",
    "df_covid[\"processed_abstract\"] = df_covid[\"abstract\"].progress_apply(spacy_tokenizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1669/1669 [00:11<00:00, 140.72it/s]\n"
     ]
    }
   ],
   "source": [
    "df_covid[\"processed_title\"] = df_covid[\"title\"].progress_apply(spacy_tokenizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>authors</th>\n",
       "      <th>title</th>\n",
       "      <th>journal</th>\n",
       "      <th>abstract_summary</th>\n",
       "      <th>language</th>\n",
       "      <th>processed_abstract</th>\n",
       "      <th>processed_title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1632</td>\n",
       "      <td>005891341c5478c028356dac60945667e6ad77ea</td>\n",
       "      <td>10.1186/s13037-020-00235-9</td>\n",
       "      <td></td>\n",
       "      <td>On March 11, 2020, the World Health Organizati...</td>\n",
       "      <td>Stahel, Philip F.</td>\n",
       "      <td>How to risk-stratify elective surgery during&lt;...</td>\n",
       "      <td>Patient Saf Surg</td>\n",
       "      <td>Not provided.</td>\n",
       "      <td>en</td>\n",
       "      <td></td>\n",
       "      <td>risk-stratify elective surgery br covid-19 pan...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1663</td>\n",
       "      <td>01213aa45eeb8088eea6f64614ccc066e2321f73</td>\n",
       "      <td>10.1371/journal.pone.0230548</td>\n",
       "      <td>Radiologic characteristics of 2019 novel coron...</td>\n",
       "      <td>In December, 2019, a series of pneumonia cases...</td>\n",
       "      <td>Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,&lt;...</td>\n",
       "      <td>Association of radiologic findings with&lt;br&gt;mo...</td>\n",
       "      <td>PLoS One</td>\n",
       "      <td>Radiologic characteristics of 2019 novel&lt;br&gt;c...</td>\n",
       "      <td>en</td>\n",
       "      <td>radiologic characteristic 2019 novel coronavir...</td>\n",
       "      <td>association radiologic finding br mortality pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1671</td>\n",
       "      <td>0146de390eb6bdb814a5bd33459ce2c74176a72d</td>\n",
       "      <td>10.1186/s13643-020-01343-4</td>\n",
       "      <td>Background: A new type of coronavirus, novel c...</td>\n",
       "      <td>Recently, a new type of coronavirus was identi...</td>\n",
       "      <td>Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...</td>\n",
       "      <td>Traditional Chinese herbal medicine for&lt;br&gt;tr...</td>\n",
       "      <td>Syst Rev</td>\n",
       "      <td>Background: A new type of coronavirus, novel&lt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>background type coronavirus novel coronavirus ...</td>\n",
       "      <td>traditional chinese herbal medicine br treat n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1679</td>\n",
       "      <td>018269476cd191365d6b8bed046078aea07c8c01</td>\n",
       "      <td>10.1186/s40249-020-00640-3</td>\n",
       "      <td>Background: As reported by the World Health Or...</td>\n",
       "      <td>On 31 December 2019, the World Health Organiza...</td>\n",
       "      <td>Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...</td>\n",
       "      <td>A mathematical model for simulating the&lt;br&gt;ph...</td>\n",
       "      <td>Infectious Diseases of Poverty</td>\n",
       "      <td>Background: As reported by the World Health&lt;b...</td>\n",
       "      <td>en</td>\n",
       "      <td>background world health organization novel cor...</td>\n",
       "      <td>mathematical model simulate br phase-based tra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1693</td>\n",
       "      <td>021144f6c1945b9bff9ea9e4b04b24dcf53330b4</td>\n",
       "      <td>10.3390/v8030055</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a memb...</td>\n",
       "      <td>Coronaviruses are enveloped, single-stranded, ...</td>\n",
       "      <td>Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...</td>\n",
       "      <td>Identification and Comparison of Receptor&lt;br&gt;...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a&lt;br&gt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>porcine epidemic diarrhea virus pedv member al...</td>\n",
       "      <td>identification comparison receptor br binding ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      paper_id                           doi  \\\n",
       "1632  005891341c5478c028356dac60945667e6ad77ea    10.1186/s13037-020-00235-9   \n",
       "1663  01213aa45eeb8088eea6f64614ccc066e2321f73  10.1371/journal.pone.0230548   \n",
       "1671  0146de390eb6bdb814a5bd33459ce2c74176a72d    10.1186/s13643-020-01343-4   \n",
       "1679  018269476cd191365d6b8bed046078aea07c8c01    10.1186/s40249-020-00640-3   \n",
       "1693  021144f6c1945b9bff9ea9e4b04b24dcf53330b4              10.3390/v8030055   \n",
       "\n",
       "                                               abstract  \\\n",
       "1632                                                      \n",
       "1663  Radiologic characteristics of 2019 novel coron...   \n",
       "1671  Background: A new type of coronavirus, novel c...   \n",
       "1679  Background: As reported by the World Health Or...   \n",
       "1693  Porcine epidemic diarrhea virus (PEDV), a memb...   \n",
       "\n",
       "                                              body_text  \\\n",
       "1632  On March 11, 2020, the World Health Organizati...   \n",
       "1663  In December, 2019, a series of pneumonia cases...   \n",
       "1671  Recently, a new type of coronavirus was identi...   \n",
       "1679  On 31 December 2019, the World Health Organiza...   \n",
       "1693  Coronaviruses are enveloped, single-stranded, ...   \n",
       "\n",
       "                                                authors  \\\n",
       "1632                                  Stahel, Philip F.   \n",
       "1663   Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,<...   \n",
       "1671   Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...   \n",
       "1679   Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...   \n",
       "1693   Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...   \n",
       "\n",
       "                                                  title  \\\n",
       "1632   How to risk-stratify elective surgery during<...   \n",
       "1663   Association of radiologic findings with<br>mo...   \n",
       "1671   Traditional Chinese herbal medicine for<br>tr...   \n",
       "1679   A mathematical model for simulating the<br>ph...   \n",
       "1693   Identification and Comparison of Receptor<br>...   \n",
       "\n",
       "                             journal  \\\n",
       "1632                Patient Saf Surg   \n",
       "1663                        PLoS One   \n",
       "1671                        Syst Rev   \n",
       "1679  Infectious Diseases of Poverty   \n",
       "1693                         Viruses   \n",
       "\n",
       "                                       abstract_summary language  \\\n",
       "1632                                      Not provided.       en   \n",
       "1663   Radiologic characteristics of 2019 novel<br>c...       en   \n",
       "1671   Background: A new type of coronavirus, novel<...       en   \n",
       "1679   Background: As reported by the World Health<b...       en   \n",
       "1693   Porcine epidemic diarrhea virus (PEDV), a<br>...       en   \n",
       "\n",
       "                                     processed_abstract  \\\n",
       "1632                                                      \n",
       "1663  radiologic characteristic 2019 novel coronavir...   \n",
       "1671  background type coronavirus novel coronavirus ...   \n",
       "1679  background world health organization novel cor...   \n",
       "1693  porcine epidemic diarrhea virus pedv member al...   \n",
       "\n",
       "                                        processed_title  \n",
       "1632  risk-stratify elective surgery br covid-19 pan...  \n",
       "1663  association radiologic finding br mortality pa...  \n",
       "1671  traditional chinese herbal medicine br treat n...  \n",
       "1679  mathematical model simulate br phase-based tra...  \n",
       "1693  identification comparison receptor br binding ...  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "After filtering, number of papers related to tasks and subtasks: 1635\n"
     ]
    }
   ],
   "source": [
    "# Create a filter with 'False' values\n",
    "index_list =  list(df_covid.index.values) \n",
    "filter = pd.Series([False] * len(index_list))\n",
    "filter.index = index_list\n",
    "  \n",
    "# Update the filter using the synonym list, checking if a synonym appears in the title or the abstract of a paper\n",
    "for s in keywords:\n",
    "    # Check if a synonym is in title or abstract\n",
    "    filter = filter | df_covid.processed_abstract.str.lower().str.contains(s) | df_covid.processed_title.str.lower().str.contains(s)\n",
    "\n",
    "# Filter out papers in metadata dataframe using the above filter\n",
    "df_covid = df_covid[filter]\n",
    "\n",
    "# Sanity check\n",
    "print(\"After filtering, number of papers related to tasks and subtasks:\", len(df_covid))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We need to find new keywords now.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "list_abstract = df_covid['processed_abstract'].to_list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['', 'consolidation 0.047 opacity 43 0.021 consist radiologic hospital 67 mainly 47 characteristic association 24.5 low vs distribution 2019-ncov 85.6 likely collect central 0.018 mortality prediction p novel comorbidity diagnose involvement grind iqr 55 lung 0.025 study consecutive 73 combine 2019 frequency zone peripheral 15 35 bronchogram 60 significantly year 29 74 30 discharge median survival recover feature clinical involve woman 63 prognosis die value 84.5 group elderly infect condition optimal 12 80 man 68 high 7 patient image predominant bilateral important specificity 17 confirm retrospective 13 understand coronavirus especially evaluate 6 include 10 cutoff simple 11 96 ct ncip 40 27 capable compare chronic 86 0.003 predict pneumonia air sensitivity 69 rate score age finding glass mix method fully', 'proceeding virus infection size screen assess prevention participate periodical database associate cnki cause knowledge traditional december january chi-square egger medicine vip science dissertation degree treatment keyword covid-19 international relate meta-analysis standard cochrane reviewer technology central datum \\ufeff1 risk p background trials novel data yl xl discussion relevant funnel study trim high-quality registry independent dz r 2019 affect consent 2020 organization review cbm wanfang effect approval infrastructure analysis chinese 0.10 30 embase lg controlled publication heterogeneity increase health synthesis publish academic information fill ethic statistical prisma biomedical 5.3.5 pubmed type conference national investigate public gray accord wuhan trial software significance biases declare 3.6.1 conduct emergency list electronic methods peer-reviewed concern numb coronavirus evaluate version include literature require extract china plot ethics manager world case herbal test begg register bias provide pneumonia journal viral search manually guideline appear finding systematic late reference level', 'severe basic virus reservoir approach infection acute reservoir-people assess bat respiratory population develope causative authority country simulate january 2 etiology bats-hosts-reservoir-people low international huanan calculate 2019-ncov adopt background korea novel mathematical market matrix network explore committee study expect similar introduce middle r 2020 seafood organization february wholesale chinese syndrome individual aim rp health value result clearly potential reproduction mers infect conclusions 0 transmissibility hard republic sars-cov-2 high 7 person probably public mean focus wuhan single methods concern generation susceptible numb coronavirus estimate source 11 develop human simplify 3.58 model bats-hosts-reservoir east results world 2.30 taxonomy transmission identify pneumonia viruses secondary', 'virus coronavirus-like carcinoembryonic structure weak 141 united molecule develope piglet β-barrel attachment ntd 253 pathogenicity example outbreak states adhesion rbds open association assay 1977 diarrhea kb genome consider 20 spread mutation 55 rapidly 793 lee co-receptor 1385 pork reach rbd 2010 membrane farm 3 156 member play vaccine swine ped 324 prcv surface enzyme 164 investigate belong 50%-90 conform strain strategies 1335 aminopeptidase 13 date 10 11 bind human loss substantial massive insight drug frame n-terminus responsible compare deletion recognition identify predict rate orf1a target asia tgev ctd april acid severe find variation peptide polyprotein associate encode occurrence 21 protein porcine 28 tail n crucial determine 1 spike mortality difference different transmembrane portion antigen 794 isolate papn cv777 study similar bcov characterize pensaert recently contain exhibit 16 chgd-01 sugar-binding e indicate 1359 s subdomain pandemic read 7 demonstrate 19 confirm single betacoronaviruses especially sugar mhv helpful 13,22 enteritis capable world domain previous nl63 entry 88 prototype sudden mutagenesis bovine death watery enteric role structural change respiratory variant 25 respectively homotrimeric major 1a cov symptom angiotensin-converting s2 loop suckle vomit weight virulence 1358 datum receptor-binding gastroenteritis verify motif possible share 155 14 betacoronavirus hepatitis economic affect fusion key co-immunoprecipitation pathogenesis amino discontinuous sequence clinical genus host location disease alphacoronavirus 4 high differ cellular pedv interaction nucleocapsid m concern coronavirus transmissible 6 include necessary conclusive 18 model orf1b 163 ace2 highly global orf3 s-papn 2013 viral viruses despite serve hotspot tip breed exact cytoplasmic industry fragment antiviral concentrate locate acute envelope participate six-amino-acid cause 9 mutate 2 genetic s1 contagious minimal region murine act belgian designate 5 recognize signal epidemic gene particle mediate 15 insertion 60 homology similarity activity cell n-terminal ceacam subsequently residue c-terminal 2016 field 12 17 hcov-nl63 56 glycoprotein huge producer 1b sars currently crystal 8 affinity receptor finally provide 638', 'severe virus find research cross infection elucidate structure acute outside prevention rapid ability coronaviruses bat summarize respiratory population notably male harmless cause origin 9 pathogenicity country biological outbreak protein discuss advancement animal therapy characteristic arabia decade treatment low international remain border countermeasure tremendous peninsula mechanism pathophoresis nosocomial diverse prior failure therapeutics spike mortality build closely achieve korea novel covs process design lesson explore surface-located isolate critical pathogenic share possibility contribute south tract middle suitable barrier coronaviral cov-host hinder preferential current systemic saudi immunopathology review relatively option bring allow strategy re-emergence ultimately renal pathogenesis 2004 2012 cell syndrome indicate replication adaptation return importance 2015 feature play individual attention construct subsequently epidemiology clinical arabian result pivotal species regard host die potential mers progress june s infect disease lead learn pandemic surface late trimeric lack unravel zoonotic high patient 7 unprecedented outcome interaction detect demonstrate sars-cov sars-cov-like focus based important scientific mers-cov. trial vitro declare recent detail mers-cov understand coronavirus travel emerge control 6 recapitulate glycoprotein 10 include develop certain function human model east outline manage insight highlight sars guide prevalence describe highly sputum global reproducible researcher common occur development compare transmission mammalian identify pneumonia viral rate affinity 8 entry good conquer target receptor provide infectious role fully', '', 'coronavirus novel disease', 'draw small illness classify 1373 datum understand coronavirus numb ci incidence infection backcalculation estimate 946 employ risk member 766 individual novel intervention consider cumulative 5 onward close 102 crow time respectively onset curve ship contact policy epidemic limit 2 2176 case passenger movement 570 restriction 4 47 cruise board 587 predict abruptly princess 2020 based time-dependent period method february impose greatly diamond total confirm reduce decline peak analysis 199 95', 'severe virus allele structural acute screen respiratory population protection help 120 associate cause immunological 21 outbreak protein 2 emergence genetic a.a.q t m.r.m. n covid-19 identically b globally sars-cov. spike offer novel m.mckay@ust.hk consider spread design mutation study contribute mhc derive 2020 potentially february set analysis similarity cell gain syndrome † vaccine way sequence imminent s perform exist sars-cov-2 sars-cov-derived propose high nucleocapsid sars-cov coverage map work equally understand coronavirus begin control estimate leverage observe develop abstract china 2003 insight broad guide experimental immunogenic development immune identify available effort epitope good experimentally-determined target finding seek provide', '', '459,890 virological define march infection structure outside assess 500 uncontrolled 250,039 line population cause 39 37,194 little a. note compartment simulate ≥ 2 39.4 5-year sample seven intensive region covid-19 50 6.9 distribution 147,717 nosocomial sir 68.8 i(a datum 1 notify project age-specific 70 care risk contribution credible susceptible-infectious-removed 20 assume consider different proportion 7,375 matrix exposure record know rapidly preliminary epidemic obtain expect exclude 593 consecutive represent distribute day r containment long current 2020 municipality community incorporate 59 aggressive february emilia analyse 49 year strategy worker analysis chinese 29 30 3 province million inhabitant 366 probability symptomatic measure veneto individual heterogeneity italy municipality-specific group time potential severity r(a lombardy 0 contact situation disease posterior 4 cri ongoing patient place 22,632 polymod hubei mean accord 19 projection interval list stochastic 95-year-olds overall system 94 generation equally numb coronavirus uncover control leave estimate include base 3.1 6.6 require 3.2 2.9 model 40 modelbased impact dynamic fraction case average evaluation gamma occur compute p(a transmission healthcare predict asymptomatic particular week rate 8 69 age end romagna sustained death total provide infectious 95', 'small severe frontline molecular team approach infection repetitive intravenous wenhong respiratory shanghai traditional creative try therapy medicine characteristic express treatment unique low significant covid-19 scale weight medical crucial depict invite multiorgan composition ill quick bedside care management quality intervention chemical addition share introduce zhang hongzhou chinese furthermore anti-viral importance complicate publication clinical course result carefully taisheng leader expert lead disease decision sars-cov-2 critically nature ongoing immunoglobulin propose patient emphasize important wuhan trial timely abnormality lu concern overall system early li coagulation observe develop function china professor manage drug heparin observation tailor case supportive evaluation responsible send suggest anticoagulation provide infectious', 'severe basic virus research acute prevention bat respiratory develope help cause cover outbreak 2 threaten etiology symptom treatment low covid-19 response mechanism mortality youth rapidly diagnosis similar attempt transmit catastrophe far swiftly 2019 affect review question virology 80,000 kill syndrome individual publication epidemiology increase woman result prognosis severity elderly infect disease sars-cov-2 man sars-cov subject timely comprehensive numb coronavirus understand emerge article eradication thousand require human china 3,000 answer 2003 sars hope world homologous transmissive provide', 'severe find sulfate infection acute 500 phosphate respiratory 25 chloroquine storm simulate 2 support point treat μm mechanism ill safety datum 1 \\ufeff1 separately background break consider different spread 5 explore immunomodulatory lung load malaria share advance pbpk day ec50=5.47 reach whilst evidence autoimmune sporadically effect hydroxychloroquine activity cell syndrome daily pharmacokinetic follow subsequently 400 regimen potency effective result concentration time vero infect condition orally sars-cov-2 twice 4 critically fluid 200 propose implement ec50=0.72 patient based wuhan cytokine vitro late-phase methods coronavirus inhibit control main physiologically-based profile useful abstract china model results potent drug currently action prefer tolerable mg test occur dose maintenance pharmacological worldwide integrate recommend', '', '', '', 'antiviral considering infection pose assess prevention rapid imply nm develope cause protein cross-reactivity 259 6.3 doe cov interestingly treatment 2019-ncov cr3014 cr3022 receptor-binding monoclonal therapeutics spike difference threat \\ufeff1 m396 novel critical 2019-ncov. neutralize site 2019 relatively newly fail vaccine specific health result identity time potential 11,900 high laboratory-confirmed sars-cov important anti-sars therapeutic combination coronavirus specifically urgent include necessary develop bind human sars-cov-specific overlap ace2 potent impact currently candidate domain development kd identify potently antibody suggest epitope target death rbd implication', '', 'class virus receptor-binding buff variation coronavirus past define accompany structure adaptation observe natural base ability change bind rna human close solely population model mutation replace result complex hcov-229e successively improve evolution alphacoronavirus crystal neutralize domain environmental characterize random responsible extend x-ray high n differ viral year rate affinity antibody fitness loop good interaction 50 mean apn loop-receptor ectodomain receptor aminopeptidase relative phylogenetic provide rbd analysis', 'number fatality confirmed practice indictor improvement surveillance coronavirus article fast contribution recover necessary daily attention intervention indicator health factor influential china recovery explore country dynamic suspect ratio action outbreak discuss great learn world global etc contribute case recommendations apply far update national rate adapt accumulative public trend good organization death implication', 'acid severe virus pp1ab classify orf1ab antiviral direction strong acute readily dsdna ~30 respiratory 5′-ss rna polyprotein 25 14,15 nsp13 ~490 cause complex inhibitor pp1a encode major 21 superfamily protein ntpase/helicase 4,5 animal cooperative single-stranded tail therapy characteristic distinct dsrna 28 mrnas open helicase metabolism treatment poor reaction signature pro central interfere 1 processivity kb ribosomal core genome motif novel ofr1a consider different process 20 chemical 9,10 substrate addition accumulation nonstructural cysteine non-structural gene frameshifting rna-dependent nsp12 spend hepatitis kda derive synthesize atps subsequent produce replicases membrane-bound nsps 3cl duplex effect activity exhibit relieve 16 claim syndrome replication play replicase 5′-end 2,3 length rdrp protease increase sequence involve 24 result concentration potential helicases infect s disease ntp nucleic present read c d atp high patient inhibition replicative sars-cov important unwind 19 17 single m strand herpes decrease 13 repair class early positive coronavirus dna translational inhibit 6 double-stranded depend rna/nsp13 essential include proliferation 11 18 primary require bind function certain scv model simplex translate polarity 1b 2003 7,29 replication-transcription small-molecule sars entire translocation frame prefer drug candidate 800 envelop two-thirds ssrna autoproteolytically processively development inefficiently compare hydrolysis 3′ polymerase viral rna. hsv despite affinity suggest 8 importantly effort motor recombination ~790 energy target prove putative subgenomic −1 death 5′ infectious role comprise', '', 'severe cws 0/30 elisa virus mers-covspecific infection immunofluorescence additional respiratory truck donor cause setting immunological outbreak 16/30 sensitive hospital emergence t arabia sample unclear seropositive assay 50 response lethal cepi likely mild route coalition care welldocumented direct novel spread comorbidity possible previously exposure preparedness epidemic obtain transmit middle neutralize innovations driver initially community saudi contain repeat kingdom worker 30 cell indirect formally syndrome importance vaccine individual measure health virus-specific healthy result potential mers handler infect 0 (cov)mediated cohort majority disease ksa high blood patient immunosorbent demonstrate appearance seronegative important herder mers-cov-specific camel list explanation mers-cov coronavirus emerge control episodic and/or continue source develop totals approximately uninfected east ifa describe enzyme-linked titer highly case attribute development acquisition occur transmission acquire antibody good target well-documented', 'neighbour past virus cause(s soap fuel news research march infection hysteria expectation prevention practise trust population develope help associate happen knowledge communicate song example outbreak local certainly creative educate 2 link cope hospital commons characteristic loud symptom delivery slow support protect open term cite medium treatment accurate covid-19 treat properly remember event international hygiene-people globally preventative plan remain distribution variable determine likely ask adopt turn datum government truth mortality threat thirst overcome actionable novel consider 20 spread friend possible singe health-care 5 network recovery hygiene know address commodity critical expect well-resourced lag channel inform easily ready site wash exactly brink trustworthy subsequent long current community collate 2020 organization promisingly simply professional look systems worker frequently reputable security 3 recover member vaccine individual behavioural measure way health want healthy effective fear 000 well-informed time understandable consistent severity information elderly infect potential ward fill permit reproduction lead disease original 180 pandemic come lack 4 attribution access wellbeing perspective second national outcome unprecedented person up-todate sense public future duration social gap timely reliable succumb receive 17 work vulnerable behaviour contract system concern enable understand reinfection panic benefit internet article child inaccurate nearly continue equip source include underlie combat questions misinformation hand resource undoubtedly appropriate problem announce incorrect family impact hope drug action clear quickly better capable vital world buy entail collection development motivate digital accurately bias available identify viral face rate online effort good importantly age short tell end guideline target effectively seek death rationale provide infectious worldwide level initiative', 'virus santos march participant retrieve formulation rna discovery database wc chloroquine oseltamivir identifier repurposing outbreak traditional little rev december medicine approve capture treatment low covid-19 distribution 2019-ncov facilitate novel intervention 20 market salud rosa study inform cost interferon betacoronavirus represent distribute reach methylprednisolone 2019 2020 ritonavir organization contain publica strategy hydroxychloroquine chinese utilize province remdesivir arbidol subsequently lopinavir health clinical 24 genus involve tcm time clinicaltrials.gov favipiravir perform infect condition panam 4,614 disease 12 limitation eligibility sgv exist sars-cov-2 80 supply immunoglobulin attractive patient bevacizumab emphasize 2020;44:e40 mammal criterium hubei wuhan period trial bird list pharmaceutical class numb coronavirus article essential include base chain human abstract china reposition drug launch describe envelop world case test identify pneumonia search 125,048 death', 'severe especially risk fatal respiratory develope host drug disease transplant high patient immunity covid-19 treat review cancer focus immune-suppressive immune-stimulating effect', '', 'fatality notable reservoir enter infection structural respiratory discovery country outbreak protein discuss animal induce generate arabia ultimate response medical tremendous mechanism monoclonal spike \\ufeff1 novel intervention agent spread possible critical study persistent middle current saudi 2,200 review mediate humoral strategy 2012 syndrome vaccine individual aim health clinical potential infect s 35.4 high public trial therapeutic recent wide protective mers-cov concern coronavirus glycoprotein include bind east translate infectiousness 27 insight highlight currently hurdle candidate limit global development well-studied immune available viral rate entry antibody target characterization provide role', 'similarly virus surveillance outside halve 0.55 assess originate country 0.099 outbreak generate 47 symptom 2019-ncov thailand ensure risk korea credible assumption 24,500 data spread representative 5 0.41 japan onset south emphasise current 2020 february intense 0.012 probability importance usa fortunately follow 24 time infect 0 lead pandemic ongoing 0.27 patient 492 mean wuhan confirm interval human-to-human early coronavirus transmissible estimate import include china sars describe limit global world arrive case transmission pneumonia hospitalisation effort sustain death', 'correspond severe infection acute respiratory population witness cause intrinsic country outbreak protein little fact covid-19 likely rigidity notify difference consider spread know epidemic 14 middle shell coronaviral wuhan-2019-ncov affect 2020 organization february predisposition 2012 syndrome tool health 24 1370 september result potential mers infect 2002 transmissibility infectivity exceed differ laboratory-confirmed sars-cov 8000 toll 65,000 emergency mers-cov evaluate coronavirus dramatically china east 26 2003 computational sars disorder currently quickly global two-thirds world case attribute predict viral 2494 death worldwide', '', 'dataset percentage enhance 34,598 mape country outbreak local december 2 ssa term forecast covid-19 upcoming discover determine avoid fpassa datum absolute fpassa-anfis anfis optimum novel different spread previously record improve study determination error official fpa day reach coefficient parameter r 2019 current 2020 organization february furthermore weekly squared daily usa increase health 24 time drawback pollination exist present propose adaptive outcome rmsre mean wuhan confirm relative system numb coronavirus city inference evaluate swarm estimate main employ root base model china general world neuro-fuzzy case test compare compute flower 8 influenza good algorithm performance idea trap salp', 'severe fatality virus fragment reservoir infection structural structure acute subunit overviewed pose natural rapid non-s bat summarize respiratory develope 70000 cause protein december cov section arabia approve seven significant 2019-ncov topic antivirals therapeutics spike threat \\ufeff1 covs design isolate pathogenic 34.4 introduce transmit advance middle far microbiology 2019 affect current saudi review key variety virology 2012 write syndrome newly vaccines vaccine health non-rbd full-length emerging host receptorbinding potential june infect 2002 s lead 2.7 illustrate pandemic type zoonotic public future sars-cov basis recent mers-cov overall intermediate coronavirus emerge helpful continue include 10 factor function human china east currently describe global case domain development investigation identify available frontiers viruses rate rbd', 'fatality virus opportunity infection natural percentile govern 9 little 2 hospital approximate treatment covid-19 distribution best-fit right illness datum risk novel 95th consider spread 5 onset confidence quarantine study epidemic 14 day recently 2019 incubation 3 median length epicenter lognormal result time event-date 4 delay present ongoing investigate epidemiological based mean wuhan period fall 17 interval history 13 coronavirus truncate emerge estimate and/or isolation geographic truncation china dynamic case publicly available admission death range provide recommend 95', 'datum generation coronavirus province cases travel date \\ufeff1 indicate emerge additional individual-level include novel spread health china help onset detail information geo-coded outbreak study epidemic december curate disease aid world inform decision track generate symptom transmission support available national robust online 2019 evidence epidemiological covid-19 good real-time public hubei admission important wuhan confirmation municipal history human-to-human collect key analysis provincial', '', 'coronavirus gain nearly equip novel awaken emergent lesson group outbreak echo world advance emergence previous technological decade deal sars-cov important 2019-ncov ago 2b recent', '', '', 'virus seropositivity infection acute -hku1 immunofluorescence beijing natural non-severe respiratory population 218 develope protein 3.65 childhood t sample express assay s-igm anti-s spike \\ufeff1 adult 70 igg background detectable proportion 794 non-sars igm tract negative 576 plateau reach (non-sars)-related evidence year positivity 293 29 igg. cell indirect syndrome -nl63 individual measure increase healthy -oc43 characterise hcov-229e s majority apply blood place detect s-igg methods coronavirus 6 child include s-protein-based human hcovs ifa seroconversion general results recombinant prevalence four-hcov conclusion common test serum occur asymptomatic antibody age', '29 presence assuming virus fatality coronavirus comparable incidence infection estimate indicate 5.0 risk screen 565 include individual symptomatic novel 7.5 charter evacuate 20,767 china japan consistent 1958 31 9.2 0.3 infect asian individuals-is confidence arrival citizen 1957 january detection inform ascertainment passenger mildly 0.6 pandemic test day symptom 20.0 japanese asymptomatic actual rate influenza 2020 serial mean wuhan flight 2019-ncov (ifr)-the interval total window death 95', 'severe virus surveillance infection respiratory hospital-based 25 clade cause nucleotide protein 2 hospital genetic sample initial switch low relate response globally mild collect 75/5573 insufficient spike closely genome detectable background transcription whole-genome exposure pcr 1.3 similar hcov-oc43 reverse tract genotype evidence nasal repeat set endemic elicit exhibit selection indicate monophyletic individual sequence diversity hcov-229e conclusions s pattern location circulate coastal contemporary high pediatric kilifi select kenya detect community-based hcov-nl63 methods protective positive lifetime coronavirus reinfection accompany child observe human pair form 2014 results prevalence titer 2008 repeatedly limit global absence occur multiplex immune unexpected pneumonia nl63 viral persistence additionally suggest real-time admission target', 'severe virus notable chick infection acute conclude fipv coronaviruses respiratory expression cause major mass41 emergence animal doe n low b 229e ibv slightly peritonitis 1 bhk-21 gastroenteritis constitutive non-permissive mass miguel iowa97 transient exception ca99 review tgev fapn cell 3 syndrome pharr bhk rescue ark99 increase efficiency host species identity group transfection potential hcov-229e infect wang 0.01 disease feline c interaction coronavirus-receptor important strain aminopeptidase suggestion susceptibility recent bronchitis susceptible understand coronavirus transmissible gt continue include primary factor certain human ark_dpi infectious kidney sars account currently case canine previous compare avian investigation functional 41 entry suggest brief good prototype serve receptor range utilization role level', 'severe coronavirus offer syndrome article infection acute risk health respiratory population emergency die authority explore infect relevant 2 sars-cov-2 3,019 reason response psychological suggestion reduce provide worker chinese', 'prior mers-cov severe illness virus percentage positive coronavirus sentinel syndrome infection 22.6 hcov-hku1 2015 11.62 israel aim soroka respiratory population clinical human co-circulate hcovs east center 43.43 spring-summer cause pcr hcov-229e 2016 ili infect rsv study monitor hcov syncytial disease survey university similar hcov-positive hcov-oc43 mainly middle winter hospitalized 44.95 absent 10.36 sample type symptom term patient 195 1910 influenza public real-time detect influenza-like hospitalize appear discover medical period mild year circulation collect recent analysis hcov-nl63', 'severe past virus classify research life structural structure acute size pathway envelope respiratory modulate rna 25 categorize associate nidovirale pathogenicity country encode twothirds 21 protein outbreak discuss hcov geographically roughly 2 cov 28 distinct fact single-stranded tail initial mrnas alpha- 32 open n messenger region product b event innate response international enclose mrna nf-κb act facilitate exploit progeny 1 alphacoronaviruses comparison spike mortality club-like genome hcov-host virion transcription stress covs 20 process canonical 5 extensively substrate spherical downstream onset 22 addition know committee capacity vary non-structural cycle study 14 kilobases hcov-oc43 contribute gene middle far betacoronavirus cap derive community poly review 35 moderately package year membrane variety set pathogenesis eastern exhibit cell intersperse 3 16 e syndrome replication 23 replicase pleomorphic sequence swine mapk genus 24 replicase-transcriptase host template group species hcov-229e alpha-or 2016 infect s accessory diseases location 12 4 coronaviridae read symmetrical propose high outcome lie cellular immunity sense interaction apoptosis er sars-cov nuclear nucleocapsid genomic 19 microscope projection 17 deltacoronaviruses m spotlight recent betacoronaviruses wide hcov-nl63 mers-cov positive understand coronavirus numb travel main hcov-hku1 base include electron 18 factor human beta- approximately hcovs east roniviridae alphaor 26 translate orf1b form 27 family kinase entire overlap frame orfs unlike limit one-third envelop two-thirds mitogen-activated case taxonomy stem kappa order gammaand avian transmission 18,19 identify terminal 3′ artierivirdae viral viruses rate gamma-and extraordinarily helically orf1a appear finding final interior subgenomic 5′ range table infectious super-spreader comprise thrust', 'find early numb claim paramount infection article emerge acute availability aim conclusive non-steroidal literature given health corticosteroid certain exercise exacerbate publish information drug surround advise world pandemic sars-cov-2 state beneficial far symptom available identify utilise patient phase viral anti-inflammatory evidence current covid-19 collate treat review appear mean caution reliable conflict organisation clinician nsaids', 'virus infection pipistrellus ability bat line respiratory expression develope origin respectively conserve protein peptidase abramus prompt distinct support seven express 0.0174 relate 229e mers-covs mrna determine tylonycteris replicate overexpression pachypus spike closely p tropism different critical confer middle far tylonycteris-batcov exploration sinicus (mers-cov)-related t. significantly utilize cell syndrome primate replication fail p. residue sequence dpp4 non-susceptible host species ancestral diversity emc/2012 hcov-229e infect 12 infectivity 4 hku5 non-human high cellular sars-cov strain mers-cov. pipistrellus-batcov susceptibility camel dipeptidyl mers-cov susceptible coronavirus include primary bind factor human dromedary east sars-related-cov broad capable test previous hdpp4 identify viral suggest hku4 finding r. receptor rhinolophus level', 'severe virus find raise molecular ratg13 variation stage define variability weak natural 103 evolve complete ~30 bat population linkage cause nucleotide major snps outbreak little december january genetic sarsr-covs symptom support prevalent relate likely datum receptor-binding spike difference genome sars-related designate intervention different spread previously portion mutation record study epidemic pangolin far site combine neutral 2019 start 2020 frequency aggressive relatively selective analysis old selection indicate sequence increase clinical result ancestral divergence s disease pressure sars-cov-2 4 l strongly type place investigate patient epidemiological genomic wuhan strain 17 comprehensive relative chart decrease concern immediate early coronavirus version urgent date estimate nearly evolutionarily ~70 hand human china impact quickly global domain development viral functional extent suggest good recombination finding sarsr-cov late rbd', 'severe virus surveillance reservoir research respond carry acute (mers)-cov-was change respiratory population develope briefly cause genetic mainly cov arabia unclear decade inefficient remain response mild habit illness datum severely threat novel covs teach spread toolbox record know pathogenic error aid hcov-oc43 middle travel-related signs saudi year strategy kingdom key 2012 syndrome clinical unexplained mers hcov-229e cov-the academic disease pandemic come 80 future human-to-human therapeutic camel hcov-nl63 challenge 2000 mers-cov understand coronavirus targeted emerge control date hcov-hku1 continue include primary human east sars impact currently characterisation world case transmission identify capability', 'disease limit covid-19 epidemiological clinical community coronavirus paucisymptomatic setting transmission patient challenge', '', 'system cell furthermore find conformation cd26 spike mortality assist therapeutics urgent structure immunoregulatory underline glycoprotein shield camouflage glycosylation homo-trimer distinguish defence accentuate feature increase health factor involve close human pneumonia-causing china model host o-linked hijack sars highlight outbreak study global s1 n-and domain ligand-bound development site adhesion issue open predict unique covid-19 public potentially ligand-free finding interact virulence recent key morbidity', '', 'acid structural respiratory associate encode protein hcov genetic characteristic express n unique significant 229e abundantly sars-cov. multi-functional \\ufeff1 genome localization process multi-domain vary detailed cycle study share obtain similar tract characterize coronaviral stark differently analysis contrast 2004 furthermore cell n-terminal replication member nucleus feature aim involve result species severity c-terminal hcov-229e infect oligomerization disease nucleic biochemical present progression cellular nucleocapsid sars-cov important coronavirinae subfamily hcov-nl63 transfect numb coronavirus especially observe bind human describe reveal homologous domain responsible subcellular nl63 viral level alteration surprisingly', 'coronavirus province march infection establish risk 80,815 include necessary hospital-specific direct battle novel follow measure nurse guangdong human involve china cause 2003 general zero suspect sars 3073 contact epidemic disease hospital case staff present protocol second high implement patient rate 8 2019 covid-19 2020 treat interaction 3000 maintain vulnerability medical 35 260 death confirm reduce emergency key provincial work guangzhou', 'industry small transfer virus wean epithelial raise requirement peptide rely antiviral infection cholesterol acute enhance resistance respiratory population variant line reproductive piglet cause 9 edit major biological viable 21 example outbreak etiological little viability 2 porcine animal wipe induce cd163 generate unclear lesion prrs-resistant adhesion protect apn-null metabolism assay necessity significant suckle 229e remain vomit multiple weight lethal crucial collectively determine technology somatic knockout valuable sads-cov diarrhea aminopeptidase-n america 1 alphacoronaviruses vivo mortality gastroenteritis normal villus covs agent tropism process intervention 5 prrs 20 antigen addition relevant improve wildtype study epidemic 14 role primarily far day dispensable recently economic subsequent produce affect apn 15 100 2010 whitworth unambiguously year membrane crispr/cas9 variety analysis exhibit cell apnnull 3 16 syndrome indicate widely tool pig 12,13 follow swine involve deltacoronavirus effective result host species neonatal regard potential hcov-229e infect perform disease great lead reemerge tissue lack devastate present scnt high 7 outcome cellular pedv yield detect experiment demonstrate nuclear mean curiously strain 19 significance vitro 17 typical confirm unresolved susceptibility morbidity virulent work challenge concern generation susceptible believe understand coronavirus 10,11 transmissible pregnancy emerge date control 6 include 10 uptake 18 require bind function clarify resource human model histopathological loss pdcov traditionally highlight highly global cd163-null dehydration resistant body previous eventually intestine immune available particular 2013 identify viral resolve rate 8 entry immunochemistry suggest good functional post-weaning target receptor breed conflict embryonic enteric watery asia provide tgev range consolidate', '', \"pan-coronavirus severe virus classify gccdc1 define swab acute positive-sense bat respiratory originate cross-species 2 emergence generate distinct single-stranded characteristic leschenaulti sample unique international event mrna likely enormous speciose orthoreovirus genome designate novel strike know committee inter-family similar gene middle heterologous biodiversity provisionally contain rectal plos analysis p10 2012 cell syndrome indicate sequence species 3'-end potential 2002 cellular-level ro-batcov homolog formation mammal criterium demonstrate sars-cov accord hku9 mers-cov pathogens syncytia coronavirus especially genomics next-generation east rt-pcr observation sufficiently taxonomy ictv order interest transmission identify rousettus phylogeny viruses functional recombination putative subgenomic induce integrate\", 'acid severe elisa smm v369 peptide structural acute respiratory y367 cause respectively 374 antigenic mutate protein 374-derived g368 cov t significant ifn-gamma production response sars-cov. directly possess a371 s358 spike lysine background novel mutant arb replace immunize facs know series h-2 tcr study k alanine c366 synthesize steric side-chain n50 electrostatic predicate splenocytes effect analysis furthermore cell unusual syndrome importance tool residue elispot s optimal disease surface d interaction bimas demonstrate sars-cov mean important impose obviously confirm single bioinformatics decrease ctl coronavirus dna emerge estimate aspartic bind exaggerate hydrophobic ann sars results disturbance evaluation cd8-t s370 mouse kd anchor predict s366 functional l374 affinity additionally t372 epitope good mutational k373 systematic interact induce infectious role', 'severe de antiviral acute envelope enrichment dactinomycin mercaptopurine rapid line respiratory discovery subnetwork emodin plus respectively conserve nucleotide repurposing protein hcov medicine capture region signature 2019-ncov sars-cov. network-based phylogenetic datum novo offer mortality genome hcov-host novel drug-gene shorten exposure network know 89.6 neighborhood study epidemic share cost hit separate far represent 2019 15 platform strategy 79.7 analysis validate cell repurposable 16 syndrome sequence effective identity time potential quantify pattern transcriptomics pharmacology-based lead melatonin exist sars-cov-2 proximity toremifene present prioritize high implement interaction interplay sars-cov nucleocapsid interactome reduce morbidity combination system coronavirus specifically evolutionarily summary include 96 anti-hcov hcov-induced integrative human hcovs identification drug currently complementary powerful candidate reveal methodology global compare identify sirolimus target protein-protein 2019-ncov/sars-cov-2', 'mainland find numb coronavirus travel benefit control outside estimate depend risk import include assess screen tool measure novel consider cumulative increase close develope china group ii time reproduction countries computational country major reduction outbreak policy baseline local evolution europe assessment case destination loc middle illustrate restriction beneficial far iii express high investigate efficacy select parameter entry r low dependence asia frequency importation connectivity area relatively grow reduce effect combination key america', 'virus research rely antiviral continued prevention rapid 89.2 cause preventive outbreak discuss animal kind characteristic origination symptom association treatment covid-19 relate response fatigue diarrhea practice affiliation care novel market long-term proportion hygiene explore diagnosis relevant quarantine scholar study studies primarily far high-quality initially current valid seafood review english analysis chinese short-and fever write surge symptomatic specific measure publication epidemiology increase way health clinical connection effective regard publish time cough information conclusions infect dyspnea contact majority methodological avoidance 67.7 manifestation public reported focus wuhan period reliable hemoptysis mask confirm reduce headache emergency list analyze early understand coronavirus date control article language include base hand page manage trace results detection case supportive domain transmission statement journal pneumonia 38.5 good finding prove provide reference', '', 'surveillance infection explosively enhance assess exponential particularly 21 outbreak month january 2 chaotic accurate decelerate datum build difference \\ufeff1 decision-maker initiate detectable background novel assumption consider intervention diagnose signal study epidemic similar 14 inform characterize far day derive encourage coordinative 2019 start 2020 february professional decline analysis indicate cumulatively increase health derivative effective result information conclusions disease immediately 4 apply nature public detect period timely clinician true methods early coronavirus gradually emerge control success 18 require model china massive general responsive results action nonlinear monitor highly limit detection case occur eventually close-population collaborative rate effort suggest appear finding method accelerate infectious', '', 'validate furthermore pubchem library evaluate coronavirus understand molecular antiviral direct-acting infection control approach main structural strong structure gain feature base altogether tool hiv-1 compound lopinavir protease 20 develop pharmacology active derivative effective chemical result associate saquinavir inhibitor silico group broad series outbreak reveal obtain lead block contribute sars-cov-2 previous site present deep cluster zinc www.zinc.docking.org viral treatment 2019 produce epidemiological ritonavir interaction relate based sars-cov serve target effect late optimize analysis hiv work activity', 'virus molecular structure strong machinery cleave document 43 leucine/methionine discovery develope nsp13 suspect example outbreak vast started according open remain multiple peninsula mild \\ufeff1 adult genome suffer direct consider 20 integral mutation substrate animal-to-human 55 address n3 hcov-oc43 middle far site p1 dominant typically 46 year renal cotranslationally nsp14 30 2012 replicase acceptor vaccine protease rational group mers 37 lead present enzyme patient investigate public substrate-recognition usually genomic strain coronavirinae subfamily recent camel 13 believe main essential 10 11 human insight drug frame reveal 33 identify available pneumonia rate hospitalize wide-spectrum target positive-strand 5′ distress 95 acid severe pp1ab find polyprotein rna causative inhibitor complex encode protein unfortunately animal 9,16,17 low treat 50 relate 48 pro determine mechanism diverse posttranslational failure mature 1 papain-like mortality young glutamine covs 1,3,4 different process comorbidity isolate nonstructural study similar transmit tract deadly comparatively start clock 42 contain variety exhibit 3d 16 syndrome indicate 822 arabian effective result frameshift consistent progress infect s commonly nsp5 coronaviridae read attractive histidine inhibition orf1 etiologic future demonstrate 19 bird significance relative atypical 3c-like pathological position 40 26 damage 2003 family quickly 800 envelop occur development 7-month-old eventually immune nl63 41 entry suggest polypeptide bovine death enteric role mutable classify pre-clinical reservoir structural coronaviruses bat respiratory population 25 conserve pp1a pocket cov conservative therapy symptom approve angiotensin-converting significant 38,39 illness therapeutics possible previously design 22 mosaic critical 50,51 share 14 betacoronavirus 49 ancestry 3cl strategy contrast amino sequence health clinical genus host identity substrate-binding hcov-229e disease alphacoronavirus circulate biochemical croup 4 high cellular mammal sars-cov alveolar ago 1,2 m numb coronavirus begin 34 6 employ identical include 18 primary dromedary china preference comparative 44,45 form ace2 highly sars-like cleavage global case viral face conjunctivitis late requirement antiviral infection bronchiolitis acute 37,53 consist cause 9 upper 2 emergence 47 degree interestingly region unique cold comparison ribosomal 5 recognize 563 architecture addition 48,49,52 know spectrum anti-cov p2 epidemic patients co-infected south suitable coronaviral potentially 15 nsps relatively component analysis homology similarity 2004 replication conservation 23 compound divergence potential plp 12 unchanged perspective zoonotic netherlands based proteolytic 12,18 consequence basis peptidomimetic hcov-nl63 wide mers-cov pharmaceutical system counterpart child hcov-hku1 probable hcovs east synthetic michael sars currently two-thirds crystal diffuse common ancestor transmission compromise 8 recombination vector infected receptor provide worldwide', 'calu-3 acid severe virus find epithelial magnitude approach infection acute change topological hour line respiratory expression modulate cause combining protein sa emergence genetically distinct point remodel kinetic response innate stat3 sars-cov. up-regulation adherens junction reminiscent failure 1 pro-inflammatory difference ifn designate novel different predicted know pathogenic signal relevant obtain computationally gene middle cytokine-stimulated mediate activation component key analysis homology cell-to-cell extracellular cell 3 amino syndrome feature filter follow clinical result host time potential mers conclusions infect perform transcriptomics il-1α 12 predominantly statistical late cluster zoonotic technique patient immunity airway strain atypical recent mers-cov post analyze early coronavirus emerge include genomics-based distinguish human east comparative responsive sars results highly compare immune progressive identify pneumonia viral persistence robust differential tnf suggest eng induce transcriptional reminder', 'protective coronavirus reform service novel health 300 diagnose possible china outline regard manage disorder major quote outbreak psychiatric discuss disease january mental supply lack far gear patient recently reason 2019 covid-19 caution professional challenge chinese insufficient', 'acid virus infection subunit conclude screen ability coronaviruses 25 conserve cross-species antigenic particularly protein cross-reactivity 2 porcine naturally s1 cov sample support low 229e non-feline fcov 2-specific possess diarrhea antiserum presence 1 spike \\ufeff1 ortholog covs consider recognize addition know diagnosis epidemic exclude delta evidence cd s1s cell amino indicate sequence epitope(s species identity potential hcov-229e infect feline type widespread pedv mammal bird map analyze positive react coronavirus observe 137 bind human serological pdcov experimental monitor seventy-eight engage common immunogenic serum domain development transmission entry antibody good epitope neutralization receptor cat fcovs total provide role level exclusively', 'fatality mainland research approach infection complete develope cause add outbreak unfortunately remove try characteristic phenomenon significant covid-19 calculate sir solution datum chernivtsi prediction background mathematical calculation spread previously know versus preliminary study epidemic expect obtain official dependency day lot parameter 2020 february question analysis count complicate up-to-date 12289 1989 equation 1988 value time infect conclusions optimal disease great statistical long-time come late present update high person patient public objective linear duration focus scientific area ukraine methods detail number susceptible numb coronavirus victim article estimate child 10 include simple require model china dynamic results case occur compare interest investigation identify available predict rate effort differential death exact', '', \"prior virus early alphacoronaviruses comparison coronavirus spike 1980 acute additional genome recover 3'utr novel sequence 1960 respiratory human acov full-length open-reading associate identity consistent spin origin hcov-229e isolate nucleotide entire frame hcov similar disease gene common 2007 ancestor exist occur zoonosis transmission anthroponosis alpaca identify decade suggest 229e demonstrate genomic nucleocapsid appear putative genetically 92.2 true\", 'severe virus molecular infection variability swab acute respiratory confirmatory rsv outbreak sensitive hcov 2 genetic cov symptom sample association percent significant reaction influenza-like pancoronavirus open-samples collect quantitative department mortality rhinovirus nl63-like possible sole hku1 diagnosis pathogenic study syncytial introduce hcov-oc43 contribute reverse negative feline-like represent transcriptase evidence 59 35 arkansas nasal 2010 analysis 17.5 multiprobe 3 16 syndrome importance aim follow epidemiology sequence health result potential hcov-229e twenty-three strain-specific seventy-nine circulate hcov-oc43-like 200 patient investigate parainfluenza conventional seventeen 39.5 pre-screened detect sars-cov subject strain qrt-pcr confirm morbidity analyze positive coronavirus underestimate and/or hcov-hku1 chain human (rt)-pcr 2003 rt-pcr impact highlight interspecies frequent monitor highly test transmission polymerase nl63 influenza differential method samples', 'severe classification virus practice understand coronavirus 3 environment csg establish syndrome acute spillover nomenclature assess enhance document bat respiratory recognize human develope result tentatively clade group form committee family preparedness major improve outbreak study epidemic disease animal taxonomy responsible coronaviridae present decade virus-host coronavirus-associated phylogeny viruses covid-19 interaction placement prototype international based ever-changing future corona- 19 2019-ncov significance sister taxon', 'severe fever standardize coronavirus operational infiltration syndrome infection acute feature include management respiratory clinical develope china breath cause cough rapidly lung diagnosis outbreak experience december disease 2 sars-cov-2 shortness statutory pneumonia treatment 2019 sars-cov-2-related inflammatory infectious peking list recommendation', 'acid severe virus find surveillance predictive cross usual infection non-human-origin fast g-gap bat respiratory close database matthews origin maximum encode protein sample seven capture term jan correlation scale correlation-based 229e collect composition train spike prediction achieve risk genome background novel data mutation hku1 ii explore curve study ggap continuously large-scale 2666 negative 98.18 far barrier 10-fold coefficient couple 2019 humanorigin 2020 big g key 29 pc-pseaac 3 amino syndrome aac feature sequence convert health result species regard angiotensin potential information conclusions infect perform pattern field optimal exist sars-cov-2 circulate random enzyme nature cluster propose national warn public sars-cov pseudo-amino-acid gap smooth relative methods challenge mers-cov early positive evaluate coronavirus genomics 0.9638 simple cross-validation human resource model china center parallel distance results dynamic mcc clear acc forest 507 oc43 beneficial manner identify predict evolutionary nl63 41 dipeptide suggest 2159 good algorithm performance method 2019ncovr receptor total multidimensional', 'hcov-specific virus molecular variation infection acute coronaviruses respiratory cause 9 hcov december kenyan january distribution contemporaneous phylogenetic circulation illness presence 8.4 1 molecularly yearly retrospectively \\ufeff1 background diagnose know isolate study 2.4 obtain hcov-oc43 gene nasopharyngeal 2009 characterize hospitalization amplification evidence partial purify 35 analysis homology 2012 cell selection monolayer play individual subsequently follow sequence species identity group time hcov-229e information conclusions pattern ll-cmk2 evolution 12 hcov-positive considerable circulate 4 inoculate sars-hcov. high immunity kenya display primer strain pol important confirm morbidity methods hcov-nl63 specimen mers-cov 2.1 analyze positive especially child hcov-hku1 10 paper real 2.9 human hcovs rt-pcr results prevalence limit global common responsible 417 evolutionary polymerase compromise age prototype characterization total role comprise', 'classify approach acute opacity bat respiratory rna close database develope nucleotide outbreak december link animal bat-sl-covzc45 cov sample n 29,881 huanan multiple 2019-ncov likely phylogenetic bronchoalveolar btcov/ genome novel covs market sole abundance balf 1.5 rapidly lung share orf1a/1b introduce lavage gene prjna601736 patchy independently independent 2019 seafood low-input organization partial analysis fever infiltration unusual syndrome indicate genbank feature length rdrp sequence accession health clinical genus 4991 identity cough s field contact sell circulate lack read fluid 0.62 high patient investigate bilateral accord wuhan strain bat-sl-covzxc21 history ground-glass 370 coronavirus include base β-coronavirus next-generation metagenomic human extract mn988669 highlight entire archive world mn988668 case announcement common bioproject kp876546 mngs exotic horseshoe identify 87.9 pneumonia evolutionary viral suggest good 98.7 live rhinolophus total level', '', 'severe virus reservoir research infection structural acute envelope natural summarize respiratory expression cause country encode major knowledge protein 1a term open n unique re-emerge kb spike mortality \\ufeff1 genome novel spread process ~10 ii know study 14 2903 subsequent affect current review contain effect membrane ultimately 2004 30 2012 e syndrome replicase individual length result infect 2002 s accessory disease 4 read iii cellular nucleocapsid sars-cov human-to-human m coronavirus control isolation continue include china 1b orfs frame homologous eventually transmission identify predict functional rate viruses efficient homologue late worldwide april', 'mers-cov severe illness generation monoclonal find therapeutics coronavirus exhibit antibody-peptide peptide antiviral mortality syndrome single-chain antibody-based acute normal m336 control infection construct novel designate respiratory hr2p clinical previously human develope effective east engineer cause potential antigen-recognizing knowledge potent s protein describe pseudotyped inhibitory anti-mers-cov link case middle domain cell-cell combine high protein-mediated year functional effort antibody bispecific suggest fusion element multi-specific tremendous igg1 ch3 contain diabody-pep immunotherapeutic single recent fully activity', 'pathogenesis virus understand coronavirus offer antiviral benefit newly syndrome control genomics specific novel intervention epidemiology agent respiratory possible clinical develope host cause drug describe priority discuss disease world pandemic exist sars-cov-2 neutralize development immune identify high nabs treatment effort antibody 2019 current consideration re-emergence future response sars-cov review focus greatly important pneumonia-associated sars-cov. remain implication option provide therapeutic homology challenge', 'fragment perforate virus classify reservoir artibeus infection relationship natural united ability ~30 change vicinity bat north respiratory expression rna intrinsic origin 9 cause emirates setting country largely nucleotide 21 peptidase outbreak 4,5 2 emergence restriction intestinal arabia sample support transiently relate innate distribution peninsula replicate light shed circulation america tomb failure 1 confine spike roost closely care korea novel internal 20 addition isolate lung obtain south gene middle tract numerous northern day moderate transient egyptian initially efficiently index evidence travel-related saudi kuwait 100 jordan renal kingdom variety analysis dependent 2012 cell eastern sign 3 taphozous syndrome indicate africa rdrp measure sequence health clinical dpp4 arabian result host ancestral hypothesis group potential species 3,4 jamaicensis majority 190 1600 disease europe considerable lack 4 inoculate eurasia c fecal zoonotic widespread patient investigate cellular belong maintain detect focus 19 mers-cov. qrt-pcr vitro mers-cov-specific jamaican single betacoronaviruses recent camel dipeptidyl chiroptera mers-cov induction intermediate mers-cov-like coronavirus 6 control isolation import glycoprotein 10 organ observe fatal case-fatality human appropriate dromedary investigations bisha east histopathological 27 host-virus general highlight oman americas fruit limit detection case qatar match lesser order identify polymerase pneumonia rate effort suggest extent antibody arab receptor interact expend asia role level', 'mers-cov emc 2012 severe failure find 34 coronavirus furthermore molecular indirect syndrome infection date acute immunofluorescence genome include suffer paper complete novel sequence respiratory discovery human hcov-emc develope result east retrospective y w geng study limit characterisation detection advance case middle present ongoing investigation culturable identify initially available patient assay recently subsequent epidemiological renal 61 laboratory-confirmed summarise genomic tan h j. death rename recent', '', '', 'number concern government coronavirus city travel infection \\ufeff1 mandatory pose break novel measure kit service increase spread health alleviate society continuous multi-sectoral effective china trace challenges information major series definitely drug quarantine action contact epidemic world detection etc case hospital supply pandemic lack development governance logistic support national guidance effort restrict covid-19 public solidarity international end wuhan medical 2019-ncov municipal death body central provincial insufficient', 'understand coronavirus benefit control effectiveness measure novel health china lesson economy bold 2003 complex sars impact improve outbreak epidemic similar global attempt cost link reputation threaten science implement politic national unprecedented suggest successful public international response remain demonstrate event future outbreakwe question consequence balance', 'severe system repair find validate inhibit infection additional vaccine microenvironment specific intervention overactivation endogenous strike lung particularly drug currently improve cohort study msc afflict sars-cov-2 therapy far immune available pneumonia patient treat covid-19 promote therapeutic challenge', 'severe percentage march d-dimer radiologic 16th male laboratory protein december january hospital neutrophil characteristic sample abnormal lymphocyte low district relate multiple datum 0.05 2th platelet p background novel spread rapidly study creatinine composite alanine 2019 2020 higher february analyse 60 year dehydrogenase activity count endpoint leukocyte old cases xinzhou c-reactive aminotransferase outcomes follow clinical value condition great α high blood patient laboratory-confirmed future mean wuhan aspartate creatine confirm 25th retrospective methods coronavirus city emerge lactate factor extract china 40 rt-pcr results -hydroxybutyrate kinase temperature world case conclusion pneumonia age real-time finding seek total level 95', 'stage research install pose assess tendency knowledge outbreak staff transportation crisis logistic facility significant treat covid-19 medical tremendous determine quantitative solution recommendation real-world datum improperly risk effectiveness management novel spread design network rapidly study epidemic obtain reverse far integer 2019 current program strategy analysis application selection establish temporary importance aim increase effective result time information location policy disease lead limitation illustrate multi-objective present waste propose high patient experiment future focus period wuhan conduct uncertainty system coronavirus control base paper human incinerator multi-period model china manage exponentially general computational insight global vital case order available suggest short deal mix accelerate', 'virus surveillance protection authority origin laboratory country suspect outbreak little 10th 9.6 hospital according 3444 383 2019-ncov 1 mortality \\ufeff1 genome management alternative spread diagnose recognize network 909 improve 2019-ncov. 34.4 2019 current 2020 february strategy chinese cure province feature epidemiology 2.3 clinical 24 mers information phenomina medication intercity status present ongoing epidemiological hubei wuhan comprehensive confirm understand coronavirus think urgent control isolation fatal require china announce family sars block person-to-person case home occur 40,261 compare transmission identify pneumonia week efficient end accelerate death 23,589 provide worldwide', 'virus structure additional document reflect rna expression 1960s pathogenicity nucleotide encode protein gc abundant mrnas n low production discover mrna codon blot composition presence datum genome background transcription 5 inspection know study sg hcov-oc43 gene northern spring easily extremely u coronaviral significantly strategy c-count analysis pathogenesis furthermore cell e indicate replication member tool follow sequence increase discontinuous synthesis hcov-229e infect perform s leader pattern evolution usage 4 coronaviridae present c high differ detect nucleocapsid sars-cov content confirm m strand 1a-1b-s-orf3-e-m-n. hcov-nl63 culture overall generation early 34 coronavirus expense employ code identical g. human identification 2003 family insight sars experimental describe powerful one-third orf3 order compare viral end mutational subgenomic grow level', 'severe virus find molecular structure acute comprehensively natural jeddah indicator bat respiratory cause cross-species outbreak protein survey emergence characteristic arabia low relate determine codon mechanism human/camel illness lineage mortality \\ufeff1 examine genome break transcription different 5 mutation isolate study contribute gene saudi analyse significantly selective endemic 2012 www.impactjournals.com/oncotarget/ selection gain replication 2015 increase result host species time mers pattern evolution lead pressure usage 4 nature high zoonotic epidemiological future content important strain mers-cov. hedgehog camel g+c mers-cov influence understand coronavirus 6 main observe include require factor function human insight recombinant co-circulated previous transmission bias hcov-229e-related rate extent additionally recombination mutational nidovirales secondary', 'globe severe industry virus small classify reservoir die-off applied swab clean acute manufacturer additional direction assess complete united coronaviruses change bat polyprotein respiratory rna arctic pfam cause 9 31 add v protein 1a biomatters canada states members 2 porcine genetic animal gammacornavirus gammacoronavirus biosystems generate 28 rambo-k seven region international presumptive multiple remain discover tm ibv bigdye ampure 65 3130xl directly diarrhea amplicons 98 tcov kb 1 comparison gcov \\ufeff1 minute dolphin genome near quality 72 novel mass bay process spread 5 recognize 20 previously coulter geneious xp cetacean committee sw1 cycle epidemic beluga greylag trim mk359255 ° gene primarily abi cygnoides 2009 betacoronavirus poultry indo-pacific derive 2.5 partial 15 cgcov sanger platform relatively ngs analysis contrast align 29 30 spades 3 1ab analyzer snow cambridge syndrome expire feature whale filter sequence acovs sequencing accession user assemble genus acov duplication deltacoronavirus host species amplicon beckman perish draft relatedness infect accessory norway perform 12 trimmamatic alphacoronavirus 4 coronaviridae present read c manual second 7 sense belong vastly detect v3.1 nucleocapsid sars-cov demonstrate important accord proteolytic bird cloacal ncbi single strand recent bioinformatics work bronchitis positive believe numb coronavirus terminator 0.36 version 6 include enteritis 10 distinguish 11 kit human turkey approximately annotations tentatively 40 anser 26 27 family tcov. impact orfs expand currently describe taxonomy ictv dcov domain avian identify available viruses 8 despite suggest nunavut domestic bottlenose goose bead remote fastqc infectious 9.1.8 95', 'severe virus wildlife research concentrate infection acute natural succeed bat respiratory cause dry major occurrence discuss 2 environmental origination initial validation region low unique relate cold fashion season achieve break covs different spread mysterious epidemic convenient celebrate contribute start existence year trajectory pathogenesis utilize conducive syndrome harsh survival epidemiology increase scenario host invade time prolong pattern condition disease sars-cov-2 winter nature enzyme progression widespread consumption receptor-angiotensin-converting gather sars-cov bat-carried holiday social wuhan (ace2)-for dietary defense 17 vulnerable easy influence coronavirus -released travel sars-covs factor human china general sars temperature occur origin(s body order noticeable viral promote final provide humidity', 'severe system find numb coronavirus especially syndrome \\ufeff1 acute paper tool novel 96 kit confront different increase respiratory health previously china vary authority publish cause trace pcr rt-pcr germany laboratory commercial perform announce country rapidly outbreak describe experience contact december europe one-step 2 case sars-cov-2 arise compare establishment investigation travel-associated assay implement probe 2019 good public real-time diagnostic performance end primer wuhan timely cycler bio-rad cfx', 'consolidation co-exist find opacity change close 25 follow-up 66 localize multifocal node 47 lesion significant covid-19 61 multiple absorb 76 20 diagnose grind lung hydrothorax day enlarge 73 patchy complications effusion 3.5 peripheral 15 100 91 46 fever 109 play lymph clinical involve time cough mediastinal pattern contact examination present progression patient image manifestation bilateral chest detect hubei important wuhan period lobe history observe include ct 83 27 pericardial thicken rare highly quickly case average pleural identify suspicious 41 short live glass mix total role', 'category severe virus surveillance acute respiratory b. hcov creative hbov 2 commons term open assay cite medium reaction properly distribution bocavirus collect illness hospitalise 1 rhinovirus karolinska transcription routinely 680 study syncytial university hpyv hcov-oc43 reverse south tract agedefined polyomaviruses hpyv-wu 2012 3 insitute africa reproduction hcov-229e permit original sari enterovirus attribution type access patient investigate enroll select parainfluenza detect washington adenovirus hcov-nl63 specimen african work coronavirus article hcov-hku1 include chain metapneumovirus human prevalence hpyv-ki test multiplex polymerase 2013 influenza randomly real-time provide', 'virus elisa immunofluorescence hcov-nl63-related screen assess 0.509 develope 25 originate major animal sample assay n significant likely collect confirmation 1 comparison difference p possible 5 proportion know study hcov-oc43 u 42 significantly f 215 0.001 indicate probability reactive aim 27.50 increase density throughput value known host species 84 hcov-229e 0.437 high mean livestock hcov-nl63 coronavirus-characterized believe intermediate positive coronavirus ghanaian distinguish human recombinant highly hcov-nl63-negative immunofluorescence-classified optical hcov-nl63-positive test serum evaluation transmission 8) optimization antibody capability algorithm domestic 55.50 role', 'percentage find size prevention gradient high-risk cumulative origin obvious rise reduction 66 outbreak surround survey characteristic reside region scale district distribution 2019-ncov rural provincial datum household middle-aged correlate novel different 5 migrants proportion echelon rapidly registration epidemic 2018 west 2019 community layer migration analysis 30 furthermore conducive 3 province million return member daily individual increase 71 result 75 84 situation 80 4 centre spatial exceed hometown hubei nuclear social wuhan confirm cmds decrease work 94 numb coronavirus city gradually control estimate main underestimate include 85 approximately china east business family dynamic account framework monitor prefectural-level highly case compare 2013 reason migrant circle end total county level comprise quasi-experimental', '', 'increasingly infection prevention 84,520 respectively happen 70,258 occurrence outbreak december 2 generate t phase covid-19 seir valuable divide drop 1 0.5 \\ufeff1 prediction sufficiency novel assumption intervention assume 11,044 different phasis ideal epidemic continuously strict 227,989 reach index r 2019 current 1.9 2020 indication february effect owe peak 58,077 29 province measure increase health 81,393 group 0 location disease late apply cluster high implement estimation maintain public 0.9 hubei important wuhan 55,869 regardless reduce decrease susceptible early numb coronavirus evaluate gradually date control estimate 2.6 continue necessary 3.1 model china exposed dynamic currently removed case occur order transmission pneumonia viral implementation trend 2019-ncov/sars-cov-2 infectious level', 'acid severe virus approach arachidonic infection comprehensively respiratory modulate la associate pathogenicity fas conserve flu-like symptom metabolism interestingly remodel poor 229e multiple remain response propagation axis elevate lipids diverse datum aa lipidomics perturb chromatography-mass pathogenic infections cycle markedly study middle numerous characterize hcov-229e-infected far regulation step effect significantly utilize cell linoleic syndrome exogenous replication play lipid involve clinical extrapulmonary taken result host hcov-229e outcome cellular manifestation demonstrate indispensable glycerophospholipids ultra-high (uplc-ms)-based human-pathogenic mers-cov coronavirus spectrometry druggable function human self-limit model liquid east inhibitory reveal fatty highly common supplement suppress pneumonia suggest importantly end performance target metabolic range', 'fatality severe virus antiviral infection inoculation acute gs-5734 respiratory reduction emergence animal therapy lesion support treatment h prior presence datum initiate novel stress consider lung 2019-ncov. middle macaque prophylactic prevent sign syndrome primate replication availability remdesivir (sars)-cov context clinical 24 completely effective severity mers disease 12 tissue strongly present high formation efficacy trial vitro reduce therapeutic wide decrease mers-cov coronavirus benefit inhibit emerge continue include model east currently clear case mers-cov−induced test rhesus mouse rate nonhuman effectively range provide postinoculation', 'severe virus opportunity cross antiviral infection acute summarize respiratory discovery origin pathogenicity largely outbreak discuss storm 2 animal virus-host covid-19 international determine mild shed usurpation presymptomatic comparison committee pathogenic middle moderate barrier 2019 current organization review question cell proinflammatory syndrome adaptation health clinical relation host species progress infect disease lead transmissibility track sars-cov-2 present ongoing zoonotic outcome manifestation interaction public interplay sars-cov important defense cytokine declare history emergency wide concern induction understand coronavirus article defence include human east programme highly world case taxonomy immunodeficiency asymptomatic pneumonia viruses real-time community-acquired death range provide distress', '', 'virus molecular surveillance variation march infection swab acute 4.3 year-to-year 981 respiratory 0.03 associate respectively excellent rsv 21 1.6 month little hcov upper hbov etiology low relate 229e 48 bocavirus collect presence 1 2009/10 rhinovirus adult methodology/principal p background 2011 recognize addition 157 non-sars hku1 study syncytial co-infected tract nasopharyngeal 2009 characterize frequency 42 february 35 60 significantly year co-infection chinese 16 piv p,0.001 newly 157(30.57 clinical 24 species hcov-229e circulate 4 urti high patient parainfluenza detect specimen positive coronavirus undifferentiated findings 2010/11 11 96 metapneumovirus human 1.1 hcovs rt-pcr sars impact 9.8 detection case oc43 common test 16.0 0.003 identify sensitivity nl63 rate influenza flu age real-time hmpv systematically', 'draw past virus infection curb rapid respiratory witness cause country outbreak little january 2 cautiously colleague transparency initial slow international relate border globally crucial response thoroughly re-emerge thailand illness datum 1 misidentification \\ufeff1 genome virologist spread 5 alert japan 22 mysterious share lose represent recently step community organization distantly virology chinese applaud 3 claim newly 2015 individual attention sequence increase health scientist identity understandable zika infect situation disease learn 4 type perspective high 7 place investigate public sars-cov important wuhan human-to-human recent believe numb coronavirus emerge 6 thousand include continue china release 2003 2014 sars clear world case transmission viruses 8 consideration coverup ebola lessons live chikungunya neighbor', '', 'virus environment respond de sulfate infection change line population rna emergent associate 38,0006(illumina nucleotide passaged simulate genetic distinct deep sample support point passage region event multiple diverse presence datum kb novo spike host-switching insert genome in-host different pre-exist mutation lung lab-adapted gene characterize genotype efficiently shift subsequent pool adapt frequency fusion nasal relatively non allow selective year analysis cell indicate unpassaged residue sequence host diversity hypothesis potential arginine infect array pressure 12 exist circulate present type high place select quasispecies demonstrate genomic coverage strain macrophage 9506(454 single enable coronavirus nearly code position include consensus bind human approximately fixation sars heparin rare reveal quickly average occur reproduce identify viral rate entry good dominate bovine amplify level', 'severe find respond infection acute complete life-threatening respiratory expression cause mononuclear lactoferrin 2 mainly express open treatment response poorly innate microarray determine realtime differentially datum s100a9 \\ufeff1 verify background 186 novel pbmcs design pcr lipocalin study epidemic possibility gene comparatively derive affect inflammatory peripheral february analysis immune-pathogenesis cell trigger syndrome specific filter healthy result host time array disease lack strongly blood investigate patient criterium usually cytokine system understand coronavirus numb emerge control code observe profile 2003 form sars results highly diagnostics compare immune viral differential suggest real-time stringent method up-regulated late', 'illness fatality 2012 failure virus coronavirus 3 travel transmissible 6 \\ufeff1 emerge acute member danger real individual resident novel sequence spread summarize respiratory clinical mid-february genus human september die result east cause 9 family isolate rapidly outbreak reveal highly sars-coronavirus 12 world case middle arabia cluster exactly patient 2013 index pakistan presentation suggest evidence current brief saudi laboratory-confirmed uk sars-cov 8000 review event picture sars-cov. ago recent history year provide renal reminiscent analysis', 'acid virus find orf1ab reservoir elucidate structural pathway bat respiratory ty-batcov compared protein peptidase animal cov sample support unique region amurensis relate ea-hedcov neocov phylogenetic tylonycteris collect possess receptor-binding spike closely genome novel covs different merbecovirus germany warrant critical non-structural epidemic middle represent site erinaceus/vmc/deu/2012 evidence analysis amino syndrome member batcov residue sequence species identity interphase mers evolution 12 amur arise 4 mers-cov-related mammal important unlikely hedgehog hku31-rbd-hdpp4 european dipeptidyl african immediate mers-cov understand coronavirus source bind dromedary human model china east betacov interspecies cleavage hku31 domain compare transmission hku31-rbd hdpp4 investigation identify predict erinaceus suggest hku4 good recombination finding putative 79.6 receptor rbd', '', 'datum favor changes receptor-binding magnitude spike approach million subunit spillover observe rapid aim change sequence spread bind function human result host species cause silico reduction perform ace2 protein study epidemic disease ligand world s1 sars-cov-2 domain compare present ongoing transmission high zoonotic viral rate affinity suggest affect covid-19 significant interaction detect event produce mutation(s energy promote receptor determine spike/ace2 consequence morbidity/mortality effect recent bat-cov', 'severe fatality obstetrical external stage research life infection acute natural assess special respiratory population aerosol cause pathogenicity country experience december unfortunately 2 maternal approve seven funding term treatment poor low significant multiple discover medical 2019-ncov virulence nosocomial thailand prior datum 1 mortality threat novel spread given 5 design japan infant rapidly address epidemic expect similar obstetric hcov-oc43 middle tract betacoronavirus initially fetal reach 2019 produce current 2020 affect fund immunopathology review continent effect 16 newly million syndrome replication feature vaccine adjacent specific subsequently health clinical woman genus result species neonatal publish potential mers hcov-229e infect majority 12 alphacoronavirus republic sars-cov-2 present cluster zoonotic person outcome belong epidemiological public scramble future sars-cov wuhan trial 1,2 pregnant 194 anticipate receive human-to-human declare morbidity hcov-nl63 mers-cov early understand city coronavirus travel pregnancy 6 estimate hcov-hku1 include 11 certain factor human approximately china communication east loss sars dynamic currently reveal limit researcher case common recommendations occur order eventually extend transmission constitute investigation progressive interest identify pneumonia air viral viruses rate implementation reasonable consideration appear finding conflict death total', 'virus-positive presence pharyngeal virus analyze severe 34 coronavirus stage retrospectively infection swab 6 indicate strong article p-value detectable readily altogether novel 11 ct clinical rna 24 value result concentration cause progress pcr 57 severity 0.0001 39 anal cohort unexpectedly disease 2 lab tract 28 serum site symptom high blood pneumonia patient viral correlation 8 annal suggest importantly real-time detect extra-pulmonary 2019-ncov 2109-ncov confirm history replicate digestive', 'fatality basic severe find infection evolve sidr cumulative population � suspect outbreak calibrate note december 10th january 2 mainly fact forecast actual low significant covid-19 evoke subset mild datum mortality \\ufeff1 simulation consider calculation recovery 909 flash confidence quarantine 180,000 expect disease-2019 official attempt susceptible-infectious-recovered-dead 11th contribute far day hospitalization reach parameter r 2019 2020 45,000 february sird repeat 1st decline plos analysis 29 count province 40,235 recover 2,700 internationally individual measure epicenter scenario 18th course fear value time reproduction infect 0 evolution unchanged exceed high estimation epidemiological ahead hubei based caution wuhan period toll confirm interval basis number numb coronavirus locally especially presently control estimate main leave 2.6 10 base 11 unfold 3.2 bind factor model china 26 https://doi ratio reveal 4.6 case average 90 publicly compute available particular asymptomatic week rate suggest death total provide', 'severe instead acute defensins change respiratory expression generalize associate cause immunopathological little predominate 9.6 52 afflict signature international innate discover sars-cov. mortality discriminate normal background novel spread non-sars know epidemic eosinophil-derived gene upregulated organization peripheral rank sars-infected syndrome recover health involve host severity pattern disease suppression july genome-wide cluster blood patient immunity attack based sars-cov accord gap smooth recent coronavirus travel control neurotoxin 8,437 employ include profile human damage 2003 general sars account results plot quickly world transition accurately identify rate method total asia worldwide distress', 'watching past datum comparison operational busy respond assist stakeholder news \\ufeff1 acute include background feature rapid complete source literature follow analytic health resource intend topical manage information relevant field traditional outbreak unlike obtain briefs digest interest investigation open responder current public response review feedback provide key', 'dataset fatality small virus define approach infection additional high-risk cumulative population division authority laboratory tend little sensitive cope actual abovementioned covid-19 obstacle mild window illness practice adult young risk care comorbidity diagnose proportion onset appropriately address epidemic represent individual measure health involve time severity elderly infect majority disease mildly delay ongoing second high technical seasonal epidemiological uncertainty understand numb estimate underestimate observe underlie require problem substantial general ascertainment detection case common test occur bias identify asymptomatic influenza short diagnostic death', 'https://www.imperial.ac.uk/media/ team mortality attract control examine paper attention coarse intervention ferguson 03 way spread college context model explore impact discuss contribute taxonomy manuscript healthcare imperial-college/medicine/sph/ide/gida-fellowships/imperial-college-covid19-npi-modelling-16 npis modeler demand covid-19 2020 non-pharmaceutical response 2020.pdf mitigate significance imperial reduce recent analysis london', '', 'respiratory severe mammal systemic host cause infection man avian well-known enteric range include coronaviruses wide fish', 'virus raise sulfate infection swab beijing size respiratory expression e. conserve antigenic protein cross-reactivity express n antigenicity rnp blot antiserum datum different anti-sera hku1 isolate study obtain sds-page crcov-bj202 gene characterize far np efficiently derive clone purify rnps relatively distinctly analysis subgroup dog chromatography indicate nps sequence electrophoresis sequencing serologic polyacrylamide pet result column group hcov-229e crcov diseased interface belong purity nucleocapsid escherichia sodium coronavirus ccov-bj70 successfully summary exclusion human ccov china gel cross-react recombinant dodecyl reveal coli oc43 nickel-affinity canine animal-human mouse western nl63 finding final citation 95', 'molecular structure epclusa clin cleave united molecule modulate analogue dual develope lindquist asn28 dock cheng states accuracy 4568 medicine initial kim cite treatment catalyze enzymatic cj fatigue namasivayam 525 kuo rey library hu trott chen calculation 20 free mutation substrate subsite olson manickam lee middle aj site u purchasable ritonavir 2010 res 40(3 g mf plos muramatsu binding old 3 256 pymol protease chemotherapy chembioeng 24 hsu garner 324 lead ph xu l enzyme maturation syndrome-coronavirus wu 408 280(35 krivov headache server 12(4 13 yw proteins main 10 11 bind human steinkellner https://doi schrödinger 2014 insight dynamic drug x reveal 4574 residues 43(15 polymerase predict score efficient consideration thorax target gabelli characterization 143(4 cy level severe pp1ab ledipasvir/sofosbuvir find text autoprocessing sh screen jr 4308 web opinion polyprotein penultimate inhibitor 58(8 nucleotide 21 repurposing takemoto protein a. mr chem cooperative 28 n 867 clinically virtual pro theor mechanism malaisree hart 1 prediction different process cooperativity improve study similar confer word side-chain 132 review 100 77(4 118 16 e syndrome psychotic 2015 f1000research effective progress s sci kt infect wang chu 12997 commonly sars-cov-2 pubmed dimer sc d attractive propose ledipasvir 7 bellamy ml inhibition scwrl4 49(20 yap js wuhan 19 specificity 2005 stability 13002 3c-like hiv 2000 31(2 article source base debolt 389 abstract 26 27 multithreading y potent candidate inhibitory dyall development previous 43(w1 dayer kumara 86 optimization 4317 huang 461 proteinase overview 388 reference role 3clpro 113(46 structural pillaiyar change lj respiratory antimicrob 25 publisher lagorce vina conserve 31266 particularly v chang prepare vc approve fan graphic 2019-ncov 2521 therapeutics autodock ms simulation cm z ortholog novel 252 nelfinavir yl liu 22 coleman three-dimensional 14 k barrila aka 14916 wei zhang richardson r 2019 biochemistry biochem 3cl biol adjacent specific lopinavir sequence clinical natl identity interface disease 129 nucleic mtiopenscreen 4 536 4885 high gg o e13823 interaction holshue proc sars-cov gruber mj med m arch 455 coronavirus dimerization 45(50 18 integrative function velpatasvir model 2517 disrupt 2008 highly cleavage chemother case hydrolysis viral jm catalysis 59(14 screening small lopinavir/ritonavir virological antiviral approach infection stoermer acute bioorg velpatasvir/sofosbuvir ma ju dimerisation rl catalytic llc 9 cause 2 14908 t jan minimal mv covid-19 vs engl sars-cov. reviews 2017 hung 59(3 comparison conformation w448-w454 e343 795 rotamer p xj 31257 jt 5 2006 improved know 2009 shapovalov acids combine structure-based coronaviral xw stockman 2020 peptidomimetics long-range 6595 15 bj 334 effect owe virology analysis homology activity 2004 peng 29 taleb-gassabi lovell 4893 23 freire shi compound residue involve chemrxiv acad potential c-terminal 2016 perform 12 c 12(10 bacha based dunbrack j 17 conformational liang bioinformatics comput -what counterpart system parasite 254(4 version li yt http://www.doi.org/10.17605/osf.io/hcu8x 96 combat dis near-identical east general sars action 861 crystal sb nukoolkarn 3(9 6628 labbé agents 8 harvoni energy finding 778 systematic', 'acid severe virus find excess reservoir research cfr infection outside acute united bat wet refer respiratory alarm stick line mid-december protection associate cause origin 31 respectively country nucleotide dock representation mutate protein experience note december states little ralph january 4,500 link magenta animal s1 cov 28 generate symptom hong initial region relate multiple event 2019-ncov seemingly 14(1):3 illness datum 1 offer \\ufeff1 kong novel label market 1.5 vary know pcr isolate critical epidemic hydrogen aid black protocol hospitalization 2019 travel-related current 2020 step 100 dev dash contain question worker homology similarity 3 province gain amino syndrome sars-rbd vaccine casefatality colour ctries residue health clinical involve leu472 result species commission silico prevelant severity respective infect green contact grey original 80 present cluster asn479 perspective zoonotic high patient place bond interaction 105 laboratory-confirmed sars-cov wuhan specificity j confirm 17 human-to-human atypical therapeutic taiwan concern mers-cov generation spike-receptor intermediate numb city begin coronavirus comparable emerge child estimate emphasis source include chain -2019-ncov bind approximately china model humanto-human form insight ace2 domestically currently rare wiv1-cov case development cyan transmission https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus healthcare pneumonia resolve rate red good efficient thr487 diagnostic appear provinence death particular rbd level', '', 'outside 5and additional 141 change cumulative 81 short-term generalize phenomenological particularly outbreak upper generate logistic slow forecast covid-19 65 datum government prediction best-case wave near different spread previously epidemic far limited growth current 2020 february forecasts chinese validate province complicate 23 daily measure health epicenter scenario commission potential 10-day disease ongoing implement national epidemiological ahead social recent 13 understand definition specifically continue include 354 richards 44 guangdong model china distance impact bound zhejiang 507 case transmission 169 available predict 875 despite suggest extinction sustain sub-epidemic infectious', '', '', 'conclusively 29 datum percentage virus characteristics coronavirus virological approach emerge estimate probability risk continue causation assess real observe specific novel 5 previously routinely drive china identification result cause time know 31 rule laboratory oppose consistent outbreak non-virological x december disease january aid assessment advance case test descriptive etiology characteristic site compare ongoing update propose express pneumonia week medium available infer 2019 current 2020 quantitatively demonstrate social wuhan medical 49 collect determine atypical', 'susceptible quick machine web spread possible population identification mobile improve survey learn case propose covid-19 algorithm phone-based reduce', 'non-deferrable italian sicut conscious sico mortality paramount ensure infection acute underline care minimize importance pathway ability sice aim siaarti sifipac require society function human resource sector preserving clinical result surgical group workforce major recommend financial mindful describe anesthesiologic surgeon hospital pandemic detrimental collaboration manuscript covid-19-positive healthcare organize protocol high patient specialize rate sic effort face current covid-19 dedicate important professional manpower utilization sicg train acoi', 'severe basic virus early sign furthermore coronavirus stage reservoir intermediate syndrome emerge coronavirus-2 acute pathway natural designate novel pangolins bat summarize respiratory possible wait host cause origin know potential briefly infect knowledge highlight currently outbreak little evolution chemotherapeutic advance sars-cov-2 occur development characteristic far symptom ongoing transmission investigation pneumonia patient recently good current event review option finally role key', 'side-effect concern criterion datum trigger oncology emerge self-isolate acute chemotherapy context possible line anticancer publish onset advice knowledge currently contact experience purpose note expert similar disease strengthen inform case test therapy order interest symptom anosmia immune support patient treatment ageusia evidence covid-19 suggest whilst summarise systemic cancer rhinology act existence receive clinician particular', 'severe march infection united country particularly outbreak myeloma intensive treatment covid-19 multiple medical illness nigeria mortality ensure \\ufeff1 care risk service novel intervention 36 record attempt evidence 2020 platform professional strategy kingdom activity write discharge unit 23 return follow chemotherapy way health completely effective result time group condition provision pandemic exist state man centre type letter high blood patient interaction practicable receive confirm reduce history vulnerable governmentapproved oncology isolation include ground china outline disrupt physical limit global case home undergo oncologist digital transmission chronic lagos week 67-year-old suggest good monday cancer admission surgery death', 'severe raise infection acute gel01 respiratory gel01-adjuvanted develope cause outbreak protein local link 2 pa intestinal protect product response rbd-linker-pa2 rbd-pa3 illness receptor-binding therapeutics lysin rbd-linker-pa3 motif gram-positive different matrix design substrate immunize promise study middle tract particle prophylactic systemic fusion humoral repeat activity 2012 prevent 3 syndrome indicate lactis)-like vaccine specific rp linker increase externally enhancer fear result potential mucosal cellular public display lactococcus number mers-cov rlp coronavirus especially control fatal include bind human model east -gem adjuvant bacterium blp candidate lysm test domain development immune mouse anchor urgently intranasally gem rbd worldwide', 'department coronavirus especially research define version article comment risk combined feature base screen rapid simple novel ct primary commentary clinical close exposure advice proposal diagnosis infect suspect contact auxiliary experience out-patient introduce military case test examination symptom strongly title perspective pneumonia blood suspicious patient treatment image 2019 score epidemiological guideline additionally routine standard medical 2019-ncov confirm recommend', 'concern severe virus coronavirus province mortality syndrome acute rapid spread respiratory china cause answer potential biology family highlight knowledge month outbreak epidemic world 2 transmissibility emergence sars-cov-2 state 2019 significant current demonstrate hubei question late recent morbidity', 'increasingly virus safe stakeholder adequately adoption enhance multi-lateral democratize 9 nationalist country supplier outbreak surround month survey transparency region covid-19 international relate event nation technology directly datum urban ensure management political possible disaster non-productive grind network share advance numerous collaboration ready noncommunication protocol emphasise economic encourage affect 2020 standpoint backbone platform sphere contain 46 cooperation dependent write gain tool measure increase health effective result economy regard liveability cater lead lack smart technological perspective 7 place national social quarter thematic dimension emergency catchment work standardization influence system early understand coronavirus city specifically argue benefit urgent include paper hand solely china communication impact entire highlight expand tailor global detection world case healthcare 8 equity seek concept lockdown provide level view', '', 'plausible numb coronavirus incidence infection estimate underestimate strong thousand novel epidemiologically cumulative 5502 market 24 china 9057 exposure 3027 exportation confidence december january link case thirteen occur order cluster reach pneumonia 2019 2020 reported event seafood indication wuhan 2019-ncov likely interval late untraced 95', 'severe virus epithelial life infection acute respiratory low-pathogenic atcc associate immunocompromise cause n-(2hydroxypropyl)-3-trimethylammonium inhibitor cationically earle chloride hm-htcc doe therapy degree modify minimal medium polymer act cold macaca substitution different previously mulatta poland know infant pathogenic htcc llc-mk2 hcov-oc43 hospitalization fetal exception hydrophobicallymodified hanks chitosan typically plos cell 3 technologies derivative effective progress mers hcov-229e elderly ccl-7 lead disease exist circulate mem propose heat-inactivated patient interaction maintain demonstrate hcov-nl63 culture coronavirus inhibit date hcov-hku1 essential require human kidney sars potent drug highly block anticoronavirals case common supportive serum supplement available entry importantly receptor bovine worldwide', '', '', '', 'mers-cov endemic 2012 virus datum surveillance coronavirus heavily reservoir spill syndrome infection acute africa novel bat store respiratory population involve human dromedary east host origin potential study disease introduce animal middle responsible serum present unclear decade alpaca investigate suggest syndrome-coronavirus multiple distribution serve discover ago confirm phylogenetic camel geographical', 'acid virus carry structural 219 envelope size remarkably laboratory nucleotide encode conserve protein hcov ccu region 229e relate dutch determine orf4 collect cold 98 vivo spike closely genome possible isolate extensive non-structural gene adapt current orf4a uk organization contain so-called analysis exhibit cell unusual amino indicate unit play sequence clinical result split group hcov-229e accessory netherlands orf4b pedv 660 important strain single hcov-nl63 culture analyze early coronavirus essential identical include truncation primary human 1b results reveal highly salisbury 2-nucleotide conclusion common orf3 deletion suggest prototype putative homologue orf4a/b role level orf', 'severe research antiviral carry acute beijing meta-analyses rapid respiratory reporting database develope laboratory major suspect outbreak items support assay phase reaction globally 2019-ncov cochrane likely reviews confirmation 1 library therapeutics near management transcription novel intervention study 2019-ncov. personal reverse middle protocol 2019 evidence review strategy supplementary prioritization embase syndrome widely high-level vaccine specific compound (sars)-cov clinical effective publish potential point-of-care condition pipeline prisma institute pubmed policymaker google preferred efficacy syndrome-coronavirus criterium asia future genomic sars-cov important trial timely vitro combination electronic list mers-cov early numb coronavirus accordance include chain kit resource china communication east 27 serological synthetic rt-pcr commercial guide drug currently candidate case dna-based test diagnostics development identify polymerase search guideline real-time good appear systematic total systematically fulfill', '30 virus 1 coronavirus 3 infection fluorescent hcov-hku1 acute management sybr curve-based rapid specific distinguish 10 sequence respiratory clinical human develope syto design hcovs replace amplicon associate clearly 9 copy hcov-229e rt-qpcr diagnosis curve µl green improve temperature sensitive hcov global detection dye hcov-oc43 gc-modified × 2 common evaluation characteristic represent sample multiplex assay sensitivity patient treatment accurate reaction hospitalize demonstrate distribution important simultaneous primer tm confirmation reliable method melt peak analysis hcov-nl63', '', 'illness 0.05 2012 datum find positive coronavirus 3 54 season spike infection swab hcov-hku1 examine base background 2-year sequence respiratory 5 clinical human 0.09 phylogenetic alignment clade hcovs cause hcov-229e insight results s 0 prevalence 0.79 study majority hcov december january hcov-positive hcov-oc43 emergence gene nasopharyngeal test circulate october 0.32 sample 2013 patient generally rainy 5833 suggest region age influenza-like detect tree period 19 mers-cov. determine aspirate 46 coincide year provide collect recent peak hcov-nl63', '', '', 'susanne system lütgehetmann coronavirus svenja emerge article euro surveill throughput https://doi rt-pcr marc detection style correspondence nörz sars-cov-2 evaluation assay high dominic pfefferle 2020;25(9):pii=2000152 s.pfefferle@uke.de reucher citation quantitative', 'virus find 95%ci infection swab hcov-22e acute wet respiratory develope associate 1.77 cause 0.3 compared country upper mainly reaction significant multiple determine 6.16 rural comparison season mortality difference adult background ghana 1.5 study obtain 2.24 hcov-oc43 reverse tract middle harmattan combine transcriptase 150 5.15 dependent old syndrome africa genbank play seasonally sequence result publish ari hcov-229e lead 4 2.36 146 subject area single conduct morbidity hcov-nl63 mers-cov positive recruit especially coronavirus 21.65 control child hcov-hku1 chain 12.0 human hcovs east results 1,213 detection case nasal/nasopharyngeal 11.78 conclusion test occur asymptomatic polymerase real-time seek 12.4 role 3.72', '', 'severe small classical virus reservoir antiviral approach acute size natural respiratory rna expression develope cause renilla outbreak little genetic generate express kinetic 229e ligate facilitate re-emerge plaque insert vsars-cov-3prime risk genome sars-related transcription recovery isolate pathogenic similar reverse gene separate 10-fold heterologous clone produce mediate vsars-cov-5prime analysis contrast biosafe cell syndrome replication vaccine measure subsequently permissive health cdna effective hku-39849 template transfection hcov-229e hdcs 2002 transcript disease original lead frankfurt-1 cdnas zoonotic public supernatant demonstrate sars-cov reporter strain vitro virulent culture concern system coronavirus emerge control real difficult recsars-cov human dendritic approximately parallel comparative release form sars drug titer genome-length absence global virusbased case order well-studied vaccinia luciferase robust parental efficient vector create characterization finally infectious', 'correspond small depending mainland analyze prevent numb coronavirus travel incidence infection control outside estimate median probability respect measure novel 226 counterfactual data 20 diagnose scenario model china japan result volume time ii drastic reduction impact quantify major 86,449 confidence 70.4 epidemic little january statistical case decision movement restriction 28 delay fallout compare day iii predict 7 outcome economic export covid-19 2020 epidemiological freedom february confirm interval reduce range balance 95', 'molecular surveillance approach infection swab enhance rapid surgical respectively 31 laboratory december hospital 28 environmental characteristic hong sample 32 n room .001 undertake bundle 5.9 collect nosocomial airborne 1 hcws \\ufeff1 kong 93.1 saliva care cm p novel copies/ml active previously exposure 22 know preparedness load quarantine 14 nasopharyngeal day 2019 pool 42 significantly worker 29 unprotected prevent measure increase infect perform contact disease 413 2.7 × come sars-cov-2 cluster implement patient epidemiological wear objective 66.6 mask confirm methods 13 early analyze numb coronavirus locally 6 control isolation observe 10 11 1,275 require appropriate china 27 throat trace chin family distance results describe case 7.7 announcement conclusion test transmission healthcare 33 identify pneumonia air viral 8 acquire diagnostic 3.3 fulfill', 'severe past approach associate vest careful forecast accurate significant covid-19 plan reliability variable datum assuming prediction risk historical danger novel spread exercise recovery forecasting continuation introduce far ample personally symmetric affect rarely psychological question contain repeat analysis play follow way increase fear time potential pattern disease perceive decision pandemic overspend objective future reliable confirm uncertainty influence timeline numb coronavirus react underestimate continue paper simple require certain factor massive impact describe powerful sizable answering global case interest predict suggest good method live death provide role implication', '', '', 'socioeconomic covid-2019 prevention rapid complete participant optimistic consist population generalize associate rise knowledge preventive outbreak survey 56.2 characteristic sample logistic labor degree medium win low covid-19 multiple p<0.001 bachelor 65.7 adopt n=6910 respondent practice 0.90 battle resident spread network likelihood 98.0 confidence improve study epidemic negative day 0.75 questionnaire affect regression program relatively question significantly analysis chinese adherence measure aim health clinical woman regard 97.1 correct majority 12 cautious status ongoing high unprecedented investigate popular wear maintain hubei period mask assessments recent overall recruit control nearly successfully helpful include 63.5 knowledgeable hold appropriate china attitude completer self-developed limit mental engage 90 education rate online kap score finding particular representativeness', 'consolidation severe 7/14 nodular acute white opacity respiratory cause laboratory major 35.7 2 pulmonary pediatrician mainly staff characteristic symptom abnormal 50 covid-19 fatigue mild collect datum 57.1 adult 70 normal tightness/pain different process 66.7 recognize 22.2 grind onset pcr admit study 14 long count cell fever discharge syndrome 7.1 aim 71.4 health clinical result prognosis time cough infect lymphocytopenia sars-cov-2 status sore blood patient image 21.4 manifestation public chest detect decrease analyze positive early coronavirus child nearly main include 10 difficult 28.6 throat family general stool test transmission asymptomatic 11.2 shadow glass', 'severe find peptide predictive de allele acute pose respiratory population database develope iedb according cov 28 t ipred degree assay validation 18-february-2020 ncov treatment globally weight 2019-ncov 48 4.0 positional novo threat background deposit novel lastly given previously matrix ii know immunogenicity 72,000 tcr curate characterize shortlist proteome recently 2019 align similarity chinese cell newly vaccine health 63 time silico potential conclusions infect lead pipeline second high hla detect comprehensive european conduct list methods work coronavirus 9-mer 1,016 identical develop bind resource model china identification syndrome-related results sars experimental candidate limit global netmhcpan common immunogenic development immune recognition identify predict provide viral epitope search algorithm target accelerate receptor death total late', '', '', 'consolidation severe oxygen infection elucidate acute opacity life-threatening respiratory develope causative immunocompromise cause link 2 ards immunocompetent symptom low 229e multiple remain medical cold younger gradual \\ufeff1 adult consider agent comorbidity diagnose grind pcr lung tract administration negative day benign effusion start systemic nasal fever improvement deteriorate syndrome empirical indicate corticosteroid healthy involve clinical time cough lrti hcov-229e elderly field lrtis antibiotic lead pao supply present patient image bilateral chest female strain history headache vulnerable immediate early positive coronavirus abgs child human describe clear case diffuse common attribute pleural multiplex identify secretion 45-year-old glass particular distress /fio', 'virus 54 elucidate carcinoembryonic structure additional cleave positive-sense m41-ck 43 molecule attachment 253 -vero link 52 gammacoronavirus adhesion rbds modify remain enclose standard fcov progeny kb alphacoronaviruses c-type e01044 genome oligomerizes alternative 55 series error beaudette-specific hcov-oc43 reverse middle site independently growth britton 46 repeat membrane utilize 30 3 importance 627 vaccine protease cysteine-rich rational 24 84 vero lead apparatus surface trimeric 45 nucleocapsids present enzyme lectin investigate genomic mean strain terminus map aminopeptidase titrate virulent culture bronchitis 13 cd26 o-acetylated chain require bind human https://doi reveal responsible armesto identify postinfection target trimer tgev infectious citation acid severe find observable peptide ability beaudette-associated rna associate complex 21 protein porcine stalk tail 28 n 50 plate cd209l 48 determine 1 spike bilayer virion biosynthesis attache different process transmembrane fold furin-like homotrimers study confer 2018 microscopy poultry cap synthesize glycosylated 535 incorporate 59 contain abolish stevenson-leggett variety rationally 16 e syndrome indicate coronavirus-229e lipid effective result s infect l-sign oligomerization replacement type intercellular 7 invoke future demonstrate 19 vitro single betacoronaviruses susceptible mhv position expensive unsegmented 40 26 27 observation envelop average oc43 domain canine order anchor multimeric 41 entry live create heptad ectodomain polypeptide interact cell-specific 1,162 role correspond opportunity structural outside determinant coronaviruses change respiratory chimeric helical 31 57 hen major surround peptidase ribvs generate single-stranded fact angiotensin-converting express s2 cumbersome ibv h virulence 53 vivo gastroenteritis maier background egg 72 tropism previously design vary 22 ii inactivate hemagglutinin-esterase hepatitis fusion narrow 49 existence ribv contrast 2,3-linked beaur-m41(s amino adaptation specific hj p. sequence 6-well synthesis genus host virus-cell information hcov-229e location 4 principal cellular nucleoprotein supernatant nucleocapsid sars-cov noncovalently virol m conversely 92 enable polyadenylated coronavirus think transmissible 0.005 attenuate include electron primary 18 44 ccov problem release form half ace2 highly cleavage global harvest 90 avian extend journal viral despite induce cytoplasmic comprise ␣ industry small avirulent requirement chick infection acute subunit envelope 20-nm dc-sign consist 39 sialic embryonated 2 genetic s1 32 region murine endoplasmic replicate beaur-m41(s1 0.5 project p 58 beaudette nonintegrin extra know compose signal determination introduce m41 possibility cytoplasm gene moi s2= particle kda produce mediate 15 beau-r activation pre-golgi virology 29 cell n-terminal ceacam bar molecule-3-grabbing 23 subsequently cryo-electron reticulum involve ibvs c-terminal determines perform sufficient bickerton 12 180 feline golgi clove-shaped c proteolytic ck j conformational combination dipeptidyl mers-cov system generation 56 glycoprotein swap observe minimum factor dendritic east kidney recombinant currently antigen-related mouse receptor grow rbd fulfill', 'severe small virus find cross approach antiviral infection tylophorine-based life acute comprehensively pathway positive-sense coronaviruses cyt387 molecule resistance respiratory mechanism(s underling rna consist associate intrinsic inhibitor cause 9 complex outbreak protein upper 2 porcine etc animal asclepiadaceae cov single-stranded therapy activate ikk-2_iκbα/p65 open n testicular cooperatively treatment anti-coronavirus production murine remain se nf-κb rnp st act iκbα jak rna/ribonucleoprotein mechanism light directly cold inflammation convergent 1 anti-coronavirals mortality pro-inflammatory gastroenteritis genome transcription alternative novel agent intracellular synergically 5 chemical www.nature.com/scientificreports/ ~10 addition ii promise pursue reports isolate pathogenic cycle study published 4105 14 advance gene middle primarily tract hepatitis untreatable ~35 regulation coronaviral p65 tylophorine synthesize mediate 15 dominant activation contain jak2 effect significantly variety xx feasible activity pathogenesis 2012 cell additively surrogate 3 16 vigorously syndrome anti-coronaviral replication phosphorylation survival play vaccine specific compound silence swine increase chemokine effective result anti-sars-cov host time potential mers infect lead disease complexity 12 come plant 4 impart 7 cellular inhibition usually nucleocapsid sars-cov nuclear important mers-cov. scientific cytokine chemically comprehensive 17 combination override work xxxx mers-cov 13 class talk system coronavirus transmissible inhibit mhv date 6 include 10 base commercially 11 underlie factor human ikk-2 east moraceae 2003 family sars potent drug inhibitory reveal (cov)-229e limit block envelop vital case common anti-tgev responsible development exert κb constitute nf-κb-mediated mouse replication/synthesis available cov-oc43 viral rate 8 entry despite search target jak2-expression effectively seek gastrointestinal finally induce tgev role', '', 'percentage virus rhinitis approach swab fast coronaviruses rna major emergence animal generate low b spia datum difference achieve genome novel deep-sequence copy ovation biology brbv study expect similar bcov represent desire couple amplification produce highthroughput 100 nasal depth analysis set sequence/ 944 indicate importance sequence health efficiency full-length relation result regard mers 0 99 45 284 present read technique high quasispecies coverage focus important primer map single influence understand coronavirus numb bcov. vs. observe summary kit human sispa approximately sequence-independent sars entire prefer clear limit characterisation order compare 0.07 169 identify viral trend 249 isothermal method bovine reference', 'oncol 524 virus coronavirus approach infection article ensure 6:518 care risk minimize helpful vaccine high-risk novel different life-threatening health respiratory result east addition jco cause manage know occurrence particularly describe outbreak continuity situation adopt episode global large-scale hospital middle etiology easily arabia patient expose treatment harm acquire syndrome-coronavirus covid-19 saudi event future organization cancer medical outbreaks interruption undertreatment provide infectious recent readiness', '', 'severe virus reservoir requirement infection acute prevention bat respiratory discovery drive originate cause origin pathogenicity knowledge outbreak discuss hcov emergence animal cov seven switch successful covid-19 identifying sars-cov. mild sister central cold illness genome direct covs different mutation addition lifethreatening know non-pathogenic epidemic middle zoonosis cov-host derive 2019 current review investigating year contrast pathogenesis syndrome adaptation context co-evolution host severity mers evolution disease transmissibility exist sars-cov-2 devastate surprise present perspective high zoonotic interaction important focus reduce history spotlight thrusted intermediate understand coronavirus flip thousand include human china hcovs east 2003 insight sars interspecies highlight reveal common compare transmission coin good importantly recombination end serve overview implication', 'basic severe mainland infection acute exponential respiratory 25 cause maximum country under-report outbreak december roughly si 540 january cov initial phase 2019-ncov determine likely illness 1 comparison \\ufeff1 background 469 novel covs consider spread likelihood curve 2019-ncov. epidemic middle growth swiftly r 2019 2020 serial 15 syndrome follow increase 24 unreported result reproduction mers 0 pattern situation 403 well-known estimation future wuhan 21-fold 17 interval confirm methods approximation numb coronavirus ci emerge estimate foreign 18 model china 2.63 east half sars results case average conclusion occur investigation 2.56 rate 2.49 95', '', 'acid external virus antiviral infection envelope bat origin remarkably nucleotide encode outbreak protein sars-like-covzxc21 animal b relate 2019-ncov sars-cov. likely phylogenetic hunt spike lineage closely genome sars-related novel market design orf1a/b mysterious share orf8 study betacoronavirus far 2019 secrete start seafood organization tree wholesale contain alpha-helix membrane strategy analysis pathogenesis furthermore amino follow health completely identity ancestral mers perform evolution subdomain beta-sheet(s cluster patient nucleoprotein important wuhan basis strand bioinformatics atypical camel optimize vaccination overall understand coronavirus orf3b emerge source bind human china tentatively 40 trace announce sars world 89 domain compare provide pneumonia week learning short diagnostic civet finding receptor late role 82', '', '', 'severe virus reservoir infection outside united ability rapid respiratory cause country knowledge pneumonia-like outbreak little december states advancement discuss treatment treat remain 2019-ncov inter-human illness \\ufeff1 novel rapidly 35,000 2019 produce review february question pathogenesis newly proper anti-viral vaccine tool increase health 24 effective regard time potential fill transmissibility plant ongoing unanswered wuhan gap biopharmaceutical declare emergency recent system early numb coronavirus emerge nearly territory include develop combat human china biotechnology currently global researcher case responsible development transmission collaborative identify available effort short diagnostic prove late', 'native similarly small virus cell-mediated vlps nanovectors research requirement infection structural structure elucidate envelope repetitive assembly render molecule respiratory traffic expression gentamycin develope 25 atcc crl-7701 b. ribonucleoprotein 9 cause curvature 31 incubator particulate major 21 crl-1711 protein wide-spread upper assessment 2 porcine animal induce shape cov 28 egress characteristic delivery protect express 32 interestingly modify medium μg/ml bvs low vlp production response remain coronavirus-nl63 tailorable ni protrude ibv cargo valuable diarrhea datum spike \\ufeff1 gastroenteritis amphotericin virion novel tropism 20 frugiperda design spodiptera antigen vary ciliated 22 poland immunogenicity promise compose study epidemic obtain 14 introduce tract numerous middle far particle handy hepatitis modification fetal coronaviral kda efficiently recently hcov-nl63-based amplification produce span narrow purify 15 tgev platform humoral baculovirus relatively 100 150 penetration penicillin tag membrane plos systems -- 29 30 cell trimerize 16 e chromatography syndrome 23 versatile vaccine deliver tool specific procedure usa convert 24 threads-particle result host time severity potential mers c-terminal angiotensin s infect 27˚c. majority 12 surface tissue 0.25 enzyme manuscript present iu/ml high cellular immunity pedv interaction maintain display branch demonstrate trichoplusia important focus 19 fbs scientific specificity 17 basis m streptomycin hcov-nl63 work challenge bronchitis concern 13 generation system protective purification evaluate induction coronavirus 34 influence transmissible mhv 6 culture main essential propitious 10 base bud epithelium esf 18 require bind function human east release 26 27 form https://doi ace2 sars recombinant describe transduce titer candidate ribonucleocapsid highly engage humidify test responsible development orf3 supplement interest nanoparticle avian constitute property mouse investigation immune identify anchor nl63 viral 33 serum 8 antibody additionally entry efficient good serve vector target materials method non-infectious characterization receptor ectodomain selectively interact sf9 bovine hf finally provide infectious exposition exclusively thermofisher', 'pathogenesis concern severe virus presymptomatic coronavirus research syndrome acute vaccine health respiratory cause origin diagnosis highlight disease global 2 sars-cov-2 development ongoing transmission asymptomatic viral treatment 2019 important question emergency shed', 'observer virus early coronavirus requirement indicate strong emphasis spillover novel possible market originate result exposure substantial hypothesis origin animal-to-human curve epidemic december sell case animal common stem overemphasize initial transmission cluster bias support identify zoonotic index 2019 unmet potentially reanalysis seafood event huanan relate wuhan remain 2019-ncov history human-to-human', 'mers-cov severe virus positive cell disease-19 coronavirus understand syndrome infection control acute replication importance include pathway coronaviruses covs mini-review combat process increase respiratory agent rna human lysosome result east host group cause know mers endocytic endosome sars knowledge pathogenic discuss inclusive epidemic disease envelop 2 middle sars-cov-2 cov single-stranded development clue ongoing decade provide viral treatment entry covid-19 good genomic sars-cov element important target focus autophagy strategy therapeutic key', 'pan-coronavirus severe small virus peptide infection structural structure complete molecule respiratory -hcovs cause fusion-core attachment conserve add protein side-by-side upper s1 term s2 229e da determine mild facilitate conformation comparison spike mortality adult core different process hr2 design addition weaken study similar aid complication represent far hr1 structure-based polar subsequent fusion electrostatic mediate contain layer repeat membrane cell individual assemble involve host publish potential mers hcov-229e opposite s lead pack resolution alphacoronavirus surface noncanonical differ interaction usually å -hcov hcov-nl63 overall system coronavirus inhibit position heathy 1.86 profile certain human six-helix hcovs membrane-fusion hydrophobic sars 3hr1 x reveal highly preserve domain immune viral entry good appear heptad postfusion', '2004 presence evaluate coronavirus season incidence infection child background respiratory diagnose human associate 2003 know explore hcov-229e rt-pcr infect sars currently study disease hcov-oc43 oc43 tract winter identify assay nl63 recently hospitalize 229e sars-cov belgium pancoronavirus samples optimize hcov-nl63', '', '', '1 coronavirus arbovirus \\ufeff1 child article alphaherpesvirus human plasma haitian hcov-229e isolate 2016 knowledge suspect description disease 229e focus strain', '', 'delaware presence virus 1 under-studied coronavirus reservoir closely shorebird emerge indicate acute thousand findings background novel usa bay sequence migratory turnstone population discovery variant grind associate conclusions feed highlight monitor emergence ruddy poultry avian sample wild fecal astrovirus extent yield nephritis important finding method bird unbiased deltacoronaviruses distant analysis homology sanderling', '', 'severe virus research approach infection acute evolve respiratory causative cause laboratory major occurrence outbreak pulmonary open region remain virulence mechanism datum offer mortality genome encounter direct novel agent network system-virus epidemic contribute far miss effect pathogenesis cell prevent indirect syndrome feature vaccine health involve clinical regard potential situation disease lead exist arise read attractive high widespread interaction sars-cov important vaccination morbidity pathological deleterious system coronavirus control hazard difficult mutability require who-led sars frame experimental world development immune identify viral effort target infectious role', 'virus molecular antiviral infection immunofluorescence 159 special consist respiratory cause suspect little 2 suboptimal sample assay percent remain routine collect quantitative decisions saliva adult \\ufeff1 management direct transcription novel pcr load improve study reverse negative nasopharyngeal affect frequently supplementary 16 27/159 measure clinical emerging 56.3 258 cohort 99 disease salivary device pandemic 83.8 high patient seventeen epidemiological concordance detect important choice specimen positive evaluate coronavirus benefit control isolation include human expectorated incremental npa test precaution avian multiplex sensitivity viral rate influenza additionally hospitalize microbiological aspirate total npas infectious', 'find research life screen develope govern undetectable https://doi.org/10.7554/elife.55570 knowledge evidence-based elife emergence symptom gostic support covid-19 plan response ill failure 1 breaking best-case effectiveness mathematical assumption different spread previously traveller advance far parameter current miss program 2020;9:e55570 unaware key prevent underscore 2015 tool measure individual follow infect policy lead epidemiological future mitigate history recent work understand emerge estimate success prospective fundamentally combat 18 factor model half ubiquitous impact limit global case transmission expose finding', 'virus structure assess develope atcc gammacoronavirus virus-host modified remain linda virus-induced diarrhea progeny tether \\ufeff1 kong threat bromoviruses genome 20 onset address middle far step uk eagle significantly membrane year allow farm 2012 gamma- 30 3 member importance hepes usa swine 24 deltacoronavirus spherules 37 majority resemble twice state present arteriviruses vesicle aldrich branch strain µg/ml titrate recent camel work culture bronchitis 13 date 10 11 human beta- pdcov 2014 dynamic theme 33 identify flaviviruses rate characterization positive-strand range infectious severe double-membrane find pdcov-induced rna associate country 21 protein alphaand porcine animal 28 sample support 50 determine presence 1 rearrangement mortality different organelle isolate study atrophic microscopy characterize poultry initially ibv-infected adapt 16 sigma syndrome pig spherule stain species infect emem commonly 80 arise type 7 formation jump important 19 nodaviruses confirm deltacoronaviruses livestock betacoronaviruses morbidity source enteritis convolute 26 damage 27 family llc-pk1 ohio world development toroviruses previous dulbecco interior cat interact horse mouth coronaviruses bat pinch connect respiratory population 25 origin respectively 31 particularly shape alpha- significant alphaviruses vomit ibv ros following illness cm novel 2011 possible previously gammacoronaviruses vary dmvs network 22 critical cycle 14 channel betacoronavirus hepatitis ro economically oh-fd22 gillingham debris sequence health synthesis genus host kindly regard qin disease enterovirus 4 strongly high cl-101 cellular interaction maintain detect er sars-cov saif trypsin 34 coronavirus 6 emerge include electron 18 function pair approximately release form pellet impact highlight harvest avian viral importantly materials induce industry small infection acute refer invaginated antibiotic-antimycotic 9 cause companion (sads)-cov prof. 2 emergence hong 32 medium region stock endoplasmic freeze/thawed replicate possess 5 visible 36 addition pathogenic dmem university cytoplasm tcid 2009 particle produce 2.5 15 35 tubule question dog 29 cell replication 23 subsequently publication reticulum potential perform 12 tissue c zoonotic single-membrane neaa fcs foot 17 history detail wide methods mers-cov observe zippered east cpe absence common supplement dose 8 cattle civet gastrointestinal provide', 'acid fragment safe 588 infection strong prevention respiratory develope cause country protein peptidase halt t arabia express treat modality crucial receptor-binding therapeutics spike mortality \\ufeff1 igg novel spread 212-amino promise fuse s-specific middle neutralize 606 far efficiently saudi purify contain 293 2012 cell syndrome indicate 588-fc vaccine residue dpp4 effective 377 mers potential s fc disease 4 high patient supernatant mers-cov. therapeutic dipeptidyl culture mers-cov transfect coronavirus save truncate inhibit emerge bind human vaccinate east infectious recombinant highly block domain development mouse potently antibody suggest s377 finding live 367 effectively receptor induce rbd', 'practice team coronavirus gradually research version 6 infection comment base rapid novel increase health clinical china advice publish answer continually committee diagnosis knowledge suspect experience fight awareness guidelines disease strategy case pandemic late republic ongoing update issue letter 7 national treatment 2019 good 2020 guideline covid-19 diagnostic criterium finding accord february 2019-ncov confirm provide reference worldwide', 'similarly acid severe partially direction acute enhance united m-nsp13 coronaviruses north respiratory rna expression nsp13 cause inhibitor conserve knowledge superfamily protein states animal cov single-stranded seven express helicase catalyze discover ku directly america 1 \\ufeff1 5=-to-3= motif novel s-nsp13 substrate know nonstructural load study obtain strep-fused k middle efficiently derive clone long processive purify contain duplex utilize 2012 syndrome replication africa length result helicases disease europe inversely nucleic biochemical enzyme atp important unwind relative strand therapeutic wide 5= proportional mers-cov 13 purification understand coronavirus dna double-stranded human east separation insight recombinant bacterial responsible property hydrolysis identify viral rate motor short energy target characterization range finally provide', 'presence virus believe molecular find coronavirus positive stage carry infection swab likewise organ base novel epidemiology spread respiratory china oral release cause time oralfecal diagnosis soon infect anal improve outbreak local december disease world transmit detection hospital late tract negative test serology intestine investigation provide pneumonia patient blood warn rate 2019 suggest good future oral-fecal cautionary multiple wuhan 2019-ncov conduct induce shed confirmation route', 'system department meet especially offer oncology university-based measure blur society mandate resource compromising communication help high-end radiation time country hospitals tackle modern university learn statistic great departments pandemic crisis personnel prioritize patient outcome treatment covid-19 caution cancer effectively oncological neighbor preparation challenge', 'acid fatality severe virus find peptide life antiviral cross infection structural structure locate subunit envelope cleave coronaviruses consist respiratory rna close prefusion aspect cause complex emd-9584 9 attachment conserve major outbreak protein emd-9587 667 compartment upper 2 emd-9591 animal e1007236 s1 induce 6ack gammacoronavirus distinct approve angiotensin-converting open n s2 treatment emd-9595 region loop treat successful micrograph of~1,300 protrude sars-cov. ibv mild bundle mechanism adopt central receptor-binding 1 conformation comparison spike emd-9583 ~700 triggered rearrangement threat carboxyl deposit stable s1-s2 virion different data emd-9594 spread recognize process emd-9596 extensively 5 architecture acidic exposure addition disassociation hku1 biology critical pathogenic cycle study 14 6acj large-scale hcov-oc43 advance microscopy characterize betacoronavirus site barrier hepatitis s1-ace2 synthesize rbd emd-9597 fusion bank mediate 15 contain bring coordinate repeat membrane plos key virology outer rosette-like metastable 2012 cell trigger prevent bury s1/s2 3 pathog 16 amino indicate availability play member feature vaccine cryo-electron epidemiology protease accession health residue assemble clinical involve 6acc completely genus deltacoronavirus result host regard species precursor hcov-229e s 2002 condition disease ph 12 alphacoronavirus surface trimeric emd-9588 circulate state emd-9586 4 130 enzyme cluster high ~600 formation 7 cellular 6acd sars-cov (c)-terminal 660 proteolytic trypsin map low-ph vitro 6acg terminus conformational 17 recent hcov-nl63 wide number mers-cov 13 system heterodimer pathogens class understand coronavirus especially specifically mhv nervous emerge 6 hcov-hku1 and/or flexible glycoprotein observe 10 electron 11 em require bind positive-stranded human six-helix emd-9585 release hydrophobic 2003 https://doi form family pdcov ace2 sars insight drug reveal cryo-em cleavage global glycoprotein-mediated pre-to envelop highly transition (n)-terminal undergo domain responsible monomer mouse statement 14(8 viral expose emd-9598 rate entry suggest additionally 8 675 emd-9593 good target promote trimer heptad mimic receptor gastrointestinal postfusion emd-9589 provide retain role', 'virus classical molecular environment oxygen antiviral infection strong oas relationship enhance change phosphate resistance expression modulate 25 redox 9 39 31 21 protein allosteric implicate premature oxidative 2 hemolytic deficiency predispose -oligoadenylate 32 association clinically phenomenon treatment low redistribution production 229e response remain innate discover crucial nf-κb ros 6689 retardation mechanism overexpression transduction synthetase ubiquitination adenine 1 ifn dengue examine risk sirna initiate nmral1 stress regulate 20 spread (g6pd)-deficient 5 process worthwhile genes-tumor g6pd 36 addition 22 dinucleotide address proteolysis gtpase signal sensor study 14 gene negative interferon upregulated isg-encoded growth r albeit produce affect alter degradation 42 mediate 15 35 activation 6706 tnf-α-stimulated differentiation effect hscarg dehydrogenase g6pd-deficiency analysis activity exhibit cell -5 30 trigger (mx1)-in 16 proinflammatory isocitrate exogenous replication phosphorylation 23 upregulate 2015 reactive play measure increase 300 degenerative involve 24 traf3 substantially 71 result host species normally hcov-229e infect 37 disease ev71 12 senescence enterovirus status nadph promoter 4 elusive state 38 type principal high 7 patient immunity cellular necrosis apoptosis display maintain demonstrate strain 19 g6pd-deficient defense cytokine 17 myxovirus reduce stress-induced susceptibility glucose-6-phosphate decrease 13 susceptible tnf-α coronavirus dna 34 iκb nicotinamide inhibit 6 control essential homeostasis 10 culminate include proliferation underlie 11 partly 18 regulator factor bind human 40 alpha downregulated cascade kinase anemia g6pd-knockdown ratio tumor restore inhibitory highly reveal rela nf-κb. deficient mx1 attribute impair immune subcellular 33 nf-κb-mediated suppress ifn-stimulated idh1 viral viruses 41 8 suggest isgs pkr ikkβ finding nadph/nadp modulation ifns induce role level alteration', 'severe infection acute respiratory causative cause outbreak traditional discuss 2 naturally therapy medicine symptom treatment covid-19 lethal 2019-ncov thoroughly mechanism non-specific care novel spread know anti-virus rapidly relevant study introduce coronaviral 2019 ameliorate current evidence review option effect homology chinese activity pathogenesis application anti-coronaviral syndrome widely vaccine specific compound epidemiology clinical tcm publish infect disease great sars-cov-2 patient conventional experiment sars-cov receive therapeutic analyze coronavirus article genomics underlie literature 85 china insight sars drug currently world supportive occur beneficial available identify pneumonia sudden provide infectious', 'pdcov. acid basic storage find respond infection outside seventy-four conclude pathway acid-binding molecule expression modulate piglet associate cause remarkably protein porcine transportation symptom mrnas express metabolism endoplasmic response weight likely mechanism diarrhea differentially 1 fabp correlate background novel regulate different organelle appetite discussion critical fabp1 signal study 5-day-old gene alter mediate ppar digestion pathogenesis cell 3 nucleus play member aim nurse reticulum clinical deltacoronavirus result host time conclusions pdcov-affected fabp3 investigate organismal peroxisome mitochondrion important emaciation proliferator-activated decrease system coronavirus thousand observe loss pdcov family insight results experimental fatty highly preliminarily identify reason differential metabolic receptor death provide role alteration', 'severe find safe antiviral infection prevention respiratory immunocompromise cause inhibitor respectively 0.3 protein pseudotyped upper 2 fusion-inhibitory treatment low treat 50 229e bundle 1.7 229e-hr1p 1 therapeutics spike 0.5 stable agent hr2 design infant promise tract far cell-cell distribute hr1 protein-mediated fusion repeat membrane activity widely synthesis effective hcov-229e elderly µm 229e-hr2p disease patient maintain peptide-based administer coronavirus inhibit 5.7 ic human six-helix model form candidate domain development mouse intranasally target heptad characterization effectively live interact', 'pathogenesis mers-cov severe 2012 small virus sign coronavirus hamster de emerge date inoculation replication indicate e syndrome fatal include histological observe bushmaker novel intervention hamsters respiratory thomas clinical human arabian model result east associate aerosol prescott 31 potential 55 explore seroconversion study intratracheal disease prompt case emergence animal middle doe test replicate l inoculate t transmission lesion upregulation 2013 efficacy syrian e69127 baseler peninsula cytokine wit 8(7 likely j human-to-human strategy plos citation', '', 'severe virus wildlife reservoir carry considering infection conclude coronaviruses respiratory chicken cause largely genetic animal emergence 1,002 cov environmental sample relate poorly beringia medical ibv mild phylogenetic collect diverse presence examine novel covs spread previously biology pathogenic sarscoronavirus disseminate study efficiently economic frequency costly asymptomatically analysis epidemiology sequence health realise host species potential perform disease great statistical present wild high widespread investigate belong detect future important area bird cloacal recent bronchitis understand coronavirus emerge underestimate geographic gamma-coronaviruses faecal human 26 rt-pcr distance impact currently avian relevance viral suggest good finding range infectious role', 'incubate covid-2019 traveler approach screen change country major note december january restriction point reaction covid-19 importation international pass risk transcription possible rapidly quarantine 14 disease-2019 reverse symptoms-based day airport 2019 2020 organization miss conceal 30 prevent fever province return symptomatic increase health perform contact disease republic come high epidemiological public detect hubei wuhan area map reliable declare emergency recent challenge concern positive numb coronavirus travel and/or import chain hand resource china identification rt-pcr currently temperature limit world case test transmission asymptomatic polymerase entry late body thursday recommend', 'pan-coronavirus severe virus define antiviral approach infection acute pathway screen enhance ma friedel coronaviruses molecule respiratory modulate partner inhibitor knowledge outbreak protein interleukin 2 animal cov 2002/2003 virus-host dysregulation non-immunosuppressive cspa overexpression cov-229e immunopilins -nl-63 1 therapeutics 2011 covs long-term biology calcineurin/nfat e1002331 non-structural nsp1 signal study epidemic inhibitors applicable ppia cyclophilins vulnerability cyclosporine activation compatible ppib yeast-two plos broad-spectrum cell mü pathog syndrome hybrid replication play vaccine increase derivative genus host pivotal ppig immunopathogenicity s disease feline cc broad-range strongly ppih genome-wide inhibition pfefferle interaction demonstrate sars-cov important interactome cytokine j livestock m conversely gl bronchitis system induction coronavirus 7(10 emerge ller employ fatal observe include human pf identification kö ubiquitous sars block fkbp1b late-stage case avian immune available identify good neurological schö serve target live gastrointestinal fkbp1a sars-coronavirus-host induce infectious role citation', 'severe past virus surveillance disadvantage define partially burden acute bottleneck change respiratory population reproductive witness cause gender setting rise major country particularly century outbreak vast experience discuss delivery decade paralyze successful covid-19 relate remain plan failure strive srh mortality normal service ebolavirus spread recovery rapidly address lmics improve inclusive low-and economic strategy girl inequality syndrome dramatic specific national/ health woman progress group countries commitment differentiate majority disease double learn pandemic issue unprecedented place sexual social civilization connectivity consequence morbidity vulnerable overall system-related system resource-poor middle-income emerge include paper substantial srhr sars impact modern global world h1n1 eids common chronic constitute influenza suggest implementation dedicate lessons remind range infectious fragile', 'contract severe practice ocular coronavirus sweep discharge carry syndrome threat article acute chinese risk ophthalmologist contribution pose equipment ophthalmology novel summarize health require respiratory clinical close communication exposure publish potential faceto-face tear hope scholar experience frequent disease global transmit 2 hospital world conclusion sars-cov-2 proximity lens investigation 33 identify high protect patient 2019 covid-19 public unavoidable guideline domestic remain based continent conduct uncertain route', '', 'basic infection beijing prevention assess authority intensity country outbreak january emergence compartmental restriction resource-intensive seven intensive low significant 2019-ncov determine 6.47 adopt \\ufeff1 risk novel mathematical intervention spread equivalent likelihood critical quarantine expect contribute deterministic 7.23 5.71 day long 2020 devise 100 effect peak analysis chinese province 23 individual measure follow increase clinical scenario value severity potential reproduction information infect contact disease status type progression high implement estimation epidemiological maintain mean wuhan reduce decrease numb coronavirus ci travel control isolation essential helpful thousand base import restrictive expensive model china trace baseline quickly 91.14 case compare transmission identify sensitivity expose week effectively neighbor provide 95', '', 'severe hg oxygen define march 4th acute 172 screen respiratory population 0.03 9 compared outbreak experience january hospital 2 therapy ≤ support seven intubation low successful treat noninvasive h likely ill 8.4 datum failure 1 retrospectively p background novel iqr mmhg 0.04 improve study invasive patients chongqing 7/11 2020 mm 15 nasal unsuccessful 150 significantly 1st ultimately 29 median indicate 79 rescue 114 63 group 0 ventilation (2019-ncov)-infected pao intubate critically lack 4 130 ongoing 200 7 patient 318 receive confirm 17 208 decrease coronavirus vs. include cannula ncip initiation china hfnc 27 currently baseline common eventually first-line 33 pneumonia 41 rate high-flow niv 0/6 /fio', 'virus safe approach burden infection swab acute -hku1 beijing respiratory 25.53 associate 52.88 check rsv 30/416 15/67 symptom sample assay b remain multiple discover determine 17.79 department 1 adult methodology/principal background transcription 2011 agent 1-year different previously involvement address study syncytial rvs reverse tract consecutive represent combine recently flub 30.76 dominant 2010 significantly co-infection 416 12/39 3 flua -nl63 reaction(rt-pcr follow nose health clinical effective -oc43 potential hcov-229e conclusions 22/74 pattern attend strongly high pivs patient differ parainfluenza 7.21 29.73 epidemiological detect conduct adenovirus emergency 12/47 therapeutic 13 positive coronavirus date ed findings include artis advs profile chain pics metapneumovirus 220/416 human china hcovs arti throat rt-pcr impact highlight prevalence global 16.11 22.39 11.30 picornaviruses common 11.78 test rv development previous polymerase viral rate influenza flu -229e real-time adv pic hmpv total april', 'incubation concern severe work virus security coronavirus syndrome infection emerge acute difference feature epithelium epidemiology sequence health respiratory market clinical human context hcovs fear cause 2003 unexplained isolate lung sars major condition diagnosis pathogenic outbreak hcov disease lead global world 2 emergence threaten tract sars-cov-2 compare symptom origination pneumonia patient recently widespread goal treatment 2019 proteomic covid-19 seafood sars-cov review genomic wuhan method mechanism systematically similarity', '', 'virus molecular epithelial life elucidate infection bottleneck respiratory expression modulate inhibitor proof-of-principle protein authentic genetic generate virus-host unique kinetic propagate 229e innate response hrsv propagation incorporation transduction facilitate rock post-differentiation study syncytial rho-associated gene characterize far represent modification protocol affect current poly (sh)rna-mediated platform sort y-27632 validate cell establish newly fluorescent exogenous hairpin specific result host spin normally lentiviral potential hcov-229e universal differentiate proxy c lifespan interaction airway demonstrate reporter important vitro haec detail culture influence system homogenously coronavirus combined amenable finite epithelium primary factor (facs)-based human knockdown lentivirus-based inducible kinase unlock transgenic extend immune functional importantly short fluorescence-activated target create characterization', '', 'severe past virus find basic environment enzootic reservoir requirement infection acute prevention jeddah bat sporadic respiratory difficulty close male associate cause compared laboratory setting sero-surveys sensitive upper link emergence cov arabia symptom point low reaction influenza-like remain older peninsula mild multiorgan illness failure hcws retrospectively \\ufeff1 adult suffer novel 20 comorbidity exposure know rapidly lapse transmit advance reverse middle tract (rt-rtpcr)-based transcriptase growth precisely ipc evidence start saudi relatively bring jordan year kingdom worker frequently virology validate 2012 cell fever sign syndrome africa dc sequence involve arabian progress cough mers infect condition contact majority disease ksa zoonotic high patient widespread injury breathe detect interplay obviously camel disappear mers-cov sometimes-fatal understand coronavirus control lengthy fatal underlie chain dromedary human approximately 40 east kidney sars rare limit lrt detection case occur publicly occupation diagnostics healthcare available focal pneumonia polymerase affinity real-time appear death distress', 'virus find elisa antiviral infection phenotype bioassay oas pathway panel readily assess evolve accordingly coronaviruses hour line expression rna 5.3 intrinsic 9 respectively h250a barely ifn-i conserve normalize δδc particularly protein fibroblast 13.4 2 tbp dsrna t mhv-a59 cell-associated seven phase replica enzymatic endou-deficient successful kinetic significant b student innate response medical mrna wilcoxon depict collectively p<0.001 elevate 5.9 facilitate right 0.018 datum 0.05 household vivo 1 comparison severely ribosomal difference \\ufeff1 localization endonuclease detectable p data 0.016 0.002 h.p.i visible design copy know vertebrate a-c sem 0.04 8.5 pathogenic type-i confidence sensor study mefs gene moi interferon site represent efficiently independent t-test long hypothesize evade c-d manifest r01-ca044059 srw h277a activation dash layer 4.8 strategy plos key analysis peak activity prevent cell decay trigger marrow-derived 0.001 indicate replication importance replicase follow synthesis 24 c57bl/6 gapdh result host bone 9.5 publish hcov-229e infect perform 0.01 grey decision synthesis-within detrimental lack l statistically present manuscript c wild funder type zoonotic endou swift place sense immunity restrict display experiment two-sided demonstrate sars-cov mean band simultaneous mers-cov. qrt-pcr significance macrophage consequence relative preparation breakdown immediate induction early pathogens coronavirus double-stranded mhv leave l-mediated pfu include veterinary attenuate base primary blood-derived function rna-based human mount unpaired mda5 endoribonuclease potent rnase mock ifn-β describe paradigm titer highlight highly limit removal detection matched-pairs common deficient evasion collection 15.8 test immune establishment mouse evolutionary provide viral robust suggest pkr greatly negligible complex-suggests 3.3 rhs titers embryonic particular retain role level cytoplasmic 95', '', 'severe virus oxygen de swab tourism enhance famous respiratory rna centro machinal 21 outbreak protein local note january assessment therapy symptom sample seven assay covid-19 standard p<0.001 mild elevate collect shed diarrhea datum januário macau signal study urine lag aid possibility negative nasopharyngeal day moderate 2019 2020 serial february significantly dehydrogenase fever 16 3 discharge c-reactive median feature conde nps clinical chcsj group feces elderly disease great pressure ventilation decision sars-cov-2 80 p=0.002 fecal high patient enroll public duration based qrt-pcr hospitalar (nps)/sputum specimen system positive city coronavirus p=0.045 import fatal include lactate são require clarify sar arrival stool detection case common test compare healthcare sensitivity viral diagnostic admission microbiological total role level recommend', '', 'acid pan-coronavirus find molecular peptide define infection structure subunit pose enhance prevention lipopeptides develope six-helical nm associate cause inhibitor respectively mutate outbreak protein superior generate sarsr-covs protect assay s2 treatment anti-coronavirus ek1 241-and sars-cov. bundle mechanism therapeutics spike threat \\ufeff1 examine core 5 previously hr2 capacity series 1.3 hcov-oc43 6-hb cell-cell hr1 protein-mediated derive divergent prophylactic pseudovirus fusion membrane application amino establish replication specific residue health ic50s plasma effective ek1c4 s disease original sars-cov-2 circulate 149-fold intranasal interaction public sars-cov wuhan mers-cov. pseudoviruses recent challenge mers-cov solve coronavirus inhibit emerge include develop underlie human china potent currently reveal highly global crystal test domain 15.8 compare x-ray mouse viral potently suggest good target live', 'severe find research approach march infection strong acute fast respiratory difficulty population cause country biological 21 outbreak fight december violate 2 hospital support term facility protect win low successful covid-19 international globally income stigmatization 110 project initiate enemy battle novel intervention different spread preparedness share personal middle regulation 2019 containment 2020 community mankind non-pharmaceutical contain continent strategy cooperation noisome prevent coordination old province syndrome feature vaccine 93 measure tool health mobilize effective potential pattern leader expert disease great transmissibility pandemic-level supply sars-cov-2 80 nature implement 7 who-china public future sars-cov confirm 2005 history joint challenge protective mers-cov coronavirus especially date equip position include facemask mission develop 813 human resource china general drug -covid-19 quickly global case common development order eventually transmission effort solidarity provide recommend', 'severe frontline infection screen prevention first-hand rapid ability respiratory population develope rule add traditional experience december evidence-based january hospital characteristic medicine section treatment successful 2019-ncov nosocomial datum attract \\ufeff1 management resident novel process lesson diagnosis relevant 2019-ncov. university suitable 2019 2020 community doctor organization professional chinese zhongnan province widely attention rescue nurse health advice draft infect disease 12 type manual person epidemiological public hubei accord wuhan clinician request coronavirus control include general quickly methodology manager world researcher case occur development interest healthcare pneumonia viral urgently guideline provide', 'severe 28.8 research coryza pose myalgia 1210 associate gender outbreak local dizziness symptom initial 75.2 phase treatment poor accurate covid-19 low student international satisfy h 84.7 datum respondent 0.05 p background adverse stress intervention 20 anxiety hygiene improve resilience study epidemic 8.1 day spend moderate depression precautionary 2019 psychological moderate-to-severe significantly strategy depressive self-rated 16.5 member up-to-date specific measure health 53.8 24 group information conclusions psychiatric situation disease great worry status high 75.1 wear public female mask 194 reduce emergency challenge vulnerable concern contract coronavirus city include develop hand factor china family half physical impact results one-third mental home formulate available identify rate finding total particular level evidence-driven', '', 'industry administrator wreak conservation risk care base management document procedure representative health comorbidity tele-medicine triage human resource economy aha exposure arrhythmia manage professionally potential impact havoc describe discuss acc strategy global invasive role device hospital visit pandemic staff hrs acuity catastrophe identify patient personally guidance electrophysiology affect covid-19 electrophysiologists civilization method non-invasive interrogation remote clinic ally provide cardiac joint', 'infection acute prevention rapid respiratory haemodynamics repurposed associate local prepare ration hospital staff 2 therapy maker www.thelancet.com/respiratory intensive covid-19 international nosocomial ill failure government offer care risk management spread health-care streamlining capacity diagnosis address critical published collaboration practitioner 2019 community 2020 question allow key infrastructure worker administrator survival unit increase clinical triage matt policy scarce disease pandemic supply critically unanswered chance patient national focus challenge coronavirus 6 isolation include resource regional substantial researchers https://doi bed experimental world transmission online icu workflow role level april', '', '', 'severe classify elisa research additional nonrecovering database close help 6571 dairy animal characteristic symptom initial support low significant covid-19 remain weight medical crucial determine avoid right collect nonrecovered scour diarrhea http://dx mortality interleukin-6 calve suffer 20 possible active free onset repository study cost calf rear receiver economic parameter long adapt fund j. effect significantly strategy analysis furthermore prevent gain covid recover clinical result value neonatal concentration progress respective sci unrestricted operate original disease 99:6563 decision twice examination centre high 7 outcome il-6 mean important reliable re-use reduce conduct therapeutic vulnerable acknowledgement prognostic early begin elsevier source fatal 10 useful resource loss form unnecessary marker describe monitor test serum publicly compare identify mark grant welfare rate prove late samples', 'government practice numb relieve respond provider assist article examine comprehensively play practise service way spread health require resource profession help vary time potential information general country highlight scope continuity policy pharmacist global vital pressure inform decision pandemic exist order crisis healthcare maker available unprecedented adaptive place innovative demand maximise covid-19 current community public maintain response review future important restructure method seek area pharmacy activity undertake body role key unrealise considerably', '', '', 'coronavirus spike life risk novel human 63 model china https://doi sci protein outbreak evolution 457 460 ongoing transmission 2020 wuhan', 'severe approach non-severe rna short-term develope low-dose associate respectively 16(76.2 21 little 2 hospital symptom p=0.85 n 28(82.4 treatment significant treat covid-19 50 production satisfy medical mild divide collect illness 1 difference \\ufeff1 p background igg record recovery 22 55 study sars-cov-2-igm moderate u methylprednisolone r 2019 effect strategy f analysis 3 shortterm discharge e leisions recover length clinical completely effective die group severity time 75 p=0.92 conclusions expert disease 18(85.7 risk-adapted sars-cov-2 1846 45 4 l delay 0.62 22(64.7 patient investigate image 12(57.1 o manifestation chest objective accord j highlights influence despeared early coronavirus -p include paper consensus ct useful n=34 alleviation clearance results clear 31(91.2%)patients case beneficial week antibody efficient guideline end admission p=0.13 level', 'small severe virus antiviral acute envelope assembly cationselective respiratory delete inhibitor respectively encode conductance protein link ewart planar assay region 229e ibv 322 determine mechanism plaque datum c. 1 bilayer 331 hiv-1 representative 330(1 previously hexamethylene mhvδe channel hepatitis evidence mediate effect virology activity 2004 cell 3 e syndrome cation-selective replication mckinlay p. lipid taken group hcov-229e (hma)an channelinhibited morphogenesis parent inhibition belong sars-cov conversely culture bronchitis coronavirus mhv inhibit code g. taxonomic human hydrophobic form family general ion sars recombinant entire amiloride wilson gage vpu l. mouse viral appear hma provide infectious', 'severe stage -0.068 autonomous assess crp p˂0.001 reflect prefecture 9 2 hospital approve lesion n correlation treatment presentation region significant covid-19 determine mild collect confirmed -2.171 difference correlate p background -1.549 dong diameter explore committee lung critical qiandongnan study scan moderate 0.734 u coefficient r f fever e 0.693 unit measure aim follow result -2.647 group severity miao ethic disease 0.873 statistically l high patient select o objective j differences early -p necessary ct china page mann-whitney currently case conclusion positively test p˂0.05 compare guizhou extent usefulness admission -2.177 biomarker infectious level', 'fatality virus adjust cfr march objectives inevitable rapid exponential ncfr acfr reproductive website 2.04 1.83 lancet 9 country outbreak 5.08 r0 2 mainly n covid-19 engl 4.11 kucharski 3.95 5.51 mortality p 7.92 data spread germany 3.38 curve study epidemic obtain 463 aj west u growth r 2019 2020 contain 6.07 package f 6.32 edmunds dependent e indicate africa r(t))and 3.27 increase td italy naïve effective value time reproduction conclusions fit 0 wj europe great disease transmissibility pandemic exist 3.17 l 4.51 select 5.74 6.56 o 10.19 eg objective 5.72 france spain important med j european recent methods number highlights early estimate main -p employ continue 10 9,172 6.99 6.69 china priority monitor global vital case 3.10 • transmission rate real-time 12.26 ebola finding method r(t death 2.21 provide 2014;384(9950):1260 4.43', '', '', 'category classify surveillance text research predictive approach direction database 9 compared largely ccs outbreak purpose 2 t fact support term ppv n chief syndromic recall satisfactory point covid-19 b international remain 470 dictionary facilitate right real-world bilingual datum classification generalpurpose novel alternative different complaint process active free design record harmonic repository u subsequent r long potentially fund translation english f chinese-english significantly key analysis set chinese e aggregation million covid machine measure aim health value 320 s perform 0 pattern unrestricted original disease statistical exist precision cc l centre c propose 7 o adequate public experiment based mean important focus predefine specificity re-use j acknowledgement overall system early positive leverage elsevier source language paper base automate fruitful resource extract handle translate form computational results phrase multilingual detection 308 extraction non-english publicly module free-text sensitivity grant 8 despite effort performance method provide', '', '', '', '', '', 'fda mortality urgent emerge prevention profile effective th17 inhibitor disease pandemic sars-cov-2 development approve type immune propose high patient treatment covid-19 response review jak2 reduce fedratinib', '', '', '', 'severe virus classical research march infection acute prevention rapid ability change respiratory population 9 country pace little unfortunately 2 emergence carrier symptom treatment children globally fatigue mild shed vivo 0.5 intervention comorbidity spread 5 22 14 surrounding far reach affect evidence 292,124 15 189 chinese incubation fever 3 16 paramount importance individual measure epidemiology confront explain effective progress 12,784 cough elderly infect syndrome-coronavirus-2 majority evolution disease statistic 12 pandemic sars-cov-2 4 state nature high 7 unprecedented accord wuhan period scientific choice 19 17 confirm therapeutic 13 understand 6 control estimate 5.7 10 11 18 case-fatality drug case common supportive available asymptomatic air rate 8 suggest death range', '', \"basic mainland march infection outside assess m. 25 associate cause 9 outbreak a. assessment r0 2 -march n cite phase region covid-19 2019-ncov datum italian \\ufeff1 p spread coniglio his/her know study similar northern d'arienzo u derive parameter r evidence start 2020 february f key e individual health th italy value reproduction infect fit europe disease 12 well-established sars-cov-2 l pre-proof present sir-model o epidemiological 2.43 period wuhan j interval confirm work early analyze numb city emerge article control -p essential biosafety base literature china https://doi entire limit case average 3.10 previous eventually available journal suggest good finding secondary range particular infectious\", 'count system strive coronavirus occupational infection acute risk thousand pose intrahospital tool measure health factor model china potential tertiary infect zero condition describe priority 99 disease communicable preventing hospital mainly pandemic domain environmental safety transmission healthcare protect word patient achievable face goal 2019 engineering principle organizational based remain task technology strategy systems worker initiative work', '', '', 'fatality respond cross gain stakeholder infection adequately surge management include forensic follow possible handle authority advice cause committee capacity relevant experience epidemic advise manager prepare dead guidance face red covid-19 consideration international based plan ask emergency worldwide set', '', '', '', '', '', 'acknowledgement well-laid research march compass direction covid elsevier source historical follow teach active resource database free stand value aspect infectious time form repository guide aware leader unrestricted accident study original disease great come publicly medicine present centre grant guidance long haphazard covid-19 fund future remain plan mean medical re-use history right analysis fully work', '', 'lanthanide acknowledgement enable basic cell purification broaden solve research fluorescent covid europium elsevier source specific aim detergent label quantitative bind active resource database free virosome problem release addition complex form ultracentrifugation potential biology repository pellet unrestricted protein liposome study original one-step quantification insect rv coexpression delfia kind particle diagnostics rv-specific centre type formation grant antibody long covid-19 efficient anti-flag heterodimeric remain relate mean appear enhancement contain re-use incorporation entrap chelate strategy right analysis solution', '', '', '', '', '', 'industry variation research size 43 database communicate vast note 2 fact skew unique scale covid-19 remain supposedly specialize right away difference \\ufeff1 file possible active free explore repository share instance u word r long fund g f cockney meanings analysis e covid pronunciation unrestricted original commonly 4 centre speak dialect mean re-use relative work acknowledgement understand specifically elsevier source language distinguish 4.1 society resource thing regional business form extreme british publicly grant despite vocabulary create range', '', '', 'acknowledgement research article covid elsevier source active resource database free magnetic clinical form repository unrestricted original publicly centre 7-tesla grant image long covid-19 fund remain mean re-use resonance right analysis', '', '', 'virus text research de measle additional change consist database seldom la advantage covid-19 remain likely right morbillivirus 98 hepatovirus rougeole near virologist given active free replace changeover mosaic repository introduce possibility binomial hepatitis word long affect current advocate fund english year analysis debate abbreviate covid publication genus course species publish information unrestricted original decision exist plant centre implement acronym future mean scientific re-use list acknowledgement tobacco system elsevier source language resource problem form currently repeatedly nonlatinized common ictv publicly -virus property grant end measles appear abbreviation tobamovirus provide inclusion recommend', '', '', '', 'r&d approach arena ppe require stretch resource comparative capacity particularly situation expert local quickly limit global engage pandemic supply apply extend face scale current covid-19 production community polymer degradation collaborate good public method reuse recyclability mask option stability level virology bio-medical', 'acknowledgement system http://ees.elsevier.com/ 1 crude research march 6 covid estimate 23 elsevier source www.thelancet.com active resource database free previously case-fatality form compete submission repository unrestricted published original correspondence publicly submissions 4 interest centre high grant rate online thelancet/ long covid-19 2020 fund remain mean appear https://doi.org/10.1016/s0140-6736(20)30690-5 re-use declare electronic right analysis', '', '', '', '', 'virus coronavirus infection saliva control novel 11/12 promise diagnosis load monitor 91.7 patient generally viral 2019 trend detect serial live 2019-ncov noninvasive self-collected decline specimen culture', '', 'severe virus infection acute 53.57 prevention rapid causative associate respectively conserve outbreak sample assay region low reaction routine cross-reaction southern 2017 quantitative sads-cov diarrhea ⁎ \\ufeff1 gel-based genome transcription novel agent design integral study reverse gene 73.81 45/84 corresponding establish syndrome pig specific swine clinical result 84 rt-qpcr disease devastate technique high conventional epidemiological detect greenbased 62/84 demonstrate primer sads-cov. m early positive coronavirus green-based emerge control source sybr 10 base 11 chain china rt-pcr monitor limit detection probe-based investigation identify polymerase sensitivity viral rate copies/μl. real-time diagnostic effectively method', '', 'enable anti-papn virus transfect cell coronavirus transmissible inhibit infection gastroenteritis replication immunofluorescence indicate include fecov imply cdna bind expression human previously non-susceptible antigen loss east piglet cause group addition result hcov-229e papn critical papn-transfected epidemic lead great block role mdck porcine feline detection far support assay n investigate economic viral correlation pedv antibody belong good entry neutralization functional 229e serial apn lethal propagation aminopeptidase receptor confirm asia tgev combination diarrhea', '', '', 'basic virus team research rely infection respiratory variant discovery database develope parvoviridae cause major unfortunately hbov 2 animal initial decade covid-19 remain discover gorilla following bocavirus right http://dx 1 allander \\ufeff1 novel active free biology repository diagnosis series infections hbov-1 description study millennium far represent tobias microbiology long fund analysis cell primate covid clinical genus species publish information parvovirinae unrestricted original considerable hbov-3 centre belong mean strain re-use subfamily originally 2005 reduce confirm culture acknowledgement system numb accompany elsevier source base huge resource human model form family detection case publicly supplement order identify grant bocaparvovirus', '', '', 'severe acute leadership develope help experience hospital medicine crisis symptom delivery support intensive uw significant covid-19 plan response contingency illness co-morbidity department care service stress capacity address admit share advance represent moderate high-quality word adapt institution incorporate program strategy key set count 230 unit member 1721 publication context conclusions forefront palliative pandemic seattle manuscript implement patient conventional content important focus area multi-faceted conduct emergency methods number system multi-hospital include underlie abstract family results quickly input world healthcare identify goal introduction age', '', 'water severe soap mouth clean acute evolve change respiratory protection dry knowledge particularly touch local eliminate flu-like cov lens symptom product accurate significant covid-19 event standard wearer thoroughly avoid cold normal care risk management altogether adverse service novel consider possible stretch exposure eye unwashed disposable patients suitable complication reusable wash circumstance practitioner 2019 evidence step potentially unwell look option application sleep syndrome optometric availability prescription daily follow increase health nose clinical result imperative information contact correct optimal disease cl pandemic supply -2 sars-cov-2 spectacle access patient guidance restrict wear accord scientific reduce wide concern contract system behaviour coronavirus leave isolation continue include paper hand appropriate towel impact currently advise lens-care removal case compare transmission healthcare available viral face suggest eyecare guideline remind seek minimise provide retain', '', '', 'severe infection acute opacity line respiratory 25 develope male mulbsta associate laboratory mothorax december hospital characteristic jan jinyintan multiple 2019-ncov likely radiological datum failure 1 mortality risk background novel 20 comorbidity onset explore study far demographic 2019 affect 2020 analyse old cases syndrome feature outcomes aim follow clinical mottle die result interpretation time worsen disease cluster patient warn epidemiological applicability wuhan period 17 confirm ground-glass retrospective methods early coronavirus emerge organ include fatal 11 clarify single-centre china model rt-pcr general pneu case investigation predict pneumonia viral score short real-time distress', '', '', 'consolidation acid find locate white opacity change migratory laboratory dry alongside little cord pulmonary mainly 1,702 groundglass characteristic lesion fatigue subpleural diffusivity collect datum curative 76 \\ufeff1 novel spread 5 tomography onset lung negative ncp subsequent effusion fusion inflammatory analyse effect fever length aim increase segment clinical value result characterise unilateral cough mediastinal lymphadenopathy disease nucleic 80 examination 92.4 patient investigate 44.1 image manifestation epidemiological bilateral chest accord area ground-glass combination methods diarrhoea early evaluate coronavirus main 10 ct useful results account rare sputum case conclusion test pleural compute progressive pneumonia score shadow materials total range lesions 95', '', '', 'surveillance respond rely beijing indicator algeria intensify onward 25 originate respectively country outbreak local cope region ill-prepared covid-19 importation international variable determine datum heavily build risk management background direct novel spread exposure capacity preparedness cycle share epidemic contribute south resources far moderate index airport 2019 step vulnerability chinese depart province fujian africa health volume interpretation regulations countries infect disease 12 cluster high kenya detect accord ie confirm african evaluate coronavirus city travel control estimate import findings egypt guangdong china monitoring framework limit case occur evaluation prioritise transmission identify air urgently infectious', 'severe small virus infection swab assess vertical population develope lymphopenia 5-min cause 9 outbreak cord characteristic sample covid-19 asphyxia collect presence \\ufeff1 adult background novel baby lactation apgar record study similar negative fetal 2019 evidence 2020 malaise cell non-pregnant aminotransferase breastmilk increase clinical woman die neonatal concentration interpretation amniotic group information disease × sars-cov-2 4 intrauterine l sore 1-min fluid blood patient livebirths pregnant feb coronavirus pregnancy observe base 10 findings develop throat general currently monitor case test previous 10⁹ transmission pneumonia 1·0 8 suggest score newborn late distress', 'concern datum 1 evaluate antiviral molecule clinical potential broad currently preliminary discuss sars-cov-2 interferon type relevance treatment treat covid-19 review trial mers-cov. vitro activity', 'virus requirement research consist rna database help evacuolated encode protein n-terminally switch protoplast product region rnas covid-19 remain mrna mechanism right untranslated facilitate by-2 genome active free mosaic repository study rna2 long fund necrotic negative-strand contain translation cis-preferential analysis cap-independent transcribe rcnmv covid replication synthesis result frameshift template unrestricted original rna1 centre investigate genomic mean re-use vitro acknowledgement dna clover essential elsevier source p27 resource extract translate form overlap engage p88 cell-free publicly manner 3′ grant red vector element −1 role', '1 numb save e inhibit key baricitinib replication -p infection widely anti-viral p effectiveness necessary adverse ability consider 1960 increase regulator bind possible human gak aspect chloroquine endocytosis 9 know imperative immunomodulatory kinase drug rheumatologists disease limit f block vital l pre-proof property approve u n journal viral g-associated treatment r o entry aak1 relate discover anti-malarial live j effect rheumatological cyclin hydroxychloroquine safety', 'water severe increasingly virus find noroviruses 335 surveillance enterica research environment enteroinvasive calicivirus infection outside acute haiti subsp prevention imply reflect cdc leak database 25 food causative associate e. 9 country outbreak local little wade 2 contamination animal monocytogene mainly contagious lmic ubiqui food-borne recall 5000 shigella covid-19 prevalent 50 treat remain multiple poorly variable mild likely tous right diarrhea enteropathogenic morbillivirus absorb illness datum bowel 76 gastroenteritis adult listeria campylobacter direct agency 5 recognize active notifiable free liter contaminated onset network lifethreatening vibrio repository reovirus norovirus absorption study epidemic rubivirus paramyxovirus sapovirus far day moderate circumstance hospitalization non-food-borne toxigenic recently clone long astrovirus step pool fund 100 aquarium year cholera small analysis frequently etec potassium unpotable 3 incidence million covid indicate person-year daily centers usa potable increase health michel 000 volume infect unrestricted situation original disease 12 water-borne 45 salmonella 4 rotavirus state 38 centre exceed 200 cryptosporidium zoonotic 7 netherlands patient 325 person seasonal public swim mean content strain spp re-use consequence aeromonas adenovirus escherichia recent enterotoxigenic hypokalemia acknowledgement 135 travel 6 control estimate child depend main isolation elsevier source base prospective include 10 11 hand resource approximately freshwater loss trace form drancourt account prevalence stool coli contaminate case bacterial dehydration inanimate responsible publicly impair transmission investigation identify secretion week grant 8 foodborne age hospitalize vector cook infected death enteric recreational infectious', 'storage transfer meet surveillance requirement research define march population database develope intend engineer laboratory outbreak purpose local simulate 2 329 generate t initial support open n syndromic scale covid-19 b bacillus event remain border avoid right directly datum 1 project threat anthracis agent spread phasis process active free design identifiable record repository study j.g. communicable easily distribute u .no microbiology r long fund incorporate -see f analysis dependent validate e establish 2001 covid snow syndrome individual tool construction epidemiology health involve deliberate information conclusions s 0 norway unrestricted matt operate original disease two-way diffusion 1386 status arise l apply centre c cluster 7 patient national o epidemiological adequate mean important area re-use j electronic acknowledgement system early 5056/$ anthrax definition 6 geographic elsevier source root literature patient-identifiable bellika resource extract communication 2003 form sars paradigm monitor reveal global input case conclusion specification test 313 publicly healthcare identify grant goal implementation good centralise method ehr range provide level', '', '', 'team infection clean scanner connect close protection help suspect outbreak strategic 2 staff symptom initial protect reconfiguration covid-19 plan room clinic divide train department 1 examine management designate 5 exposure capacity dr fever-ct personal scan 2019 radiology re-examination strategy 3,340 set fever unit high-volume measure procedure way fever-dr result infect disease examination access patient semicontaminated sense adequate maintain objective area confirm history emergency number system buff numb coronavirus control include ct function describe highly contaminate case formulate undergo conclusion precaution good total infectious', '', '', 'illness basic virus coronavirus 3 r&d infection million child acute nearly young main threat include vaccine article novel agent influenzae metapneumovirus health respiratory hib streptococcus art develope effective addition cause infant s. spectrum country broad rsv address aris outbreak syncytial lead attempt pandemic responsible 4 development state present avian constitute type piv-3 available provide pneumonia efficacy parainfluenza influenza immunity urgently public b multiple review question death haemophilus year h. infectious worldwide', 'severe transfer classify carry infection multidisciplinary acute run equipment respiratory close originate protection particularly experience tay implicate restriction pa therapy medicine suctioning 2004;85:1365 plan routine curtailment tracheotomy failure practice droplet silently 70 care risk management novel immunocompromised bk stop rehabilitation preparedness psychologic epidemic personal strict barrier diabetes encourage affect institution rehabil significantly renal syndrome measure procedure height ys result economy feces lim contact disease learn long-staying devastate present strongly nature chance high patient interaction eg airway phys med emergency arch therapeutic decrease coronavirus control include difficult function human internist china physiatrists general physical impact sars world movement common transmission visitor secretion viral suggest ng cancer counter recur bioterrorism principle', '', 'acknowledgement nontapetal research covid elsevier source include screen histology active resource database free form eye repository unrestricted prefer midsagittal original disease genetic animal w. tapetal publicly examination section slab centre optic fundus blood grant long covid-19 fund domestic frequency remain dodds mean inherit program j. bibliography re-use determine nerve allow right analysis', '', '', 'acknowledgement research covid elsevier source active resource database free cause form repository unrestricted reply traditional original sars-cov-2 publicly medicine centre grant harm long covid-19 treat fund good remain mean re-use right analysis chinese', '', 'native severe small virus meet oxygen antiviral ribonucleosides nitrogen infection structure acute relationship enhance ribamidine molecule resistance respiratory notably rna discovery stand analogue prodrug viramidine aerosol cause 1960s inhibitor 3-carboxamidine 9 nucleotide major rsv reduction 5′-triphosphate reinforce little ribonucleosides/nucleotides implicate prompt 2 animal metabolize poliovirus therapy t fact convincingly approve support term n1 discontinuation treatment unique significant know remain multiple response discover eclipse standard relate act incorporation mechanism adopt insufficient deserve datum 1 -diphosphate conformation vivo pyrazomycin pegylated anaemia capsule n-)-methyl \\ufeff1 non-specific haemolytic genome suffer direct elimination novel intervention agent intracellular different canonical possible guanine-7 active 5 accumulate rotate proportion previously mutation substrate adenosine accumulation promise isolate mode explore series five-membered pathogenic improve study epidemic error syncytial confer attempt ° contribute catastrophe -triphosphate rna-dependent far represent particle hepatitis guanosine 5′-phosphate favour index recently shift pool current 5′-monophosphate incorporate review mediate pleiotropic translation year effect dehydrogenase key set activity utilize elicit broad-spectrum application cell crystallographic exhibit dose-limiting possibly 3 somewhat syndrome indicate replication anti-hcv ring deliver pharmacokinetic hcv ribavirin compound gold chemotherapy health structure-activity synthesis 3-carboxamide clinical tablet 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide effective derivative result o6 host consistent inosine potential monophosphate transcript antibiotic triazole-based 180 resemble imidazole-and structurally 4 guanylyl immuno-based biochemical enzyme immunomodulation c type bond high blood patient virazole cellular immunity demand 7 parent interferon-α immunomodulator rtp ago administer originally vitro reduce single rbcs therapeutic defective recent rmp hiv combination culture numb coronavirus dna specifically comparable inhibit emerge 6 success mutagen base hazard profile mimick unconventional hand factor purine hold c3-c6 model 40 transferase form sars broad notion drug currently action spatially capable global ribonucleoside limit bacterial transition case formulate test gtp responsible impdh exert property x-ray immune chronic dose deplete 5′-cap polymerase identify viral showdomycin atom despite red brief 8 nucleoside target mix live metabolite cofactor triazole trap induce', 'find gathering exponential predictability abduction help 31 57 wp heuristic allocate 2 hospital n point covid-19 ds flatten collect datum 1 comparison p spread process 5 capacity curve improve study day u growth ventilator r pfz start f ta cancel set frequently prevent 3 cases e 1,000,000 follow way course time information situation ahz expert supply wwk 4 l pre-proof present type 7 o ahead social j preparation mam system inference pairwise travel -p necessary base finite resource distance action observation x limit logical abductive journal aw-d reason search guideline diagnostic jm md', '', 'train 13 transfer department coronavirus specifically surge march \\ufeff1 acute verify care tier base include position united resident 11 novel spread health diagnose th attrition resource triage china surgical network deployment capacity critical december states lead vertically departments world command hospital surgeon pandemic cope faculty advance personnel present healthcare national practitioner 2019 principle exhaustion plan organization wuhan incident surgery question ask emergency utilization level infrastructure integrate recommend', '', '', 'severe obstruction child underestimate anti-cancer risk observe measure chemotherapy course develope cause intensity preventive delay asymptomatic treatment covid-19 oncological receive mild', 'acid virus molecular 158 antiviral approach infection structural elucidate pose assess clq respiratory chloroquine cause attachment conserve protein sialic sars-coronavirus 2 link emergence therapy support treatment covid-19 gangliosides mechanism facilitate presence spike offer aa \\ufeff1 novel spread active design stop isolate raft pathogenic improve cycle study step long mediate option hydroxychloroquine 111 ganglioside-binding cure promising cell n-terminal ace-2 clq-oh replication health lipid clinical derivative efficiency result host silico potential graphical infect s contact pandemic surface sars-cov-2 delay type high patient innovative reliable confirm emergency therapeutic recent combination highlights and/or bind model abstract identification reposition broad potent drug currently \\uf0b7 action candidate reveal global responsible domain evaluation property investigation identify viral face affinity entry suggest efficient target receptor tip range worldwide fully', '', '', 'severe virus molecular infection acute weapon pathway line respiratory cause spanish month outbreak 2 emergence genetic therapy proof term angiotensin-converting lethality crucial lethal sars-cov. enormous illness failure 1 vivo misuse spike \\ufeff1 spread 9,10 rapidly lung 14 economic renin-angiotensin 11,12 pathogenesis possibly cell trigger 3 paramount newly syndrome individual rational result fear potential infect worsen disease 4 enzyme high 7 sars-cov social explanation 13 understand coronavirus attenuate 2003 ace2 sars impact block world mouse identify pneumonia 8 influenza suggest flu good biologic receptor renew provide', 'severe transfer virus find 82.1 fatality stage infection 4.5 beijing special population close 11(4.2 male 26.0 respectively laboratory 21 192 60.4 hospital characteristic symptom 17.2 generally treatment low successful covid-19 50 6.9 remain fatigue medical 73.3 determine mild 6.7 collect illness datum classification \\ufeff1 5.0 background service novel designate resident onset series 10.9 quarantine study obtain 262 day demographic step 2020 community doctor 81.7 relatively 46 year incubation furthermore prevent fever old discharge median 47.5 feature measure clinical 26.3 non-pneumonia interpretation time cough information infect dyspnea contact 216 cluster 48.5 patient outcome epidemiological detect 0.9 focus wuhan period confirm interval history headache emergency basis methods feb 13 susceptible analyze early coronavirus isolation findings include 10 45.8 china 2003 family 116 sars ratio no-pneumonia 82.4 case common test compare transmission asymptomatic pneumonia rate age diagnostic 6.5 17.6 provide', 'ace2s utilize severe virus intermediate evaluate coronavirus newly prediction screen direct imply bat convert sequence certain human alignment originate result host species murines pigeon cause angiotensin know help s ace2 currently contact tend receptor-utilizing 2 pandemic sars-cov-2 lack t enzyme transmission c cluster horseshoe identify predict pneumonia r capability probably mammal b receptor unlikely bird existence rank phylogenetic chinese', '', '', 'category transcriptionpolymerase meet research carry retrieve respiratory chictr.org.cn website outbreak traditional little december evidence-based survey 259 hospital medicine seven ordinary significant covid-19 reaction medical round 2019-ncov determine mild collect classification 78 core effectiveness trials 58 different delphi addition series critical preliminary study reverse far protocol registry 2019 pool 132 set chinese comet length aim heterogeneity pharmacology clinical group time clinicaltrials.gov expert disease lead statistic negativity type waste issue outcome select accord important trial cos conduct handbook list standardization coronavirus version 1.0 measures include develop chain consensus resource form rt-pcr tackle development order register constitute identify journal cos-covid search guideline editor total', 'virus classify 武汉病毒 n-cov news 6.71/25 evolve cumulative audio inter-observer respectively outbreak 2 mislead 67 term modified low 50 reliability medical viewership reviewer videos 3.12/5 attract background novel recognize video rapidly specify exclude coefficient index 2019 current 2020 mandarin 42 review 15 february min english 1st analysis 3.25/5 youtube group information 21,288,856 disease 4 pre high popular .72 duration content mean wuhan agreement methods criterion analyze evaluate coronavirus source language base mici useful 6.28/25 results account kappa previous duplicate discern score search 2nd view', 'pathogenesis uncertainty severe virus cell understand coronavirus offer life antiviral syndrome control structure acute vaccines genome pose base analogy direct measure novel profile mutability respiratory cytocidal expression involve possible china problem comparative regard cause 2003 origin potential sars largely pattern frame preventive outbreak protein cycle study similar recurrence world role contribute animal gene distinct development read wild immune insight identify open viral region prospect immune-mediated future civet response target important cat virulence mechanism effect southern', '', '', '', '', 'severe adequately infection acute pose respiratory 59·7 associate 9 laboratory 21 outbreak december 2 52 hospital 67 staff ards symptom pneumothorax seven funding jan intensive treatment survivor vs older likely 710 sd 65 collect ill 98 illness datum 1 mortality dysfunction adult care risk background hospital-acquired data comorbidity proportion non-survivors sars-cov-2related invasively non-invasively critical admit study demographic jin 2019 start 2020 15 35 year cardiac 29 yin-tan 30 fever incidence syndrome survival unit 23 aim increase clinical single-centered course 71 value 13·5 interpretation 13·3 time severity information 37 scarce 28-day ventilation 12 great considerable sars-cov-2 45 critically man ongoing 7 patient outcome enroll injury mean 51 wuhan strain receive retrospective methods feb 94 coronavirus especially findings include organ primary require function resource china 40 26 damage kidney observational describe mechanical occur compare chronic pneumonia week icu age admission live secondary death late distress', 'dataset acid de overlapping expression close variant originate protection 97 nucleotide protein a. discriminant accuracy cite crucial mechanism composition possess novo genome substitution alternative pre-exist design know study computationally gene separate neurodegeneration 100 component overprint selective analysis virology apoptin toxicity amino 319 non-overlapping feature assemble genealogy ancestral potential respective pattern sars-cov-2 apply principal homolog high detect power pavesi coronavirus article include 237 anticancer https://doi insight overlap frame x reveal common experimentally evolutionary viral good induce 82', '', '', 'acknowledgement http://dx system research covid elsevier source respiratory active resource database free form repository unrestricted infections original publicly centre grant microbiology long covid-19 fund remain mean re-use right analysis', '', 'small virus find elisa foal u.s.a. research inoculation 523 neutralizing glareolus m. publishers population variant database f. 9 weiss cause laboratory rise kaderli occurrence antigenic note discuss 2 animal maternal symptom science seropositive sample steck decade reaction covid-19 remain right horses vulpes horizontal sheep correlate elisa-negative active free amsterdam germany repository neutralization-positive animals study 1984 obtain apodemus negative neutralize swiss microbiology microbiol long fund decline analysis activity rabbit dog ungulate inverse covid --printed pig clinical horzinek m.c. result species sylvaticus vet unrestricted inconclusive original -531 feline 4 random centre wild widespread synchronous netherlands fox consistently france mean re-use offspring b.v. berne number acknowledgement 13 positive probable berne-type elsevier source veterinary observe 83 resource pair human abstract form seroconversion titer goat test serum publicly mouse grant cattle antibody neutralization sudden r. mare antibodies induce horse clethrionomys', 'sus demostrado meet un ser disciplinas research de retos complete hacia distintos pero afrontar population database 5691/$ médicas la maximum más experience specialty con formativos ocupa medicine competencias experiencia crítico intensive covid-19 remain posean pasos importantes medical disponer se prestar habrá es creación homogeneización right train ill objetivo población completa como young que care atención por quality especialidad different process active clave free específica teniendo repository determination role recibido liderada long step especialistas fund paso program 0210 resumen -see professional pacientes key analysis comparación covid play discipline member specific miembros specialist necesarias necesario creation 2011;35(4):232−235 matt unrestricted muchos máxima profesionales el original europe lead estados actualidad dado critically state debe satisfacer para present centre calidad principal high patient dar determinación los objective future mean important med joven en re-use receive enfermo challenge standardization acknowledgement formación papel primaria main elsevier source necessary programas asistencial ha primary resource abstract las form medicina y aunque currently forward intensiva www.elsevier.es/medintensiva publicly compare hayan presenta futuro grant face europa asistencia una necesidades proceso otras ofrecer han provide competence críticos', 'small asthma virus birth research life infection wheeze bronchiolitis clin relationship change respiratory database recurrent associate 2 induce childhood cockroach maternal t allergy unclear generally covid-19 continuing remain allergen response act 2000;105:s503 likely right inflammation 1 rhinovirus \\ufeff1 adult young risk mite infancy different given active free causal exposure repository lung critical syncytial contribute long evidence fund year analysis provocation set contrast dust cell 3 covid play feature increase nose scenario time severity sensitization precipitate unrestricted original ige odd immunol strongly present centre allergic consistently attack maintain objective mean indoor ie re-use j acknowledgement child elsevier source simple 18 nonetheless factor resource form h2 ratio prevalence clear home common occur publicly smoke immune dose viral grant 8 antibody suggest age domestic finding late role', '', '', 'acknowledgement asthma virus research infection 732 covid elsevier source background enhance responsiveness increase respiratory active resource database free antigen form know repository sensitization unrestricted purpose original inhalation publicly development centre investigation type mouse viral grant clinically influenza long covid-19 fund objective airway remain mean promote re-use determine right analysis', '', 'count illness enable system early sign 713 provider e burden -p care p computer screen cornerstone increase health connect burnout abstract expenditure result physician well-functioning telemedicine distance workforce lead caregiver well-being pressure 2 hospital direct-to-consumer pandemic l webcam-enabled manuscript healthcare word n u patient reach r o covid-19 smartphones medical effectively virtual platform 91 j overwhelm total allow f workload enormous', '', '', '', 'severe cell coronavirus antiviral establish syndrome inhibit strong acute replication observe stably novel respiratory synthesis active interferon-beta human effective interferons mxa. cause vero sars protein study little inhibitory interferon-gamma responsible interferon-alpha far strongly term express antivirally multiplication treatment interference mxa prominent pretreatment demonstrate sars-cov interferon-induced sars-cov. cytokine effect induce contrast culture', 'acknowledgement highlights research covid elsevier source vaccine antitumor novel active resource database free rna-based center form repository mda5 agonist adjuvant unrestricted original publicly ongoing centre pan-antivirals grant long covid-19 rig-i fund remain mean target re-use strategy right analysis hunt', 'ileum small basic virus raise research infection fipv coronaviruses symposium respiratory population rna database nm b. cause knowledge pathologic tend localize immunopathogenetic apparently surface.2o animal carrier medicine characteristic columnar duodenum lesion predispose covid-19 immune-mediated continuing remain response protrude virulence determine peritonitis mechanism following right light ill younger m.r mature villus tropism active free diameter oral repository improve .c. patients v.s. terminally represent particle coronaviral john long fund review 100 fip contain question relatively year analysis pathogenesis 29 covid member pleomorphic clinical 24 species vet infect august unrestricted original disease feline state present centre jejunum outcome seroepizootiology restrict objective mean strain med projection re-use single strand recent acknowledgement system peplomers understand coronavirus article and/or elsevier source vasculitis organ epithelium dramatically factor resource clarify solely answer form cross-react general apical fraction eventual advances envelop average 3.10 responsible publicly development accurately chronic investigation equal m.s. asymptomatic petal-shaped immunologic grant viral affinity antibody r. cat gastrointestinal induce infectious', 'virus 54 disinfectant clean structure gut modulate protection govern mononuclear setting careful knowledge touch 52 67 medicine predispose treatment presumably remain multiple fatigue medical disposal mild distinction diarrhea recommendation 98 0.05 78 pro-inflammatory \\ufeff1 adult constitutive risk genome suffer inappropriate consider spread market rapidly 55 relevant quarantine virus-contracted syncytial hydrogen middle microbiota 11.8 1.4 plastic u efficiently macro- big option significantly 25(oh)d 30 prevent fever old 3 play vaccine individual rational 24 italy naïve concentration severity mers prebiotic third-known 0 contact majority sex surface cardboard l patient outcome belong public apoptosis 0.1 female strain 23.7 comprehensive reduce autoimmunity headache preparation contract 13 iu/d accompany essential 10 11 chain refine require human frequent monitor vital contaminate detection compare 33 pneumonia week rate polypropylene guideline nutrient inadequate conceptual deal piece promote 62 aggravate probiotic humidity infectious 0.2 co-exist severe 77 twenty-four variation adjunctive measle utensil ugly minimize rapid ability close age-related 21 cover viable little monocyte chloride animal mainly 28 environmental carrier sample support promotion 0.02 n low signature 50 peroxide unidentified-origin response crucial polyphenol determine beta-carotene diverse sars-cov-ii inflammation presence 1 confine spike mortality difference young management sneeze agent different comorbidity process antioxidant bad hygiene epigenomic study expect snake tract day diabetes hypertension review 59 contain marrow 16 object e syndrome symptomatic follow alleviate way fiber woman course connection 71 effective result pivotal infect inconclusive conforming pandemic commonly coronaviridae pre-proof d type 7 blood public-touch sense nutritional lymphoid social important 19 selenium cytokine declare human-to-human sodium decrease protective susceptible article position colorful 38.1 40 26 27 supplementation family framework non-smoker regular world occur immune 2·3 maintenance toxin immunologic suggest immunocompetence desaminotyrosine ethanol metabolic live biocidal digluconate prone secondary death modulation role competence fatality transfer mouth structural relationship pose determinant myalgia hour bat change micro-and respiratory population drive 25 male aerosol origin respectively 31 57 reduction particularly fight assessment stainless fact 80.9 fate symptom significant meta-analysis 53 65 habit avoid illness datum apart stroke quality possible previously hypochlorite 22 reports soon critical invariably inactivate 14 advance ° numerous insufficiency betacoronavirus complication wash elder couple r affect community seafood vegetable 49 meal f strategy decline contrast indirect multifaceted tool specific measure nose benzalkonium clinical healthy genus host bone cough reproduction dyspnea worsen pattern disease cerebrovascular phytonutrient critically 4 avoidance man progression high sixty-five adaptive diet o maintain sars-cov 51 vitamin hemoptysis orbiscindens-derived micronutrient cigarette concern influence tobacco numb coronavirus 34 6 bs isolation organ include necessary primary 18 hand 44 function china highlight impact temperature global case smoke impair washroom aerosolization healthcare journal viral face functional despite influenza cancer lifestyle low-grade facecovering industry basic raise approach occupational infection coronary acute 16.9 prevention second-biggest material 5·8 help food 9 cause macro-and preventive co-existing 2 deficiency keratin t degree 32 generally medium iron prevalent 5000 covid-19 61 85.6 heart ill copper droplet therapeutically cytotoxic 0.5 thymus 76 ifn chlorhexidine minute nutrition p 58 5 improving exposure 36 oral amidst eye 16.2 epidemic personal possibility 10,000 represent moderate bi-directional anti-inflammatory evidence current 15 35 look component 60 analysis 29 cell establish proper 23 attention compound increase substantially polyphenolic potential 75 fit condition sufficient clostridium 12 transmissibility come mucosal status c cluster zoonotic person immunity manifestation probably period immune-supporting mention dietary mask sensible j 17 history diminish challenge mers-cov system positive benefit 56 -p lymphopoiesis mucin factor certain identification east lactobacillus general physical sars distance recombinant prevalence action fruit common supportive transmission space zinc asymptomatic introduction age appear finding cook metabolite latethirties systematic 5.5 finally provide steel balance', '', 'fatality march generalize male intrinsic major 1.6 outbreak simulate 0.6 2 0.8 support 6,284 n 0.7 covid-19 scale distribution \\ufeff1 examine sub-exponential p korea 1.5 addition rapidly study south 1.4 u growth parameter r 2020 42 f old e empirical indicate probability daily measure aim increase effective result reproduction conclusions delay l present cluster high o discretized female social j confirm interval 0.4 crude generation early numb ci 6 control estimate -p include source base extract model 1.1 distance dynamic case publicly compare transmission available identify rate implementation age sustain death 95', '', 'severe infection objectives acute natural frequencies respiratory 2-years notably 25 9 respectively month little hcov hospital childhood distinct 47 1471 protect n 229e determine mild 1 background 20 5 design addition hku1 207 know infant seroconverted pathogenic study obtain 14 hcov-oc43 serology tract subsequent frequency indication 15 rarely 60 frequently elicit old follow sequence explain healthy group time hcov-229e infect conclusions 0 majority lead disease absent immunity 19 17 hcov-nl63 positive early coronavirus child comparing hcov-hku1 observe real uptake 85 human hcovs seroconversion rt-pcr results monitor reveal oc43 occur nl63 crown rate extent hospitalize newborn', '', 'mers-cov concern past raise safe coronavirus syndrome control geographic vaccine rapid novel spread increase respiratory effective east cause potential mers month case pandemic middle development mers-cov.', 'acid severe virus raise march infection swab acute change respiratory rna undetectable laboratory january 2 kindergarten characteristic treatment covid-19 remain shandong determine collect radiological shed datum closely detectable 20 spread qingdao lag possibility transmit patients persistent tract negative day 2019 long 2020 february paediatric prevent fever province syndrome abatement 23 follow clinical result time conclusions infect disease nucleic exist sars-cov-2 4 fecal pediatric patient epidemiological objective 17 methods specimen system coronavirus child 10 profile school china throat massive clearance dynamic results stool fomites monitor contaminate case test occur week viral 8 effort reopen gastrointestinal level', '', 'small variation enterica infection strong structure glycan prevention rapid document develope fimh 9 complex carbohydrate outbreak adhesin local degree microarray glycans conformation id allelic \\ufeff1 e.coli different atcc9184 isolate pathogenic serovars carbohydrate-protein words probe subtype mediate contain key exhibit construct k−12 result time potential r965 disease great 12 salmonella apply high investigate patient interaction detect bl−21 strain single optimize number article code include clc bind certain mannose bacterium powerful vital detection atcc31685 common test mannose-coated affinity suggest foodborne method infectious', 'severe classify molecular research virological structural acute broadly envelope prevention assembly respiratory expression help cause country encode knowledge protein sars-coronavirus generate term open treatment product profound b event sars-cov. kb comparison spike genome novel agent study 14 gene community contain coordinate year membrane re-emergence 30 syndrome 1a/1b replication replicase progress group potential accessory 2002 decipher disease read c unprecedented nucleocapsid sars-cov important coronavirus specifically emerge 2003 sars orfs frame global disturbance property manner investigation coronavirologists identify aetiological viral functional end characterization homologue infectious worldwide', 'industry severe virus research chick niche coronaviruses tunisia respiratory chicken database protection genotypic cause tendency ecological 2 animal cr88 distinct hepatic lesion serotype association low covid-19 remain response ibv tracheal divide right h120/cr88 drop 1 mortality tn20/00 70 character-ization mass 5 active free mutation vary immunize eye repository 793b confer poultry protocol heterologous couple economic long affect fund industrial nasal allow renal analysis sign 3 h120 covid broiler adaptation fail indicate vaccine measure increase clinical result host conferred group severity infect unrestricted original disease lead 4 apply centre type high experiment based mean accord strain bird re-use confirm reduce conduct livestock vaccination conversely combination wide 2000 bronchitis acknowledgement challenge evaluate coronavirus especially 6 elsevier source summary observe base 10 resource loss serological kidney form meat crossprotection observation attribute publicly compare macroscopic egg-laying grant rate score neurological recombination foremost performance flock enteric range infectious level', '', '', '46.65±13.82 predictive change breath 573 obvious laboratory protein purpose 2 characteristic shortness jan n correlation abnormal lymphocyte low covid-19 yidayang65@zju.edu.cn vomit yang coexist p<0.001 datum threat normal p 72 bilirubin exposure onset nausea patients creatinine negative u index r excluding affect long higher subtype p<0.05 ρ=-0.657 f dehydrogenase radiograph fever old 3 e c-reactive median 230 feature condition(28.8 lanjuan aim health patients(all clinical non-pneumonia combing time cough severe/critical albumin great l expectoration type high patient enroll investigate image yida o manifestation epidemiological creatine lobe j 17 history headache sodium feb analyze li 2.0 -p oxygenation lactate observe ct factor highlight results kinase \\uf0b7 world undergo serum x-ray predict pneumonia rate 8 score admission finding effectively confirmation(5d muscle total ache level', '', '', \"research march database 31 viable mobility discuss 2 restriction term covid-19 ministry st technology datum government 1 management background direct addition telemedicine scholar study far diabetes evidence utility 2020 option key consultation 3 tool face-to-face health scenario effective regard covid-19'up array ease limitation pandemic exist india state pubmed access google patient period choice wide travel emerge depend article include difficult simple require useful handle physician manage family general feasibility limit available aims welfare search guideline seek lockdown mohfw role principle view\", 'acceptance early version e article -p additional file p pertain process disclaimer visibility page addition record copyediting publish definitive form https://doi.org/ cover typesetting note error metadata f undergo pdf apply l u n cite journal r o affect format production review readability discover content enhancement final j provide legal', 'acknowledgement http://dx research covid elsevier source active resource database free food form repository feed unrestricted original publicly safety centre grant long covid-19 fund remain mean re-use right systems analysis', '', '', 'research carry conclude size pose pte respiratory database 1860 particulate reduction prepare ltd fit-tested interquartile logistic 100-fold protect non-fit-tested significant covid-19 16/22 remain volunteer st right 0.05 ffp2 airborne difference achieve overcome p novel active proportion free 22 promise repository warrant study epidemic 193-fold 184 lab reusable particle 145 far u r long fund randomise singapore significantly 1862 analysis dream mn count n95 3 covid median filter usa healthy 19/22 s fit unrestricted 135-fold original 1860s device considerable statistically centre 200 high efficacy high-efficiency subject mean compact re-use mask m protective acknowledgement totobobo hepa paul control elsevier source facemask cut 83 factor resource problem form y cross-over sufficiently test publicly compare transmission investigation air filtration grant pilot deal performance range recommend', 'uncertainty empower enable approach advocacy ensure non-specialist care play core management essential position rapid service specific proactive specialist tool primary useful succinct resource develope design compassionate complex capacity information spcs disseminate location local palliative global vital pack pandemic colleague education crisis symptom support high-quality up-skilling decision-making guidance face collaboratively expertise adapt covid-19 good consideration plan response likely overwhelm clinician provide role challenge', 'severe exhibit virus find system coronavirus especially research infection syndrome nervous acute respiratory possible function neuroinvasive neurotropic cause damage know explore pathobiology impact disease 2 detrimental sars-cov-2 cov complication property fluid cerebrospinal viral recently neurological review important brain mechanism incompletely', 'illness severe virus 1 kill coronavirus syndrome \\ufeff1 acute base novel agent epidemiology respiratory november clinical china 26 cause publish country sars 2002 infect diagnosis knowledge experience study sars-coronavirus personal case occur state present identify derive treatment 774 presentation introduction current 8098 ago overview year', 'research material database food versatility engineer major biological discuss waveguide environmental t planar science escalate covid-19 b remain h configuration right safety selectivity p doubt different active free biorecognition biology repository diagnosis signal introduce collaboration r long fund review fluorescence-based platform principles year g chemistry analysis application transducer covid fluorescence fiber clinical physic publish s unrestricted field original device l centre c technique optic popular high sense mean focus area re-use recent wide work joint acknowledgement specifically main elsevier source base include paper require resource reader form general researcher optical publicly recognition sensitivity grant goal good biosensor element overview provide principle scheme', '', 'acknowledgement cell poliomyelitis research carry covid measle likewise elsevier source vaccine way active resource database free form laboratory repository infect unrestricted original disease world 2 publicly development biochemical centre investigation cultivation assay multiplication viral grant viruses synchronously long covid-19 fund remain mean re-use impossible right analysis rubella culture', '', '', 'fatality virus impairment research de infection obesity relationship jr ma huttunen 1177 43 database schultz antigen-specifi diet-induced associate peppas 9 rev sa 2 mr charlton pa 131 ap ja intensive treatment poor reaction covid-19 harrison remain response meta-analysis karageorgopoulos uenza tseng t-cell bacteraemia right vol falagas illness c. 70 care hogue ect mass 127 5 active free 2006 repository critical marcos athanasoulia 2009 eff hepatitis rj index r long alter fund infl review vuento 35 2010 laine j. cw jf g selective analysis ag hepatology cell sheridan e 2001 covid obese pockros beck prognosis www.thelancet.com/infection syrjänen 84 infect unrestricted spronk original pandemic july 2007 443 centre 1152 c 7 patient outcome colantuoni jd stearns chest mean mj smith med reliable re-use j 2005 cd8 683 acknowledgement 13 6 elsevier source 10 280 martinez ection pj 11 pe dis factor function resource dendritic 40 form bmc impact ratio marti overweight 89 case refl publicly smoke chronic immune 86 mouse grant 8 icu lumio systematic obes body', 'dog dependent past virus trigger severe coronavirus spike province infection outside high-homology recover observe shield violent worthy attention time-lapse intervention taxonomically-related unconventional elseways clinical human china recurrent exposure result hypothesis form postulate biological infect experimental protein contact study circulate sars-cov-2 responsible evaluation far desire immune progressive patient outcome antibody suggest hypothesize covid-19 epitope short reaction based hubei confidential enhancement mild mechanism', '', '', 'acid severe virus find molecular research infection structural acute envelope rapid summarize respiratory expression wane aspect cause origin 39 country encode major protein 1a in-depth january term open unique profound expeditious remain sars-cov. re-emerge kb spike offer genome localization novel different process november vary ii know epidemic expect 14 gene subsequent review contain effect membrane 2004 30 amino syndrome replication replicase length forgive potential infect 2002 accessory biochemical read iii patient cellular attack nucleocapsid sars-cov area unresolved human-to-human coronavirus especially control nearly isolation essential guangdong human function china 274 1b 2003 orfs frame detection disturbance reservoir(s homologous serum clue eventually transmission viral antibody efficient characterization homologue worldwide', 'pathogenesis immediate virus find analyze numb coronavirus therapeutics define attract infection \\ufeff1 structure recover thousand remdesivir attention novel specific increase difficulty clinical solution china immunogenicity sars drug relevant medication situation experience action purpose corona lead great disease feasibility case pandemic immediately 80 apply previous far initially available point patient identify synthesize conventional 2019 covid-19 start experiment end globally wuhan 100 trial pharmacological conduct infectious homology feasible', 'acknowledgement p450 adjunct dna 3 research bowel covid elsevier source ps chemotherapy goldfarb 5 oxaliplatin active resource database free bind causal involvement hypotheses form 31 repository unrestricted 2005;64:802 wiseman original publicly therapeut centre cytochrome appl grant isoenzyme long covid-19 fund remain mean target cancer med ros re-use j res 2005;5:24 right analysis', 'batchs severe incubate virus elisa dillution sinica acute 1:40960 remarkable change 2-week respiratory lymphopenia respectively obvious country add μl/well testis protein threaten generate symptom sample assay antigenicity reaction plate response el-isa microtiter heart opd dilution affirm severely normal 1:1000 vol.22 igg novel 20 spread 5 biotech substrate immunize stop immunogenicity rapidly lung spleen inactivate epidemic neutralize mol/l characterize day 2-fold wash reach dyspnoea sino-american radiography serial 100 humoral contain μg/ 60 effect min peak activity rabbit elicit fever indirect sigma pbst syndrome importance vaccine specific health clinical stain effective auricular result value group time progress 37 96-wells present thirty o-pheny-lendiamine 7 immunosorbent ml public detect micro-cytopathic sars-cov 51 liver specificity interval hrp-conjugated goat-anti-rabbit proteinchip 1:2560 evaluate coronavirus 1.0 2.0 observe vein slide histopathological kidney 2003 sars adjuvant experimental titer enzyme-linked preserve coat virologica test serum development h&e immune identify viral slight antibody suggest good saline finding total worldwide', '', 'severe percentage basophil surveillance infection neutrophil-lymphocyte-ratio screen non-severe myalgia male breath laboratory dry tend monocyte eosinophil mainly t shortness symptom lymphocyte treatment low covid-19 fatigue subset act 452 elevate collect illness datum 58 novel memory 5 diagnose diagnosis critical patients helper inflammatory peripheral 286 significantly year count 235 cell fever leukocyte median increase naïve group cough examination expectoration hamper high patient regulatory demonstrate cytokine obviously decrease analyze recruit numb coronavirus especially early helpful include damage nlr case common compare infection-related good age biomarker level', '', '', '', '', 'find define infection retrieve population country knowledge rsv particularly outbreak taichung local little term correlation trends covid-19 relate response datum practice kaohsiung \\ufeff1 risk shortage given searches nationwide explore rapidly study epidemic moderate reach affect potentially strategy peak lag0 proper specific follow lag-3 increase user result \\uf0a7 volume time potential information location situation subregion pandemic ongoing taipei google high public objective detect demonstrate period mask relative taoyuan taiwan lag-2 coronavirus gradually tainan emerge gt import appropriate handwashing communication 26 results monitor case announcement common lag-1 restlessness face robust urgently search provide worldwide', 'severe transcriptionpolymerase virus acute coronaviruses respiratory develope degenerate laboratory hcov animal sample 32 assay open reaction murine ibv gastroenteritis agent different design copy addition study bcov hcov-oc43 reverse represent hepatitis amplification tgev chemistry exhibit crna syndrome tool specific clinical species potential hcov-229e green disease one-step feline read high etiologic detect generic sars-cov primer strain specificity hcov-nl63 bronchitis enable uncharacterized coronavirus transmissible mhv observe base sybr include 10 chain human 1b rt-pcr frame detection canine diagnostics sensitivity real-time bovine enteric infectious', 'acknowledgement influence early research mortality exceedingly rapidity covid acute care elsevier source angioplasty thrombolysis active resource database free form repository infarction reduction reperfusion unrestricted location original inferior publicly therapy delay excessively manner centre available myocardial revascularization patient grant efficacy swiftly long covid-19 good fund remain mean decide choice method timely re-use provide right analysis', '', '', '', '', '', '', '', 'perianal research material database 220 40.2 breaths/min note node t clinically region significant covid-19 6.9 remain weight mild right 1 normal cm gingivitis active free alert diameter 36 ambulation abdomen s. repository rr 7/9 ° long fund musculoskeletal membrane f analysis covid kg lymph cranial stain nodes condition green unrestricted original present centre c fecal detect mean re-use abnormality palpation crt acknowledgement hydrate haircoat beats/min elsevier source unkempt pink hr 104.4 resource form general responsive resent publicly grant score cat mucous body quiet', 'team coronavirus self-compassion child wise care rapid change consider way honesty trust grind skillsets communication help value connection family preparedness communicate legacy expand unpredictable palliative lifecycle safety recognition sensitivity face encourage children future routine grandchild death community-building key train', '', '', 'behavior fashion formal coronavirus offer provider belief include novel spread health possible commentary context model communication distance toolkit guide reinforce pharmacist disease limit prepare mitigation emergence pandemic home apply present healthcare unprecedented patient covid-19 community remain social timely overview suggestion uncertain provide hbm challenge', 'asthma rhinitis research adjust infection wheeze clin assess participate respiratory 81 database associate follow-up cause occurrence 66 purpose upper childhood allergy sample logistic association covid-19 remain poorly right presence 1999 rhinovirus encounter background p infancy atopic possible active free 22 know infant repository versus study nasopharyngeal initially index subsequent long fund regression 100 atopy 4.14 analysis covid rhinoviruses freeze 71 relation result regard enteroviruses unrestricted episode sex original disease 12 .047 enterovirus commonly odd immunol present centre investigate outcome adequate etiologic objective mean important period re-use 1993 j rhinovirus-positive single reevaluation 16.77 methods 2000 acknowledgement dermatitis early recruit evaluate coronavirus ci child elsevier source 10 1.02 resource 27 form rt-pcr results ratio 1992 school-age detection case conclusion common 2003;111:66 rv publicly development supplement 33 rhinovirus-negative available identify viral grant entry age hospitalize finding mix inducer aspirate role 82 95', 'acid find ratg13 reservoir natural close cause respectively occurrence outbreak protein 2 s1 cov sample furin covid-19 relate conclusively aside datum 1 closely motif novel covs spread whole-genome mutation liu explore lung study lose pangolin site 2019 evidence wholegenome 91.02 contain key malayan s1/s2 amino widely batcov residue protease sequence involve completely host species publish consistent potential graphical disease sars-cov-2 present interaction detect sars-cov-like genomic wuhan relative highlights intermediate coronavirus begin city control identical summary observe pangolins human abstract china ace2 currently pangolin-cov cleavage vital sars-cov-2-like recognition evolutionary dead suggest putative 90.55 rbd worldwide level reinvestigated', 'virus 0378-l research 103 united 43 change summarize population database spongiform morbilliviruses cause kqvwords apparently emergence animal try genetic fact science encephalopathy carnivore simian covid-19 event remain medical mechanism replicate right ientiviruses threat parvovintses agent active free know isolate repository pathogenic epidemic instance parvovirus recently efficiently microbiology long adapt alter 115 fund review kingdom variety analysis old covid i995 dramatic importance co-circulate host constant clearly reserve potential 0 unrestricted evolution original disease feline pandemic replacement fundamental centre place mammal demonstrate appearance mean strain re-use true wide b.v. ssdio378-i acknowledgement susceptible understand permanent coronavirus transmissible elsevier source veterinary observe emphasis resource human form 1995 122 frequent rare common immunodeficiency canine publicly occur responsible 135/95/$09.50 grant influenza sudden appear bovine range particular', 'severe virus find research de infection objectives rhinovirus/enterovirus acute elucidate 12.1 respiratory database laboratory suspect 2 t characteristic sample association intensive co-detection covid-19 b 6.9 remain variable codetection bocavirus right datum co-dection 1 difference dysfunction care 58 tachypnea november active stay free rio repository a(h1n1 mono-detection admit study syncytial 2009 h1n1-negative r long fund 3.5 frequency 22.4 fiocruz/rj 2(5):402 year analysis longitudinal 43.1 fever covid median unit length specific h1n1-positive clinical 63 completely 71 result picu relation 8;2 regard group severity cough june infect s 0 unrestricted amine 411 original ventilation sari picus pandemic 38 centre c pediatric high patient outcome braz organic mean leukometry re-use j adenovirus retrospective decrease acknowledgement hospital/picu analyze positive numb child comparing elsevier source profile 11 41.4 18 metapneumovirus dis resource human extract form vírus observational results describe mechanical clear detection case h1n1 test occur publicly compare viral grant influenza send age method death role janeiro', 'classical virus approach ed guinea electron novel agent sequence material virtually causative associate identifi pcr disease genetic microscopy gammacoronavirus responsible metagenomics avian present nextgeneration sample identify technique fulminate unbiased unsuccessful fowl allow virology culture', 'research acute m. difficulty nipplepail database definitive largely etiological a. discuss dairy therapy milk science labor open physiological treatment covid-19 107 treat event remain 464 h 51:452 right diarrhea speieher 108 calve lamaster young direct agent jj active wing free know repository diagnosis k. cost open-pail long affect fund j. principles question t. effect analysis 83:42 skim 109 gain empirical covid wise responses sol huber effective neonatal vet orally unrestricted 1968 original 51:971 centre fluid mean sei remake eolostrum re-use receive acknowledgement ree system control elsevier source g. difficult resource abstract outline 1958 form feed acidosis fee abstr high-solids dehydration antibacterial publicly journal grant wooden rate i.p. mix 41:1434', 'find elisa research infection database 25 develope associate outbreak staff sample seven significant covid-19 remain nec right comparison difference gastroenteritis risk correlate p 20 active enterocolitis free pediatr infant repository epidemic day necrotizing long evidence affect fund 1982 analysis unaffected covid member 27.5 serologic time august unrestricted original disease rotavirus centre patient attack demonstrate mean re-use j 1983 recent acknowledgement 103:454 positive elsevier source 10 nursery factor resource human 40 0.0001 form traditionally stool reveal highly test occur publicly development hrv hemorrhagic grant rate gastrointestinal', '', 'similarly ahr socioeconomic research adjust 0.815 0.024 database associate respectively gender setting major 0.48 reinforce 0.68 1.73 hong initial association covid-19 district international remain antihypertensive likely right eligible practice mortality difference kong p background management service agent comorbidity scarcely active free sector randomized 0.939 explore repository study 0.92 first-ever prescribe suitable combine diabetes hypertension long evidence fund 1055 ☆ 33,288 ratios year renal analysis adherence incidence newly 2001 covid prescription score-adjusted follow clinical effective die group 0.83 218,047 cox conclusions unrestricted medication cohort original disease residence exist status adjusted centre patient 0.287 public mean accord trial re-use reduce 2005 methods proportional acknowledgement class evaluate numb real-life elsevier source include hazard propensity 1.02 resource model form results drug 15.3 acei 0.87 publicly healthcare first-line provide beta-blocker grant age guideline predictors finding all-cause death range c.i. reference recommend 95', 'severe 8.8 impairment adjust march infection acute reflect respiratory develope associate laboratory major pathologic outbreak hospital hong seven presentation significant 48 tubular 6.7 multiorgan light failure 1 apart mortality \\ufeff1 kong normal risk p background novel 20 different 5 36 onset admit study share creatinine microscopy complication day dr. parameter evidence multivariate significantly renal analysis fever 0.001 syndrome newly postmortem median complicate feature follow context clinical plasma die concentration prerenal chu predominantly tissue examination 4.057 536 high patient necrosis duration sars-cov pathology insult relative conduct distress retrospective methods joint coronavirus emerge vs. observe paper electron lai factor glomerular regional kidney 2003 0.0001 sars results describe reveal 91.7 authorship occur development compare exert eventually 33 viral rate despite age range level', 'acknowledgement 2015;51(11):590 arch research e covid elsevier source neumonías bacterianas active resource database free bronconeumol las form repository w unrestricted revisión original publicly l centre c u n grant r long o covid-19 fund b remain mean del h infecciones respiratorio re-use 597 sobre víricas g right aparato analysis', '', '␣ severe virus find enter infection acute 1.2 respiratory donor 1.75 protein 2 cov association significant 50 production 229e response poorly replicate examine novel given possible previously 229e-infected preliminary study published similar tcid interferon far particle derive produce phagocytosis 3.5 purify productively possibly cell ifn- syndrome pm importance course result (ifn)- infect 2.7 differ detect demonstrate sars-cov sars-cov-like important microscope b.v. /ml coronavirus 6 oc43-infected elsevier 10 electron human sars describe unlike titer limit case oc43 interest immune viral alteration suggest range monocytes/macrophages', '', '', '', '', '', '', '', '', '', 'globe datum analyze multimodal coronavirus build threat train/test employ paper special tool attention procedure novel machine different process spread require possible clinical aidriven active primary model help promise artificial multitudinal outbreak paradigm unlike epidemic expect purpose global learning-based ai ai-driven cross-population nature healthcare issue intelligence identify ml forecast decision-making treatment 2019 learning covid-19 algorithm good future detect mean late', '13 1 coronavirus hku7 kong swab observe hku2 rickett bamboo novel 309 20 different bat discovery previously rna-dependent-rna-polymerase species addition diversity group rt-pcr 37 anal describe location reveal great 12 2 16-month gene lesser hku5 hong japanese bat-cov hku6 horseshoe capture hku8 helicase bent-winged big-footed hku4 analysis period bat-sars-cov pol area astonish pipistrelle existence phylogenetic amplify recent rural chinese', 'severe virus approach 123/174 acute fast pbs cause conserve sensitive phosphate-buffered reproducibility sample assay n 51.15 region low accurate realtime cross-reaction southern sads-cov 2017 diarrhea datum 1 \\ufeff1 genome taqman-based homogenize novel 20 design pcr rapidly specimens study gene synthesize probe 15 establish syndrome indicate 3.0 freeze pig specific swine clinical thaw effective time disease × quantification centrifuge high conventional detect primer specificity sads-cov. reliably positive coronavirus emerge observe base 10 70.69 china rt-pcr results limit detection order sensitivity viral rate copies/μl. 89/174 w/v real-time saline method', '', 'globe planeta evidenció año un birth research de carry reflejan conclude relationship estudiados pero individuos temporal colomb esquizofrénicos comportamiento database psiquiátrica la durante más hallazgos embargo concluido características con directos obvien rev. desarrollan implicaciones relación estudio prenatal covid-19 enfermedad algún remain multiple luego se partir respecto right vol objetivo historias estudios meses población estacionalidad aun que por infecciosos clínicas ausencia 2011 ciertos agent efectos periodo active free ello discusión lo repository nacimiento sugiere posibles tasas revisión exposición número study muestra expresarán datos deben long fund tienen agentes effect pacientes analysis clínico múltiples impidió lluviosos propuesto presente entre santa covid ciudad individual clásico futuras cerebro métodos sin sí unrestricted el original 4 atendidos para centre introducción desarrollo patient desarrollarse seasonal los no. 660 mean period alrededor en re-use limitaciones psiquiat estos acknowledgement efecto analizar colombia así probable elsevier source nuevos documentan mayor riesgo ha esquizofrenia develop schizophrenia certain resource 40 ejecutados resultados estacional las form general y basado publicly años estudiada expose grant ejecutado provenientes institución introduction existencia comparar una nacimientos descriptivo del cuadro marta sobre late infectious investigaciones', '', 'leaf virus 1969 sh research predictive nile rw tumefaciens khan resistance database b. associate sanjaya v geographically archives 259 single-stranded av2 support 32 n virus-satellite covid-19 remain multiple prasad se dnas right bull 1999 kirthi lineage maiya satdna motif 1986 novel hs brown active free isolate repository begomovirus clcud gene circular briddon represent antisense long divergent fund savithri virology analysis 199 agrobacterium 109 covid rep-binding s unrestricted 190 original disease cotton curl centre mansoor idris mean 19 re-use bashir 2005 single sita gl acknowledgement dna jk elsevier source vvs resource gezira identification 148 2003 form basin sp transgenic publicly development pakistan grant monopartite', '', 'severe virus antiviral structural structure acute screen coronaviruses respiratory rna develope ribonucleoprotein cause complex inhibitor encode major protein pocket cov generate distinct n significant multiple virtual determine healthrelated covs agent cycle hydrochloride hcov-oc43 middle numerous n-ntd economic hinder pj34 n-terminal 3d syndrome n-ntd−pj34 replication play 5′-monophosphates disease present propose nucleocapsid consequence reduce basis coronavirus include human model east form rna-binding ribonucleoside crystal n-(6-oxo-5,6-dihydrophenanthridin-2-yl)(n domain identify cov-oc43 viral affinity guideline target ribonucleotide-binding finding protein-based role n-dimethylamino)acetamide', '', 'severe virus surveillance acute rapid respiratory country outbreak month traditional prompt 2 28 characteristic term syndromic successful covid-19 countermeasure 2800 determine difference spread political strike rapidly quarantine large-scale strict enforcement 2019 community 2020 contain ultimately peak contrast similarity incidence syndrome interrupt measure health clinical effective result 000 severity matt contact top-down disease transmissibility implement patient differ public 8000 mean period area confirm reduce human-to-human feb coronavirus begin isolation 2003 sars 800 global case eradicate eventually transmission exportations extent effectively death infectious 82 fully', '', '', 'enable past virus early therapeutics coronavirus spike province antiviral infection emerge date article glycoprotein vaccine develop novel spread human develope design china progress mers efforts country sars s major drug highlight protein experience study candidate halt disease limit advance animal exist sars-and neutralize cov ongoing randomize decade efficacy treatment effort 2019 antibody covid-19 hubei target wuhan focus trial inducer counter mers-covs vitro history worldwide', 'o f e l pre-proof -p j p u n journal r', '', 'enable thousands safe approach outside special united health require resource exposure unnecessary states assessment home sars-cov-2 test evaluation collection collaboration healthcare intensive innovative public avoid utilization set specimen', '', '', 'severe classify virus find research infection acute prevention intravenous complete 500 change wet respiratory database protection surgical lancet associate rise cover add little survey 2 hospital staff non-responders generate logistic support association recall corona-like significant covid-19 event remain masks crucial medical likely right nosocomial roster illness airborne 1 droplet saliva risk break phasis p=0·0224 active free rotate exposure repository lung 1·2 admit disseminate improve study expect personal exclude easily scan initially index questionnaire shift recently methylprednisolone long fund doctor regression inflammatory thrice intravascular significantly publishing effect radiograph g analysis contrast 33-year-old gown 30 fever n95 selection 3 syndrome covid member return feature importance daily measure ribavirin hand-washing effective night group information infect fit ward condition unrestricted contact orally stepwise original omit viraemic illustrate query present centre coagulopathy patient place wear adequate probably concrete chest mean non-infection re-use mask reduce 356 non-infected request acknowledgement 13 concern behaviour contract numb four-fold leave glove essential elsevier source paper simple develop ct 85 resource handwashing model 102 form aerosolisations sars forward clear mg case precaution publicly reproduce transmission bias unexpected mark grant 69 face antibody suggest good final communityacquired table level recommend', '', 'excluding o f text 430 e l n main -p j p u reference r', '', '', '', 'pan-coronavirus severe past virus reservoir antiviral approach infection structural acute rodent bat opinion respiratory population discovery close modulate associate cause setting cover protein outbreak discuss emergence ards treatment multiple lethal circulation safety datum therapeutics mortality areas risk novel spread lesson vary nonstructural pathogenic middle neutralize antagonize review vulnerability 15 year re-emergence activity syndrome primate indicate increase health result host potential mers contact expert disease learn pandemic lack progression zoonotic high efficacy cellular public future based sars-cov focus history distress morbidity mers-cov system coronavirus emerge article essential profile require human model east general sars drug highly capable person-to-person viral persistence introduction good nonhuman element provide level', '', '', 'past research clark infection prevention summarize symposium database financial science support dissemination presentation covid-19 remain right practice advocacy care active free repository improve contribute long fund review publications/reports professional year analysis apic 3 covid foundation importance individual follow epidemiology health synthesis clinical rf result unrestricted field realize original state apply present centre issue outcome select mean scientific area re-use m recent peer-reviewed acknowledgement lecture sentinel control article elsevier source base annual resource form publicly journal grant goal forum implementation guideline provide kimberly', '', 'virus environment coronavirus clean daily stable possible human laboratory notion tests ambient condition viable touch temperature reinforce reveal contact university simulate surface classroom day transmission 7 suggest 229e remain finding strain humidity contain relatively relative cov-229e light frequently', 'consolidation 54 007 leukocytosis screen complete opacity 43 totally difficulty 25 lymphopenia follow-up 9 respectively 9/161 clinically-diagnosed compared laboratory 614 outbreak little january assessment neutrophil pulmonary 67 28 symptom initial lesion n covid-19 50 16/322 distribution globally modality 37/131 48 mild elevate confirmation 98 twentythree datum presence retrospectively 94/131 adult normal p background 72 ggo 20 9/13 5 involvement · 36 exposure 8/10 versus 001 epidemic 14 day scan 2020 review peripheral 59 february 24/131 effect 70/161 mixed improvement 16 non-pregnant 3 feature aim increase clinical woman interpretation group severity 37 0 disease reticulation predominantly 80 4 ongoing progression patient investigate bilateral predominant laboratory-confirmed detect 153/322 chest choice timely pregnant history ground-glass atypical therapeutic methods vulnerable concern 64 analyze early 6 56 child helpful findings include ct 18 identification 27 ratio temperature reveal detection case common undergo evaluation compare focal pneumonia 69 8 88 pure good finding body', 'consolidation severe virus life acute causation prevention myalgia respiratory close cause laboratory country discuss implicate dizziness threaten clinically production mild shed illness droplet young 70 novel spread 5 pediatr identifiable isolate mode soon preliminary tract patchy chill peripheral 405 radiograph fever province syndrome follow unilateral progress time cough dyspnea contact disease predominantly present patient bilateral chest indian area j headache coronavirus definition child probable include primary guangdong china high-grade 2003 sars fomites sputum reveal case precaution transmission investigation secretion suggest short rigor 401', '', '', 'research antiviral structure antitumor line database ¼ 2 t proof protect significant 50 covid-19 b unequivocal murine remain stereostructure pyrimidinone leukemia arabinosyl d-(à)-arabinose right furan[1 l1210 molt active free 7.9 repository series fuse obtain b-d-arabino 4/c8 arabino-pyrimidinone synthesize r long cem fund mm analysis activity silylated exhibit cell amino newly covid compound synthesis derivative cem/0 s 0 unrestricted original annulation centre c t-lymphocytes mean tricyclic re-use vitro acknowledgement evaluate 6 elsevier source 10 oxazoline ic 7.5 heteroatom resource human form inhibitory publicly x-ray cytostatic 4,5]oxazolo-and grant nucleoside', '', '', \"virus research ont de évolutifs viraux demeurent » population database viromoléculaires l'auteur l'espèce la émergé épidémiologiques humaine hantavirus leur connaissances etc risque initial interespèces adaptés covid-19 largement remain travaux se « right puis émergence avec contenu plupart d'intérêt marburg d'émergence rudimentaires d'adaptation que nipah première été dissémination encore agent ne active free simiens quels repository à alors des microbiologique d'origine voies disséminé étapes quelles long ces conduit fund souvent dédiée dans animale cet analysis virale est l'exemple foamy lien arn inter-humaine covid variés les comment nouvel grippe aviaire décennies biologique qui relation épidémiologie ayant donc mots-clés déclare unrestricted contact condition haut différentes original rétrovirus l'émergence pas maladies centre sont terrain mean dernières principalement en re-use inter-espèces sérologiques acknowledgement étudiées virales/transmission séance concernant associant coronavirus article chez avoir elsevier source hôte resource communication moyen form sras afrique par veille études pathogènes du publicly transmission mécanismes le grant résumé après l'homme ebola ensuite centrale durant\", '', '', '', '', 'acknowledgement small fever research fastidious infection covid henselae elsevier source active resource database free 24 human b. 25 gram-negative cause form repository curve hemotropic unrestricted bacterium original feline publicly centre grant long bartonella covid-19 fund remain mean flea-transmitted cat re-use right analysis scratch', 'acknowledgement 1997 escherichia research 1234 covid elsevier source g. biosynthesis subtilis factor active resource database free network form 31 bifunctional repository unrestricted original coli 1244 nucleic deaminase-reductase gene publicly centre acids grant regulatory riboflavin long covid-19 fund bacillus remain mean 15 characterization res re-use richter right analysis', '', 'concern coronavirus city province good approach heart \\ufeff1 fast equipment novel consider health respiratory china center protection country major cardiothoracic tertiary outbreak operate share local disease case pandemic staff transportation hit environmental transmission centre logistic issue hub national patient covid-19 public wrong detect international response hubei plan advent wuhan room singapore asia emergency preparation', 'incertidumbres un de infection special evolve population la aumentando generales knowledge evolucionando con inmunodeprimido infección muchas protect sars-co n esta covid-19 remain recipient recommendation propuesta población immunosuppressed como por risk p management especialmente .. clave comorbilidad recomendaciones proposal manuscrito palabras prevenir este transplant creciente u receptores r v-2 inmunosuprimidos resumen f renal pacientes manejo también prevent e persisten specific increase el pandemic sars-cov-2 4 l pandemia present manuscript para riñón está patient o los mean rápidamente 19 en j vulnerable uncertainty muy coronavirus especially article -p summary riesgo comorbid acción page kidney proteger general y aunque action quickly conocimiento específicas recommendations significa especial presenta trasplante una del grow sobre', '', '', '', 'severe virus surveillance research infection acute fast immunology respiratory c-w database protein link genetic cognate slow cite low covid-19 isoacceptor remain yang 2019-ncov host-specific codon right composition comparison genome novel chen different active free repository 590 gene consecutive calculating microbiology 2019 long affect fund translation analysis human-specific cell covid replication availability specific sequence synthesis di-codon host potential infect unrestricted original lead centre interaction sars-cov mean genomic strain non-cognate re-use acknowledgement coronavirus article code elsevier source useful resource human abstract syndrome-related form synthetic https://doi trna reveal m-f trnas publicly order transmission di-codons predict journal viral grant rate suggest capability provide', 'research allen 224 uncontrolled opinion database www.sciencedirect.com v evidence-based grade t medicine n covid-19 b remain multiple h peritonitis right nutrition p abcd data active ce free 1765 repository series study ✜ specify k novotny non-randomised u r long fund roudebush bj assoc g ta analysis 2004 application e covid justification dramatic clinical 71 result species vet s w unrestricted expert original feline iv dodd l read centre iii c mean ebm trial med re-use j m acknowledgement elsevier source base veterinary pathophysiological resource form experimental case publicly available grant online guideline infectious level', '', 'mystery research life burden coronary acute sepsis pathophysiologic vascular natural enhance special united high-risk ability crp platelet-mediated database help associate 200,000 pathobiology largely pathologic add stagger protein states implicate billion therapy ards delivery initial willebrand ali abnormal orchestrate burgeon poor covid-19 adp event remain thrombosis response ali/ards features effector mechanism right thrombosis-been facilitate illness mortality severely dysfunction platelet care risk quality novel intervention consider process 5 active plague free stratifi adenosine repository lung schema critical von study maladaptive recruitment percutaneous instance cost contribute annually comparably characterize hospitalization ammatory economic recently long affect evidence prominent fund infl immunopathology alter epidemiologic activation dysregulated effect increasing ultimately analysis pci kill leukocyte polyphosphates 3 cation incidence aggregation c-reactive covid thrombotic likewise underscore injurious player versatile individual substantially host pivotal severity potential s condition unrestricted original disease iib/iiia considerable tissue 4 uenced contributor gp 38 microvascular centre c progression hematologic perspective abnormally unravel patient outcome immunity injury necrosis chest apoptosis future mean important survive 1,2 re-use 17 pluripotential reduce history morbidity vulnerable acknowledgement in-hospital specifi understand begin 6 estimate nearly coagulation uence elsevier source include organ glycoprotein dramatically transcriptome/proteome function resource abbreviations factor 26 damage form impact highlight epsis expand diphosphate vwf publicly development body 658 immune grant rate suggest merely platelets-long icus appear target derangement platelet-associated death grow myriad range one-half role alteration considerably', '', '', 'acknowledgement hajj research 2001 covid elsevier source position health active resource database free 08 form repository unrestricted original publicly interest centre grant long covid-19 ministry fund saudi relate remain mean re-use declare icts right analysis confl work', 'consolidation 5.88 meet 58.42 infection 52.46 opacity summarize database random-effect 78.2 48.46 60.87 knowledge purpose december upper -february low covid-19 remain distribution meta-analysis 83.31 bronchograms right bronchiectasis 14.81 76.95 risk ggo proportion grind 69.43 3.38 lung pooled study expect 54.95 studies pave middle septal 70.81 interlobular pool 2019 evidence 2020 effusion affect review peripheral 65.22 5.42 anatomic sign 3 incidence 46.46 feature 81.41 adjacent symptomatic aim individual crazy involve 87.21 result regard publish 4.55 90.35 perform pattern lymphadenopathy commonly considerable pubmed high patient image manifestation criterium bilateral chest gap lobe typical 89.76 13 positive pleura especially date article estimate leave summary include ct model pericardial thicken detection common pleural identify air rate quantitatively search finding thin-section glass mix systematic total provide inclusion', '', '', \"molecular research de infection rw clin acute astragalus 1998;23:293 lyophilise panter chapter database exp la tenter immunological deficiency hartley validation rech ar 113 progesterone l'avortement 1985;46:1903 covid-19 107 remain ewe nest locoweed right 1999 comparison sarcocystis 108 sheep p cotyledonary active ce free 680 tokai pcr repository diagnosis à pathogenic ke infections sarcocystosis mcmullen lentiginosus 386 r long alter fund d'un abortusovis 91 res effect analysis pardon 112 covid bl vaccine milieu 114 legrande value species prostaglandin vet reproduction locoweeds unrestricted wj original james salmonella centre sanchis fertility heckeroth mean selenium med toxins en re-use j livestock 302 contre acknowledgement 106 species-specific elsevier source atténué lf resource form stegelmeier ann reduced publicly development 1984;15:381 1907 contaminé essai 8:53 grant nat method brevis 62 induce\", 'pan-coronavirus virus infection 27.3 screen 9.3 respiratory 4.17 associate cause knowledge 70.8 hcov sample assay 9-year significant paulo 1137 subset mild heart datum presence 1 difference risk background novel different comorbidity confidence study patients hcov-oc43 tract interseasonal community 1.9 frequency 50.0 year frequently 2004 monoplex 3 cyanosis follow epidemiology clinical 61.5 species spin hcov-229e conclusions perform dyspnea disease odd present high patient restrict epidemiological predominant detect 66.6 comprehensive interval conduct methods hcov-nl63 analyze coronavirus species-specific child são human hcovs rt-pcr general insight results ratio 2008 reveal detection 7.7 oc43 asymptomatic nl63 acquire 88 hospitalize real-time brazil provide 95', 'acid scaffold research glycoconjugates structural structure sepsis resistance database help catalytic inhibitor complex oseltamivir amphipathic pocket t perfringens catalyze non-carbohydrate-based covid-19 b serendipitous tamiflu remain right bacteremia comparison cpnani agent active free anti-neuraminidase substrate addition repository obtain similar site neuraminidase r long fund cd cyclohexyl neu5ac cholera analysis activity pathogenesis prevent covid ches anti-viral residue emerging host group arginine s unrestricted cpnani. clostridium original lead disease antibiotic resolution commonly 2-(cyclohexylamino)ethanesulfonic 2aminoethanesulfonic centre c cluster relenza zanamivir mean re-use moiety å anti-bacterial acknowledgement buff inhibit elsevier source fatal include develop n-acetylneuraminic bind resource human 1.24 hydrophobic form highlight drug bacterial crystal domain publicly development hydrolysis terminal grant influenza suggest serve target interact infectious', '', 'acid datum virus 1 molecular coronavirus spike amino closely transmissible \\ufeff1 gastroenteritis genome base enteritis complete designate novel subsequently sequence consensus diagnose clinical human associate group pcr feces frame protein study epidemic obtain similar epizootic porcine catarrhal feline gene genetically genetic case generate canine ece read present initially identify polymerase assay open clinically 3′ predict provide evidence ferret domestic relate nucleocapsid partial 229e terminus enteric phylogenetic membrane fecv analysis diarrhea', 'virus absorptive environment evaluate coronavirus cell 3 sponge 1 disinfectant infection disinfect survival glove source detectable titre strains aluminum hospital-acquired disinfection representative consider respiratory possible human chemical surgical cause appropriately hcov-229e dry add non-absorptive study little hcov contamination lead one-third upper premature hospital hcov-oc43 oc43 surface common tract infectivity sterile test characterize day proviodine medium product long suggest aqueous suspension 50 229e saline newborn standard survive h latex ® reduce susceptibility infectious solution cold culture', '', '', 'correspond small find research son allele bear 500 motherchild population linkage database close lancet cause major strength ctg n=95 genetic express expansion covid-19 b remain inherit right 1 kb presymptomatic difference assume 5 active free repository diagnosis inesa= dm.1 contribute couple amplification long evidence fund frequency regression repeat analysis intergenerational mother 1160 3 covid length explain severity longevity unrestricted sex original congenital man centre antenatal maternally spermatozoon fertility contraction mean important map re-use n=89 decrease acknowledgement disequilibrium main elsevier source factor resource pair form marker phenotype.2-s case dm occur publicly transmission grant father-child 8 despite good parental implication', '', 'coast prevent early frontline 1 write respond benefit emerge article \\ufeff1 control care additional united doubt nurse emerging time leader describe consume share purpose experience states cathartic-i 2 case colleague crisis west science support protect feel point unprecedented join encourage effort expertise covid-19 learning real-time important u.s allow officially principle', 'acknowledgement granule cell pancreas research islets covid langerhans elsevier source acd 20 population active resource database free approximately spherical inhibitor angiotensin form repository accessory unrestricted absorption original endocrine α publicly 4 enzyme opaque centre d angiotensin-converting coefficient grant pigment long covid-19 glucagon fund b remain mean ace re-use contain right analysis acid-citrate-dextrose', '', '', 'end-point research peptide ova helminth-derived igg2a database chimeric associate protein th1-type term product covid-19 remain response anti-ova igg1 right igg titre gp120-cd4 hiv-1 active free antigen helminth repository spleen study onchocerca protein-1 immunization long secrete utility fund 3446 stimulate activation isotype mpl analysis cell alum covid 23 anti-viral vaccine 37-mer potential s unrestricted rov-asp-1 th2 original volvulus augment centre exceed efficacy sars-cov mean cytokine re-use confirm 2005 single boost th1/th2 acknowledgement tdm ovalbumin elsevier source profile resource vaccinate unusually form potent recombinant adjuvant 3452 publicly property immune mouse adjuvanticity grant antibody th1 mix polypeptide total induce exclusively', '', '', 'virus inevitable infection concentrate structure b. inhibitor protein huh-7.5 hepatoma hcov n point treatment low 50 b non-immunosuppressive 48 h interruption mechanism evenly alisporivir hcov-229e-gfp genome er-bleb-like immunosuppressive cis-trans possible stay isomerase inactivate far distribute cypa cyclophilins ec abolish cell 3 nim811 replication compound cyclophilin derivative time potential hcov-229e s micromolar well-known cellular interaction nucleocapsid demonstrate post coronavirus inhibit include 18 cyclosporin bind function human -luciferase drug inhibitory candidate suppress viral encapsidation suggest effectively range csa peptidyl-prolyl', 'absorb acknowledgement utilize research utilization covid intake elsevier source ability follow increase active resource database free result loss center associate form appetite repository unrestricted original digest suppression occur publicly impair • lack centre exceed 330 grant long poor covid-19 inability fund nutrient inadequate remain mean weight metabolic cat re-use thin mechanism right analysis hypothalamus', '', 'acknowledgement practice research usual control covid case-control elsevier source nonrandomized rcts uncontrolled consensus opinion certain active resource database free clinical retrospective randomized form repository unrestricted cohort study expert original publicly • centre c statement grant crosssectional long evidence covid-19 guideline fund well-designed b remain review mean meta-analysis trial systematic re-use right level analysis', 'severe virus ocular coronavirus research anterior anecdotal syndrome emerge infection acute article widely uveitis novel covs document respiratory possible clinical human model china associate cause retinitis know highlight hope entity study epidemic december disease feline animal -2 cov sars-cov-2 tissue far neuritis optic 2019 evidence covid-19 conjunctivitis current suggest murine serve review start history implication', '', 'correspond severe fda peptide locate acute change respiratory inhibitor protein 2 link sarsassociated residue-rich approve point s2 region sars-cov. adopt facilitate central illness 1 conformation spike genome background motif novel hiv-1 agent anti-aids etiologically transmembrane active mode anti share study similar recently step fusion enfuvirtide activation zipper-like repeat strategy membrane analysis homology viral-induced activity cell n-terminal 3 syndrome member play anti-viral length construct sequence segment host c-terminal disease 4 coronaviridae differ sars-cov febrile aromatic conformational believe coronavirus inhibit include require bind juxtapose synthetic sars results gp41 action inhibitory reveal responsible leucine/isoleucine exert viral entry suggest upstream serve target heptad viralinduced c34 role', 'find research adjust size imply retrieve database associate cause country cow-years assessment dairy mr animal doe milk organically decade region covid-19 event remain multiple consequently variable right http://dx 1 herd season mortality calve difference \\ufeff1 risk multiple-year data 20 different possible active free record sweden holstein repository versus study exclude negative binomial fixed economic long fund higher regression herds 100 swedish j. 2010 year effect analysis farm covid single-year increase result time potential sci 2002 unrestricted euthanasia 4362 original herd-level great lower on-farm cow euthanize winter 4,252 apply present centre cluster house high enroll outcome organic conventional yield interaction predominant objective demonstrate mean period fall re-use interval confirm fix 6,898 acknowledgement system analyze evaluate numb comparable gradually 95 elsevier source include observe 5.1 6.6 factor resource farmer model problem loss 40 regional manage form entire pasture par average publicly identify dead welfare grant rate trend breed death 4352 scheme', '', '', '', '', '', '', 'severe 5±4 find infection assess non-severe web respiratory population database 25 help 97 compared country 21 outbreak 2 51±0 6.22)respectively 30±4 symptom science n prevalent covid-19 1.46 multiple meta-analysis fatigue cardiovascular 1 76 risk p background novel comorbidity sector 22 3.44 confidence study epidemic 2.46 14 random-effects initially u diabetes hypertension r deterioration pool 2020 1.76 59 february f cis 8±6 fever 17±7 3 embase 46248 e covid aim follow 67±7 health clinical -19 result cough infect dyspnea disease odd 3.83 pubmed l 4 68 2.36 widespread patient 7 3.42 o 1.88 wuhan j confirm interval conduct vulnerable system 34 coronavirus ci 6 estimate -p include underlie literature 11 factor model china 40 2±0 guide results ratio prevalence \\uf0b7 case compare 86 91±3 search 95', 'infection document change bat analytic population outbreak calibrate square discuss december little emergence actual flow covid-19 student collect solution datum 1 mortality 511 simulation korea novel consider spread process recovery ideal compose epidemic university topsis rush word ahp parameter r 2019 key similarity furthermore establish let return effective situation disease 12 4 propose technique future accord wuhan numb coronavirus begin urgent date code clc useful factor model china preference impact dynamic drug nonlinear penta-group world occur development order hierarchy predict rate trend method secondary', 'practice department coronavirus infection control prevention novel ct spread summarize lesson cause rapidly diagnosis improve epidemic learn case pandemic sars-cov-2 transmission support healthcare covid-19 chest radiography multiple suggestion world-wide radiology provide worker frequently', '', 'native virus cross define antiviral enhance gs-5734 ability analog resistance rna develope prodrug harbor fight porcine emergence animal efficacious cov approve assay 50 229e multiple cov. medical diverse datum therapeutics breadth monophosphoramidate covs know adenosine epidemic similar confer pneumoviridae hcov-oc43 sars-and far divergent ec potentially activity endemic dependent paramyxoviridae probability member remdesivir rdrp residue increase genus deltacoronavirus value species hcov-229e array disease submicromolar circulate present wild contemporary zoonotic future strain beta-covs livestock mers-cov filoviridae emerge include orthocoronavirinae human pdcov family potent currently clear highly oc43 compare avian transmission extend polymerase viral viruses unmet domestic target prone genetically rdv', '', 'acknowledgement validate specifi gravity research 2001 covid elsevier source measurement active resource database free value regard form repository unrestricted note refractometer urine original publicly body centre c uids grant long covid-19 fund cavity remain caution mean standard george re-use fl right analysis', '', '', '', 'past virus team life antiviral infection pose today life-threatening cause country transferable try contagious medicine support dosage decade lymphocyte treatment b illness c. threat background novel agent spread n1h5 proposal immunomodulatory relevant published ª interferon far easily hepatitis recently big year effect (hiv)-infected approval cure prevent arbidol attention individual increase health clinical disease safely present h9n1 type randomize propose person choice trial receive single combination coronavirus expectancy hand human 2014 ifn-c highly cd4 world immunodeficiency gamma avian viral viruses imodä influenza flu investigator prove effectively death provide infectious', 'severe virus elisa -thiogalactoside homogeneity infection structural acute ability determinant respiratory rna expression develope associate cause 0.3 major antigenic outbreak protein therapy express biotinlabeled antigenicity blot receptor-binding spike novel recognize soluble neutralize far probe purify contain 140-kda exhibit cell biotinylated syndrome chromatography indicate recover vaccine specific isopropyl-b-d mg/100 taken pet result vero s disease d ml patient cellular sars-cov anti-sars escherichia culture induction analyze coronavirus emerge 130-kda bind infectious form sars recombinant candidate coli envelop bacterial nickel-affinity responsible serum order identify western antibody suggest good vector receptor induce retain worldwide 0.2', 'acknowledgement http://dx system research covid elsevier source respiratory active resource database free form repository unrestricted infections original publicly centre grant microbiology long covid-19 fund remain mean re-use right analysis', 'severe virus placebo research carry infection fluticasone acute white clin prevention suggestive radiologic respiratory database 39 81.6 laboratory occurrence 21 protein tend little upper assessment sinusitis symptom allergy n clinically treatment low covid-19 remain determine radiologically right cold 98 illness 1 1998;102:403 adult young background consider 20 agent 5 sedimentation active free record recovery repository study complication day long fund radiography distinguishable effect significantly analysis frequently count cell prevent 197 sign covid reactive specific increase clinical concentration group unrestricted sinus original antibiotic immunol examination centre c randomize 7 patient outcome blood image intranasal erythrocyte etiologic objective detect subject mean re-use abnormality confirm diary rhinovirus-positive j methods acknowledgement early analyze especially gradually card 6 elsevier source profile propionate resource self-limit 40 form results bacterium prefer bacterial conclusion common occur publicly serum viral grant rate 8 differential antibody paranasal finding community-acquired total level', '', '', '', '', 'acknowledgement research covid wave elsevier source mass distention active resource database free abdomen form repository ballotment unrestricted original abdominal pendulous publicly • 443 centre fluid grant long covid-19 fund remain mean re-use right analysis', '', 'acknowledgement rossbach molecular research covid clin elsevier source rapid active resource database free clinical methicillin-resistant 2003 form pcr repository giroux unrestricted v aureus original detection sterile publicly sample centre huletsky assay 7 grant 41 staphylococcus microbiol long 254 covid-19 r fund real-time remain mean 260 contain re-use j mixture right directly analysis nonsterile specimen', '', '', 'number acknowledgement virus cell 317 dna 333 research control covid structure genome elsevier source od 21(2 active resource database free september 24 host volume commit form know 1995 repository unrestricted original capable voyles 922 latency publicly 659 centre c n 7 outcome grant growth long produce covid-19 o fund remain 660 mean provirus 925 re-use 1993 j g right analysis integrate', 'severe small virus infection acute ß prevention respiratory rna expression behalf cause protein societies animal threaten interference treat sars-cov-infected mrna sars-cov. technology speci¢c interfere spike sirna novel process speci¢cally anti-virus explore sars-associated immunode¢ciency study epidemic published introduce possibility gene hepatitis recently e¡ectively evidence degradation federation speci¢city 2004 cell syndrome tool construct sequence silence health clinical s disease rnai apply biochemical technique patient inhibition based sars-cov demonstrate european therapeutic b.v. culture coronavirus c/b inhibit date e¡ective employ identical elsevier sirnas human sars methodology world su¡ering responsible target method provide', 'mers-cov severe past coronavirus mortality research antiviral approach emerge syndrome infection acute key broadly 10 vaccine readily feature include novel tropism summarize respiratory human develope effective emergent identification east associate cause biological preventive 21 drug century describe priority discuss www.nature.com/reviews/micro emergence middle development ards apply approve available high clinically rate sars-cov review strain receptor year strategy therapeutic distress', 'small molecular infection structure molecule line respiratory expression cause major knowledge protein mostlikely region hr1-sggrgg-hr2 229e remain multiple crucial collectively bundle mechanism possess datum spike \\ufeff1 core agent possible hr2 design chemical gst coiled-coil similar tract circular characterize hr1 step produce fusion cd mediate existence year membrane furthermore rationally 3d member group time hcov-229e s disease elusive present type cross-link belong demonstrate vitro typical gel-filtration detail concern system heterodimer coronavirus nearly include human model 40 experimental drug a-helix property heptad-repeat diagram identify available prokaryotic viral target trimer well-documented polypeptide', '', 'scalable coronavirus healthcare-associated \\ufeff1 control management base sustainable measure develope lesson potential diagnosis sars canada disease learn case pandemic occur toronto transmission face 2019 suggest covid-19 hospitalize laboratory-confirmed', '', '', '', 'research rely infection pre-determine participant population develope origin country 614 knowledge outbreak month little 28 hong promotion generally medium low covid-19 student international multiple importation medical nvivo undertake topic eligible practice severely kong risk care cultural friend know explore traveller sydney study pre-travel epidemic inform barrier 2270 systemic perception big health-related professional strategy variety analysis frequently chinese return students increase health campus advice group potential information transcript lack strongly access unprecedented parent vfr precede content important focus social area software thematic confirm relative conduct vaccination list behaviour 7170 travel internet australia underestimate code source 18 hold phone abstract china attitude insight guide theme visit healthcare travel-associated face seek total provide infectious', 'virus laporte u.s.a. research resemblance immunofluorescence sucrose lamouliatte database nm f. 1987 9 21 270 elongate covid-19 relate remain right convalescent diarrhea solution diarrheic loze spike calve examine active free spherical virus-associated 261 isolate repository studies similar microscopy particle microbiology microbiol long fund 15 j. contain 60 f analysis 278 16 covid p. density value vet feces french pasquier unrestricted original great surface centre patient breda demonstrate mean re-use dimension berne rossi acknowledgement 13 react elsevier source veterinary electron morphologically breda-like resource human abstract serological form du 1.16 serum publicly immune grant electron-microscopy j.p. suggest bovine', 'virus sign coronavirus br-i immunohistochemistry elucidate inoculation observe 10 background importance include ability coronaviruses inbreed mass different change epidemiology rodent pest rna clinical discovery division result histopathological balb/c family lung perform interspecies study monitor little evident sinus genetic a/j serology examination inoculate day avian transmission lesion poultry mouse order coronaviridae investigate viral gross recently trachea belong nucleoprotein production demonstrate strain nidovirales novel replicate analysis', '', 'acknowledgement research aminotransferase covid elsevier source bilirubin active resource database free antigen 566 time form hbsag repository tb unrestricted original surface ϭ publicly alanine hepatitis centre pt alt grant long covid-19 fund b remain mean re-use total prothrombin right analysis', '', 'concern basic system government numb coronavirus build article control indicate isolation importance base paper real e-ishr attention change consider spread increase factor model china result time bed impact fit add outbreak situation epidemic awareness disease original simulate world hospital case arouse development delay order predict widespread parameter 2019 covid-19 consideration hubei wuhan effectively confirm seir 3-staged', 'native severe virus safe elisa pre-clinical infection structural structure acute subunit strong envelope comprehensively pose prevention coronaviruses mers-s1 respiratory variant antigen-specific causative engineer respectively outbreak protein traditional experience fabrication needle 2 s1 generate characteristic delivery support injection foldon assay covid-19 response flagellin 2019-ncov collectively codon exploit mna-mers-s1 vivo quick spike mna-delivered threat \\ufeff1 igg background novel agent consider long-lasting previously design subcutaneously rs09 immunogenicity rapidly promise dissolve fuse evident microneedle intracutaneously middle immunization evidence produce mna dub component strategy key officially utilize elicit coronaviruses-s1 syndrome clinically-translatable tlr4 deliver vaccine construct specific sequence health virus-specific tlr5 clinical trimerization result interpretation mers s agonist array disease pandemic trimeric sars-cov-2 4 technological ongoing driven sars-cov trial scientific optimize methods mers-cov enable evaluate coronavirus begin specifically urgent stimulant emerge findings include develop vaccinate identification east substantial sars potent recombinant describe capable global test domain serum development immune building mouse progressive viral mnas week antibody urgently effort neutralization importantly target mimic induce infectious', '', 'severe compile acute relationship complete respiratory cause origin nucleotide major protein outbreak 2 maximum-likelihood doe cov support cov. remain topology determine concatenate phylogenetic datum 1 novel covs different 5 whole-genome isolate compose preliminary characterize clone evidence tree set analysis similarity 3 syndrome indicate monophyletic individual sequence result publish hypothesis group time perform statistical 4 elusive ongoing type 7 yield belong display genomic comprehensive coronavirus relationships 6 identical position base conclusive primary clarify bayesian-inference sars reveal world previous identify resolve maximum-parsimony good short method conflict provide', 'acknowledgement system research nervous covid elsevier source active resource database free form repository unrestricted diseases original publicly centre grant long covid-19 fund remain mean re-use right analysis', 'placebo research infection fluticasone acute clin prevention assess 103 hour 7-day respiratory database develope cause little allocate upper doe 3.9 allergy re-examine medium 0.7 covid-19 remain response 48 virus-induced nasopharynx determine right rhinovirus \\ufeff1 normal p background process active free repository obtain middle nasopharyngeal aom complication day long fund inflammatory 100 86.1 14.7 year effect significantly key analysis pathogenesis 29 prevent incidence covid play daily specific increase 71 host group unrestricted medication original ear suppression status twice immunol 2000;106:467 centre 7 objective 105 28.2 duration .005 mean period 45.7 re-use administer receive 194 j otitis methods acknowledgement 2.1 child elsevier source propionate 38.1 resource 40 .13 form results uri visit conclusion common publicly development compare µg viral grant 210 randomly intranasally age end seek aspirate total range role 167', 'acknowledgement 1 research ol--4 covid elsevier source active resource database free r~ 9 form repository unrestricted original publicly centre grant long o covid-19 fund remain mean ~,,,i re-use right analysis', '', 'elisa birth research life predictive carry infection 332 publishers discrepancy database 5.3 survey dairy 2 accuracy chi-square mainly science sample association significant covid-19 remain halaihel determine right shed presence excretion c. herd comparison calve closely consider active free parturition consistency onset amsterdam faeces repository obtain similar simon day microbiology microbiol long 321 alter parameter fund 15 j. 4.8 analysis alonso garcia-sanchez selection n.g. covid daily electrophoresis polyacrylamide m.c. result value 34:321 neonatal vet unrestricted original cow rotavirus 4 92.5 centre 7 criterium detect mean ortega girones j.l. period specificity re-use 1993 latex agreement history b.v. acknowledgement diarrhoea p= overall 34 corral begin agglutination elsevier source veterinary faecal kit resource 1.1 abstract parallel gel page 1.8 0.0001 form commercial results observation o. average test publicly compare sensitivity muzquiz grant week 8 good diagnostic end range', \"lutte draw information-sharing 5th proceeding surveillance research intertropicales approach march infection de screen prevention locaux » dépistage population database drive réviser la comprendre soins recherche s'est reduction preventive proposition fight grâce local acteurs animal risque afin foster intégrative personnel crisis séminaire support seven encourager point modify treatment masson prioritaires covid-19 remain response propagation « présentons tous right train aux visant 2017 déterminants curative ici hot-spot tenu ensure risques prediction recherches risk care paris reinforcement agent 5 mar active ce free 2016actualités aide typologie 22 intégrant proposal pursue repository mode à epidemic actes aid des prévision economic encourage long adapt ces prendre fund épidémie adaptée incorporate zone sanitaires développement approche tenant démarches dans nouveaux soutien analysis publiques adherence entre suivantes chauds provider e covid les tool measure specific follow mesures politician health charge lutter qui développer détection réduire sas favoriser logiques 2016 intertropical unrestricted particulier awareness original disease great santé mieux diffusion outils present réponse centre type issue sont patient formation d'information public compte droit précoces mean nécessité spécifiques -current area façon en re-use pour proceedings malady sept l'humain émergentes contre nous d'une acknowledgement concern culture l'adhésion early s'appuyant think logic l'entraînement emerge préventives sensibilisation elsevier source develop poursuivre integrative réservés factor resource hold human abstract seminar communication outline économiques infectieuses form account disponibles prévention action priority du detection renforçant education publicly development order infectieux governance transmission l'animal healthcare préparer nouvelle available collaborative sur 22nd le grant trend politique promote create d'équilibrer gouvernance particular infectious balance view\", 'native severe virus reservoir peptide infection acute conclude size respiratory 25 nm cause balb/c outbreak protein animal assay region remain consequently light biophysical antiserum conformation spike threat novel recognize design promise prototypic grave coiled-coil b-cell cost microscopy circular neutralize characterize represent immunization produce platform repeat analysis activity elicit exhibit syndrome vaccine specific scatter c-terminal perform disease exist trimeric self-assemble inhibition display experiment sars-cov strain dichroism vitro confirm α-helcial recent coronavirus specifically nearly electron bind computational sars dynamic adjuvant highly repetitively 800 envelop development nanoparticle transmission property investigation mouse antibody epitope neutralization live heptad polypeptide particular infectious', '', '', '', 'consolidation severe fatality cfr partially infection acute comprehensively rapid document bat summarize respiratory help reproductive chloroquine cause origin biological protein experience little upper r0 2 entitle symptom initial lesion n generally treatment presentation low covid-19 plan 2019-ncov convalescent comparison spike threat genome p background novel comorbidity spread possible lesson preparedness improve study official middle \\uf06c u recently immunization r long 2019 current serial review f virology incubation e syndrome indicate remdesivir feature vaccine up-to-date measure epidemiology explain clinical plasma effective publish time potential mers exudative awareness autopsy disease decision fibrosis resemble pandemic l update progression high zoonotic patient select o beta-coronavirus manifestation future based sars-cov pathology period j interval therapeutic optimize methods tocilizumab mers-cov numb coronavirus control post-mortem -p include literature combat bind abstract east general ace2 results sars global case conclusion previous rate short greatly gastrointestinal', 'severe stage infection head develope follow-up 57 huo-gu 66 osteonecrosis outbreak purpose traditional month conservative therapy medicine point treatment arthroplasty groin covid-19 tha modality medical 53 convalescent hip 70 correlate alternative long-term tomography kaplan-meier rheumatologic oral ii 55 diagnosis study 14 steroid-associated hgf complication represent 2019 radiography 15 administrate formula resonance year effect analysis chinese prevent 16 definite arco survival aim follow plain corticosteroid tcm 63 magnetic result progress time reserve severity collapse perform pre-collapse disease commonly considerable iv delay 38 iii regularly patient enroll outcome image bilateral maintain based pain mean demonstrate receive confirm interval numb coronavirus evaluate date observe include collapse(arco femoral spleen-invigorating function osteoarthritis china 26 2003 physical results sars harris average common undergo herbal beneficial compute onfh score good remind secondary surgery total range disable', '', '', '', 'virus environment enter approach infection wreak structure pathway causative cause country outbreak traditional discuss assessment hospital symptom n phase treatment covid-19 response acknowledgements mechanism therapeutics severely risk care p novel agent spread outburst possible vary rapidly u r 2019 current potentially dangerous option significantly slowing f e adaptation increase health regard mers situation disease great pandemic globalization sars-cov-2 plant l pre-proof sick ongoing o public indian strain trial j reduce therapeutic recent medicinal concern system numb coronavirus urgent probable -p fatal sars havoc highlight drug limit global case common diagnostics compare urgency immune healthcare available journal suggest flu inadequate target worldwide exclusively', 'signatory behalf 36 †signatories appendix n.a.alwan@soton.ac.uk † list', 'o f e l pre-proof -p j p u n journal r', 'datum criterion inference city selection variation prediction main indicate 23 simple measure course model china result time complex potential information s perform impact quarantine outbreak study epidemic december january 2 strict aic numerous t compare represent present calibration c 7 akaike reason r 2019 covid-19 2020 b demonstrate wuhan february reliable confirmed-case contain undertake bayesian seir range lockdown return-to-work peak sir wide nonidentifiability', 'basic n. virus requirement structural gastroenteritis-purdue autonomous complete molecule rna chapter 9 encode major protein porcine mhv-a59 31,357 product ibv-beaudette -proximal treat 27,317 murine mrna interfere diarrhea torovirus 1 precise genome separately transcription process 5 addition know nonstructural bcov-ent share epidemic 14 gene tgev-purdue hepatitis current 115 virus-a59 organization question strategy replicon 16 3 establish e replication member importance coronavirus-229e feature length sequence genes synthesis involve genus species volume regard hcov-229e nidovirus s 0 cis-acting coronaviridae present d focus strain virus-beaudette proteolytic coronavirus-ent m defective bronchitis coronavirus transmissible arteriviridae estimate necessary minimum human di family sars one-third two-thirds occur order avian 8 infer virus-cv777 end element pedv-cv777 subgenomic bovine range infectious', 'datum 30 positive evaluate 3 6 examine normal 97.2 include misdiagnosis chain ct 5 tomography clinical diagnose suspicion value 36 addition result thirty-five respectively reverse-transcriptasepolymerase laboratory diagnosis results isolate study purpose avoid 2 case conclusion negative test compare compute day initial tests(after initially sensitivity pneumonia patient abnormal false image 8 presentation suggest reaction rrt-pcr covid-19 real-time diagnostic 83.3 produce assay(after finding miss round final confirm total typical finally repeat retrospective methods', '', '0.05 prevent early evaluate 292 especially 234 0.001 difference control traumatization vicarious care include p observe necessary attention aim nurse process 526 increase spread result mobile problem appbased general situation front-line strategy non-front-line statistical engage staff compare nonfront-line extremely high patient questionnaire physiological interestingly score covid-19 public low treat response medical psychological significantly provide pay', '', '', '', 'acid virus molecular approach infection pose rapid summarize develope cause advantage outbreak t treatment accurate reaction covid-19 b standard quick assist threat novel consider spread pcr promise diagnosis pathogenic improve epidemic subsequent r amplification review variety prevent pcr-based establish operation play procedure gold health effective regard constant time s disease great nucleic sars-cov-2 fundamental c high technique select public important timely specificity thermocycler anticipate clinician recent coronavirus save chain appropriate identification currently temperature candidate highly global vital detection researcher bacterial test chinais available polymerase pneumonia sensitivity viral microarray-based diagnostic method isothermal amplification-based live secondary infectious role', 'severe fatality virus research infection viremic resample acute size estimates rapid respiratory population rna inactivation authority donor cause respectively maximum outbreak little survey 23.57 cov low alarmingly transfusion-transmission 02 safety seroprevalence datum ensure investigational risk background novel consider spread possible recognize proportion design onset viremia study epidemic recruitment transmit contribute south far existence 11.00 strategy peak syndrome newly million indicate asymptomatic-to-clinically 6.83 individual health 14.11 seroconvertors plasma course result conclusions disease statistical decision infectivity high blood public based sars-cov mean appearance confirm recent decrease taiwan concern numb coronavirus hongkong ci date estimate useful human china shenzhen 2003 47.69 sars results ratio currently transfusion monitor detection 17.22 case transfusion-transmitted transmission identify asymptomatic rate infer suggest theoretically method infectious april 95', 'consolidation 98 datum small number sign city province accompany infection main young ggo aim opacity 18 crazy-paving diagnose 44 involvement china group septum lung infect results thicken pattern field conclusions purpose zhejiang hangzhou great patients case common 45 compare ≥60 scan lesion patchy identify air patient interlobular manifestation differently age chest covid-19 bilateral relate 59 lobe mild confirm bronchogram year collect hrct methods ground-glass', '', 'correspond acid severe virus find peptide acute document respiratory ig laboratory 2 pan contagious generate phageborne assay kinetic b production response sars-cov. library antibody-response igg motif novel antigen iga phage-displayed sars-associated study igm immunopositive far clone g pathogenesis cell amino syndrome sequence serologic clinical potential disease 4 random immunoglobulin patient select demonstrate sars-cov confirm react coronavirus evaluate specifically emerge fatal phage consensus useful bind disease-specific synthetic sars competitive-inhibition highly detection conclusion test serum immune antibody epitope diagnostic forty-nine epitope-based', '', '', '', '', 'acknowledgement research pronounce covid elsevier source active resource database free form limb repository exaggerated unrestricted original cerebellar incoordination movement ataxia publicly • centre lesion grant long gait covid-19 produce fund voluntary force remain mean re-use range right analysis', '', '', 'basic finish infection participant participate multistage population 0.3 laboratory country suspect outbreak little december characteristic sample slow treatment response calculate 2019-ncov collect 33.7 government 1 background quarantine study 14 day demographic questionnaire ban 81.7 year analysis chinese 2004 province incidence measure aim result information contact 129 stratify random implement hubei mean wuhan confirm history conduct trip 1637 methods recruit city travel estimate include 1,046 shenzhen china results centralize clear arrive case home descriptive transmission rate age method total range provide 80.2', '', '', 'dataset severe variation 333 march infection outside acute additional assess 4·77 respiratory population originate country combining outbreak little december january 2 restriction generate t jan 50 covid-19 international multiple crucial calculate thereof likely output confirmation datum 1 comparison effectiveness background mathematical 2·35 20 assume 5 market proportion exposure vary onset similar introduce passenger 1·05 independently initially r 2019 2020 february decline 29 dec 16 establish syndrome newly median probability 23 fail daily internationally measure result interpretation time potential reproduction infect fit location lead 2·39 at-risk sars-cov-2 lack evacuation 4 chance high export probably based wuhan connectivity area ie confirm human-to-human stochastic feb early evaluate coronavirus numb ci travel date control estimate 0·41 findings 10 11 chain model china 26 dynamic sars-like arrive case occur publicly eventually transmission available week 1·15 introduction flight sustain coincide late 95', 'severe virus find swab acute additional opacity change bat wet respiratory rna close lymphopenia associate setting laboratory encode 66 outbreak protein local geographically upper link genetic animal hospital symptom hong jan region low older thrombocytopenia phylogenetic radiological nosocomial datum spike adult genome background novel internal market 36 exposure onset know extensive lung traveller study university gene tract nasopharyngeal negative rna-dependent day 2019 2020 systemic sanger 60 year dehydrogenase analysis chinese 29 dec fever 3 province c-reactive syndrome return member sequence increase (sars)-related clinical amplicon publish interpretation consistent potential unexplained point-of-care infect contact surface affected 4 present ongoing nextgeneration cluster patient enroll epidemiological hubei wuhan confirm ground-glass combination diarrhoea positive coronavirus city travel date 6 child findings source 10 lactate guangdong china shenzhen throat rt-pcr family person-to-person visit respiatory transmission multiplex horseshoe identify asymptomatic pneumonia polymerase kong-shenzhen additionally age microbe finding microbiological level geographical', '', '', 'severe obstruction impairment research acute relationship change database lumen cb drainage tend bactericidal degree treatment covid-19 treat relate remain response parenchyma right turn presence colonisation achieve normal effectiveness aetiology direct macrolide process active proportion free ⁄ repository lung load cycle obtain similar vicious 5-day independently long produce fund inflammatory mediate analysis activity cure fluoroquinolone leukocyte 3 covid probability increase density mucocilliary clinical course time prolong orally unrestricted episode situation original antibiotic lead diffusion arise 4 centre high ml patient advantages probably adequate usually mean microorganism fluoroquinolones re-use reduce purulent decrease bronchitis acknowledgement pathological system generation numb ‡ airflow 6 exacerbation elsevier source 10 resource damage form marker cfu bacterium sputum bacterial sufficiently publicly eventually blactam chronic secretion provide grant rate mucus good short bronchial sustain induce', '', '', 'interstitial rhinitis impairment research life infection structure run alopecia looking bladder computer database complex example experience discuss 2 symptom bruxism intero-and phase treatment photophobia phenomenon covid-19 wrong relate remain multiple response fatigue topic mechanism heart specialize right output illness ideally 1 bowel amnestic dysfunction dysphoric process long-term active free chemical network fibromyalgia repository diagnosis fms relevant study endometriosis persistent primarily maximize bystander hit distribute irritable myasthenia m.-marsel initially limbic lupus dyspnoea long affect alter produce fund systemic activation cystitis strategy analysis sleep cell sign unfamiliar syndrome covid foundation survival individual raynaud explain sclerosis result volume bewilder thermoregulatory array unrestricted episode original lead physiology mesulam allergic centre lymphadenalgia feel patient stimulus select 1985 pain mean projection chemically re-use fasciculations headache palpitation wide work acknowledgement system numb especially understand panic neural elsevier source dysmenorrhoea blur literature cortical function resource attitude problem parallel physician reader form half computational disorder overlap transduce input vertigo common publicly message chronic immune investigation sensitivity viral grant erythematosus functional unrelated cfs flu good capability consult derangement muscle exteroceptive modulation myriad neuroimmunoendocrine range vision late luteal integrate view', '', '', 'pharmaceutical past analyze convalescent team emotional mortality gain multidisciplinary control care management vaccine special service underlie distinguish participate retrieve summarize shall population clinical counsel plasma information results drug medication therapeutical experience pharmacist discuss monitor strengthen evidence-based strategy disease hospital decision pandemic conclusion evaluation therapy support collaborative combine join patient outcome efficacy evidence covid-19 consideration objective hospitalize based promote method scientific pharmacy psychological improve reduce provide facilitate role safety chinese', 'acid severe 77 respiratory notably ⅲa 31.25 25 9 gender respectively compared obvious laboratory 21 grade hospital characteristic symptom sample jan abnormal low covid-19 parenchyma mild -63.75 retrospectively dysfunction background proportion stay 22 55 lung pathogenic 14 exclude negative day moderate falsely 2020 frequency relatively year 3.75 interim exhibit fever disease-19 3 province discharge median length aim density clinical 63 die result time cough infect jiangsu disease nucleic rest 80 examination 38 high patient investigate guidance image manifestation detect female 51 wuhan confirm history feb third-time coronavirus unconfirmed main susceptivity import imaging -68.75 base real ct rt-pcr account consecutively 46.1 detection case average test chronic 41 78.75 8 age shadow live', '', 'bronchitis furthermore virus find coronavirus ciconiiformes e date contribution genome play base p covs different sequence migratory spread possible phyl gammacoronaviruses species charadriiformes group conserve y s highlight v disease survey anseriformes madagascar emergence t l nature wild c maintenance n gruiformes passeriformes r o potentially domestic relate aquatic target strain important ibv bird h g f infectious role work', 'severe san find standardize stage po march folium herb fibrosum summarize armeniacae zingiberis cause 9 31 arecae ling cum recens 21 perillae traditional agastachis 2 invading qiao magnoliae 28 medicine arctii n treatment sojae treat covid-19 50 exterior cinnamomi osterici mild eligible composition illness datum amarum dampness periostracum platycodonis pinelliae tsao-ko terminology background p artemisiae farfare 20 5 amomi recovery sclerotium yin forsythiae scutellariae polyporus moderate officinalis u rotundus herba macrocephalae r 2019 evidence 2020 frequency korean review 15~30 15 semen seu formula asteris bupleuri radix16 g f lonicerae coicis analysis chinese angelicae 30 3 e intestines 23 fructus measure aim specific asari encumbering clinical 24 alismatis cortex ramulus pattern alumine annuae disease 12 pandemic preparatum usage pericarpium 4 l high 7 patient guidance efficacy paidu o future decursivae gypsum tang j stomach ephedrae cicadae notopterygii methods pi aurantii rhizoma analyze evaluate coronavirus belamcandae 6 -p source 10 11 radix 18 atractylodis identification page flos 26 government-issued huo unshius poria xia pis conclusion herbal citri moslae qingfei 8 search guideline interior glycyrrhizae total provide dioscoreae worldwide praeparatum', '', 'pathogenesis severe oligonucleotide-based cell 1 hyperoxia-related mhc/chaperon-related coronavirus thp-1-dc-sign 3 syndrome 6 infection acute elucidate player profile regulate cathepsin/proteasome respiratory tlr/tlr-signaling rna 24 expression extract chemokine/chemokine cytokine/cytokine immune-related receptor-related downregulated hypoxia/ result sars infect study monocytic monocyte 2 pulmonary fibrosis gene ifn-a/b-inducible lysosome-related characterize ards compare (sars-cov)-infected dc-sign-transfected upregulated analysis 229e sars-cov important microarray fibrosis-related h total distress cov-229e transcriptional key monocytes/macrophages differentially', '', '', '', 'calu-3 severe fatality find corroborate bat line respiratory expression hcov-emc nt2 associate 2c monocyte fibroblast porcine 28 intestinal t lymphocyte low h9 production malignant hfl failure adenocarcinoma mortality novel tropism colorectal isolate lung diagnosis load study evident hcov-oc43 tract betacoronavirus his-1 huh-7 barrier recently relatively effect renal polarize rabbit pathogenesis cell primate increase explain emc/2012 unexplained hcov-229e perform infect disease thp-1 tissue absent hek neuronal high patient jump airway nucleoprotein caco-2 important cytopathic carcinoma susceptibility recent crude hcov-nl63 culture coronavirus emerge 56 and/or hcov-hku1 include epithelium human supernatants immunostaining hcovs kidney broad sars interspecies detection transmission histiocytes pneumonia viral rate a549 hepatocellular u937 civet finding live histiocytoma embryonic range implication', 'environment cervical requirement research outside alopecia suggestive parasitism change database subcutaneous generalize food skin cause careful danièlle suppurative intestinal acromegaly initial region loop covid-19 b remain weight unable determine likely mild right urinalysis diarrhea cold younger illness inside lymphocytic middle-aged bowel anterior young edema nutrition risk competition gunn-moore thyroid inappropriate consider process alimentary active bulky free thorough appetite hepatopathy repository 301 diagnosis protein-losing ill-kept cholangiohepatitis insufficiency hyperthyroidism enlarge diabetes-associated diabetogenic diabetes eat long affect fund inflammatory nephropathy biochemistry typically year analysis sign old gain malassimilation miller syndrome covid individual increase involve clinical result feces aggression sufficient unrestricted lymphadenopathy diseases original lead disease thyroxin james great vomiting mass(es hematology supply polyuria examination centre fecal ventral diet nutritional detect pain mean important re-use thin 17 history palpation exocrine acknowledgement system parasite pregnancy 6 and/or essential elsevier source include develop underlie mesenteric require resource occasionally loss pancreatic endocrinopathy form enlargement general physical feed thicken drug fatty concurrent coat common abdominal occur publicly evaluation • serum ascites chronic hyperadrenocorticism greasy pancreatitis disproportionately restlessness extremity grant 8 suggest polydipsia good age consideration diagnostic eosinophilic uterus appear weather live cat enteric lymphosarcoma late body mellitus', 'acknowledgement standardize research \\ufeff1 covid elsevier source daily 5 active resource database free clinical tablet regimen time form andrographolide know repository careful recommend unrestricted majority original mg publicly 4 day centre dose grant treatment product long covid-19 reasonable fund remain caution mean trial re-use effect right medicinal analysis cold', 'acknowledgement http://dx research covid elsevier source active resource database free form repository unrestricted inhibitors original publicly centre viral grant long covid-19 fund proteases remain mean re-use right analysis', '', '', '', 'virus convalescent numb coronavirus stage travel infection \\ufeff1 child adult covid return observe 10 include member symptomatic novel respiratory recognize bus rna develope exposure his/her prolonged ＆ feces family traveller series describe contact disease 2 case sum tract common test occur clue 4 symptom sample pediatric patient expose index 2019 affect epidemiological usually mean wuhan 2019-ncov area secondary mild confirm shed key', '', '', 'severe supervise acute herb e6 screen respiratory thunb emodin rheum baill cause officinale attachment tuber protein g/ml 2 medicine protein-pseudotyped angiotensin-converting treatment multiflorum 50 retrovirus 1 spike vine novel consider agent polygoni multiflori committee dose-dependent rhei derive membrane-bound pharmacy significantly chinese cell syndrome polygonaceae widely p. compound genus value host potential anthraquinone vero s disease lead infectivity enzyme type interaction sars-cov therapeutic medicinal taiwan rhizoma coronavirus inhibit emerge control essential root 10 ic polygonum radix family ace2 sars block 312 manner caulis identify viral suggest finding receptor range infectious', '', 'virus notable surveillance research burden screen respiratory database protection cause occurrence local 2 distinct t term degree n b/victoria prevalent significant covid-19 b international remain event distribution medical circulation right composition southern datum 1 season lineage z consider data possible active free 2006 repository co-circulation improve unpredictable reemergence introduce confer moderate r long evidence fund review epidemiologic platform 0(1):81 year f analysis e covid indicate vaccine aim epidemiology quadrivalent 6;2 publish information s perform 0 pattern unrestricted original disease 2007 circulate centre c high 91.4 seasonal predominant based subject mean important 19 scientific re-use j conjunction vaccination 2000 acknowledgement understand benefit elsevier source include observe literature resource abstract form mismatch 2014 dynamic broad impact hemisphere describe headings 2008 monitor reveal limit 90 publicly compare relevance 2013 grant online influenza additionally good search trend brazil level', '', 'severe asthma virus find infection acute 224 0.9њc 1.2 respiratory population cause 9 57 0.3 maximum month note upper 2 hospital mainly distinct symptom hong significant 30.7 cocirculated 229e discover standard sd illness 1 season lineage \\u202bע\\u202c kong adult \\u202bע(\\u202c 5 1.5 addition study hcov-oc43 contribute spring day hospitalization recently 19.8 15 \\u202bע\\u202csd year deviation fever syndrome 2001 play р6 hcov-229e conclusions infect 2002 august 100,000 39.3њc disease 12 winter croup 4.4 present cluster 587 high investigate detect duration mean period febrile fall methods hcov-nl63 positive coronavirus 6 child 2.6 estimate exacerbation human 26 sars results temperature oc43 summer occur evolutionary nl63 seizure age hospitalize admission appear total range role', 'mers-cov datum virus coronavirus requirement define inhibit proper replication broadly disclose cyclophilin immunosuppressive cis-trans summarize cyclosporin bind function require fold mutant human analog host polymorphism family isomerase knowledge nucleotide results drug pathogenic protein inactivate highly common nonimmunosuppressive present well-known perspective cyclophilins cellular enzymatic inhibition demonstrate sars-cov target propagation single relatively vitro mild range effect cov-229e role peptidyl-prolyl cold', 'yamaya asthma virus epithelial endosomal enter infection p50 respiratory rna expression modulate cause inhibitor intensity protein copd glycopyrronium 2 pulmonary https:// t muscarinic cite treatment pretreatment b production 229e tracheal cold long-acting inflammation keywords background exacerbate acidic budesonide longacting cytoplasm factorkappa p65 xxx r activation nasal effect -agonists cell replication endosomes fluorescence increase corticosteroid antagonist hcov-229e s agonist infect 0 conclusions disease il-8 additive c il-6 hte airway nuclear hne cytokine camp reduce m susceptibility combination methods decrease culture ifn-b numb coronavirus inhibit article and/or exacerbation include partly primary function human infection-induced inhale results drug titer inhibitory common exert chronic investigation obstructive available viral online suggest -dipyridyl infectioninduced bronchial finding cd13 receptor formoterol level', '', 'severe percentage virus find reservoir simultaneously acute change reflect respiratory variant cause outbreak prompt generate hong protect region standard mild inconsistent sir incomplete datum \\ufeff1 kong background suffer tropism spread mutant explore study contagion epidemic similar convenient landmark superimpose precautionary affect prophylactic allow set behavior province syndrome measure follow involve effective precursor time puzzle pattern situation evolution disease exist rest present reconcile implement high person patient future important susceptible-infected-removed regions consequence recent fix system coronavirus cool observe develop useful guangdong appropriate model china identification sars account framework monitor limit world development order property identify predict unrelated suggest implementation appear weather finally innocuous', '', 'colored research distinctive gel-containing harvey separator database laboratory suspect vessel protein note contamination neutrophil etiology sample point modify meyer passage modified low significant covid-19 relate remain exudation iatrogenic st likely mild cells collect right transudate turn 1 near hydrostatic active free artifactual noninfectious repository diagnosis injure medicine-interpretation initially anticoagulant long effusion fund membrane key analysis exudate 2004 count cell 3 covid jw increase result lymphatic edta unrestricted character original pressure centre fluid blood mean nucleate dj re-use macrophage conversely reference tube number acknowledgement 6 depend ed and/or transudation elsevier source veterinary color bind resource gel form submission louis clear removal collection evaluation publicly serum chronic colorless lavender-top hemorrhagic grant red infectious', 'severe obstruction orf1ab emc2012 infection acute envelope refer respiratory causative immunocompromise cause conserve 2c protein hcov upper t generally treatment low b sars-cov. phylogenetic cold failure spike difference adult keywords genome strains sneeze novel agent addition infant epidemic rhinorrhea aid hcov-oc43 advance gene primarily tract middle betacoronavirus recently r tree review nasal membrane renal analysis pathogenesis 2012 fever syndrome sequence healthy september host cough hcov-229e s infect 2002 c patient manifestation nucleocapsid sars-cov focus strain febrile therapeutic recent hcov-nl63 bronchitis coronavirus especially begin hcov-hku1 certain human self-limit east 2003 non-rhinovirus-induced sars reveal highly common development establishment identify pneumonia seizure age gastrointestinal asia distress', 'system practice surveillance \\ufeff1 control fort base enhance health possible time country outbreak month discuss europe disease world possibility pandemic try animal support exotic reach decision-making evidence covid-19 2020 short randomise community method uncommon provide editorial frequently', '', 'severe research ggos acute 55.4 change opacity respiratory database develope a[h1n1 follow-up 57 31 oseltamivir suspect little january radiographic 28 therapy ards symptom interquartile point nppv clinically presentation successful covid-19 treat survivor reaction remain medical noninvasive .001 uenza 65 lco right illness adult risk p background monoxide data 5 active free iqr onset ii capacity repository lung a(h1n1 reverse 1.312 2009 day 5.852 initially 60.0 sixty-two transcriptase independent long start .016 fund infl regression multivariate 2010 year analysis fever 16 1.140 syndrome covid median 23 1.511 health corticosteroid 24 61.5 carbon die identifi group cox condition dyspnea unrestricted high-resolution original ventilation pressure resolution physiology mildly pandemic iv 4 man present d centre 24.541 1.395 patient high apache 85.7 subject mean 54.2 convalescence re-use receive reduce relative ground-glass diminish methods acknowledgement 13 positive ci 6 ed elsevier source 10 underlie chain ct factor abbreviations resource lft function 26 form rt-pcr results sars laboratory-confi case diffuse test evaluation publicly october 3-month chronic progressive 33 polymerase pneumonia grant 41 score age rmed death range hrct 95', '', '', 'acid water wean birth research utilization postweaning measurement 43 grain database 9 twenty-eight c0 dry skeletal protein consume tend little experience dairy 2 mr allotment 28 47 milk venipuncture sample express phase treatment low covid-19 remain 1134 verbal weight h 8961 heart right divide anda1 http://dx 1 herd hip calve glucose nutrition intake c1 a0 conventionally stress 20 starter phasis active free holstein repository preweaning visiting similar urea university calf adg/dry plane replacer rear stimulation long fund 49 j. g analysis 1430 cp calves a1 weekly gain covid indicate daily measure height regimen assign efficiency concentration metaboliz-able sci 0 matt unrestricted original great cortisol track 45 4 adg/me centre c high blood adg conventional visitation interaction mean 51 re-use receive basis reduce crude 1030 acknowledgement overall heifer evaluate fat 56 estimate elsevier source nonesterified wither observe nursery resource human form curtain half commercial feed 454 fatty block tall stir visit average removal 98:8952 jugular occur publicly opaque 916 weigh week grant 41 8 efficient newborn energy girth body comprise', 'acknowledgement cell virus research covid 523 174 immunofluorescence elsevier source woode primary g.n. active resource database free chapter rna 527 kidney form repository infect courtesy unrestricted original calf publicly centre unclassified grant astrovirus long microbiol covid-19 50 fund remain mean med j. re-use bovine right analysis', '', '', '', '', '', 'inflammation acknowledgement number cell t-cell-mediated recruit research covid indicate conclude elsevier source active resource database free human cd58 result form repository insight costimulation unrestricted complementing original disease neutrophil contribute allergen-specific publicly previous lpr t present allergic centre activate site high grant apcs cd2 long covid-19 introduction fund inflammatory remain mean finding promote activation t-cell re-use mechanism provide right analysis fully', 'bronchitis system cell virus tcov favor coronavirus find embryo inoculation structure replication isolation member egg epithelium novel different line require chicken genus develope turkey host associate diversity wide complex amniotic potential family chorioallantoic titer fabricius detection embryonated primarily gammacoronavirus suitable replicate bursa coronaviridae avian intestine support type propose provide high uids successful good yolk pheasant fl propagation characterization ibv regardless membrane infectious variety allantoic comprise route', '', 'past predictive infection acute prevention united document sporadic respiratory close develope associate cause partner emirates laboratory country outbreak uae canada upsurge link arabia product low international relate provincial canadian illness territorial hajj mortality care risk mecca novel consider agency exposure network committee preparedness address middle spring collaboration protocol microbiology evidence current nml cphln saudi 35 typically -an syndrome increase health time regulations information expert present place national guidance public based caution mers-cov. confirm camel mers-cov concern overall early numb coronavirus especially date control probable import --is include annual human east 2014 pilgrimage case october available -coronavirus rate acquire good arab community-acquired', '', '', '', 'severe past research antiviral elucidate inevitable anniversary acute infection pose complete bat line respiratory population discovery aspect cause major cross-species outbreak protein authoritative 10th emergence animal -reservoir -anti-coronavirus innate response countermeasure invite mechanism topic southern -the diverse threat management novel agent different recognize series pathogenic introduce middle far ó coronaviral pool review existence year -sars-cov -receptor syndrome replication up-to-date individual follow health effective host species time potential mers 2002 legacy expert disease come circulate surprise belong public sars-cov recent coronavirus emerge article control probable 10 paper develop function human abstract china east sars drug reveal highly clear -structures evasion development transmission recognition immune identify provide mark suggest merely introduction urgently -clinical target late', 'felis fragment procyonoides fresh infection rna spot hyena knowledge nyctereutes survey raccoon genetic animal melogale distinct prionailurus carnivore ferret silverbacked spike young novel 5 exposure asian jackal gene paguma badger moschata evidence membrane crocuta analysis chinese dog old 3 recover member importance sequence larvata genus host species diversity tanzania feces s alphacoronavirus wild bengalensis high 7 fox felidae terrestrial strain specificity 17 european m african coronavirus include china serological family highlight prevalence describe reveal limit leopard transmission palm suggest civet serve cat bat-eared provide', 'ileum virus find epithelial crosstalk expression rna partner communicate outbreak protein peptidase surround december atla 2 mainly esophagus express low facilitate cellphonedb cov-targets at2 covs different colonocytes explore know spectrum lung signal similar proximal gene 2019 colon phagocytosis manifest 119 tubule membrane analysis frequently pathogenesis cell importance ecs convert health 400 chemokine dpp4 host consistent angiotensin potential infect pattern sars-cov-2 tissue enzyme type intriguingly public hubei 51 wuhan cholangiocyte defense stomach declare confirm macrophage single emergency conduct recent 13 analyze understand coronavirus especially include co-receptors human china rectum kidney ace2 highlight co-expression candidate global enpep immune identify entry suggest co-receptors/auxiliary target live receptor keratinocyte anpep level', 'research g.h.a. infection acute screen publishers uytdehaag database 25 develope ccv-and cause complex major ccv science sample sandwich assay covid-19 remain virus-induced osterhaus h. right diarrhea egberink correlate active free antigen amsterdam antigen-detection 0378 repository serology rimmelzwaan g.f. parvovirus microbiology microbiol long fund borst j. analysis dog indirect establish covid result vet respective 1135/91/$03.50 unrestricted original a.d.m.e. double cpv- ctb rotavirus centre cpv fecal immunosorbent netherlands 1991 mean re-use history b.v. acknowledgement system coronavirus elsevier source veterinary resource abstract f.g.c.m. 40 26 serological form enzyme-linked block detection groen elisas canine publicly serum grant antibody good trap', 'train in-hospital department early fever coronavirus safe establish objectives article control achieve isolation ensure management include prevention special aim horizontally nurse summarize reasonably charge function group respectively workforce infect series ward critical centralize allocate disease vertically nursing staff conclusion examination 2019(covid-19 orderly support sustainably patient warn treatment logistical implementation supervision icu efficient admission medical publicity timely clinic psychological contingency death coordinate strategy facilitate command methods work referral', 'acknowledgement water 135 c. 1 po 0.4 research 0.5 covid elsevier source q8h g d. corticosteroid active resource database free mg/kg form 8h repository dissolve unrestricted amoxicillin ampicillin original antibiotic i. q6 cephalosporin publicly centre sucralfate grant 8 long covid-19 suspension fund remain mean re-use administer cisapride metoclopramide right analysis 0.2', '', '', 'behavior 0889 xxx-xxx sominsky l. brain 1591/ immunity xxx xxxx', '', 'acknowledgement system cell 1 auricle research mastoid direction covid acute elsevier source head cortical process require active resource database free surgical bone form extension cortex drainage repository appreciate v unrestricted original soft 816 ear 52 inferior middle tissue pa publicly t palpate centre mastoiditis air overlie displace grant fluctuance defect r long lateral covid-19 mastoidectomy fund inflammatory remain mean re-use right analysis frequently', 'utilize globe virus understand coronavirus e control -p p bat spread health possible human china identity share candidate f emergence sars-cov-2 l pre-proof high zoonotic point u recently n inhabit r containment o good recognise potentially detect journal j concept reduce continent strategy level', 'acknowledgement respiratorias arch research e covid elsevier source active resource database free bronconeumol 9 las form repository w unrestricted original coinfección publicly l centre c infantiles u n grant r long o covid-19 vírica fund b remain mean h infecciones en re-use g right 2015;51(1):5 analysis', '', '', '', 'draw mg/day antiviral conclude uncontrolled close maximum doe term n clinically treatment hcq medical standard mechanism safety 1 coalition p shortage 5 load study epidemic administration antimalarial high-quality protocol u lupus swiftly immunomodulating r adapt systemic doctor review effect f hydroxychloroquine prevent 600 mg/kg/day e 6mg/kg/day 2,3 attention follow health want post-exposure scientist concentration potential contact expert lead supply tissue l pk/pd pre-proof avo blood patient efficacy o public mean j erythematous positive evaluate control -p include drug ratio caregiver limit case home match test evaluation beneficial dose expose risk-benefit journal threshold consideration prove worldwide bodyweight', '', '', '', '', 'protective acknowledgement http://dx system research covid ras elsevier source arm active resource database free form repository unrestricted original publicly centre grant long covid-19 fund renin-angiotensin remain mean re-use right analysis', 'classical trigger wildlife surveillance coronavirus reservoir approach \\ufeff1 novel sequence bat population human chapter potential rt-pcr pcr conserve sars impact highlight describe study reveal highly animal fact far transmission identify zoonotic assay subsequent clone product detect mankind target incident finding important program hunt', 'severe virus infection strong acute e6 weak accordingly respiratory immunological protein etiological mobility pseudovirus-infected express low 50 murine response leukemia sars-cov. facilitate convalescent safety spike immunoassay 1:15 novel agent mass possible capacity cycle similar -170 role large-scale neutralize particle kda glycosylated produce fusion devise mediate humoral allow membrane x-gal analysis activity elicit 30 cell electrophoretic analyzer syndrome primate hybrid play procedure (s)-glycoprotein stain full-length result elispot consistent vero infect quantify 1:25 ph-independent biochemical d apparent high patient cellular virus-infected important oligosaccharide pseudoviruses susceptible understand coronavirus begin specifically inhibit s-protein and/or difficult automate primary mannose human approximately high-throughput sars account titer detection blue serum property manner immune identify viral entry antibody suggest pseudotype neutralization target receptor ectodomain interact range 160 level', 'acknowledgement research covid elsevier source 289 clan active resource database free human stromelysin catalytic hydrophobic complex form inhibitor repository unrestricted original domain publicly alanyl ma(e centre grant 69 long covid-19 fund remain mean aminopeptidase re-use membrane right analysis -ml', 'fatality percentage virus office respond march infection document respiratory population associate 9 respectively rule country preventive little 0.6 2 67 intensive covid-19 b 53 elevate street datum government 1 mortality difference care risk latin assume spread different possible exposure capacity markedly affect zone contain corresponding 60 year 118 endpoint old 16 -108 establish climatic individual measure health explain italy information american infect condition location situation pandemic exist sars-cov-2 exceed c high national patient differ epidemiological spain european dimension concern system mediterranean early numb coronavirus colombia estimate tropical geographic 11 18 require frequent limit case average week viral rate despite 8 implementation 243 effectively death range table 160', '', '41.0 twenty-five infection opacity lymphopenia dry suspect interventions inc. hospital multiple standard room 2019-ncov medical right illness 78 management tomography 22 study ó scan diabetes hypertension cross-infection 2020 19.6 year deviation exhibit prevent fever old indicate covid 23 measure procedure mottle draft reserve cough conclusions 37 operate majority disease apply 4 68 present implement patient bilateral chest laboratory-confirmed female demonstrate mean wuhan 19 confirm reduce ground-glass emergency digestive system control main elsevier 10 include 11 19àspecific anesthetic 27 results compute chronic 8 guideline age effectively 62 measurements range', 'acknowledgement 3 research e 256 covid elsevier source p active resource database free 9 form repository s 0 unrestricted original 2 241 publicly t centre c u n grant r long o covid-19 fund b remain mean h re-use g right analysis', '', '', 'severe stage antiviral ≥18 acute d-dimer respiratory sequential rna 17·0 help associate cause prolonged 31 laboratory outbreak experience december 2·61 assessment 2 hospital pulmonary characteristic sample logistic jan jinyintan treatment poor covid-19 survivor 1·10 medical shed illness datum failure 1 mortality adult risk detectable background intervention p=0·0043 non-survivors iqr record 18·42 explore 1·03 study 128·55 day demographic sofa 2019 long 2020 regression serial year 24·0 strategy old discharge syndrome median 12·23 increase clinical p<0·0001 course die prognosis inpatient interpretation potential infect 37 multivariable cohort optimal disease great sars-cov-2 odd 2·64 high patient epidemiological future duration wuhan µg/ml clinician retrospective electronic detail in-hospital early coronavirus ci isolation organ include observe factor extract china multicentre laboratoryconfirmed ratio describe p=0·0033 univariable detection 1·17 compare identify 5·65 viral 20·0 score good age admission method death rationale provide 95', '', 'external virus molecular structure cleave molecule nm attachment g4 solvent example entity square touch 15th c503 doe assay b exterior globally mild carboxy-terminal \\ufeff1 initiate intervention 20 free l588 b-sheet decorate middle far site 2a helix bank peripheral repeat membrane renal a-helices possibly fever solvent-exposed 3 bat-derived atomic b9 angiotensin arrange contact surface present enzyme centre patient delineation c478 genomic mean b-propeller aminopeptidase terminus strand recent b7 work 13 cd26 solve accompany code 10 require bind c425 human b3 c437 unlike reveal nm. engage test residues property recognition identify five-stranded score anpep table distress acid draw severe variation emergent 2.99 complex 15.1 21 protein mainly hydrophilic b5 n b4 relate phylogenetic divide c383 failure 1 spike severely closely 16.7 core g3 data c526 fold capacity study sheet similar contribute consecutive antiparallel recently diverge apn mers-covwhich contain resonance furthermore supplementary exhibit 16 newly syndrome indicate b2 unit dpp4 8,000 consistent exploitation infect s subdomain g2 pandemic hku5 dissociation bond core-domain strand-dominated future demonstrate 19 208 betacoronaviruses crystallize position c585 40 2003 potent 800 envelop dali homologous amino-terminal c407 domain previous anchor b1 nl63 expose entry search cd13 heptad interior death reference delineate structural respiratory connect respectively flat v 2c peptidase engagement purpose 1a pulmonary s2 loop virulence cell-surface-expressed clinch illness receptor-binding c-terminal-domain z motif novel density-traceable possible b10 k n-and 606 hepatitis superimposition clamp fusion strategy deviation pathogenesis amino well-aligned adjacent specific measure sequence b6 clinical host virus-cell cough pdb interface disease stabilize circulate 4 surprise high ref cellular interaction sars-cov b11 1,2 m å coronavirus 6 include 18 pair form ace2 highly case attribute manner 2013 viral functional hku4 real-time b5/6 protein-protein small infection locate acute subunit refer variance alignment intervene cause 9 2 s1 b7/8 unique region murine -helices sars-cov. globular fatalities-has 76 7,8 5 recognize know b9/10 compose blade pathogenic represent individually 2.79 2.5 mediate 15 virus-receptor analysis homology cell disulphide a1 conservation 23 attention residue convert virus-specific constant potential c-terminal b-strands b8 12 resolution iv essentially manifestation 17 basis typical conformational dipeptidyl detail mers-cov v381 class equally 10,11 sheet-face root observe identification east 1b asymmetric plasmon clear crystal g1 1c 367 receptor total rbd worldwide 1.793 2dd8', 'consolidation transfer virus infection opacity respiratory develope male governmental authority rule 21 2:1 local multifocal 2 hospital cov nodule arabia treat cov. multiple radiological central 76 \\ufeff1 novel 5 diagnose stay grind hilar 36 study obtain 14 patients ± middle day scan organize saudi serial review 35 adenopathy year non-contrast 2012 patch establish syndrome specific aim follow confluent september die progress mers conclusions mediastinal pattern pathognomonic 12 resolution resemble high widespread patient outcome bilateral chest subject accord ground-glass single retrospective mers-cov coronavirus 6 10 include ct 18 sign(s human east results reticular prevalence average case descriptive x-ray identify pneumonia age finding method glass total range', '', 'wean research life structure minimize hour change molecule gut database month purpose little milk applications product significant covid-19 production remain crucial solid elevate right diarrhea datum calve \\ufeff1 nutrition intake management feeding novel alternative step-down active free abundance know repository published study calf plane tract maximize microbiota represent protocol growth microbiology long affect fund review contain allow strategy analysis sources calves proper microbial-based covid survival compound increase health synthesis result regard volume potential information conclusions sufficient unrestricted original antibiotic disease great colostrum apply centre high adg place nutritional productivity future mean re-use decrease bioactive peer-reviewed acknowledgement susceptible benefit main elsevier source base necessary literature resource massive form feed fee transition digest positively publicly development grant implementation create gastrointestinal myriad late distress recommend', 'behavior 0889 xxx-xxx brain 1591/ immunity xxx xxxx', 'virus define oxygen infection prevention screen intravenous cumulative close cause suspect antimicrobial contagious therapy treatment reaction treat standard room outpatient facilitate light co-morbidity datum illness airborne supplemental mortality risk designate novel consider november possible exposure hygiene isolate sars-associated attempt negative strategy variety 2004 gown broad-spectrum old write provider member goggle symptomatic specific measure clinical 24 efficiency time 2002 contact majority pressure july winter 4 avoidance fluid high patient epidemiological criterium laboratory-confirmed detect future sars-cov 8000 important mask positive numb coronavirus control glove 10 unrecognized include chain hand appropriate abstract china center 2003 family sars case test supportive -a precaution evaluation transmission healthcare identify polymerase pneumonia rate antibody worldwide recommend', 'endemic severe virus positive wildlife surveillance coronavirus reservoir emerge kong acute importance source miniopterus novel m. bat respiratory 63 identification highlight interspecies disease 12 emergence animal pusillus commonly circulate hong transmission wild exotic sample fecal suggest syndrome-associated sars-cov finding 19 act area particular recent', 'small basic 77 find mouth southeast research traveler approach burden infection clean tourism reflective change respiratory close database develope impoverish 25 b. associate cause respectively 31 obvious country financial touch discuss note local sub-saharan little airline 2 47 6,7 symptom 40,000 treatment region presentation covid-19 oceania international remain response medical h ask avoid right flier ill america facpm illness datum 1 1990 \\ufeff1 dengue care risk upward data given arm 5 diagnose active free exposure likelihood repository diagnosis improve mph study 940 studies large-scale south characterize represent site spend south-central wash between-flight long travel-related affect fund 15 2010 giardiasis analysis tai endemic fever 3 faact destinations-from syndrome million covid turnover proper africa increase nose jet involve journey result publish consistent potential prolong quantify pattern unrestricted seatback original disease malarial ventilation commonly surface rest proximity twice 4 lack delay surprise present centre type high 7 patient hcf asia mean accord important febrile 1,2 re-use 17 reduce vaccination trip tourist recent work vulnerable challenge acknowledgement contract especially travel emerge article estimate nearly 6 ed discomfort elsevier source 10 include hand resource approximately tray 26 form destination-based half distance unnecessary impact robin frequent modern reveal unexpectedly eyelid limit world arrive destination common publicly compare eventually mcfee transmission unexpected air travel-associated viral grant 8 extent suggest good consideration lavatory seek gastrointestinal enteric adding infectious disturb remiss', '', 'classify find 54 research predictive 43 develope cause 39 57 major no.1 dizziness hospital 52 47 characteristic symptom logistic 140 covid-19 treat 30.7 b international 50 fatigue 48 53 somatic classification risk management intervention complaint design exploratory 36 vary 55 study expect epidemic nausea sleepiness questionnaire independent evidence 2020 regression 42 35 february 49 46 rd strategy analysis disorders sleep 3 province specific aim nurse health epicenter 31.4 result perform 37 dyspnea jiangsu sex 45 present icf c cluster splash high implement investigate enroll select 21.4 breathe objective based pain 51 wuhan fall headache 19.3 methods work 17.9 protective 34 56 safeguard base factor functioning 44 china 40 clearance general chest-discomfort-and-palpitation disorder results overlap nurses highly sputum disturbance xerostomia conclusion establishment pneumonia ssds disability face 41 icu ssd glass gastrointestinal total provide infectious urine/feces', 'illness severe droplet coronavirus hcws health syndrome \\ufeff1 article acute control care management feature prevention chain specific novel centers epidemiology ct spread etiologically respiratory recognize november consist summarize clinical cdc china result tomography regard rt-pcr information country sars 2002 sars-associated currently disease link case primarily supportive 750 therapy ards compute transmission available polymerase recently reaction sars-cov appear 8000 febrile death reverse-transcriptase southern distress worker', '', 'retrieval italian mother team sterility urgent infection infertile and/or sifes-mr indefinitely position egg novel document specialist require art society counsel woman reproductive carefully outline time reserve country schedule curve critical situation share monitor priority global guarantee cautious contribute pandemic advance oocyte collection maternal order represent medicine support plateau ivf patient unprecedented rate would-be parameter whilst evidence covid-19 drop-out treatment age oncologic ovarian postpone fertility pregnant reduce emergency peak', 'virus antiviral infection e6 assess visualize expression reduction traditional purpose morphology cxcl-10/ip-10 medicine protect assay abnormal treatment treat covid-19 production response yang mrna quantitative plaque 1 pro-inflammatory virion novel regulate lh pcr series markedly study particle huh-7 anti-inflammatory affect formula significantly effect strategy chinese activity broad-spectrum furthermore cell indicate replication measure tcm result host potential vero lianhuaqingwen conclusions disease sars-cov-2 regulatory il-6 attack demonstrate microscope cytokine vitro reduce methods tnf-α zifeng inhibit control electron results cpe exert transmission immune influenza goal real-time finding ccl-2/mcp-1 level', '', 'pathogenesis enable severe dissipative early understand coronavirus emerge infection novel temporal ct phasis tomography prognosis cause rapidly lung occurrence disease resolution evaluation examination development compute lesion progressive progression high phase image objective serial appearance demonstrate finding allow sort', '', '', 'severe virus italian analyze coronavirus syndrome acute young conclude additional paper develop agent consider respiratory possible healthy italy exposure record prolong lombardy condition europe lead world 2 link sars-cov-2 northern pollute development suitable eventually chronic high air investigate correlation stimulus region lethality evidence infective inflammatory based romagna atmospheric subject live emilia area prone co-factor pollution death distress provide pollutant level', 'severe small virus surveillance infection acute assess respiratory population associate cause 9 1.6 little hcov december january 2 hospital sample n intensive reaction children likely collect southern cold department immunosuppressed care risk p proportion tertiary diagnosis study rvs reverse tract nasopharyngeal 58.8 transcriptase independent affect 3.5 subtype year positivity frequently 2012 0.001 unit immunosuppression specific aim epidemiology comorbidities increase relation hcov-229e/nl63 inpatient die infect dyspnea ventilation sari patient adequate detect important primer cross-sectional conduct overall analyze positive 34 coronavirus especially ci 6 child essential chain factor human hcovs rt-pcr general impact account mechanical 7.6 oc43/hku1 case common responsible multiplex investigation polymerase 2013 viral rate 444/755 age hospitalize brazil admission 62 death aspirate 95', 'acknowledgement research sosome covid elsevier source irus p ulum active resource database free plasma alpha-,ortho-and somes tonavirus complex form nuc repository unrestricted original rhabdomirus coat envi publicly centre © n .~r~ grant -coated ech long covid-19 fund remain mean q re-use j t. membrane right analysis', '', '', 'respond skilled midst essential care management difficult tool service specialist clinical communication imperative family skill specialty front-line palliative pandemic crisis symptom support access patient covid-19 clinician train', '', '', '', 'datum severe positive evaluate coronavirus retrospectively objectives syndrome swab acute base novel aim ct respiratory population reactivation clinical result record throat cause information general laboratory 55 admit outbreak study disease limit 2 sars-cov-2 previous characteristic scan sample available pneumonia patient 2019 covid-19 chest laboratory-confirmed review methods', 'virus find 75,000 surveillance infection fast bottleneck rapid evolve change imply respiratory population variant overlook 25 associate country upper sample unclear support distribution virulence elevate bronchoalveolar datum 110 1 vivo risk background novel 20 spread different oral polymorphism lung strengthen similar lavage gene microbiota represent cap evidence current affect purify metatranscriptome selection indicate median individual sequence healthy involve clinical diversity infect 0 evolution transmissibility sars-cov-2 infectivity 4 elusive fluid commensal patient 51 microorganism consequence conduct intra-host numb coronavirus control observe necessary bacterium limit person-to-person conclusion transmission pneumonia viral dominate community-acquired interact range level', '', '', '', 'acknowledgement diarrhoea abscess severe occasional protozoal research bowel infection covid maldigestion elsevier source villus 18 increase active resource database free associate cause form repository unrestricted original common malabsorption publicly crypt hiv-seropositive symptom centre person persist grant despite long covid-19 apoptosis fund frequency remain mean atrophy re-use enteric table right analysis hiv', 'severe environment surveillance research define respond acute successive respiratory cdc complement database computerize rule country note sensitive simulate 2 t activate 170 n timeliness covid-19 b remain response h determine mechanism right datum practice department care fast-response p spread process active free design repository mode critical registration lag specify channel communicable-diseases regulation u r long current fund station g analysis prevent weekly e syndrome edicts covid daily health time s 0 unrestricted policy original disease exist track smart centre c issue propose implement 7 national o detect demonstrate mean accord timely bird re-use emergency work taiwan acknowledgement cost-effective insurance system off-line card 6 control elsevier source paper base ic real primary resource center emerging/notifiable form sars collection publicly avian transmission grant 8 161 influenza flu real-time prototype usefulness on-line induce infectious level', 'covid-1 transfer safe adjust march structure screen web m. protection medicare knowledge communicate a. staff according doe curriculum medicine crisis approve n cite ehrlich morning covid-19 student response sign-out medical virtual responsibility h. covid19 chat train educator patient(s 1 overcome care risk p meeting spread aamc possible teach exposure telemedicine audio-video capacity address adhere quarantine disseminate share regulation u efficiently recently swiftly r current 2020 institution suspension conferencing program allow f activity utilize prevent 3 e residency temporary feature 2,3 way elkbuli increase involve effective fear hipaa participation american 3,4 learn stabilize pandemic fundamental l pre-proof update conference high patient demand o interaction maintain social scientific area j 17 indispensable emergency challenge lessen system save expense article -p continue school function lives communication physician https://doi practical distance schedule regular vital disruption login home education development healthcare journal online potus live method effectively telecommunication m&m provide mckenney recommend', '7411/ 1551 xxx-xxx research social pharmacy hincapié-garcía co administrative j.a. xxx xxxx', '', '', '', 'qt-interval globe prevent off-label coronavirus lopinavir/ritonavir risk unwanted drug-induced rage potential drug repurposing race disease global lead possibility q6 pandemic deadly considerable prolongation treat sudden 19 death cardiac hydroxychloroquine', 'variation τ sufferer population d(t)-deaths γe-recovery susceptibles suspect outbreak traditional simulate 2 βi t e(t forecast n r(t)-number αi ordinary α-death picture -death seir collect cold datum r(t)-recovered susceptible-exposed-infectious-recovered effectiveness novel mathematical consider alert accumulate (t)-total free innovatively quarantine epidemic βe-probability introduce negative arouse -recovery far ea -probability reach 2019 february η-ratio peak set ε-rate province qi analyzer fitting unit person/d nomenclature measure i(t)-free healthy equation time potential infect qe(t)-quarantined contact disease qp delay state apply e(t)-free d progression propose person δ(t)-quarantine experiment future based hubei duration social i(t confirm qs(t)-quarantined true γ(t)-recovery susceptible analyze positive evaluate coronavirus panic steady date article real t-time s(t)-free factor model release practical guide schedule dynamic qn describe reveal global (t)-quarantined transition case -quarantine common non-linear transmission γi expose rate optimization differential reopen trend end −1 infectious -time', '', '', '', '', '', 'datum meteorological analyze department surveillance find jakarta e incidence -p employ correlate p include aim health rainfall minimum abstract maximum spearman-rank 0 .392 indonesia temperature study input average pandemic republic test l pre-proof c u n journal correlation rate r o covid-19 ministry serve weather mm secondary p<.01 r= j component reduce significantly f humidity analysis', '', '', 'severe virus find tetrahedrally antiviral structural chymotrypsin-like acute structure -cys consist polyprotein respiratory develope catalytic cause inhibitor complex zinc-coordinating cvb3 pocket cov therapy 229e pro cov-229e presence process active previously relevant study 147 3cl coordinate coxsackievirus syndrome replication specific compound residue protease explain result cv regard picornavirus potential exist present 200 belong sars-cov strain specificity basis peptidomimetic 3c-like solve coronavirus medically combat require bind human 3c 40 b3 family sars drug dyad crystal development viral optimization target provide', 'vertebral cats research cross weak pathway complete database cause proprioception limb cord infection/inflammation knuckle anomaly paresis point abnormal paralyze covid-19 remain 918 spinal right -the quick apart 907 p active free repository paralyzed trauma far cuddon long gait fund voluntary 42 peripheral analysis cerebrum weakness covid sensory unrestricted diseases original disease congenital incoordination commonly present centre place neuraxis 906 paresis/paralysis mean foot re-use abnormality decrease acknowledgement system paul nervous elsevier source summary ataxic resource solely loss form physical disruption movement common ataxia occur publicly body • grant functional motor misplacement cat reference', 'datum small virus inference prediction paper process model help time country curve relevant forward realize study backward error disease official epidemic situation decision transmission 2019 based corona analysis', '', 'influence system numb coronavirus mortality nonspecific and/or vaccine specific different vaccination health population develope protection associate immunize puzzle capacity postulate country pattern policy expect confer case sars-cov-2 transmission heterologous attain low hypothesize fragile covid-19 adopt bcg morbidity vulnerable', 'severe scopus virus raise notable research infection 24.3.2020 web respiratory database cause outbreak fight experience interleukin december etc science treatment keyword covid-19 international relate 2019-ncov reviewer monoclonal \\ufeff1 quality novel isi data design immunotherapy relevant 2019-ncov. study similar suitable protocol word 2019 evidence review option write valuation vaccine attention publication effective result time perform prisma exist pubmed present type 7 criterium demonstrate sars-cov 51 subject mers-cov. evaluate coronavirus emerge control article include base develop exclusion human describe candidate conclusion extraction viral antibody search method final systematic late inclusion', 'severe virus surveillance infection acute positive-sense myalgia respiratory rna associate cause laboratory-documented little hcov pulmonary 67 etiology symptom logistic 665 assay identified-hcov-229e reaction 50 107 multiple determine likely singlestranded ill cold illness respiratory-virus 1 season adult background active 22 know confidence 14 similar hcov-oc43 4-fold hospitalization systemic frequency regression 678 multivariate year analysis mid-1960s exhibit spirometric sign old 16 incidence feature vaccine increase serologic clinical result 0.13 hcov-229e conclusions worsen majority disease winter 1998 0.27 patient chronically 2215 detect strain regardless receive basis methods hcov-nl63 culture early coronavirus definition reverse-transcription accompany hcov-hku1 ldi 11 chain human results 0.58 limit envelop detection 90 common serum compare chronic obstructive identify polymerase influenza antibody 8 total -99 95', 'severe percentage find impairment infection remarkable opacity respiratory high-density dichotomic predictor follow-up cause reduction vessel caliber node pulmonary mainly short-axis ards initial lesion covid-19 tubular radiological multi-segmental oval presence apart \\ufeff1 adult novel previously alert lung study similar tract enlarge scan moderate 2019 effusion deterioration sign syndrome insurgent increase italy consistent extension conclusions infect mediastinal pattern lymphadenopathy present progression patient image bilateral chest objective sars-cov appearance pathology wuhan area uncommon recent mers-cov early coronavirus travel include develop literature ct china center sars-cov2 x-rays enlargement results describe case infiltrate common pleural progressive identify predict introduction appear finding sudden element sustain finally distress', 'acknowledgement research covid elsevier source histological ne2 biopsy north active resource database free histochemical b. e. form reprint repository rectal address v. unrestricted b!emona original fleming great hospital publicly requests sick centre victoria newcastle-upon-tyne 3ax newcastleupon-tvne grant long covid-19 road fund children remain mean infirmary re-use cooperation right analysis specimen roval', 'conclusively severe virus coronavirus establish newly emerge syndrome acute include screen rapid agent sequence analytic respiratory useful human identification amplicon species know rt-pcr hcov-229e sars single-tube sars-associated describe outbreak study obtain canada hcov-oc43 test restriction present enzyme sample toronto assay high sensitivity good etiologic detect prove sars-hcov provide analysis', '', 'acknowledgement http://dx research administrative middle-income covid aspects elsevier source active resource database free form countries repository unrestricted original publicly low-and centre grant long covid-19 fund remain mean social pharmacy re-use right analysis', 'severe cardiorespiratory oxygen infection equipment participate chiefly develope protection surgical associate pcr-confirmed reduction hospital pulmonary characteristic section unclear alike anaesthesiologist reaction covid-19 spinal radiologically safety presence intraoperatively 57.1 1 perioperative risk ropivacaine theatre background novel active record pcr confidence study personal 5/44 45/49 scan 0.75 2019 review 4/7 91 84.1 supplementary zhongnan 3 lower-limb deliver symptomatic subsequently anaesthetist clinical 11.4 conclusions perform 37 operate p<0.01 majority disease 2.7 safely mildly patient outcome wear wuhan 95.3 confirm interval relative reduce retrospective methods protective anaesthesia coronavirus 63.7e99.4 chain ppe ct require 44 china results undergo compare transmission polymerase pneumonia expose compromise rate forty-nine caesarean appear surgery provide level 95', 'small virus find march infection swab carry size respiratory associate chloroquine reduction add reinforce upper survey hospital symptom sample point cov-19 treatment presentation low significant covid-19 refuse treat azithromycin presence confirmed day6-post elimination consider arm 22 load study negative nasopharyngeal tract protocol significantly effect hydroxychloroquine set chinese depending 600 16 d6-post daily th clinical french sars-cov-2 reduction/disappearance patient duration receive single early untreated evaluate carriage control include literature center absence mg case average test compare asymptomatic viral despite efficient end inclusion role', 'concern high-intensity emotion early find stage team self-reflection life positive simultaneously gradually discomfort care member play include adjustment affection colaizzi face-to-face summarize nurse consist rational increase health 7-step fear anxiety cause firstly interview family outbreak experience epidemic gratefulness front-line theme pressure style mental negative self-coping occur development present support finally secondly patient growth covid-19 interweave telephone maintain appear fatigue important method coexist analyse act dominant psychological cognition professional responsibility conduct role thirdly helplessness altruistic work', '', 'mouth po research respond crtz intravenous hour gut database subcutaneous associate cause -dopaminergic chlorpromazine 2 efficacious prochlorperazine phenothiazine dosage injection concurrently treatment low covid-19 dopaminergic remain vomit serotonergic h act right sq 1 0.5 sedation agent possible active free subcutaneously spectrum repository mode diphenhydramine administration vestibular cholinergic stimulation long affect fund motion -histaminergic metoclopramide analysis activity dog 3 mg/kg/day covid fail specific increase sickness 24 histaminergic constant antagonist gi unrestricted medication original disease predominantly pressure 12 motility commonly 4 d centre intermittent blood 0.1 usually mean choice re-use gastric 0.4 motilin acknowledgement hypotension numb 6 pronounce 1.0 helpful elsevier source include resource erythromycin mg/kg form infusion broad drug monitor limit case publicly -adrenergic im grant intramuscularly 8 antiemetic good appear ondansetron promote receptor 5-ht dimenhydrinate 0.2', '1/3rd illness highlights virus 1 analyze characteristics fever 3 e objectives retrospectively -p import p detectable data 5 clinical abstract table design undetectable onset group half tertiary dynamic load temperature 14 2 common 4 l compare day symptom manuscript characteristic u n patient 7 viral r o covid-19 laboratory-confirmed duration 51 method secondary contain low-grade j non-imported f', 'acknowledgement acutely old research covid bear 976 elsevier source reluctance difficulty active resource database free onset form limb repository insidious unrestricted rare original lameness limping swell occur publicly • site present centre generally grant neoplasia long covid-19 inability fund usually remain mean weight walk cat re-use right analysis', '', 'pathogenesis mers-cov severe 2012 fatality virus sign coronavirus 54 coronavirus-erasmus antiviral syndrome emerge date infection elucidate inoculation replication histological indicate vaccine novel develop 114 respiratory monkey clinical previously human hcov-emc arabian model center east associate develope know mers infect study intratracheal disease case animal middle neutralize cov suitable rhesus macaque lesion antibody production medical peninsula', \"severe asthma classify 8.0 research define de predictive objectives infection 3.84 respiratory consciousness database associate country month 10.96 0.84 organization-defined 2 hospital 689 28 logistic intensive clinically poor covid-19 children remain 2.72 right 4.0 middleincome 2.25 rabat risk care 2.27 management 4.02 13-month adverse data 3.79 active free likelihood 55 repository admit confidence improve study university rhonchi 2.88 27.2 morocco index independent auscultation 0.46 long fund regression 59 1.32 multivariate ascertain strategy analysis 1.79 2.50 fever 3 cyanosis covid survival pital moroccan hô health prognosis die severity 72.8 conclusions perform unrestricted scarce csp 1.58 original odd 3.83 0.25 4.15 centre house d'enfants outcome investigate mean re-use interval history risc 1.05 methods acknowledgement prognostic positive recruit early definition 95 ci child elsevier source prospective include 41.73 pallor 2.45 metapneumovirus require factor resource human identification 1.24 form results ratio 2.09 1.34 world smoker publicly impair pneumonia grant 1.18 1.13 score good age live 2.13 prematurity death 187 5.04 fulfill\", 'correspond industry virus − definitively burden infection subunit render determinant line expression cause engineer hela protein porcine genetic s1 intestinal cell-surface express n significant pretreatment 229e st overexpression hcov-229e-s1 diarrhea alphacoronaviruses spike \\ufeff1 gastroenteritis examine genome tropism soluble pathogenic ablation study epidemic combine infectability economic step villous long apn effect crispr/cas9 exhibit cell knock indicate swine result host hcov-229e infect s tgev-s1 mdck surface apply consistently pedv interaction demonstrate atrophy aminopeptidase consequence pedv-susceptible susceptible coronavirus preincubation transmissible version emerge main essential glycoprotein include epithelium require bind human unlike observation block dehydration conclusion resistant huh7 pedv-s1 viral functional entry prove receptor tgev role', '', '', '', '', 'transfer prevent away coronavirus numb evaluate provider life childlessness establish pregnancy jeopardize infertile medicalcare survival comprehensively risk include quality position adverse attention measure accordingly freeze fertilization increase possible factor art human appropriate woman reproductive result irreversible cause time neonatal age-dependent physical infect perform embryo priority disease transmit case pandemic doe delay separate present couple outcome stimulation 2019 current infertility covid-19 future ovarian end assisted focus appear gamete pregnant technology non-life-threatening effect strategy', '', '', '11.5 march infection fast 9,840 protection associate fight experience assessment 2 according symptom n treatment covid-19 treat relate plan 1 \\ufeff1 adult 70 young risk benefic-risk p novel 20 comorbidity exposure proposal dilemma mind disseminate 234,073 patients day u r 2020 22.7 organization 60 year f old e median covid 79 individual increase health italy ethical severity situation disease pandemic sars-cov-2 80 l pre-proof progression high patient o period 12.5 declare confirm j recent tobacco coronavirus -p defence case-fatality china physician exponentially highlight impact temptation world 89 case 90 ageism journal face rate suggest personalize age short cancer 19.7 death range provide worldwide distress balance', 'basic molecular relapse immunology line demyelinating associate donor 31 twenty-eight antigenic protein hcov cross-reactivity genetic environmental t 32 n tcell region reaction b murine 229e relate ev t-cell vβ mechanism mimicry yc ms cross-reactive long-term previously tcc promise 267 155 obtain race derive clone amplification r autoimmune ag proteolipid selection e specific sequence 114 virus-specific involve healthy clinical plp w myelin-specific s 258 disease w. 2007 myelin l ms-like c attractive 7 patient investigate o pathology strain vitro confirm hcov-229e/myelin overall clonality coronavirus 123 isolation 10 chain factor human initiation ava rt-pcr candidate oc43 hcov/myelin cdr3 investigation tcl identify finding r. mbp induce role level implication', 'virus sweep acute respiratory chicken originate unprecedentedly politically 9 cause slaughter 21 outbreak experience sensitive note hospital emergence medicine hong ill pay curdle failure department kong novel stop disseminate instance deadly three-year-old 2009 day barrier microbiology hoi-ka intravascular h7n9 year effect key fever 1997 3 province million recover play swine epicenter lam die species infect disease learn pandemic faculty track sore coagulopathy blood jump decide vigilance boy fall coronavirus emerge successfully queen combat guangdong human china throat kidney 2003 sars action world responsible avian h5n1 identify 2013 flu live death elizabeth infectious role', '', '', 'research prevention ability traffic cause ¼ country major financial outbreak month experience cope restriction support medium treatment significant international medical 2019-ncov solid technology valuable facilitate enormous datum government difference effectiveness p formulationdpublic lesson network improve preliminary epidemic originateddhubei aid strict far day community coordinate cooperation consultation chinese application province provider capital measure increase health involve effective time group information infect policy expert pressure pandemic late implement patient public future deeply hubei wuhan area 25th emergency city nervous china communication 0.0001 general quickly case forty-thousand motivate compare healthcare pneumonia rate suggest good greatly total provide', 'severe virus pre-clinical research ethically document summarize chloroquine cause purpose meuri interventions t approve n treatment in-vitro covid-19 b international editorial safety datum unregistered effectiveness know adhere registries narrative study high-quality r 2019 evidence review organization indication justify f embase e replication 23 aim health clinical effective regard time conclusions s expert disease long-time sars-cov-2 pubmed l state ongoing c letter patient national o public trial vitro emergency methods concern pharmaceutical contract coronavirus article include paper consensus monitored china form results framework limit world urgently search guideline systematic rationale', '', '', 'fda reservoir research mg/day text manufacturer adjustment special respiratory database maximum note 2 therapy hepatic approve dosage tid treatment product covid-19 remain divide right adult risk prophylaxis alternative 20 5 active free repository prescribe administration recommended insufficiency yr circumstance long fund higher 100 150 60 f renal analysis old mg/kg/day e covid daily ≥10 ≥65 concentration information mg/ml. unrestricted expert original device centre c pediatric mean period re-use acknowledgement 13 child elsevier source 10 hr require resource mg/kg form monitor mg publicly dose available grant age consult aerosol-generating mg/ml recommend', 'severe virus san research infection gathering conclude minimize united restaurant brace respiratory alarm college close population food aerosol cause laboratory country knowledge spanish financial particularly trainee little discuss states wide-ranging assessment educate 192 2 cities personnel precedent protect generally discretionary uniformly covid-19 50 court event technologist avoid adopt nonpharmaceutical recommendation presence 1 droplet offer sport risk pathologist service novel cultural gym 100-year-old spread cytology political 5 intervention mass mandate different exposure addition vary explore st. series company similar 15,000 transmit https://www.elsevier.com/authors/journal-authors/highlights reach recently eat 2019 affect current potentially fund institution ban review repeat cancel peak analysis 30 kill bar closure write somewhat 3 million daily francisco specific measure follow increase health clinical disinfection/hygiene fear die time group potential kansas american perform infect contact situation disease lead predominantly great pandemic commonly surface sars-cov-2 state delay manuscript implement widespread patient unprecedented wear public duration mean social pathology 19 mention mask consequence reduce recent specimen work church contract susceptible 1918 early numb coronavirus city travel article estimate isolation territory continue include paper 10 school require function 350,000 forget distance highlight louis currently fomites milwaukee global world music case home h1n1 test interest transmission healthcare rate influenza drink 675,000 technician grow range provide infectious worldwide', '', 'pathogenesis mers-cov influence coronavirus 3 sgrnas unusual difference structural structure main article near genome relationship 10 feature positive-sense novel covs 11 rna human genus capsid matrix china translate associate accessory encode orfs 0 highlight outbreak protein little one-third genetic pandemic sars-cov-2 cov betacoronavirus compare pneumonia viral belong covid-19 comprise nucleoprotein based genomic sars-cov important wuhan contain typical phylogenetic singlestranded betacoronaviruses phenotypic similarity -terminus', '', 'protective requirement selection stakeholder adult acute and/or care management include screen tool equipment document intend outline workforce suspect relevant personal hospital physiotherapist patient treatment covid-19 plan determine confirm physiotherapy preparation set recommendation', 'find 929 fuel research adjust burden special web provinces/cities database develope cause country knowledge major occurrence 1.6 purpose copd 2 hospital 139(4):920 disparity scale covid-19 relate remain distribution medical act features heart right facilitate opd rural adopt enormous datum failure proquest 1 government mortality urban risk management credible 2011 different comorbidity 5 active health-care free exposure vary addition repository lung diagnosis address improve study epidemic strengthen personal contribute characterize signifi site depression economic long deterioration evidence community fund current infl review thomson professional rank self-management year strategy analysis chinese 3 covid aim increase health effective economy consistent unrestricted policy optimal original great disease lead immediately 4 pubmed contributor exhaustive centre c issue high patient probably public chest reported biomass mean focus impose area re-use reduce morbidity true challenge acknowledgement concern 13 early evaluate especially expense date article uence elsevier source include society function resource factor clarify china physician form physical impact account currently prevalence 2008 global mental smoke publicly development previous reuters progressive grant 920 face imbalance suggest search good guideline admission dystrophy death', 'diarrhoea co-morbidity system datum immediate coronavirus research unusual march emerge covid blocker fast 23 prophylaxis management background base feature aim literature follow rational renin clinical regard interpretation chloroquine angiotensin inhibitor conclusions ibuprofen results testis scholar narrative confusion discuss disease limit conclusion track test pubmed symptom enzyme issue term google persist patient treatment brief evidence current search 2020 covid-19 ace-inhibitors multiple review cardiac 19 till live receptor gastrointestinal biomarker role hydroxychloroquine safety methods cardiovascular', '', 'small virus find wildlife surveillance protozoon research cross infection agricultural ä natural change resistance protozoan population chapter database 175 associate cause complex major cover particularly 66 previously-identified local little note survey antimicrobial animal emergence according assortment taylor medicine section term protect association interestingly scale covid-19 significant international remain border tabulate 61 likely right re-emerge route 307 practice 1 rickettsia background 58 consider spread political recognize active free causal know helminth repository pathogenic study epidemic pre-travel university transmit contribute modification exception woolhouse recently growth long fund institution review bring analysis edinburgh behavior exhibit old 3 1407 incidence newly 2001 covid adaptation discipline 177 increase health epicenter involve emerging host species scientist publish regard result advice 75 organism perform pattern leader unrestricted contact diseases majority original disease centre update wild zoonotic fungus jump usually mean strain microorganism area interdisciplinary re-use comprehensive 217 2005 clinician re-eids acknowledgement 135 emerge habitat control encroachment tropical geographic elsevier source include veterinary literature factor resource human regional form gowtage-sequeria broad drug bacterium prion capable 287 538 eids publicly resurgence property transmission constitute collaborative h5n1 identify minority grant influenza effort domestic prove 1415 microbiological total range -but infectious', '', 'severe fragment molecular reservoir infection pipistrellus complete ability coronaviruses change kuhlii bat respiratory rna cause origin country cov switch decade correlation event mild phylogenetic illness italian genome covs consider mutation study rna-dependent characterize affect frequency ngs analysis chinese alpha-cov establish individual attention rdrp sequence increase sequencing genus host species diversity potential elderly hucov-nl63 demarcation disease high zoonotic hucov-229e detect sars-cov strain evolutive beta-covs european conduct mers-cov generation numb coronavirus child main base human reveal polymerase 2013 suggest recombination worldwide fully', 'obstruction research fresh database associate cause little eosinophil node etc treatment covid-19 remain vomit poorly weight loose right diarrhea lymphangiectasia inflammation 760 p consider active eosinophilia free repository protein-losing ± long fund systemic melena relatively analysis dog 3 covid increase lymph result lymphatic feces condition unrestricted original hypoproteinemia circulate malabsorption 734 centre blood usually duration mean re-use acknowledgement elsevier source primary enteropathy resource loss ibd form responsive disorder rare infiltrate common publicly • chronic week grant neoplasia mucus eosinophilic secondary cat watery', 'severe datum cell vivo transfect instead coronavirus furthermore truncate system syndrome infection structural acute e6 \\ufeff1 genome observe envelope virion construct novel cdna respiratory assemble expression full-length know vero infect encode co-expression frame protein similar cleavage predominantly biochemical particle present read virus-like open express 3a viral product transiently detect demonstrate sars-cov purify baculovirus incorporation vitro homologue membrane', 'acknowledgement find research covid elsevier source active resource database free scintiscan form repository subjective unrestricted original visual assessment mislead publicly surprise centre 1192 grant region long covid-19 fund objective remain appearance mean standard re-use right sacroiliac analysis', '', '2004 basic severe virus incidence newly kong emerge acute syndrome elsevier feature source possible respiratory associate addition diagnosis infect sars published discuss disease animal cov responsible avian hong d identify coronoavirus pneumonia patient person discover february live h5n1/03 b.v.', 'severe virus mouth 335 epithelial research infection acute assess respiratory database develope lancet associate cause country outbreak 2 329 sample pharynx covid-19 articles localise remain sars-cov-infected discover likely replicate right presence macaca background agent diagnose active hyperplasia free causal repository sars-associated study similar personal attempt microscopy macaque day combine long hyaline fund sporadically membrane excrete analysis fascicularis exudate cell syndrome newly covid postmortem replication serosanguineous nose clinical characterise cynomolgus interpretation 75 infect fit pneumonic unrestricted original 12 centre type high patient formation criterium necrosis detect sars-cov mean alveolar area re-use 436 methods acknowledgement syncytia coronavirus definition immunohistochemistry 6 isolation elsevier source necropsy findings electron metapneumovirus primary require resource human damage form rt-pcr sars experimental prevalence case diffuse test publicly reproduce transmission pneumonia grant 41 worldwide prove pneumocyte role fulfill', 'virus raise molecular surveillance fast bat population periodical 25 originate clade origin phylogeographic maximum country outbreak assessment genetic animal ncov 2019-ncov likely mechanism build risk genome spread november previously record isolate preliminary study epidemic similar epizootic betacoronavirus 2019 clock 2020 tree strategy analysis 29 indicate sequence th effective result time pattern circulate high patient probably epidemiological accord wuhan bayesian agreement recent coronavirus city reconstruction urgent emerge article geographic continue phylodynamic underlie clarify genebank china credibility 2003 family dynamic sars describe observation highly sars-like global ancestor common development transmission available suggest recur rhinolophus provide', '', '', 'small molecular research infection structural immunology gut database propria ig piglet mln rotavirus-specific asc gnotobiotic node antibody-secreting porcine 2 intestinal numbers science 2427/95/$09.50 assay generally low 0.7 covid-19 plate remain response right 1 lp igg 2427(94)05343-q different 5 active free antigen 3677 biology gottfried iga repository nonstructural address spleen 14 similar university igm day rotavirus-infected site combine long adapt fund immunopathology program immunospot 46 rotavirus-coated peak pid analysis ssdio165 (1995)265 cell 0165 3 covid indicate replication adjacent pig specific lymph elispot reserve 0 orally unrestricted original lamina 45 mucosal tissue rotavirus 284 inoculate 4 present state centre immunoglobulin 216 high 7 cellular predominant mean developmental re-use relative proportionately fix b.v. number acknowledgement 13 evaluate elsevier source veterinary enumerate mesenteric resource post-inoculation form 1995 ohio ratio enzyme-linked sb occur publicly order intestine diar- coating viral grant antibody age 263 range', 'water uranoscopidae research venomous fish superclass database stingray actinopterygii 1200 mantas covid-19 remain bony david right scorpaeniformes 1 shark catfish active free antivenoms manufacture repository ° box weever long fund dangerous rarely jellyfish fish-synanceja/synanceia perciformes key analysis relieve 3 rajiformes covid sting feature figs rayfinned cartilagenous species hot unrestricted osteichthyes original 134 45 siluriformes centre c 200 squaliformes scorpion warrell pain mean spp re-use stone-lifters acknowledgement class think elsevier source fatal resource dogfish stargazer form inflict family lion publicly • order marine envenoming grant trachinidae chondrichthyes stonefish', 'globe ecosystem particularity virus coronavirus 3 panic closely travel fast conspiracy novel mass way spread misinformation -and pair strike china purchase fearmongering origin rapidly information 21 -about century infomedia outbreak mislead link emergence circulate racism virality crisis identify week face mark medium covid-19 theory public social create rumour st 1,2 mask virology coincidence', '', 'acknowledgement research basement covid conduct elsevier source collagen destroy change imply active resource database free glomerular form pcr repository v unrestricted protein original pan occur compare centre investigation injection ecms western grant long covid-19 remain mean tubular re-use effect blot right analysis digestion', '', 'virus (1976)65 research respiratory material database bc discuss characteristic section 32 covid-19 remain stott 65 foetal replicate right datum 1 titre active free haemagglutinin antigen repository particle reach microbiology microbiol long evidence trachea adapt fund l.h. j.c. analysis fluorescent covid replication 1976 freeze stain vet infect bridger unrestricted field original -69 tissue inoculate centre fluid jebbett technique detect mean strain re-use culture acknowledgement coronavirus isolation elsevier source veterinary organ observe electron primary thomas resource abstract microscopically form jersey publicly grant antibody e.j. bovine', '139,000 m.w. 110,000 respectively 68,000 53,000 major v 22,000 pretreatment b vp2 act vp5 rbc c. dvim p destroy virion designate addition rapidly isolate vibrio 7.3 ° reverse minor neuraminidase rde contain cholera analysis activity cell newly 37 100,000 optimal hemagglutination ph surface 4 vp4 l enzyme c rat blood differ 38,000 vp3 rbcs bromelain coronavirus specifically agglutination inhibit glycoprotein filtrate ha describe influenza-a digest vp1 constitute mouse vim red suggest 6.5 agglutinate receptor polypeptide enteric', 'consolidation research march vascular 27.3 multilobar methodical opacity line database respectively purpose 35.7 multifocal 59.5 node hospital nodule support fibrous fifty-eight prevalent covid-19 50 b distribution subpleural radiological 98 23.8 datum 57.1 como ggo tomography 14.3 36 22 spectrum blines lung study 2.4 distortion pave consecutive enlarge effusion 2020 review peripheral 15 february 100 bronchogram year radiograph sign embase feature 7.1 37.5 publication crazy increase lymph italy woman consistent stripe perform pattern original predominantly sars-cov-2 examination pubmed man ongoing patient investigate enroll image manifestation bilateral chest laboratory-confirmed cxr 64.3 comprehensive 46.9 typical conduct ground-glass retrospective twenty-two recent valduce ultrasound evaluate emerge hazy observe include multi-modality literature forty-two ct 18 28.6 26.2 results thicken diffuse conclusion pleural compare compute single-center identify pneumonia air thirty-two twenty-six architectural search age hospitalize admission finding materials method range provide', '', '', '', 'pathological severe fragment cell monoclonal early intrasplenic coronavirus mabs dna spike approach 3 syndrome inoculation establish acute fast hybridoma evaluate virus mlv/sars-cov-infected e6 mab direct specific novel difficult determinant line respiratory recognize effective antigen result cause plasmid vero diagnosis sars encode antigenic protein study pseudotyped highly mlv/sars-cov disease prepare vital immunoinformatics anti-spike s1 neutralize effect generate infectivity select immunization antibody albeit secrete pseudotype efficient production linear murine dangerous sars-cov epitope leukemia single-shot single induce infectious', 'severe virus classify find epithelial reservoir cross infection coronaviruses bat molecule respiratory rna causative associate immunocompromise 9 cross-species 21 protein fibroblast 2 animal sl-cov-w1v1 progenitor 32 angiotensin-converting lymphocyte low b peptidase-4 relate globally discover sars-cov. mechanism phylogenetic circulation cold kb receptor-binding lineage spike closely alpha-coronaviruses sl-cov-wivi genome direct novel tropism agent consider 20 previously gammacoronaviruses ii infant isolate lung 14 similar hcov-oc43 tract betacoronavirus distribute barrier recently fusion mediate 15 rarely membrane key analysis chinese cell alpha-coronavirus bats 16 outstanding newly replication feature sequence synthesis dpp4 genus species host hcov-229e s hcov-nl634 evolution disease europe 12 transmissibility tissue enzyme microvascular c type 7 patient beta-coronaviruses precede beta-coronavirus airway sars-cov alveolar strain 19 specificity 17 macrophage pneumocytes wide dipeptidyl mers-cov 13 coronavirus hcov-hku1 main organ base 10 11 18 hand factor human occasionally china 26 ace2 broad interspecies sars-like endothelium envelop ancestor common domain occur transmission immune recognition mammalian horseshoe delta-coronaviruses 8 entry investigator civet appear target receptor range asia positivestrand', 'severe magnitude infection strong acute respiratory cause doe cov initial glycoproteinbased protect modify minimal interestingly response remain sars-cov. datum vivo dna-s spike mva-s achieve novel prime 5 monkey ankara nab explore promise critical pathogenic study persistent neutralize maximize heterologous chinese rabbit syndrome play vaccine regimen necessarily s optimal sterile type technique high immunity sars-cov important ad5-s adenovirus boost vaccination combination challenge evaluate coronavirus date require human vaccinate sars development previous rhesus compare vaccinia mouse predict provide viral antibody secondary induce role level', '', '212:385 acknowledgement inflammation acid dermal research inhibit platelet covid adult wound elsevier source 1996 surg wind possible active resource database free endogenous pediatr function release form repository unrestricted corvin original lower porcine scarless dyn explanation aj oo publicly 1998 centre heal mouse olutoye fetal 31:91 grant 393 long covid-19 50 fund hyaluronic inflammatory remain response mean 51 49 dev cytokine re-use j reduce right analysis implication 95', '', '', '', '', '', 'epicenter wuhan background', 'small find elisa research infection locate variability m. liprandi rna database f. 1987 esparza month i. porcine animal north-western -february sample assay correlation region antigenicity covid-19 remain right collect presence monoclonal herd examine genome p direct different active free electropherotypes ii isolate repository study 1984 subgrouped microscopy consecutive characterize far microbiology microbiol long cavazza fund 35 j. analysis migration subgroup exhibit garcfa old electrophoretic covid pig specific d. 27.9 segment genes september vet perform unrestricted a5 majority original great circulate rotavirus 4 38 centre botero -45 immunosorbent venezuela select belong detect mean specificity re-use 1983 atypical specimen acknowledgement 13 diarrhoea analyze positive rez-schael elsevier source veterinary observe 136 electron m.-e. em 10 11 gorziglia resource human abstract 26 form -6 prevalence describe enzyme-linked common test publicly l. week grant antibody characterization', '', '', 'illness severe longitudinal virus excretion 64 analyze coronavirus indirect immunoassay positive discharge weekly syndrome swab \\ufeff1 acute immunofluorescence 6 continue novel chain conjunctival respiratory 5 rna throat cause time seroconversion 9 124 seroconverted 116 sars prevalence stool study urine 7.8 collection test serum occur bodily enzyme sample seropositive polymerase assay patient week 7 viral 8 antibody reaction real-time sars-cov cross-sectional determine 126 total collect shed specimen', '', '', 'define 372 43 close develope breath 1-a husband 2 shortness personnel symptom sample funding 32 covid-19 1 hospitalise active health-care exposure addition contacts onset admit 14 patients negative far day 60s-returned 195 2020 community 152 convenience unprotected fever symptomatic follow woman interpretation cough prolong contact sars-cov-2 patient person detect wife confirm methods overall positive travel date mid-january findings include china frequent monitor person-to-person case undergo test occur transmission investigation identify asymptomatic pneumonia week 8 despite late 347', '', 'category percentage virus classify molecular find outside natural pid=8 consist respiratory b. intrinsic outbreak protein antimicrobial animal cov n peculiarity low 50 b remain distribution likely shed datum build saliva spread active expect pid=9 easily particle shell fecal-oral long pid=6 membrane variety pid outer behavior prevent tool pid=48 host group potential respective infect optimal great hard ai sars-cov-2 later enzyme c cluster fluid contagiousness high place nucleocapsid sars-cov based mean fall m protective mers-cov number intermediate coronavirus resilient 6 depend include strange 44 factor human model family disorder account highly resistant transmission predict viral empirically-based effort fitness capability body level implication', 'acknowledgement system prevent environment percentage evaluate research occupational covid 0.0 elsevier source management aim 59.4 health active resource database free chemical design result aspect 26.0 respectively form 65.3 commitment laboratory repository critical unrestricted accident ohse study policy original hazardous researcher average education evaluation publicly descriptive compliance safety present centre high toxic expose grant long implementation covid-19 fund student semiquantitative remain institution mean ohsems plan review re-use overview 33.0 right analysis', '', '112 117 base assembly epidemic/pandemic 20 114 given require long-term different resource society division communication 22 press mers 116 impact sars 21 communicate example entire specialty epidemic global world pandemic h1n1 crisis allergy type support 113 adapt immediacy covid-19 115 future ebola fellow 19 program virtual unlikely unite history provide 118 recent train solution view director', '', 'acknowledgement 3 research hsct incidence covid elsevier source special active resource database free clinical 40 form repository unrestricted original pulmonary common publicly complication section centre conditions grant long covid-19 fund remain mean 15 re-use 60 right analysis recipient', 'influence analyze begin beijing assess service retrieve china record first-visit epidemic visit characteristic demographic patient reason current covid-19 background/purpose seek dental emergency utilization methods', '', 'severe virus molecular reservoir structural acute additional relationship special evolve rodent bat summarize respiratory originate origin encode protein 1a hcov 2 emergence animal mainly generate relate event discover phylogenetic 1 lineage closely genome covs mutation video addition know nonstructural epidemic hcov-oc43 contribute gene middle zoonosis exception shift dangerous review component variety key 2004 gain attention sequence clinical species host hcov-229e accessory array evolution disease great coronaviridae wild zoonotic differ adaptive sars-cov mention coronavirinae beta-covs subfamily 2005 recent fix hcov-nl63 specimen mers-cov numb coronavirus specifically think hcov-hku1 include ecology human abstract hcovs loss syndrome-related east family stir responsible order interest viral good recombination finding nidovirales', 'acid alri research infection variability acute respiratory population database 0.013 causative respectively conserve nucleotide little geographically 2 hospital genetic distinct t cambodia association low significant covid-19 b remain 1.7 divide right provincial hospitalise lineage \\ufeff1 p novel agent 5 active free re-infection vary repository diagnosis co-circulation study share gene tract consecutive annually 2009 far genotype 34.2 r long a2b fund year f g analysis homology sub-genotypes 3 amino incidence 2001 covid all-ages b2 vaccine sequence clinical result 56.3 diversity group severity s unrestricted majority original disease circulate 2007 centre c high investigate patient belong detect mean strain simultaneous re-use anticipate acknowledgement overall recruit child elsevier source observe metapneumovirus resource human form currently frequent common responsible publicly identify available pneumonia b1 grant sub-genotype age hmpv level bronchopneumonia', 'numb coronavirus magnitude establish infection paper intervention consider spread reasonably explain human model constant rule mers sars fit outbreak cycle purpose nonlinear reveal obtain disease situation double parametric twice compare characteristic day transmission order pneumonia patient growth rate inhibition parameter suggest low covid-19 region hubei propagation infectious analysis', '', '', '', 'acknowledgement severe 1 raise research build covid recover elsevier source 10 active resource database free septicemia bone skin 9 group form limb repository diagnosis american unrestricted thrive alligator mandibular original a. congenital lead animal circular tissue publicly rear centre wild type lesion mississippiensis captive grant 41 eat differential long covid-19 necrosis fund hatch remain crocodilian mean protrude fracture re-use abnormality uncommon right deformity analysis', '', '', 'acknowledgement http://dx research covid elsevier source 21st active resource database free food form repository unrestricted century original publicly safety centre grant long covid-19 fund remain mean re-use right analysis', 'lopinavir/ritonavir(lpv/r virus assess day14 9 respectively laboratory 21 52 characteristic support seven jan treatment covid-19 day7 response conversion lpv/r adult initiate p background novel spread 5 diagnose · oral diagnosis(day7 rapidly diagnosis improve study similar 14 invasive patients negative nasopharyngeal far day scan 2019 2020 15 35 endpoint 16 arbidol aim clinical group progress monotherapy 0 cohort disease ventilation sars-cov-2 apparent patient chest laboratory-confirmed detect 5(29 wuhan 17 receive favorable 11(69 retrospective combination methods specimen feb 13 94 analyze coronavirus city 12(75 emerge date 6 05 include ≥18years ct primary china results baseline conclusion compare pneumonia rate age corona', 'severe percentage respond march acute 4000 exponential respiratory help authority 9 maximum country reduction particularly 21 outbreak mid-april allocate prepare 2 hospital personnel facility intensive response italian 1 build closely difference care spread political proportion capacity grave similar day containment affect start 2020 100 analysis 30 depart 3 province syndrome newly unit daily measure follow health italy 000 regard imperative infect matt leader situation pandemic sars-cov-2 4 consistently national patient hubei social actively reduce feb decrease concern system numb coronavirus continue include 11 require resource china manage bed distance currently quickly global case 90 predict pneumonia week trend dedicate effectively worldwide', 'severe meteorological infection relationship generalize associate cause gam laboratory rise flat ambient cover little -china january 2 support n 3.209 covid-19 6.513 globally determine collect 1 keywords p background novel piecewise explore curve study 14 ° separate -novel u r 2019 affect evidence 2020 municipality regression february exposure-response f decline 118 analysis 29 count 3 lag0 e indicate survival 23 daily aim increase health result conclusions majority disease -generalized warm apply l additive pre-proof 4 c policymaker o epidemiological public linear mean j confirm detail methods positive numb coronavirus city ci -p essential include useful factor model approximately problem 122 results 4.861 -covid-19 prefecture-level temperature nonlinear case transmission sensitivity pneumonia journal robust suggest threshold finding weather materials method range provide implication 95', '', 'optimise carry swab respiratory population rna cause country biological december carrier sample assay oropharyngeal h presence government \\ufeff1 background transcription novel process 5 anxiety quarantine epidemic reverse passenger negative decisionmakers day 2019 pool start nasal shipment analysis covid sequentially 24 french 0 disease repatriate sars-cov-2 twice ongoing fluid national place investigate patient france hubei decide wuhan 337 reduce time-scale methods coronavirus include extract china (rt)-pcr sars-cov2 sars-cov-19 results arrival sputum absence detection nasal/oropharyngeal home test order asymptomatic viral send real-time end live', '', 'opportunity team research approach ireland rapid change surg imply participate database help surgical follow-up aspect pace edinb experience specialty little survey 2 hospital surgeons self-assessment section 326 covid-19 subsection relate remain standard organisation right safety educational canadian recommendation colleges practice care quality management service on-site process active free coll repository rigorous improve continuously represent © r long 321 fund review set edinburgh analysis activity 2004 improvement continuum covid deliver internationally attention aim proactive clinical irel 75 unrestricted original learn surgeon arise 38 centre inherent issue patient outcome recognise mean focus re-use j 17 recent detail acknowledgement understand evaluate 6 elsevier source accreditation include position function resource programme form royal guide oppose action modern publicly healthcare available grant good deal transformation effectively total comprise', '', 'kuba virus excess 54 define downregulates 3,15 enzymatically additional collagen sepsis-induced cleave enhance 43 transform imply bleomycin-induced resistance discovery modulate example fibroblast 52 c-terminus doe dipeptides initial japanese association cite abnormal treatment successful carboxypeptidase multiple remain ace-deficient mild right directly copd-related cardiovascular losartan initiate normal genome exercise influx matrix syndrome/acute substrate contractility breathlessness firstly rapidly 55 lung markedly trauma instance reverse site ventricular 273 growth derive sarcoidosis 46 significantly year cardiac dependent 30 trigger fever 3 survival play importance feature individual protease histology 24 63 plasma 59,60 concentration group angiotensin severity ace2-regulated 37 diseased cohort insertion/deletion lead complexity resemble 45 enzyme patient outcome investigate injury apoptosis subject pathology trial reduce retrospective recent culture 13 accumulating early hypotension solve and/or essential prospective 10 11 regulator bind require human wild-type loss downregulated 274 notion experimental drug frequent reveal disruption -spread beneficial compare exert artery 33 obstructive identify provide pneumonia h5n1 diagram arteriole rate irradiation-mediated score target 62 23,24 infectious level distress ang acid severe classical stage peptide burden phenotype factor-b1 pathway inactive injury-promoting 20,21 opinion discrepancy line expression close associate inhibitor growth/proliferation 272 protein local discuss little neutrophil animal remove mainly immunopathologic 28 ards support protect phase downregulation angiotensin-(1 low 50 production response 48 parenchyma mechanism inflammation failure 1 endothelial spike mortality difference dysfunction non-specific different process aberrant mutant chemical capacity isolate improve study expect similar endocrine confer contribute characterize immunoreactivity genotype imai hypertension recently frequency 42 review multinucleated ace layer application d/d exhibit extracellular angiotensinogen 16 infiltration syndrome newly indicate i/i hypertensive follow counterbalance result publish muscularized infect fibrosis commonly bleomycin-or d type fluid propose worldwide/ blood 7 formation inhibition display experiment demonstrate important 19 smooth cytokine specificity vitro oedema salt single atypical sodium mediator 2000 protective pathological syncytia especially inhibit control develop fibrotic proteintreated 40 permeability 26 27 2003 potent endotoxin forward 800 ards/acute world mg homologous serum development elevation interest immune spike-treated 41 reason suggest good secondary homologue death role mystery epithelial opportunity partially allele change rodent respiratory 25 inactivation male undetectable upregulates 31 57 biological vessel major add octapeptide month www.sciencedirect.com 1a implicate pulmonary generate etiology symptom unclear angiotensin-converting express remodel term significant instantaneously 53 catalytically central re-emerge deposition illness vivo allelic -fold edema background novel regulate possible active causal 22 ii critical versus dynorphin 14 numerous regulation controversial stimulation affect inflammatory fusion altitude 49 monocrotaline-treated shock key contrast pathogenesis leukocyte blocker intraacinar fail des-arg(9)-bradykinin rescue pharmacology clinical healthy connective host hypertrophy regard antagonist elderly dyspnea worsen disease pressure embolism apelin circulate 4 strongly progression capillary rat high fertility maintain idiopathic sars-cov 51 alveolar conversely 276 numb coronavirus 34 ii-independent 6 emerge organ include proliferation vasodilator attenuate epithelium 18 primary 44 function model china approximately form ace2 disorder highlight account hypoxiainduced -a impair radiation-induced avian pharmacologic irradiation vasopressor progressive pancreatitis terminal viral functional despite pilot profibrotic influenza importantly serve mechanistically muscle induce body late view similarly small interstitial pneumonitis vasoconstriction approach carry infection acute vascular sepsis bleomycin peritoneal rass cause 9 39 largely endotoxin-induced copd 2 genetic deficiency 47 secondly decade 32 hypoxic correlation spike-proteinexpressing murine 61 sars-cov-infected act conversion effector knockout myofibroblasts mitogen comparison bronchiolar circulation-borne achieve schematic agents/molecules hypoxia 58 phasis 5 involvement 2006 exposure addition polymorphism 36 replace know accumulation gene negative produce current evidence systemic renin-angiotensin 35 activation hypothetically component look system-modulating effect owe analysis sars-infected activity spontaneous 29 cell sign incidence million ras replication high-level 23 residue publication increase involve potential condition vasoconstrictor malformation physiology 12 irradiation-induced tissue statistically 38 issue chronically intriguingly sars-spike decapeptide focus etiologies 17 insult macrophage consequence susceptibility challenge system generation positive understand acid-aspiration-induced 56 homeostasis observe real factor renin identification kidney sars 6:271 recombinant titer absence block resistant elastic chronic mouse 8 additionally aspiration age recombination appear finding metabolite receptor particular retain penninger balance considerably', 'basic datum virus solve numb reservoir item infection article leave main helpful elsevier source paper minimization http://creativecommons.org/licenses/by-nc-nd/4.0/ ability novel mathematical consider bat assumption market model effective result host purchase reproduction graphical dynamic infect 21 0 describe by-nc-nd university january case animal formulate faculty 28 b.v. cc ó compute present wild access available symptomatically open mark r brief engineering interaction 2020 production seafood fractional 2:4829 2019-ncov till alexandria asymptomatically reduce parameterize corona detail numerically', '77 oxygen approach infection sepsis bear respiratory 81 cdc close preterm 25 utero food website demise 28 therapy ards maternal delivery approve seven facility team-based treatment covid-19 plan nonpregnant likely failure 78 76 497 risk care management 72 data stay rapidly series disseminate administration https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html empiric complication 73 individualize fetal word complications evidence aggressive sparse principles 91 intravascular renal co-infection consultation spontaneous count 74 79 23 deliver up-to-date procedure follow increase health 24 woman 71 die 87 time mers 75 84 information contact clinicians antibiotic ventilation 12 first-trimester sars-cov-2 80 avoidance coagulopathy fluid patient abortion multi-specialty contraction overload pregnant optimally mers-cov 13 coronavirus-specific early pregnancy control isolation continue include 83 85 case-fatality 27 sars drug currently mechanical monitor 89 bacterial case 90 test compare gestation transmission investigation 86 progressive identify asymptomatic pneumonia week rate uterine 88 end secondary late 82', 'covid-19 clinical molecular france amino-acid sars-cov-2 characterization l \\ufeff1 infection https://doi deletion cluster asp268del nsp2 microbiology reveal', '', 'gown severe virus prevent droplet syndrome infection control acute meticulous glove care include high-risk specific procedure measure paediatrics respiratory require human protection aerosol cause know eye critical disposable little highly double transmit obstetric sars-cov-2 precaution transmission intubation technique covid-19 respirator minimise tracheal infectious', 'find child-care variation infection structure additional prevention assess cumulative population close associate workforce non-working reduction experience survey funding percent 17·6 covid-19 force weight 2·0 unintended monthly datum government household assuming 14·8 mortality \\ufeff1 adult contribution mandatory care background 2·35 3·1 health-care sector trade-off critical study contagion cost lose undo combine parameter 2019 evidence current standpoint 15·0 option effect year decline ultimately analysis worker prevent closure 3 old million 28·8 survival probability importance individual measure aim usa increase segment 29·1 characterise result carefully interpretation potential information policy disease lead 12 great pandemic come supply arise state within-household closing high patient obligation 2·00 social important mitigate labour reduce 28·5 15·2 methods decrease 13 system numb coronavirus benefit ci estimate probable child observe include school absenteeism 1·3 model loss release substantial family distance physical account action baseline absence case occupation weigh identify expose rate influenza suggest reasonable age create death provide worldwide level sibling 95', '0.82 research adjust case-control non-pharmacological database associate touch aor hospital 0.65 symptom seven reaction covid-19 b remain collect right marginal effectiveness p background intervention 5 active free 36 onset hygiene repository study day wash hospitalization 0.59 long community fund frequency ☆ 2010 analysis prevent 0.001 multicenter covid measure sanitizer time information dose-responsive conclusions perform provision unrestricted contact original surface odd centre investigate select objective mean spain re-use confirm methods protective acknowledgement ★ reverse-transcription benefit control elsevier source 10 chain hand require factor resource 813 handwashing form results alcohol-based ratio frequent contaminate case hospitalized match publicly 2274 polymerase grant influenza hospitalize recommend', 'leaf-nosed diversify 1800 virus 1 severe coronavirus old 123 acute ghanabt-covgrp1 covs pertain bat respiratory rna human ghana 212 ≈1686 species descent 9.76 group concentration hypothesis feces hcov-229e prevalence share ghanabt-covgrp2 morphology fruit 12 helvum 2 mg ancestor common exist test cov syndrome-like sample ad fecal n eidolon copies/100 detect 45,000 dispute cov. ruber hipposideros year recent ≈2,400 insectivorous hcov-nl63 cold', '', 'acknowledgement 3 research covid elsevier source synthesis active resource database free cyclocondensations form repository 4-(arylsulfonyl)phenols unrestricted original 2-arylsulfonyl-3-ethoxy-2-en-1-ones publicly centre grant regioselective long covid-19 fund remain mean re-use 1,3-bis(silyloxy)-1,3-butadienes right analysis', 'acknowledgement http://dx early research covid dengue comment barcellos elsevier source coelho 5 dis active resource database free cup model drive lancet publish www.thelancet.com/infection form 2014 repository infect framework unrestricted 14 original world july outlook publicly centre c forecast climate warn grant online r long seasonal covid-19 fund real-time remain brazil mean lowe re-use 17 544 right vol analysis', '', '', '', '', '', 'severe virus find infection elucidate acute relationship sympatry assess change bat colony respiratory drive origin respectively pathogenicity ecological apparently emergence genetically deep sample capture actual interestingly relate plasticity distribution crucial hipposideros sars-cov. likely phylogenetic collect elucidating thailand betacoronavirus-b previously genesis hipposideridae south-east study description illuminate hipposiderid betacoronavirus combine independent co-factor existence medium-sized key favor syndrome spill-over play africa importance rdrp armiger sequence healthy persistently host species diversity publish group hypothesis infect evolution disease great europe alphacoronavirus illustrate cluster push betacoronaviruses-b investigate interaction detect sars-cov non-invasive coronavirinae history biogeography betacoronaviruses challenge behaviour understand coronavirus probable geographic include ecology biogeographic larvatus human rt-pcr family insight broad ancient describe forward case anthropic ancestor common evolutionary phylogeny despite suggest good end rhinolophidae civet target finding host/pathogen asia amplify infectious role', '', '', '', '', 'research 1981 de allen jr ps hosp database rl cause 9 31 contamination 32 n 305 covid-19 b remain engl kollisch tin right solution 98 621 ms 72 intern moody active craven free 36 repository pseudomonas long fund iodine-champagne pseudobacteremia dk 1982 connolly cup analysis 30 197 cp 3 covid 23 berkelman favero craig s infect unrestricted newsletter original centre 7 wr mean med re-use j nrc lewin acknowledgement 6 control elsevier source literature commentary resource form ann cepacia contaminate mg attribute publicly mccabe grant 8 povidone-iodine stottmeier 95', 'virus find infection immunofluorescence respiratory inactivation cause 9 rule setting laboratory dry outbreak protein little sars-coronavirus hospital environmental hong generally treatment protein-containing h shed re-emerge solution droplet comparison kong care titre direct agent different 20 november possible chemical addition hygiene mode versus pathogenic tenacity study inactivate lose ° day suspension question 60 effect min detectability 30 newly survival procedure heat increase 24 completely september effective result 8,000 time devote prolong hcov-229e 2002 condition residual safely commonly surface infectivity state c high patient sars-cov mean scientific confirm stability reduce conduct preparation human-pathogenic protective coronavirus gradually emerge 6 56 nearly include faecal slide human fixation 2003 sars account highly absence 800 person-to-person case common exert transmission investigation effort good thermal death retain considerably', 'acknowledgement water 3,3-di(indolyl)indolin-2-ones research covid elsevier source sulfonated synthesis active resource database free supramolecular catalyst oxindoles form repository unrestricted 3-indolyl-3-hydroxy original b-cd publicly centre grant catalyze long covid-19 efficient fund remain mean re-use right analysis', 'highlights virus coronavirus stage begin march 6 control risk summary prevention include paper novel epidemiology spread increase health clinical previously emergency china originate stop spiral preparedness information diagnosis country laboratory 66 outbreak \\uf0b7 share disease global pressure assessment 2 sars-cov-2 transparency site transmission type support investigation aggregate treatment 2019 manifestation covid-19 current 24:00 2020 crucial wuhan 2019-ncov continent oral-fecal late worldwide consolidate governments activity', '', '', '', 'severe virus arthritis-encephalitis requirement research peptide infection inoculation outside subunit natural prevention special evolve ability remarkable enhance respiratory population database develope protection country macrophage-tropic example etc animal 1980s assay covid-19 production remain response enhancement peritonitis mechanism avoid right diverse offer accomplish caprine 70 dengue achieve effectiveness correlate examine hiv-1 double-edged eiavare eiavreplication active previously free routinely addition spectrum repository critical inactivate study similar applicable persistent long current fund mediate sword differentiation eiav allow strategy analysis elicit establish covid replication indicate vaccine effective result host regard balance potential delicate information infect condition sufficient unrestricted policy original disease feline sterile eiav-infected nature centre type maturation regulatory efficacy yield criterium interaction mean focus important re-use confirm protective acknowledgement concern system early suit dna control exacerbation elsevier source attenuate include resource live-attenuated vaccinate china model serological form practical synthetic general commercial dynamic experimental observation candidate reveal visna-maedi immunodeficiency evaluation publicly development beneficial elevation lentivirus property immune immunologic grant viral syncitial suggest effort good diagnostic appear live characterization compatibility range provide infectious horse', '(cell)\"-kytos acknowledgement cell syncytia research covid elsevier source refer active resource database free greek result together\"-syn form repository pl unrestricted uninuclear alternative\"-para original 2 publicly box mucus\"-myxo centre term word grant derive long covid-19 fund fusion remain multiple mean multinucleated re-use syncytium right analysis', '', '', 'acknowledgement 390 1 191 research 6 infection covid elsevier source http://infection.thelancet.com context dis active resource database free 2006 network 22 form repository v. infect unrestricted original transmit adimora july publicly centre disparity s115 grant rate suppl long covid-19 fund sexual remain mean schoenbach social sexually re-use racial j 2005 right vol analysis', '', '', '0.05 molecular coronavirus 3 define infection 202 tool rt-pcr-hybridization material analytic clinical previously possible develope respiratory amplify result human useful hcov-229e describe protein 0.01 sputum original 12 detection hcov-oc43 genetic tcid gene tract 348 test compare sensitivity n 146 provide 50 detect demonstrate primer method nasal aspirate m role specimen', '', 'acknowledgement mvo research oxygen 6 covid elsevier source active resource database free form repository unrestricted consume original 2 publicly centre conditions myocardial consumption grant long covid-19 fund contraction remain mean 49 re-use ■ heart right cardiopulmonary analysis', '0709/ otolaryngol j 0196 xxx xxxx', 'research cross weak database tone proficient limb v localize note upper 2 knuckle paresis lesion lmn low reaction covid-19 remain spinal right central 1 difference normal proprioceptive recognize active free repository versus ✜ postural spastic practitioner r long gait reflex fund peripheral increased long-strided typically delayed infrequently key analysis unaffected somewhat e covid decreased increase w unrestricted original delay examination centre choppy pelvic mean important re-use nerve decrease neuron acknowledgement system accompany nervous and/or umn elsevier source distinguish resource exaggerate form general ataxia publicly grant motor short neurological finding cat posture muscle crouch table mentation', '', '', 'virus cell µm. evaluate coronavirus 64.9 research antiviral inhibit benefit estimate replication e6 achieve remdesivir homorringtonine observe novel homoharringtonine compound lopinavir ribavirin health clinical previously plasma abstract effective 6.25 help 23.15 emetine concentration respectively https://doi favipiravir µm vero synergy impact currently global pandemic sars-cov-2 evaluation therapy 26.63 escalate patient viral inhibition combinational 0.46 urgently yield 50 0.195 100 trial vitro option reduce effect provide therapeutic combination 2.55', '', 'acid c956 variation allele pcr-amplified intron3-g395c population valine database haploid caucasian respectively nucleotide encode hcov t sample seven n region prevalent 229e volunteer belgian presence 1 apart 0.5 substitution stretch mutation polymorphism know spectrum haplotype 8.5 critical study gene alanine frequency 3.5 apn 100 relatively 3 amino genbank exon individual g978 residue sequence follow accession healthy full-length result hcov-229e intron lead 353 4 objective demonstrate aminopeptidase methods intron3-c389 analyze numb coronavirus dna essential include submit bind function human af527789 results broad describe apn/cd13/anpep conclusion occur domain g987a identify unrelated 260 receptor intron3-c429 intron3-c86', '', '', 'acknowledgement http://dx biosecurity research control covid elsevier source active resource database free food form repository unrestricted original publicly centre grant long covid-19 fund remain mean re-use right analysis', '', '', '', '', '', 'external surveillance brachytherapy dess doremalen bushmaker 277 england van elective aerosol follow-up radiation 9 lane compared localize 2019;105(3):680 therapy t medicine 10-year 285 n phase treatment international engl escalated tm 2016;375:1415 prostate hunt cardiovascular mortality tyldesley high-and p 505 adverse long-term active guerrero biology beam anti-androgen nrg 2015;33(4):332 2015;33(3):272 r 2020 ascende-rt salvage oncology/rtog sethukavalan effect year intermediate-risk analysis endpoint 479 donovan 3 lg survival 9910 dh biology• increase deprivation clinical jl group s fc cohort wj surface suppression sars-cov-2 dart l androgen man d efstathiou iii randomize 7 patient outcome high-dose spratt rodda duration med trial pisansky j receive stability 9601 hamdy boost 2017;98(2):275 other-cause early oncology 6 combined 10 vesprini 11 01/05 maldonado klotz morris 2016;96(2):341 low-dose-rate results dose-escalated monitor x zapatero 348 compare nodal oncology• dose journal 1424 sars-cov-1 8 cancer gomella secondary surgery late radiotherapy physics', '', 'severe find qinghaosu research acute rapid sequester ability resistance trop parasitise database develope rl chloroquine artemether largely preclude remove staff quinine distinct treatment falciparum covid-19 remain medical se mechanism circulation right tin trans 499 mature 1990 mortality malaria.10 difference p active free shwe oral organs.1o rapidly promise repository soon asian malaria absorption admit study gambia similar myint burma antimalarial site moderate index r long 321 produce evidence fund randomise pp analysis satisfactorily count splenic cell endpoint kill covid ring pharmacokinetic measure compound nurse uncomplicated explain 1989 unpublished effective thank volume group 84 unrestricted original pack 4 centre issue patient efficacy erythrocyte biomass mean important med re-use j reduce r2 acknowledgement understand save parasite inhibit suppository 502 elsevier source necessary pe factor function resource appropriate comparative hyg vivax high-grade form clearance microcirculation half royal drug highly vital publicly disposition dose victoria grant resolve despite soc suggest urgently age admission disease,1,8 live range artemesinin fully plasmodium', 'correspond severe basic withdrawal stage 33•1 infection 19•3 acute run size assess 277 cumulative refer respiratory population 175 plus 31 compared preventive singaporean outbreak local simulate 2 32 treatment 7•4 776 2·0 99•7 1800 assuming 30·0 1 \\ufeff1 adult 1•5 simulation 81•5 effectiveness management background resident intervention assume spread proportion iqr likelihood 207 quarantine epidemic 2•5 day 93·0 combine 6·5 20•6 r 2019 containment adapt community alter 59·0 100 7·5 singapore unsuccessful option effect strategy implementing analysis chinese 30•9 dec prevent closure 92•6 syndrome median member workplace vaccine individual measure aim symptomatic increase 1·5 scenario effective substantially value 000 320 interpretation -94•4 reproduction infect 0 contact disease 17•8 sars-cov-2 80 infectivity 245 68 164 progression high place investigate 78•2 2·5 279 99•3 eg detect wuhan confirm reduce relative human-to-human work 40·0 immediate early numb coronavirus begin city locally control estimate child isolation import findings include 670 school require model 727 trace deployment family distance fraction baseline 99•9 detection 2•0 22·7 case occur compare prioritise transmission asymptomatic sensitivity rate influenza acquire effort 50·0 249 secondary 8·5 recommend', 'abscess virus find cervical congregate research life usual infection acute arf glomerulonephritis respiratory pharyngitis database b. echovirus cause e. a. little peritonsillar 2 suppurative poliovirus t sinusitis medium pharynx significant covid-19 children remain .~,~ donald right month^.^ epstein-barr illness 1 c. lymphadenitis rhinovirus young p agent 20 middleton 5 tonsil active free encompass /96 infant st. repository retropharyngeal infections complication nonsuppurative irritation r long fund 15 rarely year peak analysis coxsackievirus fever 3 unusual covid d. group s unrestricted rheumatic agn original lead enterovirus winter 4 l centre type 7 parainfluenza mean sequela re-use uncommon adenovirus otitis herpes list acknowledgement especially coronavirus 6 0.00 .20 elsevier source include p-hemolytic streptococcus resource simplex form 00954543 bacterial case common responsible publicly gabhs ~u viral grant viruses 8 influenza age community-acquired recur ebv md', '8.27 research ethnopharmacological sgc7901 25923 natural hepg2 line expression database food atcc mrsa respectively 33324 hoechst particularly protein a. sa viability antimicrobial pro-apoptotic t medicine assay flow clinically treatment low significant covid-19 b remain bioactivities sinensis standard h folk determine methicillin-sensitive right composition possess 1 viz mtt sgc-7901 p 20 different active free chemical methicillin-resistant ht29 apoptosisinducing dose-dependent isolate repository promise addictive obtain cytotoxicity 13.18 growth r long anti-inflammatory prominent potentially fund juss western-blotting vegetable contain toona β-caryophyllene caspase-3 roem effect significantly analysis hydrodistillation activity furthermore cell o0.05 covid 43300 gc-ms 0.125 aim increase health 24 stain worm-killing value result mssa potential caryophyllene conclusions s boil unrestricted 5.06 aureus original up-regulated mic β-eudesmene dysentery oil centre c high popular investigate cytometry antidoting gc/ms probably detect mean content strain re-use tsl vitro acknowledgement analyze evaluate especially benefit inhibit leave bax essential elsevier source enteritis 84.64 include down-regulated resource china anticancer form carbuncle results tumor apoptosis-related abdominal test publicly antibacterial property manner relevance suppress tsl-eo leaves apoptosis-inducing grant staphylococcus suggest bcl-2 serve cancer materials method 10.16 sesquiterpene mg/ml copaene', 'correspond n. severe find 333 research cross approach acute screen assess respiratory numerical database develope 9 example a. 2 remove kind t protect n generally treatment pontryagin covid-19 theory b remain h determine right solution educational 1 p mathematical 342 consider assume different 5 active free extensively repository quarantine study epidemic obtain introduce possibility cost suitable u efficiently index encourage r long allocation fund partial review controlling existence -see g strategy effect allow analysis campaign 3 e proper syndrome covid 0169 temporary health result sirc s infect 0 matt unrestricted contact policy optimal original disease limitation 2607/$ 4 present centre c 7 lie immunity o interaction subject mean analytical choice stasio re-use vaccination acknowledgement system class susceptible analyze 6 control isolation elsevier source paper 10 minimum function resource model problem trace form general schedule account framework sars describe action case evaluation publicly interest immune identify grant optimization influenza 8 introduction good infectious principle', 'practice department coronavirus operation article care worker head seriously aim 77,000 health require th society 25 china economy inpatient cause complex grim impact ward situation epidemic discuss disease great case precaution present protect recently 2019 ordinary covid-19 2020 good neck otorhinolaryngology medical february room clinic surgery confirm interfere', '', 'increasingly severe molecular antiviral adjunctive infection acute respiratory associate cause inhibitor oseltamivir knowledge evidence-based pragmatic therapy hypoxemic rvi assay treatment ncov 53 ill illness datum failure rvis therapeutics mortality adult care management macrolide novel intervention agent different recognize design addition likelihood immunomodulatory statin study invasive patients middle limited neuraminidase individually 2019 typically effect syndrome widely specific corticosteroid plasma regard mers cyclooxygenase-2 ventilation exist critically present c zoonotic high patient efficacy detect non-invasive vitamin 17 reduce combination early coronavirus include require east sars mainstay highlight expand transition supportive test pharmacologic immune identify pneumonia viral influenza suggest efficient icu sirolimus prove community-acquired anti-influenza recommend', '', '', '', 'acid small peptide infection structural structure molecule connect alignment attachment conserve knowledge protein 2 shape s1 hrs hydrophilic seven coiledcoil s2 crucial receptor-binding 1 spike core virion possible hr2 design chemical compose study characterize helix hr1 polar subsequent step fusion mediate trans-membrane contain layer repeat membrane analysis furthermore cell n-terminal amino residue sequence linker group hcov-229e s interface cterminal pack resolution cellular interaction hr1s å. overall concern solve especially crystallize flexible hr2s position 2.45 bind hydrophobic recombinant drug complementary fourteen highly domain property available viral target heptad polypeptide', 'virus − structure assess complete discovery close associate respectively 57 conserve ib nucleotide century outbreak 1a hcov 27,538 n region multiple 27,550 variable determine phylogenetic genome substitution designate different spread mosaic amsterdam know isolate soon share hcov-oc43 11th gene site long diverge organization year analysis 3 member sequence clinical group hcov-229e s ∼ × 496 4 croup sars-cov relative hcov-nl63 coronavirus child employ 10 human 1b 2003 family sars describe reveal identify evolutionary rate additionally algorithm recombination worldwide', 'find meet surveillance requirement research define configurable evolve change database develope configure canada survey 2 t dissemination support n covid-19 b remain right central facilitate datum mature build achieve management service agency 5 active free architecture repository address evident similar cost distribute u 741 r long produce adapt fund layer component f key set analysis application security e covid increase health user efficiency information s 0 unrestricted policy time-to-market original disease l centre c 7 o public objective mean important software area re-use j reduce acknowledgement 6 success elsevier source inventory factor resource flexibility outline alpha form results 754 common collection publicly development grant crown target create', 'virus southeast raise carry infection swab locate high-risk camelus line rna northwest cause animal dromedarius sample seven assay reaction coronaviride pancoronavirus collect 98 c. risk transcription novel denizen study reverse contribute middle rear evidence nasal variety 3 province play health result host species hypothesis iran disease 4 present belong public detect decide important area camel azerbaijan specimen positive coronavirus anterior-optically employ observe source chain factor human dromedary east rt-pcr family traditionally detection case transmission identify polymerase discern extent grow late role colossal', '', '', 'severe define nonspecific infection swab acute 4.5 www.chestjournal.org rds equipment respiratory develope lymphopenia associate cause 39 setting laboratory preexist ast 66 little multifocal hospital cov 28 47 symptom initial bp 5.8 32 abnormal presentation reaction medical room thrombocytopenia likely sd elevate diarrhea 98 illness datum 1 department ldh \\ufeff1 70 care novel 58 health-care design onset non-sars pcr rapidly tertiary lung critical admit fifty-three study 1.3 personal patients ° reverse rt nasopharyngeal unifocal alanine day hospitalization transcriptase 1.9 organization 59 35 ؎ dehydrogenase radiograph worker 74 fever 16 aminotransferase syndrome indicate unit \\u202b؍\\u202c aim health clinical 63 course clearly time group cough consistent june perform conclusions 37 differentiate pathognomonic majority disease 38 present c taipei progression patient precede negative-pressure objective chest sars-cov 51 mean ck ie aspartate creatine distress emergency retrospective fd taiwan protective 2.1 early positive coronavirus begin ed isolation include lactate base chain ppe 18 85 abbreviations thirty-one pair center 40 27 throat 2003 sars observational results kinase currently temperature observation clear concurrent world infiltrate common test occur ϭ hcw eventually progressive investigation available polymerase pneumonia alt suggest 88 real-time diagnostic admission appear finding 6.0 method 62 3.3 ͼ late level april 95', 'count world 1,561 references suffer word currently', 'concern severe illness raise coronavirus paramount emerge infection feature novel health clinical clarify china result onset impact december world cluster pneumonia 2019 public hubei wuhan 2019-ncov', 'severe past virus cross infection acute ß cleave special positive-sense determinant coronaviruses summarize respiratory rna genotypic cause cross-species protein 2 animal subdivide single-stranded characteristic decade alpha- mechanism pay receptor-binding 1 alphacoronaviruses spike \\ufeff1 initiate covs receptor-recognition process prime 5 addition hku1 surface-located address hcov-oc43 middle far barrier coronaviral fusion review mediate contain question membrane key 3 syndrome feature attention protease involve genus deltacoronavirus host species progress hcov-229e infect s character 4 zoonotic belong sars-cov important focus scientific specificity betacoronaviruses hcov-nl63 mers-cov execute understand coronavirus base include 842x/ alphacovs factor human beta- east serological interspecies 0966 cleavage envelop transmission identify unexpected viral betacovs', 'severe cell untreated coronavirus antiviral inhibit syndrome infection acute replication examine screen include virion novel compound agent hiv-1 protease quantitative respiratory clinical nelfinavir expression design antigen result addition inhibitor potential rt-pcr rapidly vero post-entry sars infect drug etiological reveal lead experiments effect exert strongly available identify timing viral clinically treatment entry low step treat suggest analysis production good sars-cov cytopathic anti-sars induce set wide decrease', '', 'acknowledgement http://dx system research covid elsevier source respiratory active resource database free form repository unrestricted infections original publicly centre grant microbiology long covid-19 fund remain mean re-use right analysis', '', '', '', '', '', '', '', '', 'correspond permeable severe small n-terminal presence coronavirus peptide cation e syndrome establish inhibit acute anion envelope include bilayer coronaviruses novel residue polyclonal lipid respiratory recognize cause hydrophobic synthetic form sars encode ion protein channel generate planar formation antibody current sars-cov affinity-purified monovalent 19 specificity membrane', 'virus find research antiviral noticeably pathway ability resistance complement expression database protein vsv therapy assay treatment low covid-19 treat remain response interferon-stimulated e2 ifn-a mechanism right isgf3 hcv-infected ifn examine core transcription regulate different active free addition chromatin know repository study confer contribute ns5a administration gene interferon far ifn-sensitive long fund isg15 membrane-bound activation isg56 significantly effect oas2-p69 analysis activity cell ns4b 3 covid play individual hcv increase taken completely result unrestricted trans-rescue chip original status promoter present strongly centre ethanol-induced injury apoptosis demonstrate mean reporter mention qrt-pcr re-use originally confirm immunoprecipitation reduce acknowledgement main thermore elsevier source attenuate ifnstimulated function resource factor downregulated form responsive fraction titer isg54 publicly exert antagonism suppress viral grant ifn-induced isgs suggest element isre live role level', '', '', 'correspond fatality severe virus find raise hr1p enter peptide life antiviral infection structure acute subunit size positive-sense change bat respiratory hr2p analogue close rna develope material cause respectively inhibitor origin setting 21 outbreak protein 2 1251 genetic animal mainly s1 single-stranded hydrophilic solubility dmol glu decade term s2 significant treat peptidase-4 anti-mers bundle mechanism multiorgan facilitate biophysical turn six-bundle illness failure kb crystallography therapeutics receptor-binding spike lineage conformation 3,6 insert 1 core genome cm stable novel tropism chen 20 58 november 5 health-care hr2 design 9,10 know à cycle epidemic b10 similar inform cytoplasm middle characterize far betacoronavirus cell-cell barrier hr1 6-hb b30 a-helicity protein-mediated 1286 economic hypothesize 33,000 span fusion 42 100 enfuvirtide bring repeat membrane analysis activity 2012 cell improvement 3 syndrome indicate replication 23 sj-2176 residue sequence increase 222 dpp4 effective result host species hypothesis value potential mers s contact anti-mers-cov disease lead transmissibility pandemic tissue 4 coronaviridae hku5 elusive nature c 1039 cluster high ref patient lys jump belong interaction based sars-cov 19 ago 1,2 17 confirm stability 998 dipeptidyl hiv mers-cov concern 13 64 cd26 solve coronavirus panic inhibit emerge essential include 11 develop combat nonetheless 18 bind human six-helix 153 east release damage form family deg broad interspecies y drug describe sars-like global envelop person-to-person case crystal domain occur order communications transmission x-ray t20 personto-person identify 2013 arg viral proteinmediated rate 8 potently suggest hku4 introduction good apposition serve 9,11,12 target nidovirales effectively create heptad receptor prove death genetically worldwide', '', '', 'acknowledgement http://dx research administrative middle-income covid aspects elsevier source active resource database free form countries repository unrestricted original publicly low-and centre grant long covid-19 fund remain mean social pharmacy re-use right analysis', 'acknowledgement virus coronavirus research antiviral covid elsevier source hcv active resource database free scv communication form repository sars-associated unrestricted preliminary original 2,6-bis-arylmethyloxy-5-hydroxychromones publicly hepatitis centre c grant long covid-19 fund remain mean re-use right analysis activity', 'severe virus molecular surveillance reservoir research acute pathway dependable respiratory originate cause country knowledge qatari month outbreak 2 hospital emergence decade intensive response promed-mail reminiscent 76 ensure care novel intervention 20 spread biology capacity -middle pathogenic day containment affect current 178 saudi incorporate review program contain coordinate year strategy 2012 province syndrome play importance feature epidemiology clinical arabian september 2002 situation fundamental apply state patient detect laboratory-confirmed sars-cov 8000 (mers-cov)it mers-cov. receive london coronavirus travel 6 isolation ecology guangdong china communication east physician 26 highlight highly global case pneumonia air death high-containment late role', '29 consolidation severe analyze find coronavirus 16 3 76 infection atelectasis white feature ggo complete change 43 ct opacity different 5 diagnose 24 help follow-up severity respectively obvious diagnosis results lung thicken 21 extensive critical conclusions guidelines disease residual resolution pulmonary case common 4 pleural present initial type pneumonia patient abnormal septal treatment 8 unique interlobular effusion resolutive phase linear manifest covid-19 multiple demonstrate accord finding 59 periphery mild 16/21 abnormality ground-glass stratification', '', '', '', '', 'mers-cov severe system datum coronavirus offer approach emerge syndrome kong acute simulation 23 risk include real develop intervention follow spread process respiratory explain outbreak develope model equation east addition network complex potential 2003 address dynamic fit perform auxiliary policy univariate epidemic highly methodology disease great 12 discuss inform middle test occur state far iterative hong sensitivity flow recently parameter differential affect current community future sars-cov reliability multivariate variable algebraic determine reduce infectious optimize analysis', 'acknowledgement datum virus research 1981 coxsackie a24 covid indicate elsevier source ground nt material active resource database free csfs variant result countries-but clearly cause form repository tandem unrestricted preliminary bombay little doubt2 similar original epidemic observation bulk remove poliovirus test serum publicly complication centre type available eh-24 grant clinically long covid-19 epidemiological fund neurological remain ahc mean strain 925 analyse re-use repeat year right analysis conjunctivitis.3', '', 'severe virus i26a/n52a structural acute respiratory rna c222 protein crystals diffract polyethylene precipitant open product b 229e 1 423.1 nsp15 process acta mutant nonstructural cryst overexpress obtain hexamer gene hepatitis parameter hanging-drop 2.5 15 purify negative-strand analysis syndrome 85.9 unit-cell 2015 discontinuous synthesis involve 137.5 group hcov-229e lead transcription/replication vapour-diffusion resolution trimeric enzyme read c belong sars-cov important å work coronavirus nsp15s mhv crystallize base human 1b form endoribonuclease glycol frame homologous crystal 90 monomer mouse space method orf', 'globe past virus epicentre change extraordinary respiratory connect � transport country knowledge outbreak experience mobility little local airline 2 cope externality generate characteristic slow kampf term low mazareanu covid-19 scale significant globally cascella facilitate rail safety curtail droplet \\ufeff1 normal care novel consider data spread friend mass stay abundance repercussion addition know rapidly relevant hypermobile expect statistica similar introduce passenger negative far day cruise long evidence 2020 community lock-downs 15 j. t. effect year trajectory chinese incubation e accessibility haul break-up measure increase health blas journey peeri regard time potential mers globalisation leisure disease hard surface rest sars-cov-2 warn injury lock public wu mean wuhan pollution consequence reduce human-to-human work enable system early numb coronavirus everyday argue travel success 10 137 moment hand society human resource china duty manage family commercial sars schedule describe shop quickly limit world contaminate order compare eventually transmission available predict rate despite short flight infectious fulfill', 'severe fatality (lpv)/ritonavir changes find infection acute fast adjustment respiratory develope associate plus cause aerosol 9 outbreak december 2 characteristic interquartile term fpv 0.004 treatment significant covid-19 treat reaction standard ifn-a safety confounder 1 lpv/rtv examine nonrandomized p 1%-2 adverse arm 5 tomography 91.43 causal iqr oral addition versus study 14 patients interferon day independently u 2019 2.5 regression 35 effect significantly 600 improvement 16 0.001 establish syndrome million median daily specific lopinavir 400 mg/100 result group time potential favipiravir information cox (ifn)-a multivariable 1600 disease inhalation sars-cov-2 45 twice 4 progression high patient enroll image days open-label chest laboratory-confirmed 62.22 important receive 13 coronavirus comparable control include rtv 11 ct combat china clearance ratio drug baseline mg compare compute viral rate 8 short guideline range distress', '', '392 category seropositivity virus reservoir research size 500 participate database 212 25 5877/95/$09.50 associate respectively 213 preventive month 4.9 little survey tge medicine 1:8 i:8 sample seropositive logistic 3.9 science facility n ssdio167 covid-19 remain 101 determine right seroprevalence 0.05 herd season gastroenteritis non-specific risk management p consider 20 possible active free 54.1 repository xt 5877(95)00475-o study 20.1 demographic litter radius long evidence 178 fund regression 8.7 100 corresponding yanga effect significantly analysis 199 3 covid median 79 measure pig swine increase 24 25.8 reserve 0 unrestricted original odd 80 factors centre access high national restrict female mile mean seronegative 0.08 re-use history vaccination reference b.v. acknowledgement numb biosecurity nonporcine transmissible control elsevier source veterinary 10 include sow factor resource [1989][1990 abstract model purchase /prevenrive form 1995 228 ratio titer monitor 0167 movement test serum publicly evaluation compare grant neutralization introduction breed inclusion 160 spf', '', '', 'abbott proctor pbs investigator advisory multicenter trial medtronic site edwards fgpw receive support board principal grant educational', '', '', '', 'acknowledgement http://dx research covid elsevier source foods alternative active resource database free form repository unrestricted original replacement publicly centre grant long covid-19 fund remain mean re-use right analysis', '', 'severe virus find molecular mouth elisa research swab strong respiratory database hfmd 1104 immunological assay clinically low reaction covid-19 relate remain response a16 mild right examine novel different diagnose active free pcr repository diagnosis study 14 igm reverse nasopharyngeal transcriptase long affect fund ☆ activation analysis coxsackievirus covid indicate aim increase 71 result severity information unrestricted original disease ev71 enterovirus centre patient probably detect mean foot cytokine re-use acknowledgement influence concern ca16 positive evaluate especially child probable coinfection essential elsevier source include chain hand factor resource form rt-pcr detection case test publicly supplement order immune polymerase grant rate 8 antibody', '', 'acknowledgement research covid allen genome elsevier source complete dc transcription profile coccolithovirus sequence active resource database free schroeder wh form repository unrestricted original wilson publicly centre phase grant long covid-19 fund remain mean mj re-use 2005 right lytic analysis', 'severe research bear acute document summarize opinion respiratory database develope 225 suspect preventive experience sogc t maternal covid-19 force b neonate remain task right canadian practice values care management active free repository relevant obstetric 2009 fetal r long evidence fund ☆ review english analysis mother cases syndrome covid outcomes health clinical publish s worsen unrestricted expert original 2007 centre c patient outcome no. objective mean accord re-use medline 2000 acknowledgement pregnancy article probable elsevier source resource form sars limit case recommendations publicly grant suggest search guideline seek asia april', 'industry march infection accordingly change cumulative individual-based tendency country outbreak multiple propagation variable government 78 prediction separately consider spread possible rapidly dummy series study epidemic official 872 negative terminate oversimplify parameter 2019 2020 effect chinese 74 191 establish capital group time quantify policy situation disease 68 asset existing public demonstrate hubei feedback vigilance 17 interval reduce influence analyze evaluate coronavirus numb 474 control revenue meticulous helpful price model china dynamic experiments predict create final cabin 82', 'severe system risk complicate management health population develope outline describe storm lvad disease pandemic arise ards represent support myocardial patient unique injury covid-19 durable cytokine worldwide grapple challenge', 'health 2019 public world emergence threaten coronavirus 2019-ncov crisis novel spread', 'system 1 coronavirus 3 truncate peptide assist 6 prediction indicate carboxyl oligomerizes play anti-viral summary titre 10 fluorescence 11 interfere 5 bind mutant clarify structured result 9 biophysical c-terminal hcov-229e disorder series perform drug protein study inhibitory oligomerization 12 2 cov domain generate biochemical tail effect development 4 unclear hcov. cross-link n dimer-dimer investigate association viral cosedimentation 7 8 crown interaction remain based important terminus comprehensive technology mechanism systematically role ctd analysis solution view', 'behavior 0889 xxx-xxx brain 1591/ immunity xxx xxxx', '', '1.475 meteorological infection prevention respiratory 404 31 setting outbreak december eliminate link hospital ultraviolet aggregate 1.331 n correlation region low calculate 0.979 0.948 incomplete monthly 1 risk correlate background irr novel data november diagnose confidence study 2018 ± middle index community saudi regression 9.9 56.1 year analysis 2012 0.945 prevent 1.043 incidence syndrome e measure aim increase 0.956 condition august situation disease 1.065 24.7136 contributor five-month google high investigate 46.6753 mean 54.2 period interval relative methods mers-cov influence understand coronavirus riyadh evaluate ci control estimate base include source wind factor 0.912 center east half 712 results ratio temperature 0.964 1.054 case conclusion • climate rate poisson age guideline serve 1.401 total humidity integrate april 95', '', '', 'correspond severe past opportunity research mid-1990s burden infection acute prevention special rapid participate pte respiratory database drive develope hap witness cause 1960s major century specialty rst 2 hospital pulmonary medicine phase treatment 1920s covid-19 remain espiratory standard noninvasive uenza features solid specialize right nosocomial 1 department threat emphysema care management hospital-acquired phasis nippv 5 active free extensively 1970s rapidly noninfectious repository thromboembolism critical improve study cor primarily cap regulation hypertension shift r long fund infl review program 1950s bring analysis 3 establish syndrome covid foundation specialist health clinical effective result tb unrestricted original disease lead 1766 great pressure ventilation fi present centre national respiratory/medical public chest mean focus period pah arterial re-use pollution history challenge bronchitis acknowledgement positive gradually control elsevier source pulmonale achievement abbreviations resource china eld problem physician form lay general sars merge expand describe priority modern undergo common smoke publicly development chronic available air pneumonia grant icus dominate accomplishment pic community-acquired death infectious', '', 'small research flank nonspecific structure assess ingesta flexure borborygmi database signify tone proceed rise pathologic particularly strength little distinct intestinal t xiphoid propulsion clinically covid-19 presumably remain retropulsion h distinction right margin nervousness edge hear 1 minute normal p ascend active intraabdominal free abdomen repository rigid similar inter-and rush cecum auscultation r long produce colon fund frequency caudal allow analysis frequently 3 e covid indicate segment effective result prolong condition unrestricted character nonprogressive original motility 4 centre type fluid c ventral propulsive inhibition sound contraction pelvic mean important cecal area re-use typical conversely palpation acknowledgement 13 leave elsevier source difficult distinguish useful resource costal form spasmodic frequent movement abdominal evaluation publicly occur intestine pharmacologic progressive intrahaustral sympathetic grant anorexia mix wall retropulsive', '', 'sb203580 extracellular furthermore cell coronavirus antiviral inhibit infection replication line clinical human mapk involve concentration chloroquine inhibitor cq hcov-229e p38 lung kinase cpe protein mitogen-activated usage erk signal-regulated fetal viral significantly low affect suggest l132 229e demonstrate finding activation effect induce mapks decrease', '', '', '', 'available 2020 0165 march 0327/ 21 online', 'crowd severe epicentre infection relapse acute enhance respiratory short-term associate cause happen country cover month experience certainly straightforward tail appointment lesion escalate treatment region covid-19 plan multiple response junction flatten distraught prior recommendation italian 1 pegylated ms \\ufeff1 management horror break wisdom interferon-beta long-term active neurologia address t2 neurology epidemic evidence-base town tract middle neurologist box recently produce potentially reassurance review relatively question compatible uncertain year peak knee-jerk plausible 16 mri arbitrary syndrome brainstem measure health scenario woman sclerosis italy sin advice time potential mers perform maria 26-year-old pontomedullary double predominantly società pandemic ocrelizumab surprise read handful patient sound supervision public ahead scientific confirm request intermediate coronavirus especially argue urgent emerge include italiana 18 undefined society human problem east di manage sars-cov2 story sars clear highly default world case ataxia interest extend dose facebook week despite guideline community-acquired brain vision provide certainty principle view', 'research argue incidence psychotic schizophrenia others-whether increase commentary health themselves-or likelihood disorder relevant lead researcher pandemic crisis pre-proof journal face covid-19 public ask', \"cats research s-transferase immunology 99.3oh 43 ml- peritoneal polyclonal expression rna database ssdi0165 mononuclear respectively biological protein 310 anti-human fi'nf-a elseviek 47 t science 2427/95/$09.50 assay messenger product reaction covid-19 rftnf-cr-gst mopathology 9648 remain blot right monoclonal tnf-(u active free antigen gst 22 pcri1 pcr plasmid repository glutathione intravenously mhc-ii subcloning cytotoxicity gene l929 depression upregulated kda mhc-i synthesize immunol~ clone long amplification subsequent tnf-(y fund manifest immunopathology fusion peripheral factor-a 15 stimulate effect analysis homology cell fever 0165 il-2 anti-murine tnf-o covid (1995)297 230 sequence cdna 2427(94)05345-s result publish tnf-a reserve 0 unrestricted original thrombin feline cds 45 cross-reacted centre blood ffnf-(y yield necrosis mean re-use macrophage 17 typical vitro b.v. culture acknowledgement tumour biologically elsevier source veterinary include ltnf-cu chain 18 resource extract cloning form 1995 pgex-2 recombinant vetennary cleavage piloerection rftnf-a-gst rftnf-cl immt serum publicly ftnf-a polymerase western grant factor-cl antibody ng vector characterization receptor\", '', 'inside acknowledgement neuron system virus cell memorial confine u.s.a. research covid neurite elsevier source price active resource database free plasma abstract pc12 model release center form repository unrestricted rubenstein study original disease envelop mental publicly hsv-l-infected centre grant viruses immunity vesicle long alteration covid-19 probably fund r.w. fusion remain neuritic mean 311 42 metabolic r. sloan-kettering cancer re-use wall membrane right york analysis', 'acknowledgement concern research covid tourism risk elsevier source measure health recognize active resource database free chapter appropriate avert associate reader form repository crises appreciate unrestricted original matter publicly arise crisis centre issue identify protect grant long suggest covid-19 fund remain end mean important response health-related re-use right tourist analysis', '', 'illness severe pharyngeal susceptible positive mother coronavirus birth emerge infection swab child novel hour vertical spread population progresse woman china 36 neonatal cause country december disease case sars-cov-2 test complication transmission assay 2019 rrt-pcr covid-19 remain pregnant likely confirm', 'globe team operational respond conclude equipment rapid united change database flexibly communicate states 2 staff medicine hong symptom escalate covid-19 response volunteer redeploy technology adopt facilitate train illness datum 1 mortality ensure kong epi/pandemics risk care management service stress consider 5 previously design bereavement camaraderie rapidly carer improve skill narrative study resilience personal inform patients/carers west hospice protocol shift evidence produce community review singapore coordination 3 cases non-specialist africa measure aim psychosocial synthesis involve triage italy 3094 provision policy palliative prisma pandemic exist 4 propose high 7 patient accord conduct taiwan protective standardise system especially 6 essential findings include paper multimorbidity resource communication deployment observational framework included synthesise collection stuff space identify available 8) viral guideline deal mix systematic provide role', '', '', 'datum severe exhibit find cell adenocarcinoma coronavirus opportunity apart infiltration early retrospectively syndrome operation \\ufeff1 acute edema reactive biopsy novel change respiratory hyperplasia time lung pathologic currently tumor study reveal disease autopsy 2 lobectomy case proteinaceous undergo lack examination represent symptom patchy focal pneumonia patient phase recently cellular 2019 hyaline covid-19 membrane prominent inflammatory multinucleated important pathology likely pneumocytes provide giant exudate', '23rd psychiatry e march accessed -p p iranian health atefeh 101990 asian epidemic mental l zandifar u n journal r o in-15-mins-sensex-crashes-2700-points-nifty-tests-8000/articleshow/74767612.cms 2020 rahim badrfam covid-19 51 j f', '', '', 'acknowledgement severe behaviour research article covid prohibit unauthorized elsevier source pathologist necessary develop literature disclose college long-term active resource database free clinical follow-up form reproduction spectrum royal repository ischaemic unrestricted conflicts original case publicly state complication represent interest centre c © term grant long suggest covid-19 fund diagnostic remain end mean elp finding re-use determine conflict right analysis australasia', 'severe -0·19 seropositivity virus find 7·0 5·2 antiviral infection swab acute screen 4·1 respiratory complement rna 25 p=0·020 cause slope protein 2 hospital deep sample hong symptom jan assay presentation covid-19 anti-sars-cov-2-rbd response oropharyngeal older n=14 eia quantitative highrisk -0·15 datum spike n=15 saliva kong \\ufeff1 risk genome correlate igg near titre neutralisation agent internal possible health-care whole-genome copy mutation iqr 22 onset pcr anti-rbd diagnosis load study epidemic obtain urine 14 igm acceptable reverse nasopharyngeal day transcriptase emphasise np anti-sars-cov-2-np long 2020 serial 100 ascertain year decline rectal worker 30 r²>0·9 16 n=16 syndrome median 23 importance individual measure aim subsequently sequence interpretation time 75 rt-qpcr infect 37 spearman cohort 12 posterior salivary surface sars-cov-2 0·074 arise nature high blood patient ml nucleoprotein laboratory-confirmed usually gather detect non-invasive comprehensive combination methods specimen feb fast-spreading 94 -0·11 early coronavirus 0·75 ci control discomfort findings include 10 bind throat serological account potent unlike monitor r²=0·71 serum domain available identify ρ=0·48 log viral week rate anti-np antibody 88 age stringent 62 receptor range rbd level inclusion 95', '', 'severe fatality virus cell molecular sud coronavirus 3 electrophoretic syndrome emerge acute survival genome pathway specific electrophoresis segment respiratory bind involve human sars-unique unusually associate nsp3 cause 2003 gel host pathogenicity sars pathogenic non-structural protein nucleic-acid mobility little highly reveal disease oligo(g)-strings signal discuss caused contagious domain characterize absent property present mrnas regulation high assay shift affinity effort significant produce apoptosis sars-cov putative zone-interference virus-induced component recombinantly role considerably', 'acid severe system cell prevent elisa coronavirus truncate homogeneity amino establish newly chromatography indicate acute e.coli initiate play syndrome vaccine motif specific determinant adjacent novel spread respiratory delete discovery involve expression completely abstract develope problem host result ： disrupt cause column rule ace2 s quantify impact sars protein obtain deletions 496 responsible domain c seven terminal n functional 8 antibody suggest significant interaction good plate sars-cov adsorption important purify appear sars-cov. receptor penetration 388 fix', 'analyze find discharge infection article adult child immunology include ma possible recovery time cause https://doi stool x negative sars-cov-2 sample patient phase cite journal microbiology long criterium children shed recommend', '', 'fascinate find research gut connect modulate database pd tour amyotrophic aspect cause implicate enlighten landscape try intestinal symptom reside covid-19 remain multiple udayabanu right suffer direct stress memory label possible thorough active intersection free anxiety genesis repository study tract microbiota long produce evidence fund parkinson review 100 dot effect analysis behavior indirect covid comment play importance individual clinical sclerosis gm regard organism unrestricted original disease learn dysbiosis alzheimer informative centre parashar commensal patient outcome mean pathology multitude timely cognition re-use recent acknowledgement influence believe understand elsevier source thought-provoking function resource human tremendously reader form impact disorder trillion publicly development interest recognition grant lateral neurological editor grow brain provide role', 'acknowledgement virus reemerging old research australia covid tropical nipah elsevier source illustration subtropical bat active resource database free genus flying emerging east foxes 1b hendra form repository eaton unrestricted indonesia diseases islands original 8.1 world adapted madagascar publicly far present centre philippines pteropus viral grant fox region long covid-19 fund subcontinent remain distribution mean indian fly cook outbreaks re-use range right analysis', 'acknowledgement virus research cres covid indicate elsevier source active resource database free result form potential repository sars qiu unrestricted similar original 2018 publicly centre 0.75 grant long covid-19 fund remain mean antigenically 2019-ncov re-use existence right analysis', 'severe small virus infection acute weapon prevention line respiratory rna expression develope cause country major animal delivery treatment interference rnas remain sars-cov. technology interfere vivo therapeutically threat sirna adverse novel intervention spread process design promise study epidemic gene numerous macaque hepatitis produce dangerous mediate prophylactically effect application cell improvement syndrome newly replication health scare effective efficiency potential disease cellular inhibition demonstrate sars-cov important specificity vitro conduct therapeutic hiv disappear coronavirus double-stranded date inhibit include combat sirnas human endogenous abstract china 2003 challenges sars quickly world sequence-specific rhesus deal appear cancer method range late infectious', '', '', 'mers-cov find therapeutics coronavirus campaign antiviral urgent infection indicate screen hcv agent summarize clinical human potency effective potential highlight series broad repurposing drug outbreak disease niclosamide micromolar zikv viral treatment 2019 brief covid-19 sars-cov review anthelminthic nanomolar adenovirus recent fda-approved activity', 'correspond virus notable surveillance reservoir 1806 strong tiered respiratory cause clusters country arabia association correlation discover likely nosocomial household 1 classification season verify 45·1 novel extensive middle primarily subsequent affect saudi review forces kingdom 80·4 analysis 2012 cases incidence syndrome indicate increase health june 2016 majority ksa great armed lack seasonality cluster investigate epidemiological branch 51 period conduct retrospective camel mers-cov system coronavirus include source literature east case attribute occur previous transmission identify suggest temporally 564 breed death substantiate total', '', 'research approach conclude special agendum summarize short-term managerial close help major mitigation/preparedness example outbreak lead-time distinctively open facility unique successful covid-19 wrong plan propagation determine offer decision-maker examine risk simulation different long-term echelon downstream articulate recovery simulation-based study epidemic decisionmakers characterize existence allow effect set analysis behavior feature specific scenario result value time policy illustrate supply pandemic sars-cov-2 anylogistix sc present type second high outcome experiment future demonstrate duration important software uncertainty coronavirus observe paper ripple develop chain factor model outline tension operative insight impact frame observation scs methodology global disruption case identify predict sensitivity optimization upstream performance element', '', 'severe zusammenfassung nahm fatality small infection acute zur sars-pandemie dann bat respiratory werden causative sars-seuchenzug cause war führten 21 century fälle als das auf auslöser erkrankten 2002/2003 sars-epidemic carnivore zu neuartiges atypische eine diesen übrigen pandemie fleischfressende st es sondern südchinesischen southern verursachte traten failure heavy \\ufeff1 schließlich schwere novel kleinsäuger toten agent jahrhunderts für 5 spread november agens involvement mutation über viralen von rezeptorgens den jahren des transmit übertragbarkeit gene kann menschen mutationen pneumonien beim fledermäusen continent allow übertragen beteiligung 8.096 verlauf mensch infektion stattgehabten lungenversagen syndrome südostasien der schwerem pulmonal welt unbemerkt mit modell nur die regard 2002 weltweit disease verbreitete ausgang aus arise man pandemia seinen alle ein ist infektiöses zunächst angesehen oft 774 tödlichem vermittelten sars-cov dort dabei südchina coronavirus emerge daher sars-pandemia ihren nicht sich abstract china model sie 2003 sars und auch weitere wurde case februar kontinente verursacht transmission erste anfang pneumonia southeast-asia viral guangdong-provinz enterischer receptor enteric finally worldwide breitete', '', '', '', 'disease travel medicine 1477 8939/ infectious xxx xxxx', 'severe find raise research infection sepsis acute database 120 9 suspect 21 local concentrations post-traumatic hospital immunoradiometric ng/ml therapy t assay intensive covid-19 relate remain burn slightly 53 right mature monoclonal 1 comparison colonisation severely closely normal care correlate 5 active free rapidly repository diagnosis study invasive immunoreactivity complication procalcitonin substance long fund peripheral year analysis sign invasion covid 79 unit immunologically measure course value precursor concentration severity condition unrestricted episode microbial extrathyroid original disease 12 antibiotic prospectively centre calcitonin high blood patient investigate o subject mean 19 re-use decrease acknowledgement 6 child identical elsevier source 11 18 resource calcitonin-like form septic baseline bacterial serum publicly 86 viral grant age newborn 515 range 0&middot;1 infectious', 'background', '', '', 'draw increasingly transfer find safe research fresh carry donation screen readily measurement united change prescheduled extraordinary refer consist population elective database develope help donor transfusable pace 1.6 protein traditional instruction little states 2 doe therapy fact venipuncture symptom appointment maintaining decade generally clinically vigorous product accurate reaction covid-19 treat remember relate remain distribution verbal nation medical task volunteer act likely specialize right eligible divide directly collect heart recipient avoid illness pay 1 transplantation platelet ensure adult hemoglobin care substitute worrisome direct designate post-donation process label possible 5 active free addition nonremunerated oral equivalent manufacture appropriately repository critical study trauma recruitment monetary contribute applicable separate far represent combine initially regulation questionnaire long start fund voluntary exclusionary 15 economically convince question component 60 year allow effect analysis utilize 29 behavior cell old write 3 hematocrit unacceptable establish newly 2001 covid million indicate deliver freeze individual specific compel follow chemotherapy increase serologic attrition clinical plasma effective value result time information unsafe perform condition unrestricted majority cash original pack state-of-the-art 5,6 statistic temporarily disease eligibility immediately supply twice 4 examination present ongoing centre donated fluid sure blood national 7 demand cryoprecipitate criterium adequate usually mean important period re-use receive confirm antecubital single rbcs therapeutic specimen tube challenge acknowledgement believe recruit numb uncover estimate nearly u.s. elsevier source include viii organ prospective difficult vein store compensation factor resource approximately center infectious answer form commercial physical schedule recombinant disqualify transfusion donate temperature observation limit average untoward collection test telerecruiters publicly lesser message instruct property development deferral available grant rate red 8 reason cryoprecipitate-depleted brief send autologous age implementation cancer granulocyte method seek surgery total provide body', 'dataset research supervise allen successive prevention participant participate westfall database laboratory biological t n covid-19 remain right datum kancheya assist management active free design repository relevant study contribute protocol r long fund review dorak onsite g analysis e covid assemble clinical efficiency result interpretation draft s unrestricted original immunogenetics statistical manuscript centre type o hla epidemiological mean lobashevsky trial tang re-use j conduct m preparation specimen acknowledgement version elsevier source resource form framework collection responsible publicly acquisition development transmission grant zulu final kaslow late schaen penman-aguilar', 'severe raise life acute screen molecule respiratory discovery cause 9 outbreak december 2 optimisation covid-19 sars-cov. pro phytochemicals/traditional library genome process 5 cysteine cycle study 32,297 similar middle hit far anti-sars-cov-2 2019 analyse 3cl contain analysis homology chinese 3d 3 syndrome replication anti-viral 3-chymotrypsin-like construct compound protease sequence health potential disease lead 12 sars-cov-2 plant 4 enzyme 7 sars-cov medicinal recent concern mers-cov coronavirus 6 control essential 10 11 combat model east drug reveal global case development viral 8 serve prove target', '', 'evaluate coronavirus 3 ci infection high-risk rapid transcription novel ±sd simple specific tool 43 44 clinical close rt-lamp develope abstract result 40 identification 22 time 39 https://doi loop-mediated group suspect 21 37 contact powerful observation sensitive monitor visual detection reverse ± conclusion sars-cov-2 4.48 38 sample identify assay patient 41 microbiology amplification 2019 objective detect demonstrate -100 mean 26.28 42 isothermal 100 specificity 92.3 min 93.7 95', '', '', 'acknowledgement précédemment virus find 171 34 research de francophone infection article covid acute bronchiolitis keywords elsevier source summary aim infancy 181 respiratory active resource database free .. la 22 cause form repository major biological unrestricted study syncytial original pédiatrie revue des commonly tract occur publicly 2009 § centre laboratoires 2009;410:25 journal grant long low covid-19 search fund co-infection remain mean puériculture re-use dans paru right analysis', '', '', 'acknowledgement 165 research e covid contribution 50:2 elsevier source p ma special feature active resource database free abstract form general repository s unrestricted pharmacist description original f publicly t /ap • l centre c u n grant regulatory r long o covid-19 fund japha objective remain mean h 2010 re-use j www.japha.org provide right role analysis', 'dog acknowledgement 13 criterion cell cyst research cholesterol covid marked size elsevier source adjacent anisokaryosis coarse gure consider 5 binucleation active resource database free mammary result gures vary chromatin form repository mitotic unrestricted nucleolus clear 14 original lag 12 rectangular foam crystal apparatus fi tissue publicly anisocytosis oil present centre adhesion specimen malignancy formation abnormal grant cellular long prominent covid-19 poor fund display remain nuclear mean carcinoma cat re-use ■ aspirate spindle hp right analysis wright-giemsa', '', '', '', 'severe n. find c-fos march acute pathway pathdetect complete refer ap-1 respiratory expression causative encode protein little doe activate assay n atf2 relate determine transduction sas-cov datum \\ufeff1 genome transcription novel regulate agent elisa-based process isolate signal share regulation nf-jb activation selective strategy membrane homology exhibit syndrome indicate member subsequently sequence increase involve result time disease fosb promoter patient investigate cellular nucleocapsid sars-cov demonstrate important m atypical system coronavirus factor bind 2003 family sars pneumonia prove creb-1', 'fatality enter office 523 size reflect trust population 25 develope piba website lancet associate country outbreak 2 hospital doe symptom initial jan n actual intensive xiaogan region covid-19 distribution weight standard calculate 2019-ncov likely sd adopt collect right confirmation datum 1 huanggang mortality build prediction normal worrisome care mμ p novel calculation different spread 5 recognize addition vary onset know diagnosis nationality preliminary study epidemic official ± far day modification ethnic combine hospitalization u 0.75 efficiently parameter r 2019 2020 2.5 korean february formula μ significantly f deviation dec validate 3 province 16 e http://wjw.hubei.gov.cn/fbjd/dtyw/. wμ indicate unit daily 395 health italy result die value publish group commission information correct wang disease republic rest 4 l pre-proof chan d cluster high 7 patient national following-up estimation o 2.2 public future based hubei mean accord wuhan period mention gap fall j confirm conduct emergency decrease number overall 13 early numb city coronavirus σ 6 estimate inaccurate -p successfully base include real abstract china model family http://www.nhc.gov.cn/yjb/new_index.shtml temperature methodology 2σ global person-to-person case conclusion test publicly compare transmission available predict pneumonia journal week climate rate icu algorithm real-time huang 514 admission method death range particular infectious familial', 'industry severe acute respiratory food 9 cause country 21 century outbreak surround inc. animal fact chef clinically relate st southern illness 1 mortality \\ufeff1 care curiosity novel recognize lesson published epidemic spawn ć initially derive affect community disproportionate review look worker 30 syndrome subsequently health involve species handler infect 2002 disease man perspective 7 patient jump ahead fall 2005 crude number uncertainty victim coronavirus begin especially elsevier imss unrecognized distinguish useful approximately china 8500 physician half sars caterer quickly global person-to-person transmission exotic identify 8) infectious', '', 'severe fatality virus 8.8 infection acute additional change respiratory develope associate cause maximum occurrence 2 artificially symptom correlation treatment hematological treat standard 1.7 sd 18000 collect radiological diarrhea 1 confine \\u202bע\\u202c mortality retrospectively macaca p novel \\u202bע(\\u202c data 5 copies/ml onset isolate lung load 2.4 study obtain similar tract nasopharyngeal macaque day protocol subsequent affect differently frequency inflammatory \\u202bע\\u202csd significantly deviation fascicularis pathogenesis 3 syndrome median daily .01 24 cynomolgus 6.2 infect sixty-nine episode cohort 48.6 pandemic biochemical 4 inoculate prospectively high consistently patient investigate 774 mean confirm conduct detail specimen analyze react coronavirus 2.6 vs. 10 3.1 1.8 histopathological seroconversion sars 7.6 142 reproduce investigation log finding gastrointestinal microbiological enteric range role', '', 'severe basic mainland credibile epicentre infection inevitable outside acute size beijing prevention respiratory population 5·8 database 25 close reproductive shanghai cause metropolitan-wide 31 57 respectively transport major level outbreak surround mobility 304 simulate 2 link threaten 28 symptom jan forecast 113 localise multiple plan globally 2019-ncov guangzhou 98 monthly datum 1 presymptomatic quick 2·86 susceptible-exposed-infectious-recovered risk 2·68 background novel intervention data spread given self-sustain onset know preparedness quarantine study epidemic obtain similar lag official personal large-scale chongqing ready day independent 2019 long 2020 227 non-pharmaceutical serial 49 contain effect markov chinese 111 dec trigger 191 cases syndrome tencent 23 internationally individual booking health 300 scenario 24 result publish time interpretation 75 infect 37 exportation disease double posterior mitigation transmissibility 168 immediately 7·1 80 139 130 cri present 330 implement national export probably public 805 sars-cov mean social wuhan 19 metapopulation basis confirm interval atypical methods numb city coronavirus begin control estimate 56 import base 6·4 chain overseas monte aviation human model china center shenzhen 40 substantial deployment exponentially guide account domestically prefecture-level baseline absence global case previous 193 pneumonia week infer extent good domestic carlo flight method 461 sustain grow provide 2·47 815 95', '', 'severe numb coronavirus march infection syndrome acute care recover include novel increase respiratory 24 woman plasma 16,428 https://doi rapidly eliminate 2 case sars-cov-2 supportive critically responsible therapy eventually present safety randomize patient investigate efficacy treatment 2020 chest globally trial 379,661 death receive pregnant effect convalescent ill', '', 'count e infection dysfunction ldh -p risk play organ observe p crp underlie follow d-dimer indicator factor abstract damage kidney pct lung rise ctni \\uf0b7 disease decline f 2 neutrophil bacterial common l progression saa pneumonia patient u n lymphocyte r o covid-19 age good multiple important promote live death j heart role level', '', 'department oncology operation infection health clinical center radiation know employee information outbreak month occur crisis patient unprecedented uninterrupted wrong covid-19 public acknowledgements wuhan valuable provide radiotherapy', '', 'acid non-icu infection swab saliva different time https://doi rt-pcr tear dynamic \\uf0b7 urine nucleic sars-cov-2 test sars-cov-2nucleic sample fecal blood journal patient long icu 2020 comparisons nasal conversion', 'safe research approach infection measle cyd-tdv screen trust database associate rise country outbreak little january protect covid-19 unavailable event remain entirely determine right vol safety ideally dengue risk 20 active free repository determination semi-quantitative suitable philippines extremely long affect 2020 fund allow analysis endemic unvaccinated vaccines million covid comment vaccine tool result interpretation www.thelancet.com/infection flaviviral point-of-care unrestricted original disease 12 complexity status lack centre apparent technique innovative demand public interplay mean re-use 17 recent vaccination unfortunate acknowledgement save travel child elsevier source thousand include 11 dramatically require resource pair problem serological form flavivirus currently test publicly immune grant flaviviruses urgently live', '', 'variation research life de oxygen simultaneously bronchiolitis pathway united nebulized intrave respiratory database help tine cause tient laboratory states con evidence-based hospital doe therapy support covid-19 remain routine discourage nonrecommended right supplemental epi rou \\ufeff1 care intervention hypertonic active stay free addition bronchodilator infant repository dren ing cost primarily administration recom hospitalization long evidence current fund span review chil year radiograph analysis covid pharmacotherapy length mend corticosteroid clinical nasogastric unrestricted tinues original disease man inpa crease centre widespread chest mean nephrine re-use reduce therapeutic institutional optimize decrease nous standardization acknowledgement numb ed child elsevier source include base resource albuterol form unnecessary common supportive diagnostics publicly test order agement evaluation nutri improv healthcare viral grant guideline saline hydration tional utilization recommend', '', 'virus office life policymakers relationship assess participant hour 25 help country 21 outbreak month survey support wrong covid-19 pay adult normal confinement consider 20 physically active exercise vary stop resort introduce affect evidence 2020 contingent contain adults individual attention measure epidemiologically health result severity condition policy exist 38 issue wellbeing implement confirm distress feb work enable 64 early susceptible understand city coronavirus especially benefit restrictive china identification 27 physical highlight \\uf0b7 mental disruption case home chronic predict rate assistance good target live satisfaction lockdown 369 implication', 'ruminant research de infection enhance m. expression database virus-1 ndings cd11a/cd18 2 neutrophil cytolysis covid-19 b remain lkt mechanism right bronchoalveolar vivo bhv-1 mannheimia active free lea-1 addition know repository lung study lavage bat75 -integrin subsequent long produce fund pasteurellosis peripheral activation effect analysis extracellular cell leukocyte kill a1 covid mab ned increase explain result infect pneumonic unrestricted original pasteurella present centre blood investigate interaction demonstrate mean re-use ex ® susceptibility herpes acknowledgement understand numb lkt-responsive elsevier source haemolytica bind resource abstract form experimental bal occur publicly herpesvirus-1 viral leukotoxin grant cattle good greatly bovine induce', 'frontline 1 department operational 3 accompany infection control risk measure inevitably increase spread rise disease 2 strict staff 4 transmission implement image robust demand covid-19 chest plan globally radiology', 'severe fragment virus ratg13 infection relationship bat consist variant simplot originate associate cause maximum nucleotide outbreak bat_sars-like genetic doe distinct characteristic association region relate 2019-ncov virulence likely distant phylogenetic not-mosaic spike lineage closely \\ufeff1 genome background v3.5.1 novel likelihood 3′-part exact middle characterize rdp4 separate betacoronavirus far recently evidence span 24,341 analysis similarity feature subgenus individual batcov attention sequence 96.3 11,498 group hypothesis potential conclusions cluster investigate 3′-end objective branch genomic wuhan confirm bayesian single methods 30,696 coronavirus city specifically sarbecovirus position human china orf1b form half results discordant transmission 5′-part suggest search recombination orf1a putative method provide level', '', 'acknowledgement 1 department research covid elsevier source active resource database free mareiniss form brew repository unrestricted storm original dp 2016;35(2):368 publicly emerg centre grant long covid-19 fund remain mean med re-use overwhelm j emergency right analysis', 'basic severe emotion respond life infection packet additional participant college inquire governmental associate cause definitive cover unbearable experience purpose note december metadata .596 -.950 2 crisis symptom sample support correlation scale covid-19 production student event response discover medical enhancement income .001 mild 2.377 avoid .709 respondent acceptance 1 promulgation urban risk file .726 p correlate regulate intervention process spread disclaimer addition record anxiety appropriately epidemic .810 error -.817 university negative pdf moderate questionnaire economic 2019 affect format review readability generalized psychological bring effect legal analysis activity 3 indicate daily follow pertain changzhi increase health visibility copyediting publish .645 academic information 21.3 infect situation policy .752 2.7 pressure -3.804 status apply delay cluster national investigate parent public 0.9 content theoretical social area receive basis stability relative emergency methods protective early analyze evaluate 3.007 version urgent 7,143 article ci include factor china problem page loss form family guide disorder results typesetting \\uf0b7 monitor world mental undergo positively journal suggest good gad-7 -.925 effectively final live 7-item death provide level acquaintance 95', '', 'severe southeast traveler infection locate gathering prevention united sporadic summarize north respiratory authority cause rule country preventive local states hospital arabia symptom region low poor crucial peninsula america recommendation risk novel mass alert hygiene improve epidemic 14 ª official middle tract annually affect current saudi organization review professional 2012 syndrome million africa measure epidemiology increase health epicenter arabian relation awareness europe pilgrim compliance ongoing finally issue patient investigate laboratory-confirmed 28th focus important mers-cov. history recent mers-cov coronavirus travel emerge measures import include human appropriate east 2014 636 world case order reason asia', 'severe past virus surveillance rely infection acute rapid respiratory variant develope witness cause origin country emergence threaten facility international response uenza illness datum department novel respiratory-tract spread alert rapidly mode epidemic web-based self-reporting tract h10n8 middle eff economic infl doctor 15 h7n9 year 30 security cation syndrome h3n2 health identifi potential microbial disease c issue patient national gather sars-cov 8000 emergency mers-cov enable system specifi coronavirus emerge adenovirus-14 include base ective require human regional east substantial 2003 family sars impact dynamic monitor global 800 case acquisition avian transmission h5n1 viral death late infectious worldwide', 'virus molecular research 179 objectives infection 277 population database b. cause month 2 t characteristic presentation covid-19 children b influenza-like remain determine mild phylogenetic outpatient right lineages illness yearly lineage offer risk 20 diagnose active free pcr repository similar contribute complication r long fund frequency tree platform strategy analysis frequently covid 79 vaccine follow quadrivalent clinical inpatient elderly ili infect s 0 conclusions unrestricted episode cohort trivalent adolescent original great circulate 80 centre c high b/yamagata patient investigate braz belong detect mean important re-use j vaccination methods acknowledgement 4(1):73 control child main elsevier source 91.6 include dis resource form mismatch 0;2 commercial extreme case publicly multiplex phylogeny grant influenza introduction age brazil morbimortality worldwide', 'similarly fatality 7·2 mainland 3665 magnitude adjust infection outside strong estimates gradient change 22·9 cumulative 25 website 13·4 1·4 maximum 19·2 pcr-confirmed country laboratory line-list individual-case hospital 11·1 hong symptom 3·67 aggregate medium clinically 1·23 covid-19 ministry relate international distribution vs subset 4·5 likely collect 1·8 provincial datum government hospitalise 3·56 kong 28·1 risk censor background resident credible assume 1·53 11·2 diagnose proportion macau onset recovery rapidly spectrum demography obtain 15·9 0·27 far age-stratified day ≥60 18·4 2019 produce 17·8 2020 indication 5·7 60 year 165 furthermore 3·80 old discharge 1334 individual aim increase health 24 substantially 1·33 die constant commission time severity group consistent interpretation infect 37 disease repatriate n=70 stratify 3·5 80 n=151 cri 0·38 0·39 high differ outcome patient national attack 24·7 duration hubei mean 0·66 interval confirm 1·38 location-based crude 11·0 feb overall early 0·32 coronavirus age-based estimate observe findings 117 6·4 0·4 profile 16·9 require china account ratio prevalence 7·6 ascertainment parametric case under-ascertainment occur bias identify face rate robust 8 hospitalisation n=360 good age death range provide 95', 'virus cell-mediated wean 54 research infection inoculation immunology assess respiratory database protection lactogenic mononuclear proliferative mln little eliminate prepare node porcine immunopatbology protect weaned vigorous lymphocyte covid-19 suckle remain response 48 right shed diarrhea recta1 cpm 1 gastroenteritis minute contribution correlate active free exposure repository study confer possibility kontributed day moderate transient bln long fund immunopathology 42 partial virusneutralizing 35 nasal corresponding rectal analysis contrast count exhibit cell old covid oronasal indicate l-day-old pig increase lymph virus-specific 24 completely 000 group feces unrestricted contact original prcv tgev-primed inoculate centre cellular immunity age-matched 11-day-old detect mean immunolugy re-use virulent decrease challenge protective acknowledgement numb coronavirus transmissible control vs. elsevier source veterinary base 11 96 mesenteric sow primary resource abstract analyses form 1995 titer limit case 90 serum publicly immune grant antibody bronchial induce tgev prcv-exposed', 'severe molecular acute measurement respiratory expression substratebinding quantifiable protein etiological 1a mainly s1 cov assay globally pro determine substitution novel agent process subsite addition substrate cell-based study characterize alanine mediate 3cl analysis activity cell 1ab establish syndrome indicate replication play replicase importance protease rational efficiency result 3clike vero disease interaction cys145 demonstrate sars-cov important cis-cleavage proteolytic reliable vitro anti-sars escherichia coronavirus glu166 useful his41 sars drug cleavage coli gln-p1 development identify viral functional mutational polypeptide trans-cleavage role', 'severe mainland 5·2 approach 0·0 outside acute evolve respiratory population 0·74 cause 4·4 outbreak local december little 2 hospital restriction 28 t characteristic symptom jan covid-19 importation shandong variable time-to-event 8579 mixture window divide collect 1·8 provincial datum 1 young background intervention spread possible shorten proportion 9·0 self-sustain onset isolate 2·6 net epidemic similar official strict contribute rt day demographic revision reach r 2019 containment 2020 community serial 12·4 year key peak incubation dec 30 2·17 3 province 1·71 syndrome median indicate interrupt individual measure epidemiology increase 24 result interpretation time group progress reproduction information elderly sufficient 1·54 policy location awareness disease sars-cov-2 4 consistently public laboratory-confirmed hubei mean coverage wuhan period 19 timely ie 5·1 17 interval bayesian 1·32 1·08 feb decrease overall 64 early numb coronavirus begin city definition ci date 56 estimate 11·6 findings source include 44 guangdong 1·3 china shenzhen infectiousness 27 dynamic guide entire highly quickly case movement transmission 33 week 14·0 threshold suggest trend age admission finding provide infectious level 95', '', 'small cell vivo epithelial coronavirus hapn specifically marrow infection coronavirus-229e source pig hapntransgenic villus primary line cdna factor expression serologically human drive convolute dendritic transgene require bone addition kidney heterozygous hcov-229e lung infect pattern protein similar transgenic bronchus crossbreed proximal hapn-transgenic resistant match tissue deficient promoter intestinal sac intestine d immune mouse identify express n derive experiment relate apn alveolar mrna cd13 create live receptor aminopeptidase cat tubule homozygous embryonic vitro valuable knockout renal', '', '', '', 'virus research destruction outside acute transfuse assess rapid expected elective database non-regenerative surgical pointer donor associate cause normovolaemia v pcv ab genetic t medicine section n reaction covid-19 relate remain discover q determine alloantibody right hypoperfusion recipient presence datum practice mik incompatibility www.catvirus.com anaemia \\ufeff1 examine haemolytic referable 20 possible active previously free 36 toolbox repository ✜ clinicopathological includes u r long fund 15 f analysis cell sign e newly covid indicate importance procedure cross-matching usa way clinical result group www.isfm.net information w s unrestricted mike original feline reactions examination ongoing centre coagulopathy type vet-h blood patient investigate o mean subclinical re-use receive acknowledgement system concert elsevier source tachycardia 10 18 useful resource loss form physical websites naive transfusion describe ab-typed occur publicly chronic relevance identify available grant despite antibody good cat recommend', 'severe small infection acute equipment respiratory vietnam causative largely major particularly outbreak discuss canada hospital contagious environmental hong facility significant theory event re-emerge train failure airborne practice hcws droplet kong threat post-sars management direct novel agent spread lesson exposure large-scale transmit personal initially efficiently recently affect potentially contain singapore psychological strategy worker set application indirect syndrome individual measure follow health psychosocial efficiency contact microbial disease lead learn illustrate lack propose high patient recognise period taiwan protective coronavirus urgent emerge control requirements main employ isolation include paper base ic develop handwashing china programme 2003 super-spreading sars impact highly limit comply global education precaution eventually visitor transmission healthcare identify rate decontamination stringent dedicate village overview concept provide infectious', '', '', '', 'power datum coronavirus indirect establish examine recover panel relationship include direct accordingly factor appropriate model interpret publish consistent study disease case examination spatial investigate treatment 2019 affect covid-19 efficient propagation analyse variable thereof determine death confirm effect light', 'basic small research pathophysiologic vascular england consist symposium esophageal database develope bristol rheum cause remedy knowledge experience note m.r.c.v.s. discuss apparently colleague deficiency anomaly medicine association pyloric 1977 covid-19 properly relate remain vomit slightly berberis likely window right diarrhea diarrheic failure client practice vulgare dysfunction suffer gastroenterology molt active free 22 rapidly repository soon frustration cycle study megaesophagus similar lag university vulgaris numerous nictitating john long fund review contain membrane analysis disorders improvement panleukopenia syndrome covid ring clinical quantity column compete idaeus s questionable august condition unrestricted original disease congenital correspondence feline impart enzyme present centre letter patient chronically investigate sense bark emphasize future subject mean important med scientific area significance re-use comprehensive basis uncommon clinician b.vet acknowledgement evaluate afterward logic article leave foeniculum elsevier source root veterinarian rubus continue include gruffyd-jones resource pancreatic form correspondent disorder describe absence common herbal publicly chronic m.s. grant face viruses suggest protrusion consideration diagnostic serve appear r. prove remind gastrointestinal cat principle', 'severe text infection wbc acute white outside father respiratory sle develope cause 1891 clusters 2 symptom n covid-19 globally mild sister syndromecoronavirus shed 98 p novel glucocorticoid sedimentation long-term diagnose 5 oral extra 14-day diagnosis quarantine study studies 14 day title extremely initially word u lupus index r 2019 long systemic year f count incubation cell running esr 3 16 e 47year-old covid member woman -19 result time successively disease l pre-proof cluster 7 patient blood o erythrocyte period wuhan j confirm atypical number erythematous positive coronavirus leave -p include develop ha abbreviations abstract 40 sars-cov2 family clear person-to-person average case test • transmission journal rate erythematosus antibody suggest familial', 'raise gateway research ability [5][6][7][8 database develope food protection cause 9 tomato conserve protein superfamily withstand cross-reactivity mainly allergy symptom hypersensitivity sativa phenomenon nsltps covid-19 reaction remain multiple medical nsltp-mediated topic right prior anaphylaxis novel stress different given 5 thorough active free addition oral know repository proteolysis relevant study possibility reverse numerous wake long fund systemic contain component nut reactivity prolamin analysis digestion 5,8 syndrome covid indicate importance sequence clinical result nsltp nectarine sensitization unrestricted field original europe plant present allergic centre c fungus patient stone precede belong sensitize 5,10 gather mean important social fruit/vegetable defense re-use anticipate history acknowledgement system crossreactivity analyze apple geographic essential elsevier source sive summary cannabis resource handle form account expand bacterium describe highly fruit case resistant smoke publicly development peach mark grant 8 suggest ltp plum marijuana thermal grow recreational provide role', 'concern coordination understand argue communitylevel achieve health-edrm risk examine health-emergency management patent agendum enhance require disaster complement emergency outline regard aspect manage extension potential preparedness general knowledge framework provision particularly action resilience strengthen epidemic similar global utilisation sustainability cope case pandemic health-emergencies governance science 2030 humanitarian phenomenon covid-19 2020 super current future response transformation sfdrr accelerate health-related drrspecific mechanism year strategy implication recommendation', '', 'extracellular cell early epithelial coronavirus enter endosomal spike serine -hku1 air-liquid pathway ability tmrrss2 protease transmembrane clinical human previously hcovs result addition endosome cell-culture-adapted hcov-229e isolate infect field protein prefer interface similar 2 hcov-oc43 lose circulate distinct l cell-surface activate cathepsin generally passage entry acquire suggest airway bronchial tracheal tmprss2 repeat replicate culture', '', 'basic classical virus susceptible cell coronavirus indirect logarithmic dilution approach essential virologist immunoperoxidase alternative calculation titration human cause half laboratory biological series experimental titer describe hcov detection case oc43 tcid tissue inoculate represent virus-containing sample dose fluid assay express technique viral growth yield significant plate 50 229e serial cytopathic strain method reliable ipa contain 96-well effect replicate infectious plaque culture', 'acid correspond virus 0378-l research peptide partially infection tunicamycin glycosylation respiratory immunoblotting expression database reproductive antigenic encode gnotobiotic protein note porcine naturally hydrophilic science open express assay ripa non-neutralizing irmuunoperoxidase covid-19 remain nlinked 65 right antiserum carboxyterminal 76 difference p conventionally recognize active free portion ssdio378 isolate repository prototypic study gene bpo3-p rear characterize derive microbiology long fund fusion yterminal baculovirus prrsv significantly analysis 199 3 indirect amino syndrome covid monolayer reactive procedure serologic swine reserve potential american 0 unrestricted 0.01 original 1135(94)00113 read centre immunoblot mean re-use european atypical b.v. acknowledgement system peptide-n-glycosidase ipma elsevier source veterinary gnotobiotically lelystad 44 resource convalesce form 1995 recombinant frame american-origin reveal serum publicly responsible 135/95/$09.50 predict western expose viral grant radioimmunoprecipitation acquire despite 8 sera reference orf', 'induction fever instead coronavirus city incidence infection pregnancy obstetrically-indicated care unit include intravenous symptomatic myalgia increase require notably woman abstract center 28.6 cough rapidly information tertiary admit condensation experience 1218 disease limit post-partum hospital case supportive present manuscript initial seven symptom labor word asymptomatic patient intensive presentation 2019 headache covid-19 icu chest remain admission pain hydration 100 pregnant confirm single worldwide york', 'severe decode virus molecular reservoir antiviral acute intercontinental complete evolve respiratory help cause laboratory outbreak month sars-coronavirus animal transportation region accurate international 1 genome management 1000 novel agent spread possible accumulate onset know biology diagnosis asian epidemic hit obscure immunization organization review continent year shock pathogenesis syndrome publication epidemiology health clinical imminent disease hard pandemic unprecedented epidemiological 468 2005 bioinformatics 455 power enable early coronavirus control article genomics 11 human 2003 sars currently highly world diagnostics eventually collaborative identify aetiological journal viral week phylogeny effort efficient pacific neurovirology exact', '', '', '', '', 'concern positive surveillance begin infection swab importance source primary health rna active china country highlight currently outbreak assessment case sars-cov-2 test infectivity ongoing constitute patient covid-19 public international multiple oropharyngeal wuhan convalescence confirm emergency turn', '', '', 'covid-19 safe pandemic team surgical achieve outcome optimize care minimize risk patient laparoscopy goal precis', \"severe research antiviral march infection macacque acute resistance respiratory transcriptional notably expression develope 220 protection associate 9 jak1 mononuclear laboratory brisbane 21 protein sensitive implicate 2 antimicrobial mhv-1 cognate cov activate protect california www.cell-research.com treatment treat 15,18 b pkc event innate response murine subset effector ifn-γ directly safety alfacon-1 differentially datum 1 ifn examine contribution sars-related (ifn)-αs novel regulate ifn-α 20 recognize monkey design downstream 22 critical signal study receptor-mediated patients gene interferon represent hepatitis independently regulation ifn-inducible evidence peripheral mediate activation effect strategy interfer-ing activity cell 3 syndrome replication phosphorylation play specific clinical ifn-αs effective result host potential intermune urbani original disease 12 resolution infergen surface lack c p38mapk 7 patient adaptive invoke efficacy blood based sars-cov strain 19 trial map vitro 17 receive anticipate conduct therapeutic combination specimen culture 13 system early numb npg coronavirus evaluate phosphorylation-activation benefit inhibit 6 article isolation distinguish profile consensus bind comparative corp 2'5'-oas 2003 synthetic sars results kinase ifn-β candidate receptor-activation property immune identify provide coronoavirus viral unrelated functional 8 potently pilot well-described introduction additionally suggest infer pkr finding target characterization receptor ifn-α/β ifns induce role\", '', 'illness presence department fever positive 46-year-old swab return base igg 11 diagnose woman post-exposure macau cough rt-pcr test day present sample 18e21 seven 2-day pneumonia anti-sars-cov-2 covid-19 start real-time oropharyngeal emergency', '', 'embrace virus research demonstration database develope laboratory little reo-like etc colleague etiology reovirus-like carrier support clinically repetitio~ covid-19 remain entirely right bn p agent active previously free know repository reoviruslike cytoljlasm study obtain attempt possibility morphological prerequisite far particle long evidence fund tients renal analysis virology cell apostolov covid biopsy tool procedure serologic involve host progress extension unrestricted field original disease tissue nature centre virus-like technique patient mean re-use vitro confirm specimen culture acknowledgement influence understand elsevier source difficult useful resource annotations form describe corona modern cultivated publicly lately viral grant good diagnostic finding infectious', 'eigenvector severe z-curve analyze geometric instead coronavirus merit stage approach syndrome difference indicate acute direction genome relationship base sars-covs paper position measure novel construct individual sequence respiratory previously alignment approximately center associate post-genome cause group form respectively information distance consistent sars era representation outbreak three-dimensional describe description obtain simplicity study z-curves premature lose gene approximate previous characterize represent present identify propose evolutionary phylogeny parameter infer trend relate tree method phylogenetic distantly analysis intuitiveness', 'neuron acknowledgement neurons highlights trigger research article covid elsevier source necessary guinea pig active resource database free abstract mycobacterium extract mutant induces form cough graphical glycolipid repository infect sufficient unrestricted original induce nociceptive publicly centre tuberculosis activate sl-1 neuronal grant organic sl-1-deficient long produce covid-19 fund sulfolipid-1 remain mean activation re-use activates mtb right analysis', '', '', 'virus find enter infection structure subunit polyclonal inhibitor harbor conserve 2 emergence structures distinct boundary furin murine determine receptor-binding 1 conformation therapeutics spike apart correlate spike-mediated sars-related covs spread process design similar site mediate cross-neutralizing set elicit 90,000 cell biogenesis newly indicate vaccine result invade s sars-cov-2 high inhibition demonstrate sars-cov spikemediated vaccination highlights /s coronavirus inhibit emerge main glycoprotein bind human 3,000 ace2 cryo-em cleavage domain blueprint viral affinity antibody entry brief efficient potently epitope target promote trimer receptor ectodomain death finally provide worldwide', '', 'hais research approach carry infection ineffective prevention computer database help mrsa associate individual-based outbreak 2 hospital t personnel n covid-19 b remain h adopt nosocomial right 1 simulation p management associated mathematical spread active free repository infections study strict combine u r long fund organization effect g analysis e 265 covid measure s 0 ward unrestricted original 4 present centre c spatial high implement investigate o mean re-use stochastic acknowledgement system analyze evaluate control elsevier source paper resource model form insight dynamic priority publicly healthcare space grant cohorting suggest 260 provide', '', '', '', 'virus team opportunity burden infection equipment leadership develope surgical conserve hospital symptom aerosolize protect covid-19 medical room task endoscopy safety ensure threat risk background novel spread design exposure likelihood study personal site tree platform worker rationally easyto-follow operation conservation member procedure interventional potential infect pattern operate expert optimal disease decision pandemic sars-cov-2 suite taskforce patient conjunction anticipate institutional protective base school ppe describe conclusion common precaution test urgency healthcare viral despite guideline algorithm create convene corona', 'system practice department execute positive coronavirus incentive scientifically supervise team establish indicate play management prevention enhance sustainable attention nurse health material human resource echelon deploy result authority capacity general improve outbreak allocate recourse disease introduce strategy hospital nursing cope formulate supply deficiency three-level dynamically 2019(covid-19 support organize identify face functional pre-service treatment step successful covid-19 good objective efficient plan public medical method effectively pay emergency role key train fully work', 'acid virus find 54 research (chymo)trypsin-like carry locate structure structural ability 43 database catalytic cys42 cys58 major structure-functional eukaryote tn superfamily -nucleophile-base distinct t seven covid-19 remain determine right [st]a comparison near fold active free zymogen-zyme 55 repository cysteine nbczone three-dimensional glycine distribute instrumental long fund zone 15 activation contain existence key analysis contrast activity furthermore 3d amino serine/cysteine covid construction residue protease eukaryotic group universal unrestricted original lack enzyme centre type bond propose belong usually mean prokaryote fall re-use nucleophile combination acknowledgement serine elsevier source base position 11 chain resource his57 triad form disulfide nbczones transition publicly 169 prokaryotic viral grant suggest comprise', '', '', '', 'basic exhibition coronavirus build fangcang \\ufeff1 isolation care temporary essential rapid novel document construction convert stadium health explain health-care function triage emergency china food shelter referral time massive rapidly isolate family outbreak engagement frequent tackle monitor powerful disease epidemic large-scale cost hospital pandemic exist development characteristic moderate centre implement facility patient national 2019 scale covid-19 public 2020 community low serve response good social venue february medical live future mild concept component provide key activity', '', 'bronchitis system cell virus tcov favor coronavirus 3 find embryo inoculation structure replication isolation egg epithelium aim novel different require chicken extensively develope turkey host species diversity wide complex amniotic group family potential chorioallantoic titer study fabricius embryonated primarily suitable tissue replicate bursa coronaviridae intestine support type fluid identify provide high successful good yolk pheasant propagation ibv regardless membrane infectious variety allantoic comprise route', 'virus opportunity approach radiation workforce particularly little hospital inferior therapy resource-intensive support protect expertise covid-19 organisation adopt recommendation absolute offer risk care given arm possible equipoise exposure stop ii relevant share rt evidence randomise contain oncological professional infrastructure set 30 provider unusual deliver aim follow health planning/treatment clinical involve result clearly potential imperative breast sufficient expert ease complexity pressure pandemic delay iii high patient outcome guidance obligation strain trial reduce cent conduct emergency workload coronavirus urgent date control and/or moment require minimum resource translate general impact account fraction guide recurrence world visit test healthcare available statement compromise face good consideration cancer target minimise provide role principle', '', 'prior elicit dependent inflammation severe virus coronavirus province and/or geographic observe document discrepancy possible require perplex modulate lymphopenia china exposure regard answer severity antigenic epidemic local storm similar world limitation case sars-cov-2 ade occur circulate immune antibody current covid-19 epitope presumably response hubei enhancement sustain cytokine question death explanation', 'variation surveillance epicentre rely approach infection strong estimates ability outbreak 67 support point generally medium low covid-19 case-detection international likely 1 build hpdi risk background resident assumption mathematical spread fold stay 22 modestly capacity traveller underestimation published exclude contribute 2019 evidence 2020 42 100 singapore ascertain count furthermore incidence indicate interpretation www.thelancet.com/infection severity 37 0 contact location disease great 68 high consistently epidemiological probably detect wuhan underdetected connectivity 194 bayesian relative coronavirus estimate underestimate import base simple 11 18 model china 40 trace https://doi account prevalence detection world case treating previous compare visitor sensitivity online brief finding inflate finally infectious april 95', '', '', '', '', 'research de mayo-junio situaciones proyecto database la valero e. girona a. i. farmacodinamia rivaroxaban enfermedad covid-19 remain right baines grana española www.elsevier.es/farmhosp 121 active hospitalaria free 125 reflexiones repository jover revisión número especiales datos 2009 decreto editoriales dabigatran juárez long fund medicamentos j.c. analysis originales sociedad estructural 3 e tratamiento covid órgano anticoagulantes farmacia rodríguez-terol unrestricted el original 134 para centre calidad disponibilidad los climent mean oficial en re-use basis científica giménez acknowledgement tromboembólica 123 brumós elsevier source nuevos real orales resource ordovás las garcía form y expresión volumen publicly l. • interacciones 33 grant j.p. venosa farmacocinética botella sobre', 'acid consolidation severe virus throb considering infection swab white fast change opacity refer respiratory mg/l chengdu laboratory basal suspect protein 1a superior 2 47-year-old 36.7 lesion lymphocyte low reaction 50 production b remain multiple standard 2019-ncov 5.11 right department 1 normal 109/l novel 20 spread audible 5 tomography diagnose visible different capacity moist diagnosis lung 2019-ncov. 14 16.8 contribute tract day scan halo circumstance patchy 2019 long 2020 institution february 22.50 relatively significantly incubation count cell fever sign mother 3 province c-reactive feature fluorescence gold increase segment density reexamination result time cough contact location nucleic supply examination man sore d c blood 7 patient image bilateral chest unremarkable period wuhan ago lobe history headache emergency ground-glass decrease coronavirus false-negative travel helpful chain kit ct useful problem throat general physical dynamic â temperature sputum rales detection case home test evaluation compute transmission sensitivity secretion polymerase week differential extent short real-time sichuan live range body', '', 'acid severe n. peptide flank acute 289 nls respiratory egfp protein localize c-terminus mainly cov aa369 nucleolar n region unique anti-n distribution act determine nls3 rich antiserum 390 localization nls1 motif 226 novel agent intracellular mutation accumulation fuse shuttle signal confocal share cytoplasm microscopy distribute recently derive mediate contain nls2 nuclear/nucleolar analysis homology activity rabbit pathogenesis furthermore n-terminal amino syndrome 265 recover nucleus member play result perform pattern nucleolus leucine coronaviridae discernable present wild type aa38 nucleocapsid nuclear sars-cov important differences coronavirus 220-lalllldrlnrl 44 function hydrophobic family nlss sars results aa257 common nucleolar-cytoplasmic property deletion identify aetiological suggest putative role cytoplasmic', '', 'consolidation acid stage 54 oxygen partially infection 27.3 complete opacity change multi-lobe respectively spo sensitive morphology 2 hospital accuracy characteristic lesion xiaogan abnormal correlation lymphocyte covid-19 treat 50 à0.446 72.7 remain distribution radiological central 56.4 datum presence 110 retrospectively data tomography 50.1 lung diagnosis fuse negative patchy zone peripheral analyse p<0.05 frequently 30 rvalues aim 114 density clinical involve result regard progress severity location nucleic 80 examination apply present type progression thirty blood patient image epidemiological chest gather demonstrate hubei area abnormality confirm ground-glass methods number early 49.1 56 observe ct china saturation spiral results ratio 45.4 reveal detection case conclusion common evaluation compute sensitivity à0.780 diagnostic shadow materials method 62 lesions', 'count meteorological influence severe positive 1 absolute variation 3 mortality ci syndrome acute unit observe summary 2.92 daily increase -10.99 respiratory factor 5 model china 0.61 addition associate explore 5.28 sars -3.88 temperature study disease lag great negative apply additive 0.44 2,299 -19.68 -2.29 association influenza parameter diurnal r covid-19 -7.50 suggest affect relate important wuhan period humidity generalized −0.32 death -11.41 range effect relative infectious decrease 95', 'correspond severe fragment infection structural acute subunit cleave fipv respiratory proteolytically major protein ab s1 cov generate express n s2 vero-e6 protein-specific precipitation blot datum spike e.coli abs process study bcov hcov-oc43 efficiently subsequent affect fusion 3cl allow membrane analysis contrast furthermore cell e lysate indicate seriously mab specific result host hcov-229e s infect perform aibv present maturation investigate syndrome-coronavirus interaction detect demonstrate sars-cov proteolytic microscope virons coronavirus specifically mhv essential observe anti-s1 electron bind function sars tgv s2-specific observation cleavage capable envelop order immune western viral antibody good prove receptor', '', 'industry basic meet text research locate manufacturer population e88 database develope ju protection 9 complex medicare 49:4 add little 7/3/09 t facility n upgrade covid-19 articles production international remain multiple h reviews topic www.japha.org right government keywords file p e89 data agency process market active free manufacture stockpile repository study options cost aid strict advance 2009 barrier regulation u independent immunization r long subsidy affect e93 fund review costly au option english f year approval decline analysis variety strategy g selection e vaccines million covid pm vaccine aim pertain increase /au synthesis 87 tank pull academic commitment s unrestricted medication policy original lead stabilize supply 4 l d centre c issue exceed push implement high select demand o criterium public objective japha coverage mean re-use j medline ■ history list 92 acknowledgement pharmaceutical concern 94 e95 fast-track numb e90 think article success elsevier source include language difficult 10 require factor resource human problem purchase form small-molecule drug abstracts describe limit 800 innovation 89 conclusion extraction publicly development compare • finance available journal grant resolve rate entry 12:12 88 search biologic mix liability overview provide inclusion', 'past research march infection learner prevention equipment complete hour respiratory cdc patho database setting 2 t gen covid-19 remain standard cnor tarrac right practice 1 earn http://www.aornjournal.org care intervention agent active free exposure updated repository sheet expect provides personal cpan © long 534 fund incorporate component 544 year worker analysis activity application prevent aorn newly covid indicate 546 centers health effective 87 publish cough information unrestricted contact msn original disease re-emphasize examination read centre update type patient cic mean re-use j clinician ely protective acknowledgement inc emerge article control depend isolation elsevier source continue hygiene/ 11 ppe rn resource 543 appropriate page outline answer form guide -542 expand 545 2008 guidelines education shauna evaluation publicly previous precaution transmission available etiquette grant facilities good guideline method infectious', '', '', '', '', '', '', 'severe find approach endogeneity outside acute panel relationship impulse-response indicator respiratory cause 31 country suspect preventive outbreak local assessment hospital environmental initial unclear heterogeneous medium covid-19 remain collect facilitate safety datum presence 1 \\ufeff1 examine novel spread exposure recovery series study numerous evidence organization effect debate syndrome empirical recover daily tool construct measure heterogeneity covid-19-attributable health increase result time disease complexity circumvent investigate estimation provinces/states public linear cross-sectional by~0.10%-~1.71 declare confirm human-to-human emergency coronavirus ci control essential include develop factor model china unobserved 2003 sars account highlight nonlinear reveal capable global world case attributable common precaution attribute occur transmission investigation predict pneumonia dependence conceptual appear method death nexus role level 95', 'acid severe mainland team comprehensively prevention remarkable participate cumulative consist gancaoganjiang disappearance fuzheng reduction outbreak traditional 2 hospital etc staff mainly therapy medicine characteristic symptom treatment lymphocyte significant covid-19 treat discover medical over-all 2019-ncov collectively mild likely 1.7 turn practice 1 achieve 70 designate intervention process shorten stay addition recovery 22 rapidly diagnosis epidemic prescribe negative 2943 day sheganmahuang reach 2019 long current 2-mar-2020 differentiation bring effect set chinese cure improvement 3 province establish syndrome play prescription length specific rescue increase clinical tcm effective result time ward expert disease nucleic qpd patient paidu image 2.2 touxie hubei period confirm history indispensable therapeutic numb coronavirus dispatch control 58.89 27.4 80151 employ include patent base ct recipe china 102 2003 sars hope drug currently temperature 3.67 acupuncture case 60,107 average common decoction qingfei 33 pneumonia 3100 rate 47,204 suggest guideline death total body role fully scheme', \"fatality virus depuis un juin de ont infection son saoudite 803 années gestion respiratory population 16th sras-cov la comprendre plus origin humaine pouvoir touché country cours outbreak vast experience little sa prepare revue 2 kind une arabia mais treatment relate l'épidémiologie pneumonie d'efforts pay émergence lieu cas risques \\ufeff1 importante que risk première été particulièrement décrire novel different spread ce éventuelle 36 disparu diagnosis à premier epidemic faire des communicable 2018 d'infections deux middle 2260 u r sein saudi review n'est au dans l'épidémie cette year key est endemic 2012 prevent 16 d'épidémie gain confirmées syndrome les endémique raison physiopathologie epidemiology liée charge clinical qui lutter 71 enrayée détection majorité déployés observée june infect é s parmi clinique majority disease prochaine s'attache contrairement late taux pas maladies type high patient diagnostique octobre manifestation mots déclarés future sars-cov focus grande important dernières en pour confirm donné recent émergentes contre moins disappear mers-cov ainsi understand coronavirus peu transmissible 6 emerge beaucoup observé chez observe human détecté arabie nouveau east cease 27 manage d'infection pathophysiology prise acquise par installation unlike retracer du case différents october l'origine thérapeutique infectés décès le -coronavirus rate face effort l'expérience après good toujours clés liés ans death particular\", 'severe system virus surveillance coronavirus establish syndrome \\ufeff1 infection acute probable control prevention include measure procedure centers agent health respiratory november cdc human develope help result causative species stop origin 2003 extensive diagnosis sars 2002 guide outbreak similar disease global person-to-person world animal july ultimately 8096 sarsassociated test institute transmission unclear identify zoonotic 774 short public diagnostic response sars-cov appear reappear period create organization death declare genetically worldwide', '', '', 'severe infection size close cause country touch billion t estimated sensational intensive treatment covid-19 b tabulate crucial standard organisation avoid datum mortality best-case care risk 5 14 attempt cost populationand wash r unthinkable potentially continent frequently individual measure way health scenario effective reiterate die potential s infect sufficient contact pandemic sars-cov-2 4 apply c sense sound public social wuhan mitigate sober resultant vaccination epidemiologist number plunge middle-ages 6 estimate and/or base paper hand require human model china half distance currently absence global world case precaution occur realism healthcare face rate calculations death level', '', '', '', 'severe small peptide s-protein-pseudotyped infection acute e6 respiratory develope 668 cause sp-8 respectively protein 192 2 4.30 protein-pseudotyped 203 angiotensin-converting assay 494 treatment region 50 retrovirus act receptor-binding spike \\ufeff1 novel agent design nmol ± scan derive step span significantly effect sp-10 cell biotinylated syndrome 2.18 residue value anti-sars-cov vero s disease infectivity enzyme 0.71 immunosorbent cellular 0.52 interaction 1.88 sars-cov 660 683 sp-4 coronavirus emerge ic 6.99 bind disrupt ace2 sars enzyme-linked inhibitory block conclusion domain 483 suggest 679 finding infectious', '', 'severe virus find raise stage grip acute respiratory expression transcriptomic cause outbreak 2 covid-19 evoke coivd-19 relate determine exploit inside mortality contribution curiosity spread possible proportion involvement similar complication 2019 host−virus cns pathogenesis debate cell gain syndrome follow density apprehension scare result scientist regard time potential infect disease pandemic resemble tissue enzyme ongoing differ investigate angiotensinconverting interaction sars-cov genomic struggle epic recent morbidity understand coronavirus midst base human model damage ace2 world case entry short neurological receptor infectious worldwide level', 'severe virus molecular antiviral approach infection prevention non-toxic imply resistance respiratory rna variant low-pathogenic nsp13 replication/transcription cause origin complex protein hcov cov n treatment rnas 229e illness datum nucleocapsidprotein mortality mutation ii know accumulation nonstructural pathogenic obtain communicable contribute middle far independent adapt affect evade dangerous 35 selective allow 2012 prevent cell furthermore anti-coronaviral newly syndrome replication specific cold-like quantity host concentration hcov-229e infect disease lead pressure high zoonotic demonstrate strain binase reduce optimally diminish decrease culture mers-cov 13 coronavirus inhibit emerge human east ribonuclease family titer highly quickly bacterial common development available viral rate urgently target subgenomic enteric level', 'acknowledgement fragment dna escherichia research cation insert ed covid elsevier source cleave endonuclease 93 simple engineered ability foreign cdna mobilize active resource database free wastewater origin form plasmid synthetic repository unrestricted temperature original coli ph bacterial restriction publicly micro-organisms l broth centre 2.1.1 grant clone long affect covid-19 fund remain genomic mean purify relatively re-use total right preparation analysis', '', 'acknowledgement neuroftalmológicas research como de arch molero-senosiain covid por aguda elsevier source oftalmol esp active resource database free form https://doi repository y unrestricted original artículo mycoplasma posterior infección complicación publicly centre este encefalitis pneumonia desarrollo grant soc cómo manifestaciones long covid-19 citar fund 2020 diseminada remain una mean re-use m right analysis', '', 'pathogenesis dependent small virus cell severe understand coronavirus reservoir antiviral syndrome acute core envelope additional vaccine novel agent process respiratory bind shortly model help identification host attachment ace2 sars fraction protein etiological study introduce envelop 2 cytoplasm contribute surface gene animal development characterize far enzyme identify express viral recently cellular angiotensinconverting entry membrane clone functional fusion tein sars-cov sars-cov. receptor likely incompletely facilitate pro-', 'virus meet research infection acute united england participant change respiratory attendance database 14,15 suspect copd canada december january 2 hospital symptom actual treatment presentation covid-19 remain vs medical prednisone 28,514 right periods revolution blackberry datum 1 participants season 78 mortality journal.publications.chestnet.org 1.97/participant-year difference adult examine care initiate normal encounter background p smartphone-based management possible active free record likelihood sweden torch repository ing self-report study 14 exacerbations transmit necessitate northern day falsify 73 hospitalization reach practitioner long fund miss 11,12 year kingdom peak analysis furthermore exhibit trigger 191 cation covid return daily length epidemiologically 99.9 increase health identifi group conclusions s august worsen unrestricted pattern near-complete original disease 5,6 12 lead antibiotic immediately rest winter 4 compliance centre randomize alerts high 7 patient year-end tudies precede seasonal breathe criterium chest detect mean period 8.9 trial re-use diary electronic christmas bronchitis acknowledgement 13 94 enable anthonisen peaks child and/or exacerbation elsevier source 10 observe school .04 require 12.0 resource blackberry-based onehalf center problem 148 form general results 144 hemisphere wales frequent monitor 2008 one-third detection 2.5/participant-year average blackberrys collection occur publicly order 144(2):507 transmission 2013 viral grant rate 8 41 fabricate score 514 hospitalize inception characterization nexthighest coincide paper-based level underdetection 95', '', '', '', '', 'acknowledgement highlights research covid leave subtle 23 elsevier source active resource database free erentiate form 2014 repository unrestricted diff original disease january 12 2 pulmonary publicly centre www.thelancet.com/respiratory technique 2013 hypertension grant image long covid-19 fund remain mean pah re-use catheterisation heart right vol analysis', '', 'acid severe find molecular approach two-hybrid elucidate structure acute assembly measurement sucrose gradient 50-fold self-interactions respiratory rna intervene serine/arginine-rich protein note little generate science assay n express region crucial collectively fractionation mechanism blot datum 1394 core genome motif transcription novel different design m-m ssrsssrsrgnsr 1399 share 184 aid seap gene characterize 196 particle recently subsequent self-multimerization purify baculovirus abolish package analysis homology activity furthermore amino syndrome replication member pertain sequence increase 300 involve completely full-length result transfection n-n oligomerization disease high formation investigate interaction fractionate detect nucleocapsid sars-cov decide m atypical homotypic system numb coronavirus emerge observe include necessary approximately 2003 form family sars mock reveal attribute compare order deletion mammalian identify pneumonia western viral suggest mutational protein-protein finally level', 'virus find molecular research infection swab screen assess respiratory close database associate respectively ib major covid-19 remain poorly nest ibv nd right seroprevalence 14.6 72 market active free 22 backyard know pcr repository study serology negative tract newcastle poultry reach economic long affect pool fund 2010 14.7 analysis farm endemic 2012 n22,000 covid aim unrestricted original disease ndv present centre mean period bird re-use african 2000 bronchitis acknowledgement positive evaluate elsevier source resource loss form commercial impact prevalence test serum publicly avian viral grant influenza live ivory-coast infectious', '', 'incubation datum severe surveillance coronavirus transmissible travel syndrome median acute essential risk source background assess individual overseas possible respiratory clinical tour china iqr inpatient record group interpretation volume interview setting trace mode country enhanced field company contact local obtain expect disease 2 link case sars-cov-2 restriction transmission cluster investigation funding identify conference open high widespread 2019 covid-19 2020 epidemiological interaction gather community institution medical february period wuhan minimise singapore confirm lockdown methods church', 'government virus 1 equally especially old begin stage life march control india-as article successfully bpl 23 mitigate/neglect poverty culminate threat simple measure huge different spread health respiratory population consider line develope effective die problem 22 time country insight disease world livelihood case worry india carrier easily visionary seven reach dense precautionary owing despite long affect 360 covid-19 2020 treat age community incorporate attack nation till strategy', 'past virus research define carry -unaffected conclude relationship histological postweaning ß rapid pcv2 change 43 grower database associate hairiness cause knowledge pwm little sensitive 2 porcine node t 375 sample association 113 covid-19 b remain right presence herd pmws mortality titre consider data active free circovirus antigen vary know repository study epidemic similar r long affect current fund herds co-factor analyse significantly giant analysis farm 2004 cell sign pmws-affected syndrome covid postmortem indicate 23 pme pig lymph histology healthy clinical multisystemic ubiquity result -recovered publish time s sufficient unrestricted original disease lack examination coalescence present sick centre waste c high investigate mean cross-sectional specificity re-use breakdown acknowledgement definition elsevier source base pallor 10 euthanased necessary linking useful resource approximately form germinal absence highly british test serum publicly occur non-linear space sensitivity grant antibody score age diagnostic death range infectious role', 'acknowledgement counterpart intermolecular conformation monomeric research newly covid structure unit identical elsevier source swap special intramolecular chain different primary oligomer active resource database free close form multimers repository unrestricted domain-swapped interface protein quaternary oligomerization contact original case surface hinge domain publicly distinct state monomer centre type homo-oligomeric closed/primary switch functionally constitute open grant region long possess covid-19 loop fund alternate remain mean homo-polypeptide morpheeins create secondary re-use so-called adopt right open/secondary analysis exchange', 'virus mouth considering infection adoption visor develope protection surgical aerosol cause 9 check major preventive outbreak water-resistant discuss exemplify hospital staff symptom hong n lamp covid-19 treat clinic outpatient adopt route datum presence practice department droplet anecdotal \\ufeff1 kong chlorhexidine risk mandatory notdeferrable p spread conjunctival possible 5 2006 exposure addition ii know hygiene rapidly eye diagnosis study epidemic similar ophthalmologic transmit strict far day represent wash u conjunctiva recently controversial r affect current potentially doctor review contain surgical/n95 f strategy alcoholic gown possibly furthermore prevent 3 e ophthalmologist ophthalmology goggle ophthalmological academy measure follow nose nonpeer-reviewed regard template potential american infect handrub contact cohort disease pandemic sars-cov-2 attend proximity state l examination sac nature iii implement 7 patient o wear public mask j confirm emergency retrospective recent protective contract evaluate especially date 6 -p glove shield slit medically hand sars-cov2 tear sars installation frequent highly world case ophthalmic transmission face 8 differential suggest conjunctivitis guideline good deal serve respirator aao infectious role implication recommend', 'illness severe percentage presence find possibly numb coronavirus fragment infection indicate hcov-hku1 member include unrecognized 251-bp novel agent assume sequence respiratory possible discovery human previously certain require chapter causative associate cause harbor know family degenerate sars rt-pcr describe disease detection primer-based gene common tract etiology characterize coronaviridae present polymerase viral amplification low screening detect remain pancoronavirus method relatively mild range allow unidentified recent hcov-nl63 cold', 'post severe concern virus early molecular novo coronavirus opportunity research safe de positive syndrome infection control acute genome complete novel chain kit sequence health respiratory synthesis useful pair template cause pcr advantage diagnosis sars urge outbreak fragment highly obtain strategy world gene test development far protocol identify assay polymerase access viral reaction efficient good diagnostic organization primer complimentary reliable restrain provide preparation work', '', '', 'acid mers-cov severe virus evaluate coronavirus specifically amino difference structural structure conclude genome glycoprotein prevention bast complete aim change epidemiology sequence 11 different respiratory require health close mutation authority onset cause nucleotide prevalence protein study highly disease sars-cov-2 lack symptom present type term zoonotic 7 viral treatment select 2019 mafft covid-19 alternation sars-cov caution create gap software determine overview conduct corona preparation variety', 'iso-flo mouth research oxygen wheeze leukocytosis additional complete refer north respiratory notably eklin database male respectively thoracic breaths/min note survey 2 hospital animal therapy anesthetize initial sample presentation covid-19 ferret remain maxillary likely mild heart right collect painful lethargy 1 l/min possible 5 active free alert 1.5 arrhythmia expiratory 98.6 repository soon admit spleen university ° enlarge illinois teaching auscultation urbana long depress fund 42 biochemistry radiography caudal f radiograph analysis count 3 end-inspiratory covid inappetance edr6 isoflurane adjacent usa cranial clinical plasma cbc whole-body condition unrestricted sinus original gingiva laboratories chicago examination present centre il gingival castrate blood patient ml 1.24-kg maintain detect based pain mean strain re-use manipulation abnormality history palpation acknowledgement system 250 beats/min leave estimate elsevier source veterinary veterinarian facemask submit resource 4-week form physical temperature erythema reveal cavae abbott inquisitive swell abdominal canine publicly test digital vena week grant rate 18-month-old effort score hyperglobulinemia diagnostic finding urinate/defecate induce body quiet', '', 'acknowledgement fdama amendments fda 2012 congress 1997 requirement research expedited covid elsevier source include measure synchronize process life-threatening 5 active resource database free thing time form modernization repository approval authorize condition fd&c unrestricted fdaaa drug eliminate original innovation 2007 publicly safety centre establishment regulation grant recently long amend covid-19 fund inception biologic remain modernize mean review act re-use mechanism right analysis fdasia', '', '', '', 'system department coronavirus write oncology ensure operation care risk continue measure develop novel stress health develope radiation highlight outbreak expect pandemic test switzerland ongoing perspective identify unprecedented brief mitigate 2019-ncov worldwide challenge', 'acknowledgement 2015;51(11):590 arch research e covid elsevier source active resource database free bronconeumol form repository w unrestricted original publicly l centre c u n grant r long o covid-19 fund b remain mean h re-use 597 g right analysis', 'acknowledgement severe 1 coronavirus research ci difference covid elsevier source standardized active resource database free value form repository unrestricted confidence ctni original disease smd publicly troponin centre patient grant long 2019 covid-19 fund remain mean re-use interval right cardiac analysis 95', 'severe small virus research antiviral phenotype acute minimize screen rapid molecule line respiratory discovery expression rna develope causative set-up associate inhibitor reduction c12344 protein hazardous assay express minimal sars-cov. gfp valuable mechanism facilitate plaque risk novel agent copy mutation accumulation study confer hit read-out activity replicon validate cell syndrome replication tool compound involve anti-sars-cov 7 based sars-cov demonstrate manipulation confirm reduce anti-sars therapeutic system generation numb coronavirus inhibit essential automate identification high-throughput sars drug absence resistant development identify 7035 viral good replication-dependent target live subgenomic', 'acid severe classify find virus ratg13 enter reservoir infection locate structure acute subunit carcinoembryonic pathway cleave bat polyclonal molecule respiratory sequential 25 causative 97 cause 9 respectively 31 attachment nucleotide ntd largely 21 century outbreak protein 1a little peptidase two-step 2 animal mainly s1 cov trypsin-like 28 zhou www.nature.com/naturecommunications arabia adhesion activate protect angiotensin-converting furin 32 s2 covid-19 b relate remain discover yunnan determine convalescent 1 receptor-binding lineage spike closely 76 hat stable novel covs agent consider 20 prime fold transmembrane portion antigen recovery 22 know biology s. isolate critical cave study share 14 middle n-and hace2 site hepatitis kda independent recently pikfyve 2019 delta-cov pseudovirus saudi fusion 24,25 mcea-cam1a mediate 15 activation sl contain membrane renal endocytosis variety analysis 29 endemic 2012 cell alpha-cov n-terminal depending 74 16 tmprss-4 30 amino newly syndrome recover 23 availability vaccine convert beta-cov sequence protease genus plasma result host 1234567890 identity angiotensin potential c-terminal lentiviral 3,4 s 2002 oronaviruses infect phylogenetical pseudovirions 858 disease 5,6 12 180 t62 trimeric sars-cov-2 4 l elusive enzyme present c type propose zoonotic cathepsin patient 7 airway demonstrate sars-cov 8000 wuhan 19 mers-cov. strain trypsin 293/hace2 beta-covs 17 confirm typical anti-sars susceptibility camel dipeptidyl mers-cov 13 system class intermediate coronavirus begin inhibit emerge mhv serine main glycoprotein include 10 96 18 require bind human dromedary protease-2 model china east 26 27 2003 cdomain tpc2 90.1 sars drug currently reveal sars-like limit 800 cleavage case homologous c-domain serum development domain monomer tmprss-2 hdpp4 mouse identify cross-neutralization palm pneumonia 2013 viruses viral 8 entry antibody suggest neutralization pseudotype neurological beta civet 2494 end target serve sl-cov. promote receptor gamma-cov death enteric late rbd', '', '', '13', '', '', 'acknowledgement homeostatic furthermore cell pathological freely understand research locate covid strategically localization elsevier source microenvironment organ direct ability different population active resource database free chapter form lane repository condition unrestricted unhealthy eliminate original confer nk bekiaris publicly order exert centre anatomical place stimulus grant peter long covid-19 current fund migration remain response mean j.l. re-use vasileios receive overview effect provide right migrate analysis', 'similarly obstruction end-diastolic find research carry ctpa acute rved/lved minimize pte database food recurrent tendency compared mg/2 normalize ndings little 0.6 2 pulmonary 14.8 therapy t approve support dosage n treatment covid-19 50 treat event remain vs tomographic weight international ecombinant h determine 53 65 h. right safety hemodynamic inr dysfunction risk effectiveness cacy p adverse agent worthwhile 5 thrombolytic active free diameter regiment rt-pa thromboembolism dose-dependent repository lung rvwm hemorrhage registration similar maximize signifi complication scan ventricular defect parasternal r long 254 fund plasminogen 15 100 min 118 analysis exhibit improvement effi 3 angiography multicenter covid bleed long-axis instability kg perfusion regimen assign die result identifi group clinicaltrials.gov angiogram conclusions unrestricted optimal original ventilation pressure spap commonly echocardiogram fi benefi centre randomize activator patient chest er mean important arterial trial 1,2 re-use receive conduct optimize methods true acknowledgement evaluate especially 6 leave elsevier source prospective observe include 10 fatal intracranial ct rvds abbreviations resource nct00781378 mg/kg form massive 41.2 results notion recombinant ratio currently .049 systolic ich recurrence v/q movement publicly compute artery dose progressive tissue-type grant randomly importantly wall death range body view rvd', 'acknowledgement weakness research covid ineffective elsevier source nurse active resource database free form repository inactivity hypothermia unrestricted original publicly • centre 1126 grant long signs covid-19 fund remain mean crying re-use right key analysis', '', 'consolidation objectives infection fourty-seven opacity 61.7 node pulmonary 47 § lesion term covid-19 distribution round subpleural bronchograms peripherally retrospectively normal resorbed ggo radiologist crazy-paving lung fifty-three 63.8 day enlarge distribute patchy independently 2019 effusion peripheral 88.7 bronchogram feature follow increase lymph involve stripe 6.2 infect mediastinal pattern 24.2 disease predominantly 11.3 examination present patient image 78.7 chest 40.4 area 59.6 confirm interval ground-glass methods analyze evaluate coronavirus 93.6 70.3 observe include ct 75.8 2.9 76.6 results case infiltrate average undergo 62.3 conclusion pleural air thirty-three finding materials thin-section rationale 89.4', '】 improvement coronavirus team assist infection article control prevention management quality screen measure refine disinfection summarize hand 【 abstract develope result effective hygiene professionally information general family perform communicate 40.78 improve experience epidemic disease hospital accuracy staff supply compliance far 2019(covid-19 implement technique patient word rate acquire non-isolated theory objective covid-19 doctor based audit wear epidemiological standard effectively medical area 100 gridding mask history systematically key methods 73.79', 'abbreviate practice oncology provider utilization infection risk measure consider proportion resource appropriate carefully balance volume radiation breast account radiotherapy evidence-based constraint omit pandemic sars-cov-2 present contemporary widespread patient effort significant covid-19 community guideline oncologic cancer mitigate anticipate infectious optimize set', 'virus department droplet city coronavirus numb especially formally emerge infection control examine risk screen feature prevention novel aim ct spread health radiologist tomography summarize clarify effective china tentatively rapidly laboratory rise diagnosis infect reports guide month diseases contact experience december january world case etiology examination state order compute personnel transmission cluster identify pneumonia patient recently image 2019 covid-19 2020 trend demonstrate organization discover wuhan method 2019-ncov technologist medical confirm reduce radiology radiological', 'severe molecular stage infection acute enhance respiratory rna lancet sensitive sars-coronavirus 2 cov sample assay modify low 50 routine technology collect quantitative illness 1 \\ufeff1 background novel agent design onset 22 pcr diagnosis signal study negative nasopharyngeal day modification combine protocol recently 30 3 syndrome 361 subsequently time disease 80 apply patient conventional objective sars-cov confirm optimize specimen generation early positive evaluate coronavirus control observe real develop 11 44 serologically 40 2003 rt-pcr á/3 sars results currently npa detection conclusion extraction test available aetiological identify sensitivity viral 1319 real-time diagnostic greatly method aspirate samples', '', 'highlights exhibit virus infection saliva bronchiolitis replication acute direct abstract graphical feces infect naive temperature contact urine lead transmit sars-cov-2 wash sars-cov-2-infected ferret effectively nasal elevate body shed', 'interest conflict authors declare support financial study', '', '', '', 'bat-borne severe fatality virus classify safe vlps research life antiviral infection structural acute envelope screen enhance line respiratory delete expression egfp rna polyprotein 25 nsp13 causative associate replication/transcription inhibitor cause 8422 complex 9 country encode nsp8 attachment major outbreak protein superfamily 21 in-depth inc. 2 genetic animal single-stranded 1-like mrnas virus-host helicase n treatment region successful significant relate remain distribution poorly discover bsl3 determine phylogenetic blot right singlestranded possess nsp16 illness mature 1 spike mortality nsp9 \\ufeff1 threat achieve nsp15 risk genome virion transcription novel covs agent tropism spread process 5 continuous 20 previously different replace network 22 know rapidly cysteine non-structural nsp1 cycle study epidemic evident reemergence 14 reverse gene rna-dependent characterize far ó nsp12 particle recently clone ban fusion mediate 15 nsps contain bac -see 291x/$ significantly membrane effect analysis e-64d activity replicon pathogenesis nsp14 cell kill 16 province 3 e syndrome fluorescent establish replication member replicase uridylate-specific complicate 23 rdrp construct fluorescence ribavirin specific sequence cdna health synthesis assemble 24 full-length host diversity group reserve potential desirable s 2002 infect [2002][2003 green 0 matt exonuclease laboratory 12 resemble rest tissue arise trade 4 coronaviridae -o-ribose group-specific wild elusive technique 7 patient warn regulatory nsp interaction public detect based sars-cov demonstrate nucleocapsid 19 2b vitro 17 confirm conduct m morbidity recent 0.4 wide non-canonical virulent 13 system 29,700-nt positive believe understand coronavirus especially proteins inhibit 6 control main isolation code essential elsevier base 10 include difficult and/or 11 biosafety retain necessary 18 guangdong human function 0006 china orf1b handle 26 polarity family endoribonuclease sars overlap drug artificial rna-binding observation 2008 reveal sars-like absence highly two-thirds bacterial responsible previous deletion 916 polymerase western rsars-cov-de nsp2 viral rate face 8 efficient chromosome serve orf1a methyltransferase end element proteinase non-infectious remind vector subgenomic replicons impossible mg/ml range finally late infectious level fully', '', '', 'correspond prevent province oncology compile infection anti-cancer prevention management specialist interventional consensus summarize china inpatient time diagnosis critical tumor operate expert cross-over organize particular association patient point treatment region covid-19 branch hubei focus room reduce outpatient', 'virus find classify variation adjust define march infection panel year-to-year 43 respiratory rna develope associate cause 1960s 9 1.75 compared 21 sensitive hcov note upper january 2 72.1 assay association reaction 281 influenza-like 229e 0.67 determine likely mild 5.9 outpatient thailand rural cold illness 1 \\ufeff1 p 5 recognize 1156 hku1 confidence study hcov-oc43 tract combine recently mid epidemiologic 0.26 infrequently year 30 .40 epidemiology 2.3 513 genus september result hcov-229e conclusions august 12 odd 4 734 coronaviridae type 7 patient detect important strain interval 2005 methods influence 2.1 coronavirus reverse-transcription 6 control 93.6 10 11 chain positive-stranded human hcovs 1.8 2003 rt-pcr family results ratio prevalence envelop oc43 common occur responsible compare available polymerase pneumonia nl63 asymptomatic identify 8 real-time hospitalize seek 95', 'prime highlights cell sars-cov spike sars-cov-2 host offer protection receptor tmprss2 ace2 antibodies protein entry', 'transpire team opportunity pose enhance natural leadership develope surgical professionally setting cover experience prepare navigational hospital 2 curriculum unique covid-19 plan multiple exceptional nation walk topic safety 1 closely ensure adult care encounter resident different teach disaster previously physician-patient stay onset skill personal lose day circumstance word personally current institution review organization rationalization program professional bring uncertain allow strategy normalcy provider socially wellness residency measure follow priorities health completely academic door cohort academically pandemic faculty enterprise urologic technique implement patient emphasize future mean social area challenge uncertainty immediate believe forge early understand numb especially child continue necessary undoubtedly handle ohio distance insight hope framework describe action quickly limit theme transition greater order face reasonable guideline importantly serve live method akron concept grow range provide level', 'severe virus find infection acute immunofluorescence screen high-risk respiratory antigenic knowledge etiological hcov staff sample assay intensive 50 229e reliability q nosocomial 0.5 2028 care novel agent recognize routinely know diagnosis improve study hcov-oc43 reverse four-year recently year application 30 cell incidence syndrome unit member epidemiology involve clinical neonatal group hcov-229e perform tissue pediatric high ml technique epidemiological detect demonstrate reliable specificity specimen culture numb coronavirus child human hcovs currently methodology transcription-pcr-hybridization dose available sensitivity viral infective hospitalize newborn', 'twitch acknowledgement system weakness reciprocally research travel nervous covid and/or fast elsevier source head innervate coarse increase active resource database free amplitude result associate tremor form distance repository disorder fine unrestricted original disease cerebellar rhythmic diffuse movement publicly body • twitching shake centre 852 slow antagonistic synchronous differ grant long covid-19 fund involuntary alternate remain contraction mean peripheral usually frequency muscle re-use oscillatory right central analysis decrease', '', '', '', 'similarly find stakeholder korea aim network form framework improve outbreak describe self-interestoriented letter national shift covid-19 response nation neighbor shared-interest-oriented emergency key', '', '7·4 severe virus 5·2 infection swab acute natural assess rapid respiratory rna origin respectively 31 laboratory biological two-step pellegrin 80-year-old upper 2 hospital symptom sample dissemination jan low covid-19 multiple 48 h illness failure 1 \\ufeff1 young paucisymptomatic background paris titre novel different diagnose copy onset series load relevant admit semi-quantitative obtain urine 14 university advance contribute persistent tract nasopharyngeal day 2019 2020 systemic 46 year strategy chinese dec 30 exhibit cell 3 province discharge syndrome refrigerate recover feature bernard daily procedure follow clinical 24 woman plasma die interpretation infect pattern worsen evolution europe disease illustrate sars-cov-2 80 man type cluster progression high blood patient bichat-claude france hubei wuhan 19 comprehensive confirm history methods decrease feb detail believe understand coronavirus travel control isolation mid-january organ 10 titration china rt-pcr ship stool describe detection case extraction bordeaux responsible pneumonia log viral despite implementation efficient age real-time admission finding secondary 1000', '', 'transfer 01 stage host-directed 0.55 respiratory male associate 9 respectively 31 1.06 upper 4(2 t therapy symptom initial sample 86.3 intensive covid-19 50.6 likely mild 65.7 radiological 16(12 care p cvoid-19 20 onset pcr improve 14 patients negative tract v.s. day hospitalization independently u logistical r long 100 multivariate 126 significantly year cis analysis 215 count application cell fever improvement old discharge median replication 0.0 unit symptomatic 235(94.3 increase clinical prognosis conclusions s 0 pattern majority 12 delay 154(94.5 progression 7 patient enroll image duration 51 aggravation interval early control estimate essential observe 10 cells/ul 11 163 clearance results y ratio cd4 case test occur compare viral odds 8 suggest age icu confidential 249 admission total reverse-transcriptase late 95', '', 'consolidation n=56 bronchodilatation infection locate vascular opacity reflect lymphopenia 89.2 associate covid-19 multiple 2019-ncov variable subpleural presence n=69 n=29 ggo novel complaint crazy-paving tomography involvement dilatation breathlessness series critical mild/common-type 60.2 n=12 n=83 halo septal interlobular 2019 effusion summarise review 91 p<0.05 sign old 12.9 feature 93 aim clinical n=21 severity information infect disease 36.6 present centre high patient image chest n=44 appearance abnormality lobe n=8 ground-glass methods 8.6 understand coronavirus 22.6 heavy/critical include ct n=34 results thicken sieve-hole temperature tightness case conclusion common pleural compute recognition 47.3 74.2 extent age materials 31.2 body level', 'severe find infection acute relationship pose temporal respiratory lymphopenia (il)-6 respectively major etiological interleukin little 2 pulmonary characteristic symptom lymphocyte presentation treat response elevate 1 threat novel agent 5 know spectrum load sars-associated study lag contribute far day subsequent 3.5 overwhelm strategy dehydrogenase peak nadir count incubation fever sign 3 proinflammatory syndrome median replication ribavirin follow density health clinical effective information dyspnea disease il-8 4 progression sars-cov important period cytokine reduce therapeutic wide believe coronavirus 6 emerge probable lactate 10 sars case infiltrate immune viral 8 finding range provide infectious worldwide level', 'protective acknowledgement http://dx system research covid ras elsevier source arm active resource database free form repository unrestricted original publicly centre grant long covid-19 fund renin-angiotensin remain mean re-use right analysis', '', 'fda research summarize population chapter database food intend complex experience therapy product covid-19 production remain tremendous right recommendation seriousness investigational risk consider agency recognize active free reassess cell-based manufacture repository study applicable administration sponsor long current fund incorporate program variety analysis cell gain covid clinical continually potential unrestricted field original disease centre update cellular mean feedback trial re-use acknowledgement benefit date elsevier source include base factor resource flexibility form entire drug describe advise test stem publicly development grant biologic target characterization grow', '', 'acknowledgement prevent opportunity research urban approach covid whole-of-society risk elsevier source spread misinformation unconventional dis active resource database free communication business associate corporation lancet challenges form information preparedness repository setting infect unrestricted continuity epidemic quickly original lead channel disruption engage greater businesses publicly far characteristic centre false grant economic growth medium long covid-19 2020 fund plan remain multiple mean social reliable re-use stability table right analysis activity', '', '', '', 'pan-coronavirus virus magnitude approach infection inhibitor v. müller cyclosporine/fk506-nonimmunosuppressive a. fkbp animal cov t low b non-immunosuppressive collectively c. alisporivir background 2011 novel m.a. s. von gene fk506 qpcr cypa recently cyclophilins growth r drosten j. strategy plos analysis cell prevent pathog nim811 replication cyclophilin derivative effective result host concentration hcov-229e s micromolar strongly c inhibition cellular demonstrate sars-cov caco-2 interactome therapeutic diminish hcov-nl63 culture carbajo-lozoya coronavirus uncover inhibit csd require thiel human identification knockdown brunn drug block order available viral suggest urgently good noncytotoxic target cypa/ppia sars-coronavirus-host kallies provide csa level', '', 'acknowledgement virus molecular 3 research covid elsevier source active resource database free human form repository tertiary unrestricted study original university hospital publicly centre type grant parainfluenza long covid-19 epidemiological fund remain mean re-use right analysis', '', 'acknowledgement presence paralysis 1 research define dysfunction covid normal plegic elsevier source complete ability imply active resource database free function video loss form limb repository unrestricted paraplegia original -ie movement confuse doe generate publicly -should paresis centre word grant long reflex covid-19 motor fund voluntary affect remain mean re-use spinal reduce right analysis activity', '␣ reservoir infection acute participate line respiratory associate mononuclear hcov monocyte pulmonary cxcl11 dissemination activate assay production central pro-inflammatory mmp-9 spread recognize hcov-oc43 persistent peripheral activation cns cell leukocyte tnf- indicate replication follow increase chemokine involve taken result host potential hcov-229e infect disease lead motility thp-1 cxcl10 tissue strongly blood investigate productive restrict pathology vitro susceptibility mediator system susceptible ccl5 coronavirus nervous chemotaxis exacerbation include primary pbmc leukocytic human monocytic viral suggest good serve vector monocytes/macrophages', 'virus dead-box find antiviral structural coronaviruses rna expression dual nm replication/transcription inhibitor respectively mononuclear nsp8 complex protein little fibroblast 2 poliovirus cov assay helicase n 50 mrna determine mechanism datum 1 plus-strand silvestrol rhinovirus ribosomal different internal 20 pbmcs eif4a-dependent know lung nonstructural critical pathogenic 1.3 pv mrc-5 represent site (ires)-mediated recently ec peripheral 100 translation effect strategy cap-independent picornaviridae activity broad-spectrum furthermore cell 3 a1 indicate specific measure compound taken genus value species potential iresmediated hcov-229e infect enterovirus plant strongly type eif4a high blood formation investigate virus-infected macrophage confirm mers-cov analyze cov-infected inhibit employ primary require human initiation capdependent family potent highly reveal picornaviruses hrv viral luciferase entry ebola cap-dependent embryonic 5′ role', '', 'acknowledgement 1 1997 office research epizooties 16 covid risk elsevier source prevention health active resource database free oie form repository scientifique unrestricted original des revue contamination 2 animal publicly centre technique grant product long covid-19 public fund international remain mean re-use right analysis', 'dog analyze find luan spike research hamster infection article include residue cat/dog/pangolin/chinese health recognize close human pet model design host sars-cov/sars-cov-2 cause potential biophysical https://doi optimize ace2 s insight protein interface contact strategy global simulate pangolin sars-cov-2 m82 biochemical t communications c recognition mammalian identify predict association provide cite select r covid-19 public b mammal interaction remain sars-cov n82 important sars-cov. receptor cat j. range emergency recent key homology circetidae', '', 'severe find 244 research approach infection acute head participate respiratory country example entity survey hospital association actual point treatment harm significant covid-19 plan international distribution nation italian department promptly heavily severely ensure \\ufeff1 coronavirus-2 cipomo care risk service novel possible telemedicine share epidemic obtain represent word 2019 affect start dei containment community fund year cooperation set activity count syndrome continuum member collegio aim measure follow proactive well-delivered health way italiano clinical italy triage thank potential outweigh europe disease safely medici device pandemic diffusion delay present oncologi access implement patient national public primari important basis emergency work protective overall non-urgent oncologists evaluate oncology benefit midst territory anti-cancer homogeneous china problem physician 122 impact results hurdle preserve global visit oncologist investigation face fundings suggest implementation oncologic end serve cancer sarscov-2 promote', 'acknowledgement research covid elsevier source assess specific disclose useful factor active resource database free clinical form bacteria organism repository isolate unrestricted study viability original bacterial antimicrobial test salmonella publicly intestinal isolates characterize genotype property centre cultivation grant long covid-19 eg fund remain mean target epidemiologic method metabolic virulence re-use valuable allow susceptibility right analysis specimen culture', '', '', 'acknowledgement storage 1 research transplantation aorn covid mandatory elsevier source accreditation include store november active resource database free effective organizations issuance record commission aspect form repository unrestricted implant policy original hospital july tissue publicly apply • order 814 centre healthcare allograft grant long covid-19 fund remain receipt mean 82 standard 806 program re-use j 2005 right analysis joint standards', 'highlights datum cell virus understand coronavirus define approach prediction probability summary include vaccine rapid tool novel covs specific sequence spread reflect require best-characterized resource database abstract design parallel effective identification potential graphical information conserve promise iedb bioinformatic priority monitor little emergence priori sars-cov-2 development experimentally t facilitate immune recognition identify predict high available term independent expansion region 2019 epitope catalog b relate multiple sars-cov countermeasure response target implication immunodominant bioinformatics recent analysis homology similarity', '', \"pancreas de infection change ଝଝ cancer-colon hcps la complex rule selon add discuss 2 hospital données surgery-go hepatic lesion modify phase tncd covid-19 pages undertake practice comparison mortality \\ufeff1 tuech risk maganement direct alternative exposure j.-j. epidemic des strict advance incur advisable reach neoadjuvant adapt chemoradiotherapy organization objectif propositions question professional oncological au nb allow rectal peak circuit prevent indicate covid les follow pancreatic-is chemotherapy charge balance time littérature french situation optimal double laparoscopic surgeon pandemic state 4 ଝ type update propose chinoise high patient épidémique probably ahead period strategies carcinoma-morbidity judicious 19 en reduce emergency morbidity digestive system tumour 6 and/or base paper colonic t1 fonction wait defer prise impact t3 priority advise mortality-oesogastric loom compare healthcare n+ expose functional rate l'expérience hepatocellular short n0 speaker cancer oesogastric digestifs surgery radiotherapy\", 'molecular research infection complete respiratory close database develope cause little 2 genetic according t sample point 113 region covid-19 b relate remain sub-cluster phylogenetic collect right america datum 1 closely \\ufeff1 genome different active previously free repository study bcov hcov-oc43 numerous genotype distribute derive r long current fund partial analysis exhibit 16 3 covid genbank vaccine monophyletic epidemiology sequence time group french s pattern unrestricted original europe constraint status bcovs centre c widespread detect france mean period strain evolutive re-use stability relative acknowledgement 13 influence coronavirus bcov. main elsevier source include attenuate hcov-oc43s bcovs-like resource human comparative 2003 form 2014 describe frequent reveal world sub-clusters oc43 publicly compare 11-year evolutionary available grant cattle prototype recombination normandy method bovine enteric asia', 'evidence covid-19 healthy woman case present 30-week pregnant deliver baby', '', '', 'acknowledgement application cell broaden selection research specifically antiviral transplantation emerge covid overcome care isolation elsevier source aim summarize virus-specific useful active resource database free abstract clinical result time briefly form potential repository drug unrestricted original strategy hematopietic limitation hematopoietic stem publicly t complication allogeneic immunotherapy-in centre therapy-has technique viral grant recently treatment long covid-19 current fund remain review mean adoptive standard method trial focus t-cell re-use technology particular right analysis', 'globe severe surveillance-control find surveillance instead life approach carry infection acute assess alessandro opinion estimating respiratory population develope cause 9 setting country particularly month outbreak traditional discuss objectively december little survey 2 truly threaten try pu support funding n phase covid-19 b freedom milestone manuscript es output 1 risk simulation p consider spread 5 active proportion sector design hypothetical proposal revise critical confidence improve epidemic similar inform applicable contribute far represent protocol cut-off u word -iversen recently parameter r 2019 adapt produce community fund randomise ellis review contain repeat f manusc set collaborations frequently application 3 write e syndrome tp responses justification recover authors daily internationally individual symptomatic follow aim health n2 clinical johanne economy regard draft time information infect field contact disease pecially 12 mitigation limitation decision pandemic juan sars-cov-2 status 4 l random pre-proof absent present c prioritize randomize apply propose imperfect consistently 7 perspective immunity o public objective detect decide important control/management timely area reliable j receive true work system susceptible positive evaluate coronavirus begin pfree understand accompany emerge control estimate 6 -p article base veterinary 10 paper 11 literature useful human china identification tracing trace general strengths action prevalence \\uf0b7 ript limit world variegate style detection case test occur lubroth manner statement journal resolve 8 effort antibody short appear idea materials method foddai generalization systematic substantiate death concept worldwide level', 'acknowledgement http://dx system research covid elsevier source respiratory active resource database free form repository unrestricted infections original publicly centre grant microbiology long covid-19 fund remain mean re-use right analysis', '', 'research acute relapse head expression wane database food la abstract.-multiple cause laboratory reduction suppor implicate genetic relapsing-remitting environmental wax interferon43 generally treatment covid-19 evoke remain variable right subacute 1 betaseron ms care management neurologic agent immunosuppressive active free onset repository diagnosis attempt interferon-13 administration cyclophosphamide long fund frequency autoimmune resonance year approval analysis pathogenesis adolescence covid puncture symptomatic corticosteroid clinical sclerosis magnetic adulthood course severity potential unrestricted original disease lumbar examination nature present centre ongoing progression copolymer investigate image mean re-use abnormality conjunction reduce spine acknowledgement believe evaluate begin u.s. elsevier source include base factor resource problem form general drug observation highly test publicly chronic grant azathioprine late', 'severe virus partially locate locus acute additional envelope measurement complete special respiratory expression conserve encode conductance protein localize compartment homo-oligomers entitle open express networking yeast production endoplasmic act collectively possess spike sirna inward regulate different canonical previously addition explore ergic study similar channel gene oocyte viroporin 3a evidence current orf4a monovalent contain membrane set non-selective activity furthermore cell cation syndrome indicate bridge hcov-229e accessory infect reticulum/golgi xenopus read issue cellular analogous demonstrate sars-cov based reduce decrease intermediate coronavirus truncate proteins li article -channels function release form ion frame disulfide reveal functionally suppress viral suggest finding orf', '', 'severe opportunity stage requirement oxygen approach antiviral acute respiratory major example 2 therapy symptom unclear phase covid-19 datum immunosuppressed \\ufeff1 care management background consider immunosuppressive glucocorticoid comorbidity involvement onset know lung preliminary physiopathological haemophagocitic characterize day transplant hemodialysis prominent inflammatory effect strategy viral-induced pathogenesis furthermore sign syndrome increase health clinical italy infect cohort optimal disease drugs)may anti-cytokines pandemic sars-cov-2 institute present 7 patient outcome therapeutic challenge system coronavirus especially employ 10 consensus clarify occasionally kidney manage brescia world development order progressive biphasic good provide', 'pathogenesis system virus analyze find evaluate coronavirus especially mortality early dysfunction infection pathway management attention stress data process increase synthesis long-term close effective identification prognosis invade cause damage potential lung electrophysiological hemodynamics studies disease storm great contribute mainly symptom maintenance myocardial patient hypertension treatment 2019 imbalance covid-19 hypoxemia renin-angiotensin inflammatory response timely significance stability mechanism induce therapeutic pay cardiovascular', '', 'operational respond strong 43 indicator reporting 81 associate country spar categorise outbreak local assessment 2 52 28 182 term region low covid-19 event international response party light datum 1 78 build risk background novel 5 vary capacity strengthen ihr 2018 collaboration ready index 2019 review analyse 60 readiness prevent security 3 indicate widely tool measure aim health effective relation interpretation regulations potential countries disease exist 45 state 4 high national place public detect emergency enable operationally understand coronavirus control essential findings include annual develop 18 function regional half highlight global 33 suggest infectious level fully geographical', '', '', 'severe cell prevent coronavirus partially inhibit syndrome infection indicate acute e6 replication phosphorylation pathway serine phosphatidylinositol pkc~ weak residue gsk-3h 18 respiratory (pi3k)/akt mapk result downstream associate inhibitor p38 vero phosphorylate sars kinase synthase signal protein study little disease decline hpi mitogen-activated k tract 3-kinase present glycogen activate threonine pi3 viral 8 low suggest akt apoptosis detect postinfection response sars-cov virus-infected target cytopathic 3h activation h slightly death effect induce infectious recent level', 'severe virus find acute respiratory notably hyper-immunized develope il-4 cause country protein node emergence significant b production sars-cov. t-cell uv-inactivated safety insufficient spike igg virion novel memory spread long-term recognize subcutaneously antigen addition immunize immunogenicity rapidly iga study inactivate similar neutralize reach restimulation long secrete purify humoral formula elicit furthermore cell kill il-2 alum syndrome vaccine lymph result anti-sars-cov tnf-a hydroxide il-5 augment high immunity cellular nucleocapsid sars-cov cytokine vitro history recent generation coronavirus observe proliferation aluminum require human regional gel ifn-c sars adjuvant candidate serum order mouse antibody urgently choose serve induce level', 'severe virus infection structural structure acute e6 subunit screen respiratory causative associate protein prepare 2 support n persist viewpoint s3 significant anti-n microarray anti-s antiserum presence 1 9b igg detectable novel agent antigen critical cycle study neutralize 7a 3a undetected synthesize convalescent-phase dominant activity rabbit 30 cell e syndrome vaccine individual specific tool result hypothesis vero s patient detect sars-cov m 13 uncharacterized react coronavirus 6 profile human marker sars recombinant monitor candidate 3b immunogenic serum development identify week anti-s3 antibody suggest good diagnostic putative polypeptide antibodies particular', 'illness coronavirus code genome complete rapid novel health respiratory mutation diversity cause perform outbreak eighty-six observation near-complete reveal evolution global world genetic sars-cov-2 deletion provide viral region evidence covid-19 public organization non-coding declare emergency analysis', 'small virus raise infection additional hcov-oc43-positive respiratory rna associate immunocompromise cause laboratory month sensitive hcov december little upper 2 sample 2004-november seven 0.02 assay association rnas low reaction significant vomit likely diarrhea illness datum 5.0 p 1-year 5 previously non-sars pcr 0.04 meningoencephalitis 2.4 study studies role possibility hcov-oc43 tract negative 1,683 evidence virology cns 3 colorado play epidemiology clinical healthy persistently potential 84 hcov-229e lrti 37 majority lead disease lower winter twice present pediatric patient investigate conventional detect period significance 17 2005 hcov-nl63 specimen positive evaluate coronavirus 34 numb child hcov-hku1 and/or nearly submit 11 chain human hcovs 26 rt-pcr hcov-nl63-positive test occur polymerase 41 twenty-six 8 seizure hospitalize diagnostic method 62 gastrointestinal death total worldwide', '', 'younger acknowledgement research covid elsevier source head intravenous corticosteroids femoral long-term active resource database free osteoarthritis exposure associate cause form repository infusion bisphosphonate unrestricted osteonecrosis rare original great instance common publicly site centre patient grant phenomenon long affect covid-19 fund remain mean nontraumatic re-use repeat significantly right morbidity analysis jaw', '', '', 'acknowledgement 34 research primate covid elsevier source active resource database free form laboratory repository unrestricted original biomedical publicly 561 centre grant long covid-19 current fund virology uses remain mean re-use right analysis', '', 'acid severe comparison coronavirus amino newly difference syndrome acute genome substitution 380 respiratory cause divergence sars pathogenic 2019-ncov. reveal sars-like in-depth identify functional discover 2019-ncov systematic annotation', '', 'severe virus life two-hybrid structural locate acute envelope positive-sense respiratory rna originate 209 cause helical outbreak protein little animal single-stranded 423 express n region unique yeast presumably relate bipartite southern spike core genome localization novel stretch involvement know isolate signal cycle share study gene kda clone fusion lysates contain 46 membrane distantly outer analysis homology exhibit cell furthermore e syndrome member sequence c-terminal infect s dimer wild self-association patient interaction nucleocapsid sars-cov nuclear important demonstrate coimmunoprecipitation confirm m atypical system coronavirus dimerization function human china 2003 form family sars phospho-protein envelop world serine-rich domain responsible property deletion constitute mammalian predict pneumonia viral suggest short civet amino-acid putative cat', '', 'severe molecular march infection acute taqman respiratory vietnam outbreak hotel genetic cov generate distinct characteristic assay reaction 360 50 determine hsr1 plaque italian genome virion agent addition isolate sars-associated similar reverse derive affect evidence transcription-polymerase 100 membrane analysis cell syndrome feature sequence italy full-length group vero infect infectivity 4 patient vesicle etiologic ultrastructural sars-cov genomic strain m recent specimen overall coronavirus travel inhibit pfu chain require approximately 2003 form sars heparin sputum inject identify pneumonia viral real-time biologic mg/ml provide hong-kong', 'molecular intermediate coronavirus infection summary novel bat spread involve human china identification originate host potential highlight infect outbreak month december quickly passaging global block case 31,000 collaboration type high zoonotic viral 2019 suggest international end appear wuhan 2019-ncov sentence death confirm emergency 638 analysis', '', '', 'crc virus molecular monomeric research infection heidelberg 1994 rna database 212 hanseniaspora 1987 press sm self-protection protein zygocin genetic herker induce dsrna ka medicine weiler applications ja tavantzis yeast covid-19 lethality remain doublestranded neuhausen reviews right fems killer schaffrath 358 zygosaccharomyces 221 active free 2006 1765 157 s. biology repository k2 uvarum berlin caspase-mediated bruenn 1772 microbiology r long secrete fund raton bostian 132 pp f analysis virology 111 application k28 cell 109 e covid 174 a/b concepts breinig 2002 unrestricted forestry microbial original 353 168 4 k1 nature agriculture centre mycoviruses 68 257 ustilago reiter fungus maydis apoptosis virus-infected mean mj toxins re-use j 2005 toxin-secreting m acknowledgement system 276 double-stranded ed cerevisia madeo elsevier source springer resource 26 form 124 family el-sherbeini publicly -a elements toxin journal viral grant schmitt viruses bailii boca fl', '2004 fems 30 virus believe coronavirus research 760 member novel fortunately assume publication onward population discovery human previously result 2006 species cause 2003 group hcov-229e family lung infect soon describe clear quickly disease introduce rev hcov-oc43 present c identify ample 773 despite microbiol sars-cov aggressive contain overview expel recent hcov-nl63 mid-1960s', 'disease travel medicine 1477 8939/ infectious xxx xxxx', '', 'consolidation severe 82.1 anti-tumour define 95%ci assess opacity 81 25 male develope associate laboratory dry largely suspect 21 protein hospital 28 characteristic jan intensive treatment covid-19 event medical 65.0 high-sensitivity hr=5.438 collect datum 15.322 mortality anaemia risk care background designate ： record 22 lung study hospital-associated 14 patients 1.086 hr=4.079 day patchy dyspnoea 2019 current 2020 hypoproteinaemia 50.0 15 multivariate year significantly analysis covid-19-infected furthermore fever c-reactive median unit 23 feature 25.0 follow increase clinical 89.3 regard group cough perform 75.0 condition cohort disease ventilation pandemic 46.3 type high 7 patient chest wuhan 17 confirm ground-glass retrospective 60.7 feb vulnerable 13 70.0 coronavirus date include ct require factor p=0.037 china 28.6 26 results univariate mechanical frequent highly common iqr:56.0 transmission 8 age admission cancer finding method lymphopaenia death 53.6 level', 'similarly virus raise research define adjust farmers 981 reflect respiratory heifers database associate advantage little survey dairy milk association 7,272 low 305 covid-19 stock production insemination remain dutch variable determine right http://dx datum 1 herd calve difference \\ufeff1 ensure young care management optimum assume active free repository preweaning study syncytial similar attempt cost between-farm rear economic long produce fund first-lactation regression 100 multivariate 2010 j. fca 992 deviation analysis farm dependent covid median 7,164 kg d. health explain 24 single-effect regard sci sufficient unrestricted original herd-level disease lower colostrum cow decision exist status centre waste house belong linear mean re-use consequence reduce relative vaccination acknowledgement influence analyze early understand heifer 305-d elsevier source base 96 mo factor minimum resource model manage form general feed first-calving account describe 143 8,454 average 90 reduced publicly development healthcare 86 available flp grant cleanliness age deviate mix breed bovine late level', 'acknowledgement agol research covid elsevier source active resource database free form repository unrestricted original publicly agol@belozersky.msu.ru centre v.i. grant long covid-19 fund remain mean re-use corresponding right analysis', 'presence system virus cell intermediate marrow coronavirus tether antiviral bst2 indicate decrease er-golgi enhance virion bud electron intracellular factor expression human plasma antigen result bone interferon-inducible release knockdown hcov-229e broad ergic markedly compartment block envelop 2 microscopy surface restriction occur exert immune stromal identify suggest production b 229e innate subject finding regardless component effect membrane analysis progeny', '', '', 'severe virus coronavirus 3 uv research syndrome conduct acute biosafety render novel heat life-threatening health respiratory material active nm glutaraldehyde acidic inactivation cause severity laboratory sars perform condition describe inactivate disease great ph world 12 formalin • ultraviolet c term viral treatment containment 254 kinetic efficient organization sars-cov bsl3 method non-infectious sars-cov. contain manipulation alkaline reduce 65 allow light level safety recommend culture', 'bronchitis tcov virus coronavirus 3 spike exposure reservoir emerge \\ufeff1 genomics importance source strains change sequence different material chicken turkey analyses replace comparative associate result group cause potential accumulation mutation pathogenicity cross-species pathogenic highly similar disease reveal lead nonpathogenic limit genetic emergence gene tract site transmission serotype coronaviral adaptive emphasize shift poult adapt diverge evidence recombination serve ibv determine likely enteric following conduct unidentified infectious directly upper-respiratory', 'severe find march acute pathway complete ability refer respiratory expression causative fas reorganization protein little erk adhesion activate n effector down-regulating cytoskeletal fak p53 \\ufeff1 genome novel stress agent monkey actin downstream c-jun isolate signal share growth independent affect activation homology activity exhibit cell n-terminal furthermore 3 syndrome member subsequently sequence mapk extracellular-signal-regulated up-regulating condition disease caspase present phospho-akt 7 patient apoptosis nucleocapsid sars-cov atypical jnk coronavirus paper factor down-regulated kidney 2003 family p38 sars kinase devoid absence capable mitogen-activated cos-1 mammalian focal pneumonia bcl-2 fibronectin prove induce level', 'transfer research priming resistance respiratory database protection lactogenic piglet respectively immunological little porcine animal milk covid-19 suckle neonate remain response weight lethal right plaque prior illness 76 young suffer memory prime 5 active free farrow 55 repository day litter post-challenge microbiology long produce fund systemic incorporate increased strategy [175][176][177][178][179][180][181][182][183][184][185][186 analysis covid survival unit 3.0 vaccine measure subsequently passive clinical 63 effective group orally unrestricted anamnestic correspondingly original prcv × ଝ centre high immunity yield female mean survive re-use non-primed pregnant reduce 2.8 offspring boost virulent challenge acknowledgement 13 coronavirus 6 control identical elsevier source veterinary 10 pfu 18 resource loss 2003 form establishing titer limit gilt 89 average occur publicly beneficial compare immune dose provide grant rate antibody extent efficient age secondary induce tgev pre-farrowing 95', 'severe n. infection acute e6 pathway cleave line respiratory rna intrinsic cause complex helical outbreak protein localize note cov express n correlation low transiently sars-cov-infected sars-cov. datum examine verify genome localization detectable designate novel different process proportion addition n-processing cycle study epidemic n2a cytoplasm persistent far moderate subsequent activation caspase-3 effect contrast elicit cell syndrome indicate replication nucleus specific residue 400 involve scenario result vero infect lead 403 caspase-6 caspase caspase-6-mediated type high apoptosis experiment nucleocapsid sars-cov caco-2 nuclear cytopathic induction transfect coronavirus pronounce and/or nearly essential observe lytically primary function model 2003 form sars titer observation reveal highly cleavage subcellular apoptotic viral a549 suggest good prototype serve induce', 'opportunity requirement research fresh supervise burden partially size relationship expectation head assess today ability screen federal change high-performance refer reflect flux chapter database managerial develope purpose local discuss strategic little metric 2 generate static personnel fact-finding operations point successful covid-19 subsection theft remain response senior routine incident programmatic right collect -the train burglary director datum department geography examine core initiate risk management competent service intervention law assume different 5 nonemployee active free organizations vary deputy -are repository extensive critical relevant improve skill expect administration executive far minor box hire criticality terminate enforcement combine organize circumstance protocol reach initially subsequent larceny long produce aggravated fund organization vulnerability program operating look year analysis set legal activity security improvement 3 creativity operation vehicle covid indicate workplace discipline deliver daily criminal attention aim measure follow creation value constant normally employee information managers perform 37 unrestricted situation operate original great exist fundamental twice state nature 38 centre type issue ongoing apparent 7 demand assault supervision chapters mean accord important services robbery re-use sensible basis history single competency conduct recent indispensable list work challenge protective acknowledgement contract 2.1 system believe recruit evaluate analyze begin think success successfully elsevier source position include automate measurable nonetheless require factor resource appropriate center loss problem identification parallel manage form budget entire dynamic manager input computer appoint collection occur publicly previous order development • nuanced 8) grant goal private brief reason reasonable trend motor dedicate serve generalization promote effectively create personnelrelated handling provide considerably', '', 'acknowledgement prognostic research covid elsevier source ability peritoneal process uid active resource database free value form repository unrestricted obtain original disease publicly centre grant long covid-19 inability fund remain mean method regardless re-use collect fl right analysis', '', '', 'find raise environment birth research allowance respiratory close database male 97 v allocate visual dairy 2 sniff animal environmental t unclear treatment low covid-19 50 remain response h heart right http://dx 110 1 housing calve \\ufeff1 5044 young p novel consider 5 active free holstein fearful repository study vp calf individually long affect pair-housed fund j. 60 effect analysis behavior unfamiliar calves 3 covid individual preweaned follow wk health clinical tactile time auditory feces sci unrestricted contact situation permit original centre house investigate behavioral female contrary subject mean social accord re-use acknowledgement concern 5035 date 6 belief elsevier source 11 resource pair form physical block latency positively test common publicly impair previous compare development serum grant rate antibody score age short vocalize level', 'interstitial virus research nonspecific pleuroparenchymal acute hhv database lip teno pulmonary ali reaction covid-19 remain affiliations right herpesvirus epstein-barr active free pcr repository lung iip b-immobilized hepatitis torque long fund nsip analysis cytomegalovirus ild covid polymyxin hcv fiber ttv connective column unrestricted original disease fibrosis tissue proteinosis centre c injury idiopathic lymphoid mean alveolar dad re-use pmx herpes ae acknowledgement pap exacerbation elsevier source chain abbreviations resource human simplex ipf damage form diffuse publicly fibroelastosis polymerase pneumonia grant hsv cmv ppfe ebv ctd', 'echocardiography relationship equipment evolve imply opinion north reflect disciplinary knowledge courtesy purpose completeness 2 accuracy doe protect durham readers express covid-19 event medical party scientifically-verified recommendation ase datum practice offer physician-patient sole urge university invasive personal primarily asecho.org protocol merchantability evidence contain warranty 3 carolina member procedure follow shall regard advice employee information american expert decision national patient non-invasive duke basis institutional protective reliance continue base source include society action liable constitute m.s. available statement fitness guideline deal create particular reference', '', 'sublocation correspond severe classification analyze molecular coronavirus antiviral mhv syndrome prediction acute physiochemical employ genome localization relationship vaccine motif novel agent sequence calculation segment respiratory transmembrane function different database previously alignment matrix result causative close associate identity group know isoelectric conserve distance sars experimental protein study determination aid development property subcellular derivated identify evolutionary point coefficient proteomics search coronviruses sars-cov weight extinction calculate bo-coy phylogenetic homology', 'virus fda molecular cross antiviral infection structural acute fast tenofovir measurement succeed respiratory rna anti-polymerase help breath cause respectively inhibitor country dry dock (mers)-each repurposing excellent outbreak fight hcov december acknowledgment prof. kind hcovs-severe shortness symptom 258,842 approve kauther support facility n treatment covid-19 setrobuvir treat international yang anti-rdrp prior keywords effectiveness p danger designate calculation different spread market possible previously addition stop mysterious promise tightly study obtain middle rna-dependent far day barrier guanosine high-quality u dr. r 2019 2020 malaise year f approval key fda-approved wael utilize validate 2012 exhibit fever toxicity e syndrome newly availability remdesivir mrs. rdrp specific ribavirin compound health derivative clinical result potential cough hui perform 2002 appreciate shaltoot disease pandemic 168 immediately sars-cov-2 l pre-proof seed high patient guidance o public wuhan 11,268 strain mention 19 trial significance j confirm galidesivir reduce declare emergency bioinformatics m work yak concern sofosbuvir coronavirus begin city specifically emerge main -p include idx-184 require bind human abstract china approximately east model 40 computational sars potent drug currently pheic 800 world elshemey test gtp previous animal-human polymerase aims journal pneumonia viral suggest target finding method death late distress', 'acknowledgement 1603 research covid elsevier source 1986 active resource database free 153 letters form toxico/ogy repository unrestricted original publicly centre 32 grant long 162 covid-19 fund remain mean toxlett re-use right analysis', 'severe coronavirus syndrome acute imaging play management g. novel 58 respiratory clinical follow-up cause time e. 2003 diagnosis sars highly disease pandemic status antonio present patient 825 image current short review important period 832 radiology infectious role', '', 'severe system cell 13 glyceraldehydes-3-phosphate find coronavirus syndrome control lysate acute variability base evagreen substitution agent different internal sequence respiratory material transcription-pcr pair abstract design ： revere concentration pcr extensive sars quantify infect results s-gene-specific etiological study sensitive dye detection genetic gene suitable evaluation 4 establishment mrnas term identify sensitivity n viral high select probe efficient real-time diagnostic supernatant sars-cov lysates crucial tm primer strain sars-cov. mrna facilited specificity dehydrogenase gapdh quantitative taqman-mgb culture', 'protective acknowledgement http://dx system research covid ras elsevier source arm active resource database free form repository unrestricted original publicly centre grant long covid-19 fund renin-angiotensin remain mean re-use right analysis', '', '', 'mouth research tie-on manufacturer run head assess hour database protection surgical associate aerosol 9 respectively dentists setting particulate dry aware highquality certify superior meter mold percent flow low significant covid-19 dentist remain weight calculate collect right datum spray away 0.5 p background different active free record repository study bicarbonate personal /hour mannequin separate represent independent long evidence fund dental implications analysis .03 3 gain covid up-to-date filter residue clinical efficiency effective kruskal-wallis conclusions perform unrestricted original surface porcelain centre patient place efficacy mean re-use mask relative single methods 92 tube acknowledgement 94 airflow control elsevier source 96 85 resource 40 form centimeter results currently 90 vaporization test publicly compare 86 grant face rate cubic respirator provide', '', '', 'acknowledgement research infection article covid immunology elsevier source active resource database free model form https://doi repository unrestricted original lin neutralize sars-cov-2 serum publicly centre cite journal grant microbiology antibody long covid-19 fund remain duration mean lessons q sars-cov re-use right analysis', 'darunavir virus find lopinavir/ritonavir antiviral infection mt-dti molecule 94.94 nm 113.13 complex repurposing protein deep drug-target interestingly treatment treat act dolutegravir 199.17 prediction novel pre-trained agent spread consider chemical design addition rapidly antiretroviral study transformer-drug ritonavir option component strategy 1,000 prevent incidence establish replication remdesivir compound follow lopinavir increase potency effective result medication sars-cov-2 lack interaction wuhan 336.91 list 3c-like hiv overall atazanavir kaletra coronavirus include commercially bind human model china drug inhibitory nm. learning-based 204.05 test immunodeficiency kd identify available viral rate suggest efavirenz target proteinase worldwide', 'acknowledgement research anterior vitreous covid structure elsevier source cloudy change active resource database free 1254 cause form eye repository unrestricted clear original transparency lens publicly • centre grant long signs covid-19 fund 61 remain usually mean smith richard ie cat corneum re-use chamber cloudiness mechanism right key analysis', \"mystery 2481 nod find hampe pancreas research cha clin gland invest database b. 9 31 28 32 dysregulation abnormal metab covid-19 remain -375 autoantibody organogenesis right 1999 1 comparison 108 \\ufeff1 adult initiate active free 36 onset infant -2488 s. neuropathy repository study similar 957 -162 -962 organize fetal diabetes shift long fund phagocytosis inflammatory nonobese 15 35 j. autoimmune t.l. 126 singh year glutamate analysis 29 30 cell -738 1997 2001 covid -38 361 d.l. neonatal kaufman decarboxylase 2002 unrestricted original kwa salivary diabetic horm centre type 7 patient immunity c.s. lymphoid murder mean 51 med re-use macrophage consequence reduce autoimmunity acknowledgement autoimmunoreactivity elsevier source fadok uptake exocrinopathy resource model 727 2003 form v.a. schwann delovitch infiltrate gad publicly development recognition immune apoptotic m.s. mouse b.a. grant 161 epitope nat receptor immunohistochemical brain o'brien phagocyte\", 'virus 34 coronavirus requirement evaluate high-level observe coronaviruses rna human rt-lamp develope copy throughput 40 causative 39 rt-qpcr capacity diagnosis perform 100,000 37 currently study colorimetric disease limit cross-reactivity detection case sars-cov-2 test 38 facility assay high 2019 instrument covid-19 low adapt detect potentially genomic method 35 100 epidemics confirm worldwide', '', '', 'virus find structure cleave molecule analog rna develope cause inhibitor complex conserve nucleotide encode protein little 2 cytidylate generate modify product rnas region determine solution cyroelectron 1 nsp15 denature novel mass recognize substrate non-translated uridylate non-structural study rna-processing hexamer microscopy separate nsp15-rna uridine affect 15 co-factor allow analysis mn furthermore 3 unusual two-dimensional base-pairing residue electrophoresis increase 8.3 preferentially disease enzyme based subject demonstrate content 1,2 basis å understand coronavirus emerge include spectrometry bind model gel form unpaired endoribonuclease sars highly cleavage crystal hexameric recognition 3′ affinity good competitive 5′', '', 'disease travel medicine 1477 8939/ infectious xxx xxxx', 'prevent fever find numb coronavirus department virus emerge syndrome member feature rapid measure novel epidemiology spread require ncip china briefly manage cough know rise dry suspect dyspnea purpose discuss highly december similar staff contagious precaution characterize far safety present personnel type transmission pneumonia patient image robust 2019 implementation covid-19 chest plan review fatigue wuhan finding focus death radiology worldwide variety covid-19-infected', '', 'severe stage respond march infection acute size change respiratory population help 97 respectively relax reduction stagger 66 outbreak local december simulate premature 2 phased-in term covid-19 response distribution seir flatten age-structured presence datum examine background novel intervention different end-2020 health-care matrix iqr vary epidemic parameter r 2019 affect adapt community look allow effect trajectory peak analysis activity closure syndrome median workplace return internationally measure aim afford way height 24 susceptible-exposed-infected-removed effective mid-2020 interpretation time fit pattern 0 contact lead limitation rest sars-cov-2 delay ongoing progression unprecedented investigate location-specific export epidemiological maintain probably duration wuhan projection reduce work 92 lift uncertainty 13 system early numb coronavirus city begin gradually benefit emerge control estimate child findings include school underlie model china infectiousness synthetic distance physical insight general hope framework expand world case 90 extend transmission provide suggest age sudden mix sustain secondary late role restrictions april', '', 'severe past virus antiviral infection acute evolve north respiratory close person-toperson country particularly example outbreak experience hospital animal afflict contagious medicine personnel protect attain aetiologic routine route america department droplet threat ophthalmologists direct novel agent 20 spread share derive recently ophthalmoscopy year strategy set 30 prevent establish syndrome ophthalmology measure health clinical involve effective perform matt condition contact disease europe examination apply usually sars-cov important strain doctor-patient vaccination contract susceptible coronavirus control fatal source primary human model sars slit-lamp drug highly global world ophthalmic transmission avian h5n1 available week influenza appear asia infectious', 'acknowledgement past research occupational covid elsevier source nurse health active resource database free rn form repository cohn-s 21 unrestricted experience original barbara publicly tobis centre grant long covid-19 fund remain mean 35 j. re-use year right analysis', 'severe virus early southeast susceptible coronavirus 106 sign virus-neutralizing syndrome \\ufeff1 postmortem acute isolation inoculation indicate pfu organ play pig develop change chain ocularly north respiratory clinical human chicken rna develope originate result host associate species 2003 address sars pathologic orally sars-associated outbreak transcriptase-polymerase evident europe intravenously 2 reverse animal examination attempts inoculate 6week-old blood gross viral week antibody reaction intranasally domestic detect sars-cov domesticate sars-cov. speculation unsuccessful asia amplify role america', '', '', 'severe research approach acute respiratory database emergent lancet origin ltd genetic scale covid-19 international remain determine undertake phylogenetic collect right datum novel mathematical spread active free repository sars-associated epidemic personal collaboration far long community fund review key analysis 2004 syndrome newly covid internationally publish contact-network infect 2002 unrestricted evolution original disease statistical 672 4 centre epidemiological mean re-use acknowledgement coronavirus estimate elsevier source continue literature 83 dis factor resource model 2003 form insight sars hope quickly publicly reproduce transmission grant grow provide infectious', '', '', 'number 9.50 62.50 56 wbc count(*10 111.0 sex(male% 5 40 5.93(4.77 98.6 26 57.0 ast(u/l 3.50 75 9/l 10.99 34(27 67(66 67 45 63(58 49(29 9.32(6.37 69 8 alt(u/l age 64.2(56.5 32(25 46.15 cre(μmol/l 74.7 82.6(69.6 7.45 ns 44(34', '', 'pathogenesis 2004 severe coronavirus syndrome acute replication 10 vaccine novel agent respiratory 85 causative 75 sars account infect knowledge outbreak discuss evolution identify journal recently current good review 8000 finding recent neurovirology strategy worldwide', 'severe 1 fever coronavirus syndrome infection acute include novel myalgia respiratory nonproductive cause cough sars dyspnea similar 2 symptom high chill clinically sars-cov strain rigor', '', 'severe mainland march acute equivocal respiratory database country aware outbreak little 2 hong maker covid-19 107 response undertake datum practice kong contribution effectiveness intervention consider data deploy know rapidly study epidemic contribute middle far 2019 produce evidence 2020 long review singapore modelling prevent closure 16 syndrome measure effective result policy disease pandemic 4 implement national eg social period relative disruptive recent combination electronic coronavirus article control include school restrictive 18 require model china east distance sars transmission identify predict suggest search consideration 616 systematic conflict death', '', 'post small virus cell sign syncytia dvim hemadsorption infection \\ufeff1 locate examine rapid designate bud hour follow morphologically 20 length 5 clubshaped clinical nm approximately diameter antigen release balb/c-3t3 cause infant hemagglutinating club-shaped isolate basal biological syncy envelop ° cytoplasm surface granular morphological 4 particle property intestine c scan mouse fluid virus-like technique type viral electron-microscopy ia infective detect relate demonstrate 100 virus-induced projection activity diarrhea immunofluorescent culture', '', '', '', '', '1800 virus positive hcov-229 coronavirus adult employ screen include individual transcription novel respiratory recognize healthy previously human develope (rt)-pcr 1/16 know 42.0 study hcov disease 29/69 case reverse numerous nasopharyngeal responsible etiology toroviruses symptom sample corona-and assay ct12-mcodehop codehop-based detect primer outpatient hcov-nl63', 'dataset correspond severe virus find base/day acute change respiratory population rna difficulty surround square little discuss genetic emergence t seven justifiable accurate phylogenetic avoid divide genome break mathematical assumption 0.16 hiv-1 spread mutation know epidemic subjectivity k day circumstance stimulation diverge incorporate tree validate syndrome sequence september equation result host time group 2002 0 august evolution commonly pandemic apply propose high implement based important strain coincident single understand coronavirus date 6 estimate employ genomics root base simple monte useful model comparative sars results deduce world average ancestor common simplification investigation identify rate choose carlo putative method positive-strand death coincide range infectious', 'asthma best research 128(suppl):9s-16s mb immunology jr prevention college physicians database irwin aerosol strength evidence-based therapy allergy covid-19 remain ahrens mechanism right recommendation practice dolovich fibrillation risk hogue management p quality 5 active free briss 2006 repository dr diagnosis grading 471 long postoperative evidence fund hess cw ll cardiac analysis selection covid 127:335 epidemiology clinical cough american unrestricted dd original device d centre atrial 7 outcome guterman chest mean re-use creswell 2005 acknowledgement 6 elsevier source resource form 129(suppl):24 rc publicly accp grant atkins 8 rs guideline surgery physicians/american', 'consolidation percentage strong computer assess opacity 0.8373 à0.5894 ¼ purpose 2 chi-square generate lesion degree 0.004 correlation low significant covid-19 distribution right quantitative in-house 0.05 1 retrospectively hu examine separately p ggo 1/3 radiologist 5 tomography proportion computerderived involvement consistency lung obtain right/left moderate scan parameter r 2019 3 0.6282 tool follow density upper/lower result volume severity conclusions 0 disease computer-aided statistical stratify fibrosis quantification present c high ml visually image experiment demonstrate mean software lobe confirm ground-glass reliably evaluate coronavirus radiologist-and leave base include ct 44 8.160 0.7679 feasibility case test compute accurately pneumonia 2/3 score materials method range', 'acid severe virus peptide antiviral infection acute determinant modest μm. respiratory cause respectively 57 peptides 2 link artificially angiotensin-converting region 50 μm sars-cov. spike novel agent d30 22 promise critical glycine deadly alanine represent scan synthesize mediate analysis activity exhibit cell amino syndrome indicate a.a residue discontinuous 351 segment charge s perform enzyme interaction 0.1 sars-cov important chemically therapeutic k26 evaluate coronavirus 6 emerge 357 glycoprotein ic 44 ace2 sars results potent candidate identify entry mutagenesis particular comprise', '', '2020 25 march www.thelancet.com/public-health https://doi published online', 'oxygen infection mb d-dimer retrieve difficulty 39 syrup outbreak little december hospital 28 lymphocyte covid-19 aerosolisation globally medical mild sd elevate datum retrospectively background spread proportion record know lopinavir-ritonavir 14 interferon day moderate procalcitonin 2019 2020 dangerous paediatric year cure 16 3 indicate feature clinical interpretation time information 0 alfa cohort situation disease lead inhalation twice type high patient epidemiological mean creatine receive confirm 17 electronic methods feb decrease coronavirus child china kinase temperature clear zhejiang identify asymptomatic age community-acquired body level', '', '', '', 'virus italian molecular evaluate coronavirus 510 objectives 2.0 adult hcov-hku1 indicate additional observe include background 10 symptomatic 1-year sequence heterogeneity respiratory certain variant human italy design associate know rt-pcr hcov-229e isolate conclusions infect perform s results prevalence country study disease lrt hcov-oc43 433 mainly tract consecutive northern winter gene match circulate sample cluster degree patient low hospitalize detect tree sars-cov partial orf1a strain period characterization seek mixture central-southern phylogenetic collect analysis hcov-nl63', '', 'acknowledgement fungal research covid indicate elsevier source biopsy wet film active resource database free occasionally hair form mount rickettsial repository suspect unrestricted original disease bacterial common tissue publicly examination • centre imprint blood viral grant long aspiration covid-19 fund remain mean indications re-use right cytologic analysis exudate', '', 'virus research define virological pshsp5 respiratory rna chimeric database reproductive largely 2 porcine t characteristic region covid-19 b remain mechanism right untranslated 1 pshe different 5 active free replace repository study similar genotype heterologous r long clone evidence affect fund backbone vaprrs prrsv allow analysis phenotypic activity exhibit syndrome covid replication construct rescue cdna synthesis taken full-length result s 0 unrestricted original cis-acting replacement infectivity present centre type c utr demonstrate mean re-use vitro acknowledgement counterpart believe elsevier source swap base include resource infectious form vital publicly property functionally viral grant functional vtlv8 element ptlv8 paprrs level fully preservation', '', '', 'severe percentage small molecular research march infection swab acute prevention screen rapid web document respiratory rna associate protein upper 2 intestinal symptom science esophagus angiotensin-converting express intensive treatment presentation covid-19 50 treat sars-cov. tmprss2 mechanism shed diarrhea inflammation management detectable 20 prime possible oral onset promise diagnosis lung study nasopharyngeal modification pool long current 2020 colon evidence 10.4 option significantly increasing analysis furthermore prevent embase incidence syndrome indicate epidemiology protease increase clinical effective time s infect optimal pandemic sars-cov-2 trail pubmed enzyme present mechansism fecal high patient investigate precede sars-cov subject period confirm emergency overall numb coronavirus serine 10 epithelium bind manage ace2 stool frequent reveal case conclusion supportive compare transmission investigation identify viral rate affinity search algorithm diagnostic appear live method range worldwide', '', 'globe concern virus understand cases 03 different health possible authority regard know sars infect 2002 major outbreak epidemic far present transmission region brief 8000 2019-ncov work', 'variation ratg13 infection conclude bat database develope alignment careful protein link sample rebut manis unique scale 2019-ncov sorely mechanism state-of-theart datum spike build javanica \\ufeff1 genome hiv-1 reimplementation study epidemic share snake pangolin 73 evidence miss insertion 91 set analysis similarity sequence assemble host draft identity time surface present cellular 2019-ncov-like coverage bioinformatics recent analyze intermediate coronavirus glycoprotein bind metagenomic human communication clear quickly reveal global conclusion domain compare transmission pneumonia suggest method receptor particular', 'system infringe coronavirus care emphasis specific aim change economy aspect cause time highlight disease personal world pandemic undergo devastate healthcare space unprecedented short freedom review toll secondary musculoskeletal worldwide set work', 'pass acknowledgement small arboviruses classification virus system 1 acid research \\ufeff1 covid structure replication size elsevier source base subclassifications organ specific filter tropism agent feature follow active resource database free chapter group form biology capacity repository pathologic unrestricted diseases pore original 2 nucleic 134 primarily common publicly distinct filterable arthropod property initial centre hepatitis transmission type viral grant viruses long covid-19 current fund remain mean epidemiologic vector microorganism re-use strategy right analysis', '', 'severe small enterocytes structural acute e6 envelope respiratory expression haunt cause antigenic protein vast little generate distinct intestinal express reaction distribution presence spike \\ufeff1 verify 9b novel different november hypothetical know biology diagnosis signal study cytoplasm reverse far 7a coronaviral 3a existence membrane cell syndrome newly biopsy antipeptide vero 2002 array pattern transcriptase-polymerase cohort disease autopsy coronavirusinfected surface july tissue type patient investigate cellular nucleocapsid confirm pneumocytes culture positive coronavirus-infected coronavirus emerge 6 observe include organ chain undefined useful human model 2003 pathophysiology sars 3b world functionally predict antibody epitope live immunohistochemical antibodies infectious level', '', 'virus 1 infection identification cause country infect scottish december case sars-cov-2 identify person index 2019 covid-19 globally 125,048 continent 118', 'system http://ees.elsevier.com/ submissions submission electronic thelancet/', '', 'correspond virus notable research carry acute fulminant h7n9-induced respiratory follow-up major outbreak h7n9induced preclinical therapy t ards allogeneic treatment treat covid-19 b act collectively virus-induced failure mortality transplantation dysfunction risk alternative spread menstrual-blood-derived possible voluntariness promise lung improve study share similar inform complication transplant r 2019 consent h7n9 effect significantly furthermore cell syndrome survival harmful clinical die host result group s disease lower c five-year patient open-label based theoretical period choice trial mscs 17 basis conduct single human-to-human control include 44 center mesenchymal experimental corona quickly msc multi-organ msc-based stem compare transmission mammalian 2013 pneumonia rate suggest 17.6 54.5 provide body distress principle', '', 'acid water virus frontline office life occupational disinfectant infection pose equipment enhance urticaria change develope protection skin aspect otic hyper-hydration seborrheic aware preventive 2 contamination mainly therapy funding n -ppe low reaction covid-19 scale 542 preventative acknowledgements iatrogenic burn immune-suppressive interruption chlorine department 1 hcws minute risk care p novel different conjunctival pre-exist 5 atopic involvement record hygiene expect epidemic epidermal personal ° administration maceration complication far site barrier title u lupus conjunctiva r papule affect inflammatory friction hidradenitis autoimmune relatively nasal symptoms effect f dermatologic worker variety 30 running 3 indirect low-resistance suppurativa e sting goggle bridge measure specific 1919 disinfection increase regimen canal effective result hot 75 prolong condition itch sufficient contact disease pressure pandemic exist bath commonly 4 l delay pre-proof patient o injury manifestation wear social focus important dermatology mask j decrease challenge protective dermatitis peracetic concern breakdown 1918 begin uv emerge 56 6 -p exacerbation source include develop scleroderma ppe 83 dramatically dermatologist abbreviations require appropriate abstract psoriasis sanitary physician practical disorder describe erythema clear world 97.0 common attribute acquisition interest extend transmission -hcws excessive healthcare chronic acne identify journal despite entry suggest private influenza biologic ethanol prove finding c(132.8 secondary aggravate conflict range corona dermatotropic', '', 'fulfilment severe find infection acute myalgia respiratory develope lymphopenia associate cause 39 31 13·0 compared laboratory origin communicate suspect level major knowledge little hospital 28 characteristic il2 symptom 32 intensive abnormal treatment gscf production international huanan fatigue medical 2019-ncov collect radiological directly 98 illness datum mortality 76 care background designate novel data market 5 iqr il7 record onset 22 55 spectrum admit share study obtain similar betacoronavirus day dyspnoea complications 2019 seafood 15 analyse ascertain cardiac 29 fever non-icu 3 syndrome median tnfα unit outcomes epidemiology sequence clinical 63 plasma emerging die interpretation time ip10 cough mip1a il10 disease 12 prospectively 38 cluster consortium high patient outcome injury epidemiological chest laboratory-confirmed future duration wuhan gap headache recent electronic standardise diarrhoea 13 coronavirus include 10 11 ct 18 next-generation 44 human china 40 26 haemoptysis researchers form rt-pcr family mcp1 sputum case common collection compare transmission pneumonia 8·0 41 8 5·0 icu real-time admission finding secondary rnaaemia distress', 'aims introduction 40', 'acknowledgement research infection covid elsevier source management individual active resource database free form practical repository s y unrestricted expert original q6 sars-cov-2 publicly centre u statement grant guidance r long nutritional covid-19 fund remain mean espen re-use right editorial analysis', 'circuit virus coronavirus 3 virological rhinovirus infection \\ufeff1 isolation care background 280 length rapid metapneumovirus notably approximately manage hku1 laboratory diagnosis perform suspect results arrival study marseille sputum obtain limit disease detection hospital case common nasopharyngeal sars-cov-2 sample identify patient viral nl63 influenza covid-19 b detect france period method 49 h infectious reference', 'severe elisa acute refer respiratory associate 9 respectively protein outbreak 131 express n assay reaction significant response mixture immunodominant 93.7 datum comparison igg novel 20 purified antigen onset diagnosis day clone purify 100 15 30 16 syndrome measure specific sequence result 56.3 value infect disease 81.3 patient detect nucleocapsid sars-cov subject strain escherichia atypical 13 positive coronavirus control observe 10 base commercially kit hold sars recombinant coli detection coat test serum available pneumonia viral antibody suggest diagnostic worldwide', '', 'severe small sars6 peptide infection structural strong acute noticeably additional envelope 103 respiratory cause sars3a antigenic outbreak protein c-terminus 28 unclear region antigenicity response remain sars-cov. illness spike genome 9b background novel different hypothetical onset study obtain persistent day 7a serial 59 humoral analyse platform moderately effect membrane 2004 elicit syndrome individual specific potential infect chip disease patient investigate 774 objective detect nucleocapsid sars-cov toll methods coronavirus 6 ctermini profile 2003 sars results n-terminus 3b world immunogenic serum epitopes identify viral antibody epitope 8098 create putative death antibodies infectious', 'burden assess participant line respiratory close respectively workforce occurrence survey staff scale medical hama likely eligible hamilton 2042 department 2299 suffer stress different anxiety improve study 1.4 depression questionnaire 2019 institution hamd psychological significantly strategy furthermore non-clinical individual measure health effective fear group severity time infect nrs contact disease pandemic status twice 257 feel high unprecedented enroll patient focus cross-sectional conduct emergency work susceptible coronavirus especially include disorder above-mentioned world numeric mental compare single-center rate online score icu total provide infectious administrative', 'severe surveillance research infection acute respiratory database semi-critical associate 2 hospital 6.3 t 37.8 n intensive reaction covid-19 b influenza-like remain heart right 68.8 illness 0.05 failure 1 mortality rhinovirus adult z care p agent active free repository diagnosis lung ≥3 critical admit patients reverse tract characterize ≥60 represent hospitalization transcriptase reach r long fund rank co-morbid year f significantly analysis chile old cases e covid unit aim group elderly conclusions s 0 condition unrestricted original antibiotic present centre c high patient 5;1 mean re-use j 23.7 21.9 12.5 receive methods acknowledgement decompensated in-hospital intermediate emerge elsevier source chain require resource human rhinovirus-related curb-65 form rt-pcr 124 general case 9(2):118 90 publicly chronic hrv identify available polymerase pneumonia viral thirty-two grant influenza score admission 31.2', 'protective acknowledgement http://dx system research covid ras elsevier source arm active resource database free form repository unrestricted original publicly centre grant long covid-19 fund renin-angiotensin remain mean re-use right analysis', 'bronchitis enable amazon virus 1 untranslated numb coronavirus 3 2bp/4bm utr11-/utr41 cassin green-cheeked procedure rna chapter oligonucleotide pair extract turkey species rt-pcr feces conserve single-tube viridigenalis describe sensitive highly strains/samples detection 2 one-step gene parrot test avian investigate region produce relate primer moderately infectious combination work', 'demitting acutely frontline find almond nephrology showcase predictive respond clin acute manchester evolve ability reflect opinion gut population college physicians collections/wuhan-novel-coronavirus develope help associate excellent alongside month experience outbreak local discuss little evison 2 mitchell hospital colleague addiction pa medicine nhs delivery sample 10-year crisis generalist section degree treatment presentation significant treat roll covid-19 dixon plan remain act mixture topic 65 avoid collect datasuch train hes cme datum practice 1 formal department rcp fashion mortality project \\ufeff1 adult soong care enjoy management service novel consider 1-year 5 tomography lake stay routinely lesson kallis commit know rapidly improve smoking admit study curate share personal inform dependency scan protocol alex r long grainger potentially fund uk review sight references renal analysis ag cure old 3 outstanding syndrome nhs-based importance feature jw length measure follow specialist plain health involve clinical scenario www.gov.uk/government/ result advice group time potential condition frailty episode cohort policy majority mike disease original epileptic stratify decision -this late -is 4 examination present read 3-year proudly ongoing update feel c computed national patient guidance select outcome hiding popular manifestation -much future audit content period nimble ■ clinician emergency retrospective recent challenge standardise tobacco influence statistics immediate coronavirus think date 6 subtle code epilepsy essential paper develop factor plenty resource model page physician marson royal submission highlight impact observational framework insight-provoking hope priority regular theme global average treating case common education delight previous cessation compute interest especial opt-out healthcare relevance identify predict journal rate seizure good age algorithm performance admission editor finding elegantly piece secondary litigation overview provide role level principle ottawa', 'dog acknowledgement 26,35,44,66 cats text research compile syndrome infection covid elsevier source natural † data active resource database free clinical form signs/disease repository list unrestricted original case animal 71,75 publicly d centre c 86 grant long seroreactivity covid-19 fund remain mean cat re-use confirm right analysis reference 77,83', '', '', '', 'basic severe infection susceptibility-infection-recovery prevention transform population country outbreak r0 generate medicine symptom treatment product ordinary treat covid-19 light directly 110 practice normal effectiveness novel mathematical different shorten rapidly improve epidemic expect day hospitalization parameter review formula strategy chinese cure application individual epidemiology clinical tcm effective progress reproduction infect 100,000 disease issue patient epidemiological theoretical important reduce wide system susceptible analyze early numb coronavirus think benefit control nearly base model researchers dynamic block case transmission establishment western pneumonia face rate prove non-infectious infectious role integrate scheme', 'dataset 1 surveillance coronavirus 3 twenty-five variation https://www.gisaid.org fast genomes genome prevention novel spread snvs 44,000 network cause mn908947 group 84 country haplotype outbreak share december quickly 2 case track far transmission single-nucleotide evolutionary 2019 crucial wuhan 2019-ncov secondary death valuable gisaid provide reference analysis 1,000', '', '', '', '', '', 'γδ research objectives estrous pdk4 igk expression heifers database associate slaughter limb endometrial particularly dairy t adhesion term express n dkk1 covid-19 insemination b 61 remain response relate lactational microarray determine collect right reln differentially http://dx absolute glucose intercaruncular regulate intervention lactation fold active possible free matrix parturition organelle 1.5 equivalent addition igll1 ighg1 repository improve cycle gene interferon cyclic day ontology upregulated long affect fund program j. effect analysis tai extracellular 74 cell 16 covid p-value cows genes assign 5675 noninseminated endometrium group time sci unrestricted 0.01 original 12 cow tissue 4 l state 407 centre 7 regulatory synchronization select interaction fertility detect ovulation subject mean developmental defense re-use 17 pregnant 702 comm acknowledgement criterion nonlactating dna pregnancy 6 neural elsevier source lactate 10 136 immunoglobulin-like homeostasis factor function resource 40 downregulated non-membrane-bounded form artificial nl reveal 295 candidate trd inseminate occur publicly domain development immune 33 grant 210 8 randomly 5657 up-and total 95', \"cristallographique incluant severe fatality virus find molecular un san reservoir fut l'identification de progre`s structural structure acute ge´nome majeures natural certainement bat line respiratory intend causative la plus cause press ou morts graˆce 8400 country major chinois outbreak entity civette revue emergence fonctionnel une 0147 qu'ont virologie/immunologie apre`s international e´te´obtenues travaux aigu pro southern chercheurs solution pay de´cryptage hitherto sud de´couverte e´tude \\ufeff1 diffe´rents que sars-related novel possible extensively involvement 9571/$ www.elsevier.com/locate/cimid record l'exploration cause´e mole´culaire study obtain e´mergeantes des pathoge`ne e´mergeante collaboration causant a`la vise a`souligner r whole-genomes passant l'e´pide´miologie re´servoir review 3cl overwhelm -see dans au cette pre´coces infectieuse 30 chine claim e syndrome newly thanks paradigme les majeurs re´alise´s chauve-souris epidemiology macromolecule maladie journey se´ve`re progress ge´nomique matt a`l'origine decipher disease l'e´mergence soulignant de´clenchement type suite unprecedented place re´cepteur sars-cov toucha re´alise´tre`s en pour re´sumeĺ malady naturel macromole´cule record-brokenly d'une fait ainsi coronavirus peu emerge article nearly successfully genomics complet include sars-covs donne´es shortly internationale china identification outline nouveau comple`te 2003 infectieuses sras ace2 sars structurale par paradigm reveal sars-like 800 du e´tait case crystal breakthrough mise l'e´pide´mie l'agent l'objet c'est le viral functional pre´ce´dent civet temp premie`re l'importance receptor cat respiratoire range primordiaux personnes infectious virology/immunology re´ve´lant\", '', '', '', '', 'correspond acid find infection structure cys69ala rna oligonucleotide 9 complex occurrence protein hcov oxidative single-stranded disulfide-bonded assay polymer 229e homodimer singlestranded cys69ser solution disulfide-linked nsp9 correlate novel stress different previously mutant chemical mutation mode relevant non-structural similar organize long organization relatively resonance contrast cell aggregation replication electrophoresis host hcov-229e nucleic surface hamper dimer rod-like cross-link propose high experiment sars-cov believe coronavirus biologically observe bind human wild-type model gel form sars plasmon reveal deduce crystal viral affinity suggest trimer zone-interference induce', '', 'acknowledgement http://dx practice early surveillance research control covid elsevier source refer continuous active resource database free factor interpretation infectious form repository guide unrestricted outbreak warning original disease collection publicly centre grant long covid-19 fund relate remain mean finding systematic re-use right analysis', '', 'severe surveillance research spacetime march acute united respiratory space-time 649,000 hopkins cause add outbreak allocate december states 2 uthe 28 support maker decision-making satscan significant covid-19 globally 30,249 likely 6.7 johns datum 1 \\ufeff1 5 active rapidly critical improve quarantine study university official inform strict site scan r 2019 allocation 2020 ban analysis utilize 115,500 syndrome rerun daily increase health th result disease statistic decision pandemic sars-cov-2 statistically present cluster update implement 2.2 public detect demonstrate accord wuhan period timely confirm conduct numb coronavirus travel emerge estimate geographic u.s. continue source prospective 18 resource china 1,891 monitor case test identify available rate spatial-temporal end -notably death grow total county provide level', '', 'acid severe virus variation infection structural structure acute complete rapid bat connect notably respiratory close help causative origin contig december 2 zhoushan animal bat-sl-covzc45 genetically emergence distinct sample jan region 50 huanan relate 2019-ncov sars-cov. determine likely phylogenetic distant collect facilitate bronchoalveolar receptor-binding closely genome background novel agent consider spread market explore isolate warrant obtain similar lavage 2018 betacoronavirus represent extremely amplification 2019 long divergent 2020 seafood partial sanger provisionally relatively key analysis homology eastern exhibit amino bat-derived syndrome adaptation 79 individual subgenus length subsequently residue sequence cdna involve genus full-length host inpatient identity interpretation microbial 99·98 evolution original sell present enzyme fluid patient angiotensinconverting future branch sars-cov (sars)-like wuhan bat-sl-covzxc21 fall confirm history human-to-human relative culture 2000 mers-cov intermediate coronavirus urgent sarbecovirus findings unidentified next-generation bind human model china 26 human-infecting reveal visit case sufficiently domain property transmission investigation identify terminal pneumonia evolutionary viral despite infer suggest 88 importantly end live receptor late', 'water cold-stressed wean research life assignment additional assess indicator respiratory database male plus e. transport dry reduction 1.6 protein 38.7 mineral fructooligosaccharides dairy 2 inc. stature ng/ml 28 intestinal milk sample support facility n treatment protein-containing product low covid-19 50 refuse remain response weight determine solid ankeny right solution cold 13.9 98 http://dx 1 freely offer mortality calve \\ufeff1 intake cm stress 20 starter active previously free gammulin 1.5 addition record holstein g/d 99:9027 repository study af obtain 14 urea calf administration replacer electrolyte long evidence affect one-time fund 2.5 42 formula j. contain component effect g analysis 66.0 arrangement calves old cp weekly e gain covid survival 5.6 9039 93 daily measure length wk increase health assign plasma result species 23.5 concentration group 84 sci 0 orally unrestricted matt original great antibiotic cortisol stratify × 4 centre fluid fecal blood 7 experiment 8-wk mean 66.6 dietary vitamin re-use administer receive morbidity crude decrease fos acknowledgement early bw fat benefit control 56 vs. elsevier source apc resource 1.8 supplementation form 9.2 half acute-phase feed arrival 17.0 serum publicly previous supplement body factorial available mark grant despite ia randomly score ng performance total provide serum-derived', 'acknowledgement http://dx research covid elsevier source active resource database free form repository unrestricted original cord stem publicly medicine centre blood grant long covid-19 fund remain mean re-use cells right analysis', '', '', '', '', 'positive sign orf1ab successive importance management change ct process increase diagnose clinical course result value rt-pcr laboratory diagnosis dynamic suspect account highlight describe absence exclude case gene negative sars-cov-2 test symptom sample pend patient image evidence covid-19 good chest laboratory-confirmed nucleocapsid target finding single specimen', '', 'severe virus coronavirus e threat -p pose p pangolins novel health diversity cause origin mysterious insight study evolution disease global f pandemic sars-cov-2 l pre-proof identify u n journal r 2019 o covid-19 public relate remain j provide recent', '', '', 'lymphomonocytes severe virus infection strong acute respiratory expression rna donor cause protein little activate response remain sars-cov-infected mrna cocultivation 48 ifn-a progeny 1 -48 vivo ifn normal background stable direct novel h.p.i possible involvement exposure know accumulation dose-dependent lung curve relevant study obtain gene moi negative over-exuberant characterize day transient plateau 5-day combine reach produce evidence ifna activation coordinate effect peak pathogenesis elicit cell infiltration syndrome newly indicate replication aim increase healthy 24 course effective result time prolong vero conclusions infect concomitant disease -2 tissue strongly d type investigate -g inhibition yield detect sars-cov genomic period cytokine single strand combination fix culture 13 induction evaluate coronavirus inhibit emerge proliferation necessary 10 pbmc ifn-g release damage released sars account results action observation manner immune provide viral immunomediated capability efficient live induce infectious lymphomononuclear', 'acknowledgement legal deteriorate 3 research merit approach control covid conclude widely elsevier source 2015 quality notably active resource database free vary time form repository universal unrestricted action original world advance publicly deep centre www.thelancet.com/respiratory air grant rights-based face regulatory long covid-19 consideration fund worldwide remain mean february re-use pollution rationale provide right vol analysis scheme', 'acid find molecular strong natural resistance organosulfur dock protein a. 2 anticoronavirus trisulfide t angiotensin-converting express interestingly picture crucial valuable 1 \\ufeff1 pdb6lu7 consider active gc−ms contribute substance effect analysis activity exhibit prevent invasion sativum amino foundation indicate individual 99.4 compound protease result host time allyl lead sars-cov-2 oil enzyme technique high inhibition interaction content 17 antivirus coronavirus article main essential include source eighteen human ace2 account garlic disulfide inhibitory synergistic l. identify suggest good 51.3 receptor body', 'disease travel medicine 1477 8939/ infectious xxx xxxx', 'power acknowledgement datum 165 analyze surveillance research 2508/$ covid play elsevier source enhance www.elsevier.com/locate/resmic tool sequence active resource database free discriminatory form 2014 era repository laboratory matt unrestricted study microbial genome-based original role affordable publicly ó 0923 centre hts bioinformatics alike grant recently microbiology long 140e153 covid-19 fund remain mean re-use -see provide right central analysis challenge', '', 'overall severe elisa у4-fold coronavirus indirect syndrome acute immunofluorescence 10 11 cross-reactive different increase respiratory (sars)-associated 5 human pair hcovs immunize antigens ifa respectively know hcov-229e antigenic sars 1-way titer enzyme-linked study cross-reactivity 2 hcov-oc43 oc43 animal serum sample assay immunosorbent western patient antibody 229e demonstrate sars-cov systematically blot convalescent analysis', 'acknowledgement presence raise research notify infection outdoor covid indicate risk play elsevier source include veterinary evolve active resource database free human suspicion authority form happen potential repository infect pathogenic unrestricted ✜ highly rare original disease europe assessment local case publicly poultry avian transmission centre h5n1 extremely wild access zoonotic high grant influenza long evidence covid-19 mammal fund eg subtype remain mean bird cat sporadically re-use confirm right role analysis', 'severe acute assess respiratory plus cause 39 december 2 hospital maternal characteristic seven 32 jan intensive treatment gestational covid-19 datum practice 1 adult achieve management background active admit study similar obstetric day fetal 2019 affect 2020 tongji year 29 non-pregnant syndrome feature aim increase clinical woman neonatal interpretation information infect 37 scarce disease sars-cov-2 patient outcome mean wuhan pregnant retrospective methods feb numb coronavirus 34 pregnancy emerge findings include literature clarify single-centre china absence available week 41 8 robust good age appear range late', '', '', '', '', 'concern severe virus early coronavirus busy syndrome emerge infection acute \\ufeff1 kong ensure control base near rapid novel procedure spread respiratory course china vietnam protection cause 2003 progress information super-spreading mode sars 2002 address currently epidemic canada disease detection hospital case staff numerous hong transmission unanswered issue initially high available widespread worldwide public importantly event end response appear future incident singapore question clinician single southern level rationalize', 'instead research infection respiratory database little simulate hospital corridor low covid-19 properly remain standard room adopt right inside airborne quality consider different spread active free design addition repository cfd improve cost cubicle far u parameter rethinking long r cross-infection fund full-scale significantly analysis prevent improvement arrangement refurbishment newly covid return widely construct result s ward unrestricted original ventilation rearrange exist centre fluid chance propose conventional maintain mean indoor re-use reduce boost cost-effective acknowledgement system numb control article isolation elsevier source simple retrofit resource form general computational dynamic y reveal capable removal disruption match publicly compare identify air grant rate good microbe performance minimise role recommend', '', 'well-developed acknowledgement scientifically 6553/ research ensure covid essential infrastructure elsevier source active resource database free appropriate layout form repository unrestricted 0196 original hospital publicly • centre grant emphasize long covid-19 fund plan remain mean re-use right analysis', 'acknowledgement 1 nitric research covid ifn-7 elsevier source ~. factor active resource database free abbreviations form synthase repository unrestricted tumor interleukin original il-1 interferon publicly oxide centre 7 micr()bi()i_()gy grant trends long tnf-c covid-19 necrosis fund remain mean nos-2 re-use right analysis', '', 'crowd infection prevention database 25 lymphopenia respectively 57 laboratory month upper 2 hospital 47 characteristic unclear treatment reside low covid-19 relate remain mild undertake heart collect confirmation recipient datum practice risk 20 pre-exist 72.4 5 quarantine study epidemic web-based negative insufficiency transplant questionnaire precautionary 2019 2020 community year 12ng/ml dec 3 establish proper 79 recover measure 96.6 follow procedure th clinical 87 result concentration information 21.3 contact majority pandemic sars-cov-2 4 man outcome epidemiological airway hubei 51 wuhan history retrospective therapeutic feb early understand travel accessible 6 successfully include require appropriate extract 87.2 kidney family tacrolimus world average case transition test htx single-center suspicious rate effort good age live', 'disease travel medicine 1477 8939/ infectious xxx xxxx', 'acknowledgement work jvl 335 research travel covid outside comment elsevier source submit 5 active resource database free gilead cepheid janssen form repository unrestricted fee original personal msd publicly centre conference grant long covid-19 2020 fund remain mean sl re-use www.thelancet.com/gastrohep abbvie right vol analysis april', '', '', '', '', '', 'severe infection acute prevention respiratory inactivation cause 9 outbreak little hcov chloride 2 emergence therapy 0.02 facility persist peroxide crucial facilitate 1 droplet 0.5 chlorhexidine minute novel agent spread hypochlorite chemical stop 22 study inactivate hydrogen tract middle far day plastic efficiently containment review metal strategy analysis incubation endemic syndrome specific procedure disinfection health benzalkonium effective time mers information surface sars-cov-2 ongoing 0.1 human-to-human sodium concern early coronavirus 0.05e0.2 control 10 veterinary literature hand human east sars currently describe reveal global contaminate inanimate transmission healthcare available persistence thread good ethanol biocidal glass digluconate 62e71 infectious', 'raise vlps locate structural assembly rna associate co-expressed 213 protein 2 assay n region vlp production gag 229e mechanism presence carboxyl-terminal 234 \\ufeff1 substitute direct hiv-1 data different previously replace gst study pull-down possibility particle efficiently potentially incorporate contain package g membrane 215 n-ha3 residue sequence linker involve result species hcov-229e ha3 n-associated virus-like interaction nucleocapsid sars-cov demonstrate m 302 comparable coronavirus depend essential human wild-type 421 half capable rna-mediated common domain 86 viral chimera suggest nc efficient apobec3 level', 'acknowledgement errores pú research de covid elsevier source active resource database free aciertos la salud las form repository y unrestricted original gestió publicly crisis centre n grant long covid-19 fund remain mean en re-use españ blica right analysis', '', '2004 overall severe external positive early evaluate coronavirus stage immunoassay improvement infection syndrome acute immunofluorescence and/or necessary quality 4/13 specific respect respiratory require result clearly cause assurance serological laboratory eqa sars perform diagnosis particularly correctly study detection participating serum development far 9/20 sample enzyme eias assay false technical antibody diagnostic detect performance sars-cov immunoblot demonstrate remain confirm eia anti-sars contrast', 'acid decomposition cov-hku1 virus equally nsp11 coronavirus amino \\ufeff1 construct change sequence dramatically split hku1 group form pattern protein reveal 14 nsp10 2 contribute usage occur distinct hepatitis manuscript cluster seven predict n differ significantly p65 recombination murine tree branch topology event putative codon phylogenetic analysis', 'acknowledgement susceptible virus research covid worker elsevier source swine market active resource database free form repository unrestricted original publicly poultry avian centre grant influenza long covid-19 fund remain mean live re-use right analysis', 'uncertainty therapeutics approach march infection multisectoral control comment risk prevention vaccine base measure epidemiology 5 population clinical health-care clearly www.thelancet.com/infection severity compete general impact communicate published 2 disruption diagnostics development interest transmission collaborative implement economic treatment online extent sound importantly 2020 covid-19 international crucial social accelerate scientific minimise option declare https://doi.org/10.1016/s1473-3099(20)30152-3 worker principle', '', 'severe 1 comparison coronavirus 3 syndrome clin acute continue debolt united novel lai respiratory dis 24 plasma lindquist publish 31 soo s infect y sars cheng states 2 wong case yo patient c jan n ml eur methylprednisolone treatment online microbiol 2019 r high-dose holshue 2020 583 engl med st 91 j 2005 https://doi.org/10.1056/nejmoa2001191 retrospective convalescent', '', '', '77 infection acute respiratory note hcov mainly autumn hong 8275 sample assay 0.05 datum kong young p 22/1500 different 22 study hcov-oc43 tract nasopharyngeal spring day 26/2380 year significantly peak frequently activity 1.09 median follow epidemiology 0.15 species 0.13 group hcov-229e 0.93 elderly infect 1.47 pattern 0 commonly circulate winter 80 six-year high patient intriguingly seasonal epidemiological predominant detect 12/2529 period fall conduct hcov-nl63 coronavirus child hcov-hku1 10 0.47 human hcovs rt-pcr insight 79.5 0.58 detection case summer occur 0.07 rate age pan-hcov range provide 95', '', 'system http://ees.elsevier.com/ submissions submission electronic thelancet/', '', '', 'transfer cell vivo susceptible virus coronavirus requirement hapn unresponsive approach understand infection replication adaptation additional detectable enhance tool human model result virus-cell species engineer hcov-229e infect situation study markedly humanize disease stat1 transgenic lead genetic animal gene generate interferon barrier humanized mouse provide n differ viral entry suggest successful interaction systemic murine demonstrate future apn crucial cd13 receptor aminopeptidase vitro susceptibility infectious crossing', '− 01 requirement march infection susceptibleinfected-recovered-deaths temporal notably population irrespective universality authority cause drastic country reduction 21 outbreak note strategic drastically point kinetic low covid-19 plan picture fair variable st window 2500 quantitative painful datum 1 mortality \\ufeff1 simulation calculation 20 spread consider possible 22 recovery appreciable epidemic meaningfully represent mean-field parameter 2019 containment albeit 2020 15 effect peak analysis 3 indicate recover unit discipline individual measure health height italy substantially time infect 0 disease ventilation 4 apparent place france gather based map fall confirm decrease analyze believe numb coronavirus estimate cut include 10 real simple 18,0 observe 03 model china dynamic quench describe quickly case eventually dead rate 8 effort suggest concerted day-lag end appear 260 death finally', '', '', 'virus find wildlife understand reservoir emerge threat pose coronaviruses novel ecology bat health discovery human help reiterate host family highlight highly evolution astroviruses shape animal circulate interest transmission wild strikingly zoonotic recently poor suggest mammal detect mankind event finding important microorganism history range genetically role diverse wide', '', 'acknowledgement research covid elsevier source active resource database free form biotechnology repository unrestricted original publicly centre grant long covid-19 fund remain mean re-use right analysis', 'sibilancias año virus respiratorias un respuesta research de son inferiores pero sincitial inmune database grupo síntomas la 9 más intensa décadas si con infección afirmar bronquiolitis rinovirus n exactitud esta covid-19 b algún remain se marcador h respiratorio es asmático bocavirus right desarrollar evidencia aclarado principales como 70 por que aguda especialmente sujetos medio active bronconeumol free clave exacerbaciones sido agente enero vrs patogénico noviembre repository paciente revisión artículo duda palabras recibido identificarse predispuestos este u 273 pequeños hace r long fund asociación aceptado infecciones g cualquier analysis asma suponen bien entre e covid seguido alteraciones 2015 común descrita hospitalizados recurrentes edad genética 2016;52(5):269 totalmente y/o caso humano sin respiratoria llegando frente aparición 2016 w s constituye unrestricted el original menores respiratorios virales actualidad 4 l crónicos para desencadenantes centre c niño información todas desarrollo está o lactantes los mean suficiente en re-use predisposición largo adenovirus arch implicados acknowledgement muy papel ellas desencadenante elsevier source mayor riesgo ha metapneumovirus vías factor resource probablemente episodio frecuente las aproximadamente form 2014 octubre y aunque asmáticas señala existe genéticamente 90 publicly virus-asma especial grant hospitalización niños episodios plazo asociado del desconoce historia on-line causa hasta sean', '', 'kk research infection 1995;24(6):863e6 bradley respiratory chicken database la 9 ling ka yy low covid-19 remain ds right lin intracellular active free biology beeckman repository ong wong tract psittaci microbiol long fund 2010 singapore tengelsen assoc analysis pathogenesis covid dc measure vanrompay 24;141(3e4 pet acad vet unrestricted original compendium centre high stobierski mean smith strain med bird re-use macrophage j virulent sy ae acknowledgement 2005;226:532e53 control elsevier source 10 resource human form singap ann mg case rv publicly pneumonia grant 8 tan chlamydophila psittacosis yk chlamydia 342e53', '', '', 'severe 54 infection locate phenotype sawalha immunology prevention enhance m. respiratory expression sle hypomethylated remission cause nfκb encode interferon-regulated fight sensitive storm oxidative therapy t predispose maintaining dysregulation coit cite n treatment covid-19 response mrna specially demethylation overexpression facilitate immunosuppressed spike correlate p chromosome stress epigenetic 127 exacerbate addition 2020sk3005 likelihood methylation hypomethylation viremia critical disseminate cycle expect epidemic overexpress disease-2019 vicious possibility patients gene complication far argument u lupus defect independent dr. r evidence current 2020 systemic zhao a.h. f key possibly prevent cell province e p. disclose increase hunan clinical course result severity disease pandemic sars-cov-2 state l pre-proof inherent patient o maintain cytokine j autoimmunity susceptibility microrna lu erythematous highlights system susceptible especially dna coronavirus urgent article control -p glycoprotein 136 https://doi 2014 ace2 \\uf0b7 x cd4 immune excessive provide journal viral compromise functional grant entry suggest target prone receptor death induce', 'virus find research immunology indicator genital 81 database protection bhv major reinfected sensitive doe 47 reactivate correlation treatment transiently covid-19 treat remain response right shed herpesvirus 1 ocular calve detectable titre active free iggl iga rapidly repository address igm long fund immunopathology nasal aud analysis covid bhvlspecific play measure increase corticosteroid time unrestricted original mucosal present centre detect mean period isotype-specific re-use igg2 salient 92 latent acknowledgement reinfection 6 elsevier source veterinary reactivation resource form 1995 experimental serum publicly secretion week grant antibody suggest bhvl appear putative bovine late role', '', '', 'excess tolerance research ): database skin cause laboratory epiphyseal local visual radiographic acromegaly macroglossia presentation covid-19 production remain gh right 1 anterior hormone glucose normal active free oral repository adenoma lung diagnosis endocrine complication diabetes hypertension growth defect long produce prominent fund systemic stimulate -fails effect analysis cell aetiopathogenesis closure mri covid gigantism nose clinical plasma result mandible unrestricted original cardiomyopathy tissue centre usually prognathism mean tooth foot re-use ■ confirm uncommon headache acknowledgement tumour broaden definition -raised elsevier source include supraorbital organ 3.1 pituitary hand ct factor resource hypersecretion ridge 26 pancreatic form enlargement disorder thicken test serum publicly cessation • chronic progressive space suppress grant eosinophilic finding insulin-like islet', 'rely main feature chain ct sequence context tomography complement rt-pcr diagnosis epidemic discuss test compute present available computed polymerase pneumonia differential reaction covid-19 current real-time review important standard microbiological confirm typical abbreviation emergency reference set', '', 'severe virus meet operational team respond stakeholder approach infection structure acute minimize expectation prevention equipment -mark evolve responsiveness pose participate respiratory leadership material confirmatory chaos follow-up impromptu maximum setting largely scope outbreak local prepare assessment hospital emergence staff cov fact initial support formidable ultimate treatment decision-making unique international plan response crucial 2019-ncov collectively uniform mechanism secure well-developed department 1 hcws mortality ensure threat initiate management designate novel assumption meeting process preproduced spread preparedness efforts load critical share sheet teams similar web-based personal options twain role applicable middle maximize expedite day protocol hierarchical organize reach couple explicit maximally microbiology relentless 2019 upu current placement frequency incorporate program informational coordinate allow key infrastructure worker set command akin coordination establish syndrome teleconference unit member availability e-mail up-to-date specific procedure nurse increase health face-to-face triage involve all-hazards fear result group consistent mers information infect leader contact correct situation disease pressure priori decision exist predetermine infectivity nature fluid feel high bedrock patient demand scramble eg detect usually appearance mean focus accord nimble reliable regardless comprehensive emergency accountability list off-hour detail challenge protective standardization concern system number joint equally understand coronavirus empower transmissible presently depend essential flexible helpful base include chain ppe misinformation human resource appropriate communication east page physician manage sars dynamic guide unlike frequent clear regular tailor limit default quickly input case test message hcw urgency transmission nuanced healthcare establishment identify face optimization streamline efficient real-time hipp organizational serve ebola immense hipps posture systematic speech grow range provide worldwide preapproved fully exchange', '', '', 'co-exist consolidation severe infection acute rapid opacity respiratory 81 cause 39 13·0 laboratory combining ≤1 assessment 2 hospital 52 49·5 11·1 symptom jan covid-19 distribution 48 sd facilitate 1 retrospectively \\ufeff1 background different 20 onset lung diagnosis admit published patients scan 2019 2020 manifest serial 42 february analyse 5·7 5·4 year dec 10·5 3 syndrome 23 feature aim 3·3 sequence segment involve clinical woman course 24 unilateral interpretation group progress www.thelancet.com/infection successively cohort evolution disease sars-cov-2 4 man cluster patient enroll image bilateral chest mean wuhan subclinical abnormality confirm basis interval ground-glass 11·0 methods timepoint overall early numb coronavirus imaging findings include 6·4 ct 2·8 next-generation china https://doi rt-pcr describe diffuse undergo compare asymptomatic pneumonia focal week online age finding', 'taiwan incubation hcws droplet argue e ensure control infection interrupt success care achieve adaptation include enhance necessary fomite health require traffic sector effective result 22 2003 ace2 impact enhanced sars expand quarantine traditional cycle outbreak contact highly similar bundling limit disease hospital transmissibility transition negative ward day transmission workers house protect asymptomatic high patient false derive expansion unique etcb covid-19 successful adapt tcb manifestation hyper-affinity incorporate zone prove period receptor particular level community-hospital-community', '', '', '', 'concern raise mother coronavirus opportunity 10-year-old antiviral infection control child \\ufeff1 isolation contribution care korea specific lastly spread require clinical close course china result country knowledge address outbreak contact optimal disease limit case negative test present issue pediatric pneumonia patient viral treatment uncle 2019 suggest covid-19 start current community serial multiple epidemiologic wuhan room relatively mild confirm strategy self-quarantine worldwide girl specimen', 'leaf-nosed fragment severe virus find molecular incongruent reservoir rely elucidate acute relationship natural ma ability bat respiratory predictor emergent cause origin outbreak assessment generate support unique relate remain hipposideros act determine phylogenetic biogeographical datum 10-kb speciose closely optimum direct novel consider well-resolved diagnose explore hipposideridae versus signal improve study large-scale gene middle phylogenomic produce diverge 42 tree insertion typically mid-miocene effect analysis set old phylogram syndrome newly outlier africa climatic exon retrotransposon genus species host diversity time divergence potential optimal intron disease status mammal replicative future demonstrate nuclear subtribe important (sars)-like 19 eocene paraphyly unresolved relative recent taxon coronavirus reconstruction urgent emerge diversification estimate rhinonycterina taxonomic primary fossil-calibrated factor approximately 40 east comparative family timetree sars-like world undergo development compare elevation nodal horseshoe phylogeny resolve rate reason persistence viral performance rhinolophidae rhinolophus provide familial level', '', '', '', '', '', 'severe safe march acute screen prevention transform respiratory protection authority cause advantage country major suspect instruction outbreak experience purpose 2 staff car cope point covid-19 101 clinic 1 outdoor minute korea service disaster design rapidly capacity registration share introduce day 2019 step cross-infection 2020 containment increased 100 atmosphere similarity dispense provider syndrome testee individual symptomatic dt increase involve progress 3,4 100,000 situation disease limitation pandemic sars-cov-2 examination present ongoing implement drive-through accord confirm specimen challenge overall system numb coronavirus emerge leave and/or include 10 base require resource center wait infectious entire global world case collection test previous healthcare space despite testees effort influenza efficient concept bioterrorism level', 'acid severe datum supplementary virus coronavirus gradually false-negative syndrome infection acute coinfection include feature novel chain sequence spread gold respiratory representative clinical tomography result laboratory study epidemic discuss role 2 nucleic genetic case sars-cov-2 test examination compute polymerase 2019 reaction rrt-pcr good real-time serve standard method recent reverse-transcriptase late worldwide confirmation', '', 'mers-cov severe coronavirus mortality syndrome infection adult child dysfunction risk complicate observe novel literature data comorbidity respiratory factor clinical human population 9-month-old east associate cause mers mode admit scarce disease attempt case multi-organ mainly middle cov characterize compare present symptom pediatric patient outcome rate presentation low manifestation poor review medical death range wide', 'severe acute (sars-cov-2)-infected change respiratory male laboratory december 2 symptom initial reaction covid-19 collect radiological diarrhea illness datum 16/18 background korea novel 20 tomography nationwide apr study virologic 73 scan 2019 2020 korean 15 year 1st fever infiltration multicenter syndrome median 6;35(13):e142 follow 25.0 clinical course time severity cough sci disease republic sore progression patient investigate outcome enroll 21.4 chest 28th cxr wuhan med 10.7 j confirm retrospective 46.4 methods early analyze coronavirus emerge include real chain require china 40 28.6 throat https://doi dynamic results case common compute x-ray 88.9 polymerase pneumonia age range 53.6', '', '', 'virus stage infection winbugs prevention qianxi rapid exponential population spot respectively rise outbreak january 0.943 correlation region low covid-19 upcoming distribution crucial 5806/9692 yunnan collect provincial emigration ensure wave risk data spread different nationwide preparedness festival load epidemic official continuously spring 1.960 represent day reach coefficient efficiently growth 2019 potentially 2020 organization emigrate relatively peak migration 95.77 30 prevent province million return importance adjacent measure individual follow increase time hot information location disease great ongoing warn owing future hubei wuhan software 17 confirm early analyze numb coronavirus city 59.91 understand control main source include extract china account case baidu previous 204/213 determining pneumonia implementation trend sichuan appear death lockdown total corona level arcgis', '', '', '', '', '', 'system department standardize coronavirus reservation infection article \\ufeff1 control isolation screen prevention follow specialist summarize process difficulty continuous clinical triage spread help stop cause explore practical diagnosis hope outbreak experience outpatient avoid december disease evidence-based strictly surgeon hospital pandemic spine combine treatment online 2019 evidence start covid-19 cross-infection collaborate globally medical revisit spinal emergency accountability optimize consultation work', '', '', '', '', 'number illness severe datum coronavirus syndrome \\ufeff1 infection acute korea different spread increase respiratory clinical previously accumulate china information country load outbreak december world 2 case sars-cov-2 lack distinct present moderate investigation patient viral 2019 manifestation start 2020 kinetic suggest epidemiologic february sars-cov. mild confirm', '', '', 'severe participants coronavirus covid-2019 province syndrome infection acute respiratory clinical design china setting laboratory infect series admit study zhejiang disease 2 hospital case sars-cov-2 responsible characteristic seven patient 2019 objective 62 confirm retrospective', 'acid consolidation severe bat-borne virus raise carry infection acute tentative opacity indicator bat respiratory close clade associate cause nucleotide december hospital maximum-likelihood cov open 87.7 globally phylogenetic intact collect bronchoalveolar datum presence 1 receptor-binding background novel covs nc_019843 previously 87.6 isolate 79.0 lavage gene middle 99.8 separate complication far jin 2019 tree radiography b-cov 29 yin-tan fever bat-origin province amino syndrome indicate genbank construct 99.9 (sars)-cov sequence health clinical die result identity 51.8 cough dyspnea disease great nucleic nc_004718 resemble present read zoonotic patient public chest hubei subject sars-cov wuhan strain mg772933 single methods specimen concern mers-cov coronavirus (mers)-cov accompany sl-zc45 isolation fatal include 18 next-generation human extract china east results frame reveal sars-like diffuse phylogenetically bal conclusion domain identify pneumonia 8 batorigin hospitalize receptor distress', '', 'cost-effective transfer numb coronavirus discharge 6 \\ufeff1 emerge isolation management korea novel 309 resource stay center result cause manage massive admit outbreak cohort purpose overcrowd 5,000 allocate disease limit hospital case pandemic home limitation complication symptom initial exceed implement 7 patient week efficiently treatment resource-saving 2019 covid-19 force institution treat community 107 medical aggravation confirm ctc total concept strategy infectious worldwide', '', 'virus life 1.31 9.99 24.57 rapid hrvs analytic respiratory plaque-forming laboratory sensitive cross-reactivity 1.73 piv-3 assay 5.46 (piv)-1 sciences 98 1 rhinovirus background korea 4.93 transcription 18.20 pcr diagnosis study 14 syncytial hcov-oc43 reverse negative (pfu)/ml flub piv-2 (hrsv)-a advansure 2.67 1.79 lg 17.23 unit 23 respect specific hrsv-b clinical pfu/ml result hcov-229e/nl63 group potential conclusions lod 59.51 one-step type high parainfluenza conventional simultaneous specificity agreement adenovirus methods specimen analyze evaluate coronavirus advs simple kit human (rt)-pcr rt-pcr results non-respiratory limit detection test rv compare multiplex sensitivity influenza flu real-time performance', 'leaf-nosed severe virus wildlife surveillance reservoir coronavirus-like acute distinctive additional megachiroptera paramyxoviruses bat respiratory discovery cause harbor conserve outbreak survey 2 animal stem-loop open n unique profound relate hipposideros phylogenetic collect facilitate human-bat mbio presence nigeria project motif covs pyrosequencing ii pcr biology cave obtain gene represent organization suborders 2010 analysis subgroup 1(4 application bats syndrome indicate importance feature tool sequence health context course diversity group contact microchiroptera evolution disease tissue read zoonotic commersoni sars-cov genomic focus commerson 2b conjunction m livestock chiroptera wide understand coronavirus begin emerge lyssaviruses include sars-covs paper consensus human filoviruses identification high-throughput 2003 insight impact interspecies overlap frame sars expand unlike frequent describe reveal global responsible development order transmission suggest efficient unbiased gastrointestinal range provide comprise', '', '', '', '', 'severe virus hamming raise operational infection acute assess readily ma bat reflect respiratory expression hcov-emc associate donor origin kindler v. müller suspect emergence seven mrnas point minimal treatment presentation relate response innate fouchier determine jónsdóttir mechanism mbio datum failure closely ifn \\ufeff1 ram detectable transcription novel different rodriguez possible dijkman 4(1):e00611 relevant reverse middle interferon betacoronavirus represent barrier oj efficiently derive r evade hartmann inflammatory drosten option avenue renal furthermore cell e syndrome replication follow permissive clinical host invade identity potential antagonist hcov-229e 2002 rnaseq 12 resemble considerable tissue lack d type iii c zoonotic outcome airway demonstrate sars-cov important cytokine reduce recent culture pseudostratified concern emc susceptible coronavirus muth emerge pronounce fatal observe epithelium hr primary thiel human hae (rt)-pcr east 2003 responsive sars highlight highly case geffers evasion experimentally immune recognition pneumonia 2013 entry suggest importantly efficient target bronchial putative subgenomic provide citation', '', 'early coronavirus begin travel paramount \\ufeff1 isolation import importance feature korea novel clinical china cause highlight outbreak december detection case betacoronavirus pneumonia patient viral phase 2019 suggest epidemiological chest radiography miss wuhan 2019-ncov history', 'licensure surveillance approach structural rapid hcov-emc engineer particularly strategic unfortunately prompt wmd foster significant obstacle production plan response remain countermeasure medical technology threat novel alternative agent process possible previously design biothreat record manufacture stockpile preparedness improve biodefense advance numerous string-of-epitope increased h7n9 significantly vaccine tool increase health clinical effective time potential avian-origin awareness great enterprise delay apply propose national conventional countermeasures public reduce phemce emergency true incompatible coronavirus emerge biowarfare real stride dramatically identification deployment computational test development h5n1 influenza capability', '', 'gut print month ahead epub j-s hu jh day include jin cite year lian x', 'acid find meet 1.628\\uf02d44.864 p=0.024 27.3 enhance covid-19-induced ability 1.098\\uf02d50.000 10.6 2.843 respiratory mg/l 78.147 cause maximum 16.01 laboratory breaths/min 66 protein december january 2 hospital 67 p=0.028 38.4 characteristic symptom sample logistic initial categorical 37.8 32 support 10.530 treatment low covid-19 48 variable likely elevate divide collect 0.018 0.006 datum 0.027 failure 14.285 1.224\\uf02d34.701 78 70 risk p background management novel associated 0.016 continuous proportion 14.3 explore tertiary admit study epidemic 1.942\\uf02d40.000 patients 38.2 far hospitalization u 0.028 index independent t-test 2019 affect 2020 1.9 regression fisher p=0.004 15 14.1 multivariate u=4.030 60 significantly year 0.046 analysis 30 fever deteriorate old province 0.001 16 c-reactive 33.1 indicate 85.9 3.0 high-level 38.9 37.5 individual aim regimen clinical 24 u=1.315 result prognosis group 64.8 conclusions perform 37 albumin 5.611 p=0.001 optimal disease lead statistical 8.999 nucleic u=2.057 type progression 8.772 high patient investigate efficacy image criterium chisquared improved/stabilized based hubei 51 0.011 wuhan 1.036 4.932 41.27±4.55 receive history 8.546 methods early positive evaluate coronavirus analyze 34 ci 1.577\\uf02d25.000 vs. base include ℃ g/l 11 18 factor 9.291 china mann-whitney 38.6 37.0 temperature 7.353 detection seventy-eight common test evaluation smoke body compare 36.62±6.60 0.003 identify 20.9 pneumonia \\uf063 week 41 rate age improvement/stabilization admission 54.5 exact inclusion 95', '', 'co-exist consolidation white 32.1 opacity respiratory notably male associate cause 57 laboratory major outbreak 81.8 little december january hospital characteristic symptom initial lesion support treatment low significant poor 61 huanan multiple fatigue 2019-ncov heart collect facilitate ill diarrhea datum failure department middle-aged 76 retrospectively \\ufeff1 normal risk background novel 20 given comorbidity market 112/137 tomography involvement exposure recovery isolate tertiary lung admit improve study primarily 2019-ncov-infected scan 66/137 2019 2020 systemic frequency seafood epidemiologic wholesale year g count 30 cell fever province definite 99/137 median deliver symptomatic aim corticosteroid clinical regimen 24 effective prognosis result cough elderly conclusions infect condition dyspnea cordlike lymphocytopenia majority disease status 80 lack critically present immunoglobulin blood patient investigate image 44/137 manifestation chest female hubei pain focus wuhan accord appearance lobe typical interval history headache ground-glass methods palpitation decrease susceptible analyze early coronavirus benefit nearly observe include 137 underlie 83 china general results drug case test compute chronic pneumonia dense viral age shadow 48.2 muscle death 72.3']\n"
     ]
    }
   ],
   "source": [
    "print(list_abstract)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['covid-19 risk-stratify elective pandemic surgery br', 'radiologic 2019 coronavirus china finding mortality br wuhan infect association patient novel', 'treat covid-19 coronavirus review herbal meta-analysis medicine systematic protocol br traditional novel chinese pneumonia:<br', 'simulate transmissibility model coronavirus br novel phase-based mathematical', 'virus binding porcine comparison characteristics identification spike receptor diarrhea strains br protein epidemic', 'spotlight mers thrusting sars br coronaviruses', 'january 2020 response coronavirus 2019-ncov laboratory 30<br country br novel expert eu/eea readiness', 'health covid-19 mental china services progression br outbreak', 'covid-19 princess backcalculating incidence infection diamond br', 'targets covid-19 immunological based coronavirus identification sars-cov potential vaccine br br>(sars-cov-2 preliminary studies', 'severe covid-19<br cell inflammatory incite t pathogenic br patient monocyte storm', 'covid-19 2020 short-term epidemic february march potential lombardy italy,<br br outcome uncontrolled', 'covid-19 clinical management br patient observation', 'disease covid-19 learn coronavirus br novel', 'respiratory severe 2 design coronavirus sars-cov-2 antiviral syndrome projection optimized vitro acute dosing br hydroxychloroquine treatment activity', 'coronavirus novel croup br nl63 associated', 'coronavirus united novel health clinical 4,<br>2020 31 outbreak december states initial br guidance 2019 public 2019–february response interim', 'disease fiscal covid-19 human lose coronavirus value china live br', '2019 bind coronavirus-specific human monoclonal coronavirus spike sars potent br protein novel antibody', '2019 epidemiological review coronavirus characteristic br novel interim', 'loop receptor-binding alphacoronavirus adaptation br evolution', 'learn public coronavirus china br outbreak novel', 'rna translocation coronavirus nsp13 cooperative unwind concentration duplex helicase sars enhance high br atp', 'sars-cov-2 br vaccine pneumonia outbreak viral', 'mers-cov saudi br infection arabia workers high prevalence camel', 'health expectation pandemic', 'covid-19 clinical trial reposition drug br treatment', 'covid-19—a evidence current review stimulate immune-suppressive systematic associations drug br novel', 'covid-19 possibility search datum 2020 china retrospective social internet predict br outbreak analysis medium', 'respiratory coronavirus middle east syndrome antibodies vaccine br', 'vital preventing surveillance coronavirus wuhan sustained intense transmission china,<br>2020 locations br outbreak novel', 'wuhan-2019-ncov light covid-19 sheds model predicted infectivity intrinsic shell disorder br protein rigidity outer', 'derivative effective sars-cov-2 br inhibit chloroquine infection vitro toxic hydroxychloroquine little', 'covid-19 confirmed china cases method forecasting br optimization', 'human emerging vaccines subunit pathogenic br coronaviruses', 'incubation 2019 epidemiological right statistical case characteristics coronavirus period publicly available truncation br novel analysis infections data', 'epidemiological covid-19<br real-time datum case information outbreak', 'br>(covid-19 coronavirus born mothers infants', 'coronavirus return 2019-ncov', '2019 january 2020 (2019-ncov),<br early coronavirus wuhan transmission human-to-human br novel pattern december', 'assessment epidemiological real-time january 2020 coronavirus china wuhan 22 infection characteristic tentative br novel', 'respiratory human coronavirus childhood infection syndrome acute non-severe br place', 'passengers coronavirus data 2019-ncov infection evacuation japanese underascertainment flights br novel rate estimation', 'kenya human molecular patterns coronavirus coastal evolutionary br nl63 rural epidemiology', 'bronchitis virus feline br infectious aminopeptidase receptor avian n functional', 'health population covid-19 tribute china group respectable br outbreak worker', 'clinical human coronavirus summer seasonality hcov-hku1 israel:<br symptoms br infections epidemiology', 'human virus review host – br coronaviruses interactions', 'limit covid-19 corticosteroid clinical br nsaids set treatment', 'cell coronavirus offer ancestral origin replication mers insight sars br bat', 'sars-cov-2 origin continue br evolution', 'respiratory coronavirus opportunities middle east br syndrome afforded ample opportunistic', 'disease limit covid-19 epidemiological clinical community italy 2020 coronavirus february paucisymptomatic setting transmission br patient challenge', 'high-dose covid-19 clinical test trial vitamin c br patient', 'covid-19 interaction human cd26 emerging spike wuhan glycan structure coronavirus:<br prediction glycoprotein shield br', '1 coronavirus incidence march united cumulative increase rapidly disease january br economic covid-19 union/european 2020 15 area european kingdom', 'nl63 human nucleocapsid coronavirus br protein', 'covid-19 ’ protection special br attention epidemic nurse', 'virus porcine piglet neonatal transmissible aminopeptidase gastroenteritis diarrhea protect br epidemic n-null', 'covid-19 transport patient safe', 'cross-family coronavirus gene putative bat-derived reovirus recombinant br', 'ctl ifn-gamma epitope bioinformatics production sars-cov spike prediction br protein analysis residue', 'coronavirus 2019-ncov/sars-cov-2 repurposing network-based drug br novel', 'assessment covid-19<br coronavirus china outbreaks outside risk novel', 'disease manifestation covid-19 clinical early coronavirus review period cause control diagnosis prevention scope br outbreak epidemiology', 'covid-19 china province medical infection management heilongjiang strategy br epidemic', '2019 disease covid-19 derivative real-time 2 surveillance coronavirus china model evaluation br month epidemic', 'covid-19 china medicine care issue critical br intensive', 'approaches:<br molecular coronavirus target protease structural silico main feature br novel sequence unrevealing', 'anti-coronavirus human design coronavirus insights structure main spectrum drug br nl63 wide protease', 'mers-cov system demonstrate innate response host pro-inflammatory approach distinct difference cytokine isolate genetically br', 'health covid-19 mental hospital china manage reform service br outbreak psychiatric challenge', 'coronavirus cats serological br infections screening', 'spreading mainland statistics-based coronavirus china br predictions epidemic', 'hand covid-19 stewardship involving antimicrobial response program deck br effort', 'respiratory human 229e coronavirus identification closely characterization related alpaca br novel', 'respiratory illness human patients influenza-like arkansas detected br coronaviruses usa', 'respiratory severe classify coronavirus syndrome-related sars-cov-2 species 2019-ncov acute br', 'severe coronavirus operational syndrome infection acute management novel 2<br>(sars-cov-2 respiratory college clinical group diagnosis union hospital br 2019 (v2.0):<br medical working peking recommendation', 'coronavirus spike infection risk dynamic feature evolutionary predict br protein monitor', 'human molecular coronavirus characterization kenya,<br>2009–2012 dynamic circulation br', '2019 rna human individual case coronavirus wuhan approach pneumonia mngs base identify br outbreak novel', 'population genetic coronavirus comparative receptor ace2 2019-ncov/sars-cov-2 br novel analysis different', 'pathogenesis respiratory severe virus proteins syndrome acute br>(sars)-coronavirus accessory role', 'engineering bispecific mers-cov fusion antibody-peptide br protein novel', 'perspectives coronavirus neutralize sars-cov-2 br therapeutic novel antibody', 'fruit mers-cov artibeus replication jamaican br shed jamaicensis bat', 'respiratory human coronavirus middle east syndrome br novel', 'alphacoronaviruses bats china reservoir important coronaviruses chinese potential support horseshoe br southern novel bat', 'evidence sars-cov-2 claim engineer support laboratory br credible', 'coronavirus china wuhan outbreak novel', 'coronavirus old lesson sars – br novel', 'cell coronavirus stem pneumonia combating promise infusion mesenchymal (covid-19)- br induced shows', '2019 clinical case coronavirus china finding wuhan pneumonia retrospective characteristic laboratory br novel analysis 95', 'disease outbreak reverse design effective coronavirus china medical wuhan network outbreaks 2019<br>(covid-19 waste management br insights epidemic logistics', '2019 attack coronavirus china emerge wuhan,<br management strategy pneumonia novel', 'nl63 human coronavirus structure genome regulation br transcriptional', 'respiratory coronavirus middle usage east syndrome codon pattern br analysis', 'organization goose coronavirus species identified die-off genome geese br novel mass canada', 'repeated influencing china factors potential outbreaks sars br', '2020 coronavirus sars-cov-2 br diagnostics bavaria february germany laboratory establishment rapid novel', 'disease study virus china southwest multi-center corona br>2019(covid-19 change image ct', 'respiratory severe illness human detect hospitalise south coronavirus africa,<br>2012 2013 acute polyomavirus bocavirus br patient', 'possible human domestic elisa coronavirus evaluation development serological hosts livestock br nl63 whole-virus', '2019 coronavirus china spring transportation prediction driven festival population-based br novel study epidemic spread', 'hospital response shenzhen china 2019-ncov infection care critical br outbreak', 'disease 2019 phase-adjusted case numb coronavirus china wuhan br estimation', 'lipid human remodeling coronavirus-infected coronavirus lipidomic characterization metabolism replication cells br profile implications', 'mers-cov prophylactic model br rhesus br>(gs-5734 macaque infection remdesivir therapeutic treatment', 'respiratory severe 2 virus coronavirus lesson tug-of-war host antiviral defence:<br syndrome acute pathogenic br', 'disease covid-19 lymphopenia predictive descriptive severity predict br study', 'upper respiratory human real-time assays coronavirus tract etiology characterization infection acute rt-pcr adults br chinese', 'coronavirus emerging wuhan borders br viruses', 'covid-19 raas angiotensin potential ii br role', 'population environments coronavirus host diversity adaptation bovine br role viral', 'respiratory severe expression response gene syndrome acute immune br patient profile', 'capable human picture coronavirus lethal infection emerge br novel', 'china amur identification betacoronavirus hedgehogs br>(merbecovirus novel', 'coronavirus fear novel', 'interaction human analysis spike sars-cov-2 receptor silico protein ace2 br role change', 'human coronavirus lessons 2019-ncov maternal potential infant mers infecting pregnant sars outcomes br infections women br>(wuhan', 'rna clinical br 2019-ncov far strong severity detectable blood viral indicator', 'data-based covid-19 model br forecast outbreak analysis', 'signature respiratory severe clinical molecular coronavirus sars-cov syndrome severity acute recover br patient', 'coronavirus wuhan novel 2019ncov', 'communicating disease covid-19 coronavirus risk death br novel', 'commentary interventions covid-19<br non-pharmaceutical mortality healthcare impact “ npis reduce br ” ferguson demand', '(sars-cov-2):<br international evidences coronavirus pending scientific br outbreak novel literature questions', 'scenario br>(2019-ncov)—current coronavirus emerging development perspective genome base evolutionary br recent novel analysis', 'respiratory genetic nucleocapsid coronavirus china canine characterization antigenic recombinant br protein derive', '(2019-ncov)<br>3c-like reveal velpatasvir drug sars-cov-2 repurposing virtual pro prediction 3cl structure screen ledipasvir br candidate protease', 'travel-related virus case wuhan 2019-ncov coronavirus:<br transmission human-to-human br novel vaccine readiness', 'covid-19 coronavirus novel share data', 'covid-19 guangdong short-term 2020 china february forecasts br br>13–23 epidemic zhejiang', '2019 january persons 2020 evaluated coronavirus —<br united novel states', 'europe january 2020 importation coronavirus br 2019-ncov risk early-stage novel', '2019 epidemiological 2020 outbreak china identification atypical wuhan pneumonia time real br novel analysis', 'survey covid-19 quarantine populations identification mobile phone-based quicker cities/towns intelligence framework artificial br', 'covid-19 operational surgery br patient directive', 'global coronavirus emerging sars-cov-2 causes threat br', 'ageusia evidence covid-19 current doe emerge symptom anosmia br patient', 'upheaval covid-19<br cancer care outbreak', 'mers-cov systemic bacterium-like receptor-binding mice mucosal domain induces particle responses immune displaying vaccine br specific novel', 'disease 2019 covid-19 clinical virus score identification simple proposal suspect perspective br stratification corona primary', 'knowns covid-19 unknowns questions', 'coronavirus city urban benefit management data health monitoring network universal artificial outbreak ai smart intelligence br covid-19 coupled sharing standards', 'health global epidemiological public coronavirus research 2019-ncov control ongoing br outbreak novel priority', 'extent 2020 coronavirus china wuhan transmission br novel', 'htcc coronavirus inhibitor broad range br entry', 'contribute 2019-ncov genome br hiv-1', 'sars-cov-2<br assessment community convenience 2020 regional br march transmission sample healthcare rapid netherlands worker', 'practice 2019-ncov control transmission dental br route', 'respiratory animal coronavirus middle east br>(mers-cov reservoir syndrome origin', 'human 229e coronavirus spike gene envelope encode single protein orf4<br', '2019 therapeutics coronavirus review br diagnostics 2019-ncov potential systematic vaccine rapid novel', 'detection human coronaviruses melting simultaneous rt-qpcr multiplex curve-based br assay', 'global covid-19 sars-cov-2 br battle', 'human molecular coronavirus characterization 2012–2013 br thailand epidemiology', 'editor letter cause netnews disorder headline br outbreak covid‐19 stress', 'covid-19<br case addition contact measure control far trace isolation br outbreak', 'detection high system coronavirus throughput sars-cov-2 evaluation emerge rt-pcr assay br quantitative', 'upper respiratory human ghana tract associated areas br coronaviruses rural infections', 'current coronavirus snapshot knowledge – br novel', 'virus-based recombination reverse coronavirus genetics vaccinia sars-related br', 'assessing br>(covid-19 coronavirus reduced travel infection dynamics impact exportation br novel', 'disease 2019 covid-19 response escalating coronavirus sars-cov-2 infection control kong hong rapidly br epidemiology evolve', 'coronavirus forecasting covid-19 novel', 'covid-19 early intensive preparing singapore care unit br experience', 'coronavirus br>(2019-ncov effectively inhibit chloroquine emerge vitro remdesivir br novel recently', 'survey covid-19 practice outbreak quick attitude period cross-sectional rapid rise knowledge online br resident chinese', 'disease covid-19 clinical virus case china characteristic child family – br character corona different', 'identification target 2019-ncov silico vaccine br', '2019 nepal coronavirus sars-cov-2 strain br genome isolated complete novel sequence', 'disease 2019 covid-19 detection virus positive january surveillance staff coronavirus china medical february 2020 recover br post-discharge', 'respiratory healthy human 229e case coronavirus syndrome adult acute distress br associated rare', 'bronchitis beaudette virus determinant br subunit infectious s2 tropism cellular', 'mediated br dominant nf-κb activation inhibition replication jak2 comprehensive targeting coronaviral ultimate cellular activity', 'covid-19 old trick br treatment challenge', 'generation coronavirus genome complete sequence sispa sequence-independent br>(spia compare combine high br amplification coverage primer isothermal bovine depth single provide', 'managing saudi coronavirus lessons oncology services arabia major br outbreak experience', 'human coronavirus 2019-ncov puzzle pathogenic br highly', 'zoonotic human coronavirus origin', 'estimating number january 2020 modelling unreported early outbreak coronavirus china cases 2019-ncov half br data-driven novel analysis', 'covid-19 lower early mortality province recognition br experience intervention jiangsu', '2019 human-pathogenic visit genomic coronavirus atypical wuhan pneumonia characterization isolate br patient novel', 'union covid-19 scenario 2020 march area potential european progression br economic epidemic', 'disease 2019 clinical coronavirus status therapy origin (covid-19)<br transmission update – br outbreak', 'emergence coronavirus development rapid vaccine 2019-ncov:<br novel biologics', 'line respiratory cell tract target coronavirus-like particle br novel', 'covid-19 sars-cov-2 research important question br', 'coronavirus br>(2019-ncov china wuhan substantial consistent initial transmission cluster human-to-human br novel infections', 'covid-19 therapeutic endocytic targeting pathway autophagy strategy br novel process', 'post-fusion resolution human 229e crystal coronavirus spike å structure core br protein 1.86', 'respiratory detection human hospitalize coronavirus tract pancoronavirus belgium infection child rt-pcr assay br nl63 novel frequent', 'score severe covid-19 case host finding 487 wuhan outside establishment risk susceptibility br', 'disease january 2020 24 case 21<br coronavirus february 2019<br>(covid-19 european region', 'human 229e plasma coronavirus strain br child haitian genome 2016 isolated complete collected sequence', 'coronavirus syndrome acute 21st respiratory associate century outbreak fight epidemic disease global world 2 track sars-cov-2 support br gis event covid-19/severe map technology geographical', 'delaware coronavirus br novel shorebirds bay astrovirus', 'covid-19 responding pandemic complex crisis humanitarian br', 'respiratory severe molecular syndrome acute sars mechanism br', 'respiratory detection virus molecular test saliva additional improve br specimen', 'covid-19 prevent estimated symptom risk effectiveness screen br spread', 'reticulum double-membrane porcine organelle deltacoronavirus endoplasmic replication spherules zippered br comprises vesicles', 'mers-cov receptor-binding therapeutics spike infection vaccines strong responses inhibits neutralizing induces protein truncated domain br potently antibody implication', 'criterium diagnostic case covid-19<br>“suspected updating ” confirm “ necessary', 'respiratory coronavirus middle east characterization biochemical syndrome helicase br', 'br>2019-ncov molecular multiple shed serological investigation infect br patient implication route', 'covid-19 department pandemic university-based br oncology radiation german statement preparation speaking', 'cell coronavirus spike host complex structure receptor ace2 sars glycoprotein br cryo-em', 'hscarg response br antiviral nadph nf-κb signaling upregulation enhances dehydrogenase sensor glucose-6-phosphate downregulation', 'patients coronavirus 2019-new review br>(sars-cov-2 infected medicine perspective br traditional treatment chinese', 'expression porcine deltacoronavirus piglet neonatal infect br profile analysis 5-day-old', 'hr2 fusion spike peptide-based hcov-229e hr1 targeting domains membrane br protein inhibitors', 'hamsters respiratory mers-cov syrian coronavirus middle east syndrome replicate br', 'corticosteroid severe precise benefit therapy 2019-ncov pneumonia potential br', 'birds strait phylogeny beringia br bering area wild prevalence coronaviruses', 'disease-2019 adequate fever coronavirus traveler return screen br', 'pan-coronavirus identification target interactome:<br sars-coronavirus-host br inhibitors cyclophilins', 'disease health right resource-poor woman reproductive emerging outbreaks:<br br setting infectious implication', 'sars-cov-2 comprehensive ophthalmology br experience chinese', 'covid-19 plasma coronavirus therapeutic approach fulminant argument br novel treatment exchange', 'health interventions public br>2019-ncov transmission risk br implication estimation', 'disease covid-19 community 2020 coronavirus team review 20<br february 6 testing 14-day br scotland', '2019 high-flow hospitalize hospital coronavirus-infected china novel pneumonia chongqing nasal br patient experience cannula', 'respiratory clinical virus patients department etiology characterization adult beijing emergency br infections attending', 'transmitted human comparison sars-cov sars-cov-2 animal-to-human systematic br coronaviruses', 'coronavirus emerging identify-isolate-inform applied 2019-ncov (3i)<br tool novel', 'cultures respiratory transgenic human airway cell epithelial virus host establishment – br study interactions primary', 'evidence covid-19 review smoke systematic br', 'coronavirus diagnostics mers transmission br epidemiology', 'efficient rna early coronavirus evasion ensure replication br endonuclease-mediated sense', 'disease influenza-associated seriousness br>(covid-19 coronavirus br assess pneumonia reference', 'covid-19 rna clinical macau sars-cov-2 evaluation patient characteristic 10<br br shed specimen', 'presence sars‐cov‐2/covid‐19 hospital looming biopreparedness br', 'pan-coronavirus br>2019-ncov spike infection previously inhibitor harbor capacity potent protein highly sars-cov-2 high br inhibition fusion target mediate membrane', 'community practice future mankind common build fighting enemy covid-19:<br br share', '2019 guideline coronavirus standard advice pneumonia rapid version diagnosis infect br novel treatment (2019-ncov)<br', 'disease immediate 2019<br covid-19 population stage coronavirus china factors psychological responses initial general br associated epidemic', 'covid-19 pain abdominal br atypical testicular presentation', 'cardiology;<br coronavirus arrhythmias cardiology,<br rhythm council electrocardiography college society clinical committee american pandemic force;<br section br association guidance electrophysiology covid-19 task heart cardiac', 'disease 2019 covid-19 coronavirus care management recommendation br intensive challenge', 'clinical sars-cov-2 sample load viral', 'disease health covid-19 public coronavirus measure br facemask shortage outbreak novel reflections', 'prognostic calf interleukin-6 serum neonatal marker br diarrhea', 'health covid-19 community frontline public ’ crisis contribution br pharmacist', 'covid-19 patients manifestations characteristic ecg br', 'covid-19 woman positive hospital case sars-cov-2 test discharge 22 day br', 'human model coronavirus spike wuhan ongoing risk protein transmission br outbreak novel evolution', 'covid-19<br patients risk-adapted strategy treatment', 'block channel coronavirus br e inhibit replication hexamethylene ion amiloride protein', 'covid-19 early stage c-reactive br protein level', 'europe covid-19 transmissibility monitoring mortality br', 'anesthesiologist covid-19', 'uncertainty covid-19 italy decision momentous br', 'classification experiment surveillance syndromic br chief multilingual chinese complaint', 'health covid-19 bell workers care tolls br chinese', 'virus traveler (2019-ncov);<br corona outbreak novel pakistan implication', 'covid-19 preventing resume period execution endoscopy meticulous screen br procedure digestive spread', 'disease covid-19 coronavirus infection comprehensive diagnosis br novel analysis', 'charge options des covid-19 du sarcomes la de proposition thérapeutiques en prise sarcome français pandémie br groupe durant', 'response target th17 emerge inhibitor cytokine jak2 covid-19:<br fedratinib storm', 'paradigm light covid-19<br pandemic neck surgical oncology reconsidering risk head br traditional treatment multilevel', 'disease br 2019-ncov kidney option therapeutic patient', 'aid public non-member covid-19 editor team medical control traumatization vicarious general member letter br', 'clinical pandemic sars-cov-2 genome feature br recent epidemiology view', 'taiwan pneumonia covid-19', 'assessment basic covid-19<br early italy numb sars-cov-2 reproduction base 0 br outbreak phase r', 'covid-19 preventing infection intra-hospital transmission healthcare br worker', 'brief useful review lung covid-19:<br ultrasound', 'covid-19 outbreak crucial psychiatrist play br role', 'covid-19 international cross br br>(icrc committee general related management dead guidance red', 'disease 2019 triage epidemic coronavirus deadly value (covid-19)<br iran service strategy br teleconsultation novel screening humanitarian', 'covid-19<br approaches pandemic maxillofacial oral surgery management br patient', 'health global concern coronavirus br outbreak novel', 'covid-19 sleep anxiety muscle relaxation progressive effects quality br patient', 'covid-19 relate monitoring insight br behavioural', 'infectious aspect diseases,<br historical', 'disease (ct)<br covid-19<br patients tomographic br>(covid-19 coronavirus progression computed pneumonia images ct', 'binding fusion target proteins receptor-activated br viral membranes', 'coronavirus diagnostics development 2019-ncov br novel racing', 'covid-19 pandemic recommendations br institute gastrointestinal aga procedures rapid', 'restage non-small cancer patient pet/ct lung 18f-fdg cells sars-cov-2<br>(covid-19 asymptomatic br uptake refer', 'covid-19 completely 2019-ncov different:<br 2020-nman', 'covid-19 2020 march 26 far know point – br mrt view', 'vocabulary chapter taxonomy 4 ontology br', 'spike-host covid-19 cell bind receptor site prediction grp78<br', 'covid-19 failure seattle kidney acute setting care br experience', 'respiratory pandemic protection br diseases epidemic', 'mapping covid-19 incidence travellers hotspot iran – br implications', 'covid-19<br student involvement response medical', 'bioterrorism viruses', 'disease 2019 covid-19 lives coronavirus courage care hemodialysis maintenance saving caution,<br br', 'migrant covid-19 refugee leave br', 'covid-19 public china transportation transmission spatial br private', 'protective global personal community covid-19 potential shortage address equipment br outbreak opinion', 'europe lesson covid-19 italian', '2019 disease covid-19 dermatologist coronavirus area potential laser surgery biological hazard br epidemic', 'virus response host sars-cov-2 dynamic', 'covid-19<br pandemic unusual wellness challenges allergist/immunologist times clinician br extraordinary', 'society covid-19<br guideline international pandemic review br gastrointestinal endoscopy update statement national', '2019 detection coronavirus consistent saliva br novel', 'frontline caution 19 pat covid healthcare doctors extreme admiration br worker epidemic', 'detection real-time coronavirus green-based development rapid emerge syndrome rt-pcr acute sybr assay br diarrhea swine', 'covid-19 clinical 2 molecular epidemiologic angiotensin enzyme feature bridge br convert', 'porcine coronavirus br aminopeptidase receptor n functional pedv', 'disease covid-19 uk coronavirus \\ufeff1 transmission br patient novel person', 'covid-19 transplant patient kidney', '5 respiratory human chapter infection bocavirus br', 'disease respiratory br>2019-ncov baricitinib potential acute treatment', 'covid-19 italy department indication therapy radiation practical letter br outbreak', 'palliative uw experience plan response inpatient medicine care creating – br covid19', 'covid-19 epidemiology diagnosis br treatment', 'covid-19 consideration pandemic important lens br contact practitioner', 'un servicio de por actividad la general y profesionales hospital digestivo sars-cov-2 pandemia br impacto del en sobre terciario aparato cirugía', 'diet health disease covid-19<br infection kidney nutrition impact management br implications', '2019 epidemiological clinical study case coronavirus china wuhan pneumonia descriptive characteristic br novel 99', \"health covid-19 response coronavirus workers care sars taiwan's br outbreak –lessons protecting\", 'health covid-19 public old br', 'clinical chest coronavirus value pneumonia characteristic br novel image ct', 'br>(covid-19 coronavirus lipids inactivate bioactive', 'commentary disease covid-19 relationship br cardiovascular', 'covid-19 importation model vulnerability preparedness country br study african', 'covid-19 clinical woman review retrospective medical record intrauterine characteristic potential infection transmission pregnant br vertical', 'covid-19 1 interferon potential type br treatment', 'rna1 virus requirement frameshift p88 mosaic necrotic replication clover cis-preferential br −1<br red product', 'covid-19 rheumatologist era br role', '38 diarrhea acute', 'disease surveillance br propagation program control distribute tool', 'covid-19 globally approach systematic contain br', 'society covid-19<br indian statement scientific rhythm risk prophylaxis heart br patient hydroxychloroquine treatment cardiovascular', 'disease department coronavirus br infection control 2019<br>(covid-19 management radiology emergency battle', 'covid-19 woman pregnant infect management br', 'covid-19 remain pandemic research quality br', 'respiratory human review research infection acute development:<br vaccine', 'severe practice 1 research benefit author(s syndrome article acute is/are direct respiratory result associate rehabilitation commercial impact financial epidemic confer medicine interest support br viral organization party', 'covid-19 physiotherapists usual business unusual time br', 'eye chapter 4 ear', 'europe covid-19 2020 international americas,<br br march facemask asia prevalence airport', 'covid-19 coronavirus antiviral chloroquine insight effect br expect', 'treat good traditional sars-cov-2 cause medicine ” “ br reply chinese harm', 'covid-19 factor risk diabetes br patient morbidity increase', 'adenosine-deaminase-catalysed viramidine prodrug design nucleoside activation drug br ribavirin implication', 'covid-19 case date 1,000,000 outside china:<br predict simple heuristic', 'ventilation covid-19 health-care makeshift hospital protection sufficient patients:<br br patient worker', 'maximizing calm response plan surgical coronavirus br>(covid-19 br novel tiered storm', 'low factor severe covid-19 infection intake risk fatal br sodium', 'concerns breathe maximizing br>(abc cancer infection control era activate breast covid-19:<br minimize heart dose', 'survey patients sars-cov-2 pediatric anti-cancer flash br infections treatment', 'molecular model sars-cov-2 chloroquine structural infection mechanism br action hydroxychloroquine study reveal', 'covid-19 strategies origin trace', 'covid-19 poverty:<br closure social child crisis school', 'injury 2 coronavirus crucial angiotensin enzyme ace2 sars – lung induce br role convert', 'covid-19 characteristics infection beijing br', 'utilize capability br>2 sars-cov-2 angiotensin receptor enzyme ace2 predicting br convert', 'covid-19 susceptible woman pregnant immunological br viewpoint', 'covid-19 present dengue mistake rash br', 'disease 2019 cos-covid clinical coronavirus core br trials outcome set', '2019 sectional mandarin coronavirus content cross youtube information source english br outbreak novel study', 'virus coronavirus begin unravel sars br', 'disease 2019 covid-19 active coronavirus smoke associate severity br', 'covid-19 bergamo italy neurosurgery department perspectives northern effects br outbreak', 'considerations covid-19 pandemic endoscopy perform br', 'respiratory severe coronavirus syndrome acute br novel', 'study clinical single-centered course china retrospective sars-cov-2 wuhan critically pneumonia observational br patient outcome ill', 'discriminant gene insight overlap feature evolutionary br viral analysis', 'covid-19 depict severity spectrum br', 'therapeutic covid-19 prevention', 'low respiratory chapter coronavirus 3 tract infection sars prevention br', 'immigration covid-19 usa:<br time act detention', 'virus animal antibodies br horse berne', 'intensive future medicine', 'asthma allergen exposure childhood development relevance br', 'estimating fatality covid-19 case rate', 'health datum wastewater sars-cov-2 potential risk source br', 'ige aerosolized virus production airway antigen-exposed infection mouse responsiveness br influenza increase', '–<br covid-19 vietnam lessons suggestion summary outbreak', 'immediate covid-19 require maintain well-being provider telemedicine healthcare br action', 'zoonotic covid-19 aspect', 'covid-19 strategies control hospitals prevention br psychiatric', 'anti-inflammatory covid-19 antiviral combine br treatment', 'sars-coronavirus interferon-beta mediate antiviral effect br protein mxa', 'lead rig-i br rome targeting mda5 therapeutic', 'immune-mediated feline br peritonitis coronaviral vasculitis infectious', 'covid-19 pandemic therapeutic br potential risk option management strategy individual', 'covid-19 medical personnel br thailand observation', 'covid-19 south severity potential transmission korea br', 'association cardiology interventions covid-19<br pandemic structural precautions coronary procedures br cardiac guidance interventional canadian', 'human oc43 coronavirus infection dominance infant br nl63', 'covid-19 managing oncology clinic distraction effect avoid br', 'safe effective calling br development mers vaccine rapid', 'disease 2019 coronavirus patient prolonged feces pediatric br shed viral', 'strategy possible covid-19 case fear xenophobia suicide prevention bangladesh br', '2019 effective coronavirus pneumonia medicine ncp br traditional novel treatment chinese', 'sars-coronavirus characterization genome encode br protein viral', 'bronchitis confer variant virus protection h120 cr88 evaluation field program infectious avian commercial base vaccine br vaccination', 'health covid-19 system pandemic spanish br resilience', 'covid-19 case brazil \\ufeff1 confirm br latin implication america', 'epidemiological clinical case sars-cov-2 finding infection characteristic br abnormal image', 'covid-19 chest adenocarcinoma cancer br lung infect feature atypical patient ct', 'delivery covid-19 guidance labor', 'physicians pandemic india telemedicine care lockdown diabetes br national covid19 period:<br guidelines', 'treat good sars-cov-2 cause medicines br traditional chinese harm', '5 hazards chapter chemical animal physical reduction biological feeds br methods', 'covid-19 multi-lead patients qt era necessary management measurement br implications screening', 'influence covid-19 mitigation course country-based br measure epidemic', 'hepa n95 control facemask filter novel factor particulate study fit-tested compare air br filtration non-fit-tested pilot high-efficiency randomise mask', 'palliative pack covid-19<br plan pandemic response care br service specialist', 'covid-19 system involvement coronavirus nervous infection br', 'acute severe syndrome respiratory', 'waveguide biosensor review br planar base optic fluorescence fiber', 'diseases covid-19 human coronavirus research br development vaccines related therapeutic agents', 'viruses chapter 2 cultivation br assay analysis', 'immediate covid-19<br practice visit vector non-emergent br cessation transmission dermatology', 'covid-19 community acquire infection br novel presentation', 'fatality case pandemic ratio influenza', 'health covid-19 molecular species basis relationship perspective br different', 'covid-19 outbreak impact gender', 'coronavirus wuhan novel thing', 'respiratory severe coronavirus syndrome acute accessory br>(sars br protein viral unique', 'respiratory severe covid-19 2 evidence coronavirus evaluation syndrome cause acute remdesivir br', 'anti-acth serum autoantibody sars br patient', 'rabbit response coronavirus histopathological immunize inactivate immune sars br change', 'health empower society mental 2019-ncov care address br epidemic', 'covid-19 response china wuhan br immune dysregulation patient', 'endoscopy covid-19 time', 'disease severe covid-19 outbreak planning pandemic ecmo infectious ards emerge provision br service', 'transmission unveiling br>2019-ncov origin', 'respiratory covid-19 coronavirus middle east br>(mers-cov pregnancy syndrome infection', 'disease taiwan search trend covid-19 case communication infectious applications risk management google br outbreak study', 'reaction detection real-time reverse generic coronavirus transcription-polymerase sybr green br assay chain', 'fever cough sars br', '2019 disease covid-19 clinical coronavirus feature br novel image ct', 'stand response china coronavirus sars 2002 br outbreak novel stark contrast', 'health covid-19 public china scientist br medical support professional statement combat', 'covid-19 pediatría coronavirus anales de infection br', 'thermometer global covid-19 emergency fever cutaneous screen non-contact br handheld infra-red', 'industry agencies coronavirus control essential importance novel health clinical partnership outbreak disease br>(covid-19 emergence laboratories br public diagnostic testing', 'accommodation covid-19 uk impacts child temporary br vulnerable', 'virus chapter feline 22 leukemia infection', 'palliative covid-19 applying children principles care communicate br', 'covid-19 pitfall pearl pocus', 'covid-19 clinical diagnostic multiple value negative test rt-pcr br image ct', 'health covid-19 community applying model communication time belief br pharmacist', 'asthma rhinovirus-induced sign childhood wheeze \\ufeff1 br infancy', 'sars-cov-2<br covid-19 pangolin origin probable outbreak associated', 'disease virus emergence permanent br change', 'respiratory severe detection profile infection child acute br viral', 'coronavirus identification metagenomics fowl guinea br novel', 'calves neonatal control treatment br diarrhea', 'enterocolitis rotavirus-associated neonatal necrotizing br outbreak', 'br>‘eagle-eyed observer nosocomial covid-19 outbreak ’ novel infection control practical promise suggestion br role experience', 'disease renal prescribe antihypertensive predictors mortality incidence newly all-cause death diabetes br patient cohort study agent', 'respiratory severe renal impairment syndrome acute br coronavirus-associated', 'aparato las infecciones del respiratorio sobre víricas neumonías br bacterianas revisión', 'inside covid-19 china answer br questions', 'sars-coronavirus human peripheral replication br monocytes/macrophages', 'post covid-19 innovation opportunity transformation orthopedic surgery br', 'disease coronavirus china 2019<br>(covid-19 healthcare infect br novel worker reasons', 'coronavirus travel threat novel health society advice traveller global january medicine latin-american – br 2019 2020 br>(slamvi big 2019-ncov interim recommendation', 'covid-19 rules decision surgical making era br set', 'health covid-19 effective communication child psychological br protecting', 'affect covid-19 psychological br intervention epidemic', 'palliative covid-19 response care br epidemic', 'health covid-19 age analysis inform metropolitan area melbourne gap delivery spatial access base identify br service disability vulnerable', 'covid-19 patients characteristics pneumonia death br diseases analysis underlying', 'learning active coronavirus ai-driven outbreak:<br cross-population train/test multitudinal/multimodal models br data tools', 'coronavirus diversity molecular bat', 'disease severe detection real-time associate development rt-pcr taqman-based assay br pig sads-cov diarrhea', 'health covid-19 system resilient high-performing br epidemic', 'un estacionalidad la de descriptivo santa estudio en colombia hallazgos esquizofrenia:<br marta br ejecutado', 'current coronavirus china king', 'virus cowpea mosaic', 'covid-19 practice lens time contact', 'n-terminal nucleocapsid coronavirus identification target domain antiviral structural basis br protein', 'covid-19 perspectives cross-disciplinary br epidemiology evolution', 'covid-19 measure contain sars br outbreak', 'covid-19 triage setting adoption low-income strategy br', 'covid-19 early patients cancer infection observations unanswered br questions', 'infection:<br covid-19 advance develope design coronavirus therapeutics immunotherapeutics emerge vaccine br prospect', 'inexpensively covid-19 trend international community-wide status infection imperative rapidly br monitor', 'covid-19 patients cases hemodialysis br>5', 'assessment 2019<br evaluate home team coronavirus sars-cov-2 approach patient br novel', 'tocilizumab antibody,<br treat respiratory case anti-il6 receptor failure:<br covid-19-related', 'coronavirus 2019-ncov pregnancy know br novel', 'chest doctor normal sars haemorrhagic-fever-like br radiograph change', 'covid-19 fight approach serostatus', 'disease possible serum biomarker severity ace ace2 predict br covid19', 'health covid-19<br system italian challenge', 'disease covid-19 coronavirus br>2019 collide crisis epidemics opioid', 'health considerations systems disease 2019 covid-19 pandemic coronavirus workers care br patients,<br cardiovascular', 'broad-spectrum discovery coronavirus antiviral drug br', '2019 basic 2020 outbreak early numb coronavirus br>(2019-ncov china novel reproduction comments phase br data-driven preliminary analysis estimation', '2019 coronavirus 2019-ncov outbreak:<br novel challenge', 'health 2004 state infection control science care br patient safety epidemiology', 'corona-steps tracheotomy covid-19<br airway method management patient staff-safe', 'university human 229e coronavirus identification surface classroom environmental clean isolation daily br touch frequently', 'covid-19 clinical woman focus pneumonia child pregnant feature br image ct', 'respiratory severe syndrome acute sars', 'covid-19 coronavirus transplantation br challenge', 'covid-19 medicine br traditional treatment chinese', 'synthesis derivative β-d-arabino vitro arabino-pyrimidinone cytostatic br furan[1′,2′:4,5]oxazolo- activity', 'health mental frontline quarantined/isolated provider issues manage care promotion relevant br patient covid19', 'covid-19 department pandemic survive surgery general br', 'virale rétrovirus des foamy simiens br d’émergence en transmission l’exemple interespèces chezl’homme afrique mécanismes centrale', 'disease case coronavirus keratoconjunctivitis medical initial 2019<br>(covid-19 br novel presentation', 'prisons covid-19 response setting comprehensive br custodial', 'action covid-19 coronavirus br outbreak novel', 'covid-19 coronavirus infection ratio asymptomatic br novel estimation', 'disease systemic ocular manifestations cats br', 'mutational organization coronavirus genome correlate sars pattern br', 'help sars-cov-2 br outbreak pharmacist', 'covid-19 outbreak response room operating singapore centre perspective heart br preparation national', 'covid-19 pandemic coronavirus recommendations sars-cov-2 kidney transplant management br patient', 'sars-cov-2<br covid-19 clinical characteristics multi-omics evaluation gastrointestinal br', 'chest coronavirus finding disease-19<br>(covid-19 ct', 'require covid-19 caution chloroquine br clarity', 'low suggest human-specific synthesis sars-cov coronavirus 2019-ncov fast codon slow protein di-codons br composition rate', 'abcd guideline feline br peritonitis prevention management infectious', 'hand covid-19 contamination precaution risk trauma br patient contagion', 'illness thrombosis platelet versatile critical br', 'palliative covid-19 families offer strategies care br patient guidance comfort clinicians', 'respiratory severe 2 coronavirus sars-cov-2 disease-2019<br>(covid-19 syndrome acute br epidemic challenge', 'hajj university', 'tomography covid-19 review meta-analysis systematic findings computed br', 'palliative br>– covid-19 action conservative care management emergency patient', 'anti-inflammatory disease severe clinical coronavirus perspectives china immunologist 2019<br>(covid-19 drug br treatment', 'chapter neonatal 91 care management br lambing', 'epidemiological clinical human coronavirus subset infection feature br patient different', 'non-carbohydrate-based acid crystal domain catalytic complex structure perfringens neuraminidase br inhibitor,<br>2-(cyclohexylamino)ethanesulfonic clostridium', 'human drug coronavirus fk506 inhibit replication hcov-229e sars-cov,<br hcov-nl63', 'epizootic ferret molecular catarrhal coronavirus associate characterization ece enteritis br novel', 'possible suspension human 229e coronavirus onsurfaces infection survival dry oc43<br source br ofhospital-acquired', 'covid-19 cell stem pneumonia management mesenchymal br', 'radiologic covid-19 result emerging poisoning perspective br outbreak methanol', 'low respiratory bacterial identification tract infection adult br', 'health covid-19 medicine transfusion care br paradigm change expect', 'leading edge insanity', 'numerical entry', 'coronavirus bottle 2019-ncov genie br', 'covid-19 prevent appropriate home isolation br spread', 'secrete induce sars-cov peptide antigen volvulus ovalbumin hiv-1<br polypeptide helminth potent recombinant adjuvant br protein rov-asp-1 onchocerca antibody', 'covid-19 ade attribute soon', 'covid-19 risk occupational infection', 'cyclosporin derivative human 229e nucleocapsid non-immunosuppressive coronavirus replication viral br protein influences cyclophilins cellular', 'chapter cat thin inappetent 18', 'covid-19 children emotional br behavioral epidemic disorders', 'bronchitis chapter 31 acute cough br productive', '2019 affect disease animals ocular coronavirus review humans (covid-19)<br eyes br coronaviruses implications', 'health public community quick br>2019-ncov outbreak coronavirus emergency br action pharmacist', 'suggest sars-cov cloaked anti-sars strategy br hiv-1 similarity', 'herd-level factor dairy cow herd mortality associate swedish risk br', 'covid-19 hospital respond outbreak:<br organise challenges french centre issue br experience reference', 'disease international coronavirus china travel 2019<br>(covid-19 importing air', 'disease covid-19 editor coronavirus occupational skin healthcare letter br worker epidemic', 'covid-19<br oncology pandemic- radiation 4r thoracic bracing impact br provincial consensus', 'covid-19 close china track contact jiaxing cluster investigation management prevention br role', 'implementation covid-19 practice patients survive rapid telehealth crisis quality br thrive helping', 'covid-19 coronavirus review meta-analysis wuhan br infection systematic prevalence novel comorbidity', 'university covid-19 based china propagation date prediction dynamics return students br outbreak optimal', 'covid-19 departments infection control radiology br', 'mortality therapy host-directed option reducing 2019-ncov:<br', 'endemic divergent rna human dependent polymerase antiviral inhibit spectrum remdesivir broad deltacoronaviruses zoonotic br highly', 'taiwan quarantine-qualified covid-19 outbreak wuhan evacuation – br national experience', 'chapter cavity fluids 6 body', 'society british consideration diagnostic algorithm design covid-19 pandemic statement image thoracic imaging br local', 'covid-19 china cases transplantation heart br', 'covid-19 public gender-specific datum january surveillance shenzhen china 2020 15 february kong hong difference:<br 10 br analysis', 'cure disease prevent imod br infectious medicine immunomodulatory ™ effect arbidol combination novel influenza increase', 'receptor-binding coronavirus spike protein sars recombinant br ability antigenicity', 'respiratory chapter 16 infection potential oil treatment br agent volatile', 'common cold sinusitis', 'current covid-19 pandemic caring child singapore disorder perspective br eat adolescent', 'covid-19 case vietnam \\ufeff1 infant secondary transmission br acquire', 'chloroquine/hydroxychloroquine concern covid-19 ophthalmological br', 'spread covid-19 inequality', 'distention chapter abdominal 22 cat fluid br', 'era covid-19 death pandemic', 'asia dialysis-related bacterial peritonitis aetiology centre 10 year south-east br experience change peritoneal', 'taiwan covid-19<br editor letters ” “ pneumonia reply', 'covid-19 maintain pandemic education residents technology br', 'newborn viral infections', 'silencing expression cell rna sars-cov spike br protein interference culture', 'coronavirus strategies emerge control sars decade br', 'core:<br fusion coronavirus characterization structure hcov-229e basis membrane br implications', 'covid-19 pandemic control', 'covid-19 case lessons apply diagnosis sars management br canada', 'covid-19 perspectives time surgery br safety', 'disease covid-19 br patient cardiovascular', 'british covid-19 society statement thoracic update imaging br radiologist', 'health covid-19 student international perception travel australia risk – br implication chinese', 'bovine virus breda studies', 'bronchitis virus brazilian a/j strain infectious infection balb/c massachusetts ibv mouse experimental br inbreed', '2019-ncov infection transmission germany asymptomatic br contact', 'respiratory severe function retrospective derangement live syndrome acute br analysis', 'nosocomial covid-19 outbreak infection control ed minimize healthcare strategy br integrated worker', 'assessment covid-19<br model e-ishr 3-staged outbreak preliminary', 'microneedle coronavirus translational array rapid development immunogenicity deliver recombinant br vaccine', 'invasive covid-19 ventilation undergo bundle ” “ non br patient helmet', 'respiratory severe coronavirus 2<br syndrome group acute relationship monophyletic br coronaviruses', 'system chapter nervous 7 diseases', 'intranasal upper respiratory prevent otitis doe infection fluticasone acute child br viral medium propionate', 'mechanisms cell tissue damage 8', 'endemic covid-19 china cancer period implement br patient radiotherapy', 'survey dairy comparison gel test rotavirus infection commercial herd:<br br polycrylamide electrophoresis', 'integrative disease current 5th trend seminar think infectious emerge march 22,<br>2016 proposal proceedings – br fight', 'respiratory immunogens:<br severe design peptide syndrome acute prototypic vaccine br novel analysis nanoparticles', 'covid-19 chloroquine', 'assistance covid-19 exposure additional healthcare br situation worker', 'rational covid-19<br pandemic mask face', '2019 mers-cov coronavirus review lesson sars-cov insight update intrim br novel', 'steroid-associated 14-years convalescent herbal follow-up formula patient sars head huo-gu br osteonecrosis femoral treatment chinese', 'disease covid-19 early serial numb coronavirus reproduction determine interval br outbreak novel estimation', 'covid-19 emerging mers story sars coronaviruses decades:<br', 'clinical tomographic coronavirus sars-cov-2 pneumonia cause compute feature br novel image', 'cure global covid-19 panic promise', 'health evidence covid-19 public inform uk response transparent br', 'safely covid-19 sichuan china effectively tip intubation perform tracheal br patient experience', 'covid-19 predict accurately difficult br epidemic', 'coronavirus structure genome replication', 'disease rrt-pcr br>(covid-19 coronavirus diagnosis ct', 'virus fever coronavirus infection control acute novel respiratory a(h7n9 emerging east pathogenic highly disease middle a(h5n1 avian issue br hemorrhagic influenza ebola focus br>(severe lassa infectious syndrome-cov', 'aid public non-member covid-19 team medical control traumatization vicarious general member br', 'covid-19 sogc pregnancy committee – opinion', 'covid-19 infection cluster asymptomatic br familial', 'covid-19 psychoneuroimmunity', 'acid detection nucleic advance coronavirus perspective br recent', 'respiratory severe theoretically shenzhen guangdong,<br china syndrome 2003 estimate acute transmission risk blood br transfusion epidemic', 'manifestation tomography covid-19 age infection compute br patient different high-resolution', 'covid-19 department coronavirus know endoscopy br outbreak', 'respiratory epitope severe cell b disease-specific serologic detection antigen peptide serum syndrome acute sars epitope-based br patient antibody', \"covid-19 mental trainees'<br pandemic safeguard hopelessness resilience:<br importance wellbeing helplessness\", 'covid-19 good fear urgent science – br outbreak silence', 'manifestation covid-19 br imaging multiplanar pneumonia role ct', 'covid-19 ascertainment high-incidence case uk pneumonia insight management br role ct region', 'nerves cranial chapter 126 brain br diseases', 'covid-19 promising system blood-purification artificial-liver targeted therapy br anti-cytokine-storm', 'covid-19 melatonin potential adjuvant br treatment', 'coronavirus home shenzhen china br incidence infection quarantine novel (2019-ncov)<br', 'covid-19 changes histopathologic immunostaining cov-2<br lung sars – patient', '2019 disease covid-19 coronavirus review br literature', 'covid-19 early model control transmission dynamic br mathematical study', '2019 person-to-person coronavirus br associate indicate transmission family cluster pneumonia familial novel study', 'pathogenesis disease covid-19 coronavirus br outbreak epidemiology', 'pathological covid-19 respiratory finding associate syndrome acute br distress', 'bronchitis treat fluoroquinolone antibiotics?<br acute chronic exacerbation br patient advantages', 'covid-19 learn italian future lesson infection diabetes br experience', 'health covid-19 mental staff medical sas sds br outbreak screening chinese', 'alter function relate pain syndrome fibromyalgia modulation disorder limbic br', 'disease prepare 2019 covid-19 coronavirus u.s. hospitals br', 'disease covid-19 chest editor coronavirus letters finding ” “ br reply ct', 'pharmaceutical clinical hospitalize hospital ’ guidance recommendations care covid-19:<br br patient experience pharmacist', 'covid-19 clinical characteristics province cases descriptive multicenter imported br study jiangsu', 'mers-cov sars-cov-2 infection rt-pcr scan vs. diagnosis reflecting base br experience ct', 'detect madagascar gammacoronaviruses bird wild br diverse', 'treat covid-19 guideline review identification herbal rapid medicine pattern br', 'covid-19<br device wastewater-based sources trace paper-based epidemiology', 'expression human function-related sars-cov gene immune regulates cells br monocytic', 'anti-chinese 2019-ncov br outbreak sentiment', 'pathogenesis covid-19 involvement plan diagnosis,<br br time musing vaccine corona treatment', 'covid-19 victim urgent collateral crisis surgery br digestive', 'line disease pathogenesis clinical cell human emc/2012:<br manifestation emerging betacoronavirus 2c implications susceptibility br novel differential', 'good chapter loss weight cat appetite 17 br', 'upper respiratory chapter infection viral 18', 'chapter sar/qsar approaches br>3c-like comparative structural insight viral br 11 inhibitors protease', 'covid-19 patients know gastroenterologists br', 'upper respiratory detection covid-19 tract sample strategy br experience different', 'covid-19 hospital staff attitude medical regard knowledge br psychiatric chinese', '2019 epidemiological clinical case coronavirus infection child series feature br novel', 'covid-19<br chest repeat necessitating pneumonia ct', 'covid-19 basic clinical connection research infection diabetes issue special br', 'block interaction coronavirus emodin spike 2<br enzyme sars angiotensin-converting br protein', 'covid-19 death pathway br patient', 'seasonal b brazil patterns relevance vaccine circulation br composition influenza', 'disease invasive covid-19 prepare fungal br', 'disease respiratory human children coronavirus hospitalized china infection kong acute hong br nl63 infections', 'human genetic 229e coronavirus deficiency polymorphism replication essential br role cyclophilin reveal', 'production human cell culture coronavirus epithelial glycopyrronium,<br effect nasal budesonide replication hcov-229e cytokine formoterol tracheal br inhibitory primary', 'hand rational covid-19<br pandemic hygiene', 'double model propagation sars br epidemic', 'covid-19 outbreak patients high-risk br cardiac protecting', 'chapter cavity fluids 6 body', 'clinical human coronavirus feature phylogenetic br analysis', 'health evidence community covid-19<br public decision surveillance pandemic animal toolbox br control – opening improve epidemic', 'health global 2019 world br>(covid-19 organization review coronavirus declare emergency br novel', 'clinical caused virus china features beijing a(h1n1 pneumonia 2009<br influenza', 'acute covid-19 leukemia time', 'analysis br>2019-ncov coronavirus usage species br receptor enzyme cross-species angiotensin-converting light shed novel 2<br>(ace2 different', 'visitation calf human performance replacer calve milk effects feed br level growth different', 'astroviruses 50 chapter', '2019 possible incubation indicating person-to-person coronavirus period novel infection transmission cluster br familial associated', 'line global covid-19 solidarity hold china br outbreak', '2019 disease covid-19 pandemic coronavirus pregnancy br', 'covid-19 high-flow randomise fibreoptic critically pneumonia trial control nasal-oxygenation-assisted intubation prospective tracheal br patient ill', 'covid-19 gathering – role mass', 'association severe nasopharyngeal species rhinovirus microbiota infant bronchiolitis br', 'embryonated eggs propagation isolation br coronaviruses', 'health public time emergency br covid19', 'low mers-cov– risk canadian', 'considerations covid-19 scai pandemic coronavirus laboratory catheterization br council interventional acc', 'covid-19 clinical hospital iranin shahid decease evaluation khomeini infection paraclinical feature mostafa br patient experience ilam refer', 'health fatality covid-19 characteristics china infection br outbreak worker', 'human coronavirus research mers sars 10 year pathogenic br highly', 'park coronavirus br diversity infection tanzania genotype wild serengeti prevalence national carnivore', '13 rna cell human identify coronavirus tissue receptor type single br sequence', 'dog netherlands system detection serology antigen coronavirus br rotavirus parvovirus infection assay immunosorbent enzyme-linked', 'disease 2019 nursing department coronavirus contingency management strategy br patient centralize rescue', 'gastrointestinal 7 chapter emergencies', 'covid-19;<br confounded patients causal ibuprofen safety', 'population covid-19 perceive mental pandemic attitude indian anxiety healthcare knowledge br study', 'disease covid-19 patterns pandemic vulnerability doe matter size – fit br resilience heterogeneity', 'injury covid-19<br inflame sars-cov-2 importance myocardial heart br patient awareness', 'chapter 52 disorders otolaryngologic', 'health sars-cov-2 perspective br outbreak', 'vírica coinfección respiratorias las infecciones en infantiles br', 'supporting covid-19<br pandemic clinicians', '2019 evidence current br>(covid-19 review coronavirus base novel', 'disease respiratory covid-19 clinical severe taiwan comparison coronavirus syndrome characteristic acute sars br experience', 'covid-19 clinical coalition post-exposure test advocacy trial potential prospective br hydroxychloroquine', 'disease covid-19 biologic initiation inflammatory outbreak bowel screen br patient viral', 'health migrant covid-19<br response refugee', '2019 disease (covid-19):<br coronavirus invisible hospitals protecting', 'case safe sars-cov-2 br 14<br infection day isolation asymptomatic enlightenment', 'brief mas chapter br history 21 7 angiotensin-(1', 'detection 1 bats reverse coronavirus reactions group universal polymerase br transcription coronaviruses chain', 'neutralization safe sars-cov development characterization assay br s-glycoprotein', 'membrane aminopeptidase 69 alanyl', 'europe covid-19 endpoint colombia br different', 'covid-19 decision time cancellation gathering (mgs)?<br mass', 'patients br>19 anesthetic procedures covid management emergency infections', 'n-gram bacterial genomic characterization genome br island', 'surgical covid-19 community response', 'health covid-19 mental pandemic medical br workers pakistan outbreak', 'factor clinical covid-19 course china retrospective mortality inpatient adult risk wuhan,<br br cohort study', 'health migrant covid-19 international br worker epidemic neglect', 'mers-cov bind human cd26 molecular coronavirus receptor basis br novel', 'mers-cov respiratory virus help middle east center syndrome single initial radiology br experience corona', 'covid-19 medium message', 'nutritional gut function dairy colostrum wean review invited calve regulation br', 'covid-19 staff help medical control traumatization br', 'respiratory severe pertinent clinical characteristics therapy syndrome acute br', 'coronavirus identification novel bats', 'travel-related illness', 'political global covid-19 public health event gather far reduce dilemma br mass spread', 'treat icu covid-19 china wuhan pneumonia symptom cluster br patient nurse', 'presentation,<br clinical infection control measures sars management epidemiology', 'health prepare covid-19<br>(sars-cov-2 past public future epidemic lessons pan-african implication ongoing africa br outbreaks,<br tackle effort', 'art covid-19 society italian fertility reproductive sterility medicine br view', 'anti-inflammatory coronavirus exert lianhuaqingwen anti-viral br br>(sars-cov-2 novel activity', 'covid-19 inform learn lesson critical care perspective br viral epidemic', 'disease covid-19 coronavirus spectrum findings progression br temporal ct', 'covid-19 acupuncture edition)<br moxibustion caam intervention issue second br guidance', 'covid-19 outbreak ’ urologists singapore efforts br stepping forward', 'sars-cov-2<br lethality italy atmospheric northern co-factor pollution extremely high br level consider', 'respiratory severe human brazil coronavirus infection acute br southern', 'traffic model revelation exploitation br viral intracellular', 'disease cured covid-19 case 13<br 86-year-old chronic', 'advance china target 2019-ncov promise br agent', 'covid-19 responding communication important protocols crisis symptom clinicians management br patient tools', 'covid-19 cancer time war care br fronts', 'putt world alert coronavirus br novel', 'disease covid-19 inflammatory bowel paediatric challenges time br', 'respiratory severe clinical 2 reactivation coronavirus syndrome characteristic acute br', 'disease 2019 genomic coronavirus sars-cov-2 diversity br patient', 'illness covid-19 forget pandemic essential care critical br', '2019 disease covid-19 current future coronavirus status perspective br', 'appropriate coronavirus sars-cov-2 br', 'manifestation infection gastrointestinal br hiv', 'disease active prototype system design surveillance track emerging/notifiable infectious control card on-line healthcare mechanism base br national', 'covid-1 current maintain effective save response live telemedicine structure healthcare br system:<br', 'health covid-19<br system link community pharmacy proposal br patient suspicious route', 'covid-19 manifestations liver gastrointestinal br', 'covid-19 china wuhan glucose blood management diabetes br patient', 'health learn covid-19 coronavirus lessons madrid spain live crisis br week change', 'disease possible covid-19 torsadogenic coronavirus pharmacotherapies 19 urgent qtc-prolonging potential navigating br circumventing guidance', 'covid-19 picture depict br d(2)ea epidemic', '2019 disease covid-19 coronavirus china perspective care critical br', 'covid-19 system initiation infection control br outbreak', 'health covid-19 mental patients disorder br epidemic', 'global covid-19 early transmissibility discourse impact br preprints epidemic', 'disease elimination coronavirus 2:control education infection dental maintaining care br outbreak specialist', 'covid-19<br pandemic weather jakarta indonesia correlation', 'commentary covid-19 patients diabetes br', 'coronavirus ready', 'proteases 3c inhibition 3c-like structural compounds zinc-coordinating basis br peptidomimetic specificities', 'chapter 42 cat weak ataxic paralyze', 'covid-19 propagation prediction br analysis', 'covid-19 resource hubei supply mortality wuhan medical timely critical br role analysis reveal', 'global pandemic coverage sars-cov-2 progression relevant br bcg vaccination', 'possible covid-19 review systematic immunotherapy br', 'disease respiratory illness human pulmonary coronavirus older acute chronic adults obstructive br', 'respiratory severe italy case coronavirus br syndrome adult radiological uncommon 2019-novel distress presentation', 'coronavirus propagated gastroenteritis non-bacterial br patient', 'detection human coronavirus identification rt-pcr comprehensive include single sars-associated br assay', 'covid-19 ’ pandemic response br healthcare hemodialysis heel states united achilles', 'available chapter practice issues 22 extent,<br pharmacy personnel effectively information pharmacists access source quality br', 'disease 2019 possible anaesthetist anaesthesia single-centre coronavirus transmission spinal observational retrospective,<br br patient cohort study rate', 'open-label covid-19 non-randomized clinical result trial azithromycin br hydroxychloroquine treatment', 'covid-19 qualitative patients caregivers psychological br experience study', 'collision covid-19 addiction epidemics br', 'diarrhea 35 approach', 'covid-19 clinical non-imported import dynamic feature load br patient viral', 'cat 45 chapter lameness', 'br>2019 coronavirus cross-species insights novel evolution', 'macaques model animal coronavirus br infection rhesus mers produced', 'poor university factor severe hospital pneumonia child rabat risk admit br morocco outcome clinically', 'require virus porcine cell br aminopeptidase diarrhea n epidemic entry', 'alarm coronavirus create situation br worldwide novel spread', 'sars-cov-2<br covid-19 italy case molecular characterization \\ufeff1', 'commentary health global world 2019<br covid-19 organization review coronavirus invited declare “ emergency br novel reality', 'severe clinical covid-19 course mortality risk br', 'corona life pandemic', 'suspension covid-19<br outbreak saudi pilgrimage curb temporary umrah arabia`s measure', 'associate coronavirus-like particle br diarrhea swine', 'covid-19 pandemic old cancer challenges management br patient', 'long-term human sclerosis multiple t-cell coronavirus-myelin derive br patient cross-reactive clone', 'flu sars bird', 'patient covid-19<br diarrhea occurrence', '2019-ncov pregnancy epidemic', 'disease learn future lessons 2019-ncov infectious prevention br epidemic', 'covid-19 review chloroquine safety systematic br efficacy treatment', 'government advisory pandemic rejection cognitive bias covid19 br operate safety', 'context ipc covid-19 status infection control professional improve prevention br', 'respiratory 44 virus antiviral drugs br infections influenza', 'covid-19 pandemic laboratory br implications cytology', 'covid-19 routine childhood protect br immunization', 'pathogenesis covid-19 phenotype genotype br role', 'health public international coronavirus oncology radiation operation facility emergency br novel guidance', 'covid-19 clinical practice hospital br acute management physiotherapy set recommendation', 'china burden proper importance management br copd', 'infectionwith management evolve clinical drug disease etc issue diabetes br patient hypertension presentation contentious covid-19 concept co-morbid therapeutic reference', 'genetic sars-cov-2 diversity origin glimpse br', 'chapter international 3 emerging traveler br diseases', 'perceptions survey covid-19 public kingdom cross-sectional general knowledge online br united states', 'italian alpha-coronavirus species characterization genome br novel bat', 'small chapter sign bowel cat chronic 33 br diarrhea', 'respiratory severe coronavirus syndrome structural acute protein br 3a novel', 'patients coronavirus particles gastroenteritis fæces br', 'require covid-19 affect herd epidemic estimate country – br level immunity halt', 'respiratory severe coronavirus responsible characterization syndrome acute br novel', 'respiratory severe coronavirus discover newly cause syndrome acute br primary', 'global molecular 2019-ncov evolutionary br analysis spread', 'preparedness global covid-19 generate', 'taiwan sars-cov-2<br transmitted case locally infection', 'cell antibody-secreting enumeration porcine piglet rotavirus isotype-specific inoculate gnotobiotic br derive', 'humans animals hazardous 134', 'covid-19 pandemic social panic travel fast br outbreak medium', 'severe covid-19<br event anthropogenic br pollution reduce avoid air outbreak activity', 'production porcine improvement epidemic agent stimulate vaccine br diarrhea', '2019 coronavirus china province retrospective population-level control wartime br measure novel study epidemiology jiangsu', 'trachea coronavirus replication bovine organ foetal br culture', 'hemagglutination coronavirus associate structural infant polypeptide mouse br diarrhea', 'radiologic manifestation covid-19 chest admission review literature br ct:<br single-center comprehensive pneumonia radiograph study ultrasound', 'covid-19 clinical 1 pandemic cancer trial br conducting phase', 'datum br>2019-ncov drive epidemic case track time-dependent transmission br study rate', 'health influence covid-19 response anxiety authority decision-maker know care professional br outbreak viral', 'production monoclonal intrasplenic sars-cov spike dna plasmid single br protein immunization antibody', 'animal emerging mers sars br coronaviruses', 'prime regimen high persistent response coronavirus neutralize ad5-s br mva-s heterologous sars induce boost level antibody', 'health covid-19 animal coronavirus perspective medicine veterinary br teach', 'human chapter host milk 163 immunology br immunity', 'disease respiratory affect sars-cov-2 infection chronic risk br treatment', 'covid-19 mitigation pandemic washington resident training therapy radiation transmission care king county balancing br patient', '2019 disease covid-19 burnout coronavirus emotional wellness prevention br micropractices', 'pandemic china coronavirus wuhan 2019-ncov syndrome br', 'covid-19 embolus pulmonary segmental coronavirus br associate infection acute hemoptysis pneumonia novel', 'internationally covid-19 lose case', 'diarrhoea rotavirus characterization venezuela isolate br pig', 'role br>(covid-19 coronavirus diaspora traveler ready romanian incoming br outbreak novel face romania', '2019 patients coronavirus china pneumonia br novel', 'virus-specific rna convalescent-phase patients discharged hospital sars br antibody', 'importation coronavirus vietnam transmission human-to-human br novel', 'injury evidence corticosteroid clinical doe 2019-ncov support lung br treatment', 'respiratory severe person-to-person coronavirus syndrome know acute transmission br usa 2<br>(sars-cov-2', 'context covid-19 local monitoring transmission widespread br epidemic', 'great covid-19 sars-cov-2 body outside shell disorder fluid predict br resilience analysis', 'health implementation system environment education evaluation occupational laboratory management high br safety', 'covid-19 clinical consideration time diabetes br patient epidemic', 'covid-19 running division pandemic virtual program time allergy br train', 'health possible public sars-cov-2 discharge endanger prolong br stool', 'chapter 77 pulmonary cell hematopoietic stem transplantation br complications', 'covid-19 utilization dental impact emergency br service epidemic', 'injury evidence covid-19 clinical china wuhan suspected myocardial br patient observation front-line', 'human molecular coronavirus genomes br evolution', 'population age human genetic 2007<br 2009 variability cambodia br metapneumovirus', 'kinetic covid-19 model infection mers sars br mathematical analysis', 'sars-cov-2<br human neutralizing antibodies coronaviruses', 'explain epidemiological covid-19 host finding polymorphism infection enzyme angiotensin-converting br', 'search covid-19 effective therapy', 'chapter crocodilian diagnosis br 41 differential', 'manifestation clinical sars-cov-2 pregnancy infection br outcome', 'inpatients coronavirus pneumonia psychiatric risk hospitals prevention br novel infections', '5 chapter food communication safety risk management br role analysis', 'disease 2019 virus retrospective br combine lpv/r versus arbidol cohort study corona', 'covid-19 italy', 'covid-19 city china br infection 122 ambient association temperature', 'mers-cov infection:<br covid-19 coronavirus sars-cov-2 asymptomatic', 'repatriate quarantine replace sars-cov2 testing laboratory-based br traditional', 'hospital br>(covid-19 coronavirus potential risk pneumonia outbreak novel', 'surgeon hospital accreditation br experience canadian', 'health covid-19 mental staff china medical care br outbreak', 'disease 2 enzyme lung angiotensin-converting br', 'derivative coronavirus br>(2019-ncov fractional modeling dynamic novel', '2019 disease covid-19 obstetrician coronavirus pregnancy know br', 'covid-19 molecular france amino-acid sars-cov-2 characterization \\ufeff1 deletion cluster br asp268del nsp2 reveal', 'reporting covid-19 judgment br consequences dissemination rush results rapid hydroxychloroquine', 'covid-19 anaesthesia infection control', 'covid-19 health-care model closure mortality workforce impact net br school study', 'hand require prevent case hygiene information effectiveness hospitalization provision br influenza', 'respiratory severe relatives close human 229e coronavirus bats ghana syndrome acute distant br', 'power covid-19 control deciphering isolation br outbreak', 'synthesis cyclocondensations 2-arylsulfonyl-3-ethoxy-2-en-1-ones 3 br>1,3-bis(silyloxy)-1,3-butadienes 4-(arylsulfonyl)phenols br regioselective', 'respiratory clinical coronavirus middle east br syndrome infection management improve', 'covid-19 pandemic burn management ward strategy br', 'covid-19 drug br alternative teicoplanin treatment', 'covid-19 response nicaraguan time love br negligence', '2019 coronavirus kidney br novel epidemic', 'disease pre-exist covid-19 br patient implications digestive', 'sars-coronavirus theory colony ancestor refuge foot-prints south-east asian br bat', 'malaria-endemic covid-19 pandemic preparedness essential br region', 'covid-19 system renin-angiotensin', 'taiwan flu covid-19 link case central season epidemiologic center medical featuring screen symptomatic br patient', 'case coronavirus 2019-ncov kong far hong br novel implication spread', 'encephalomyelitis chronic antibodies mumps intrathecal br specific increase', 'inactivation coronavirus sars stability br', 'water efficient synthesis br>3,3-di(indolyl)indolin-2-ones supramolecular catalyst br oxindoles β-cd sulfonated catalyze br>3-indolyl-3-hydroxy', 'know sars-cov-2 outbreak', 'covid-19 model india healthcare impact br mathematical stochastic epidemic', 'preventing coronavirus ai augmented detecting intelligence br role novel spread', 'covid-19<br pandemic neuromyelitis spectrum disorder optica immunosuppression br patient challenge', 'viruses evolution', 'rna chapter 16 negative-strand viruses', 'pharmaceutical covid-19 practice hospital supply care drugs management br designate epidemic', 'sars-cov-2:<br antibodies specific profile', 'prepare forum pandemic lancet br influenza', 'hand pandemic coronavirus hygiene healthcare br role novel worker', 'health covid-19 world coronavirus br novel epidemic', 'respiratory reaction human 229e oc43 coronavirus br diagnosis polymerase direct chain', 'pass covid-19 br inflection point', 'cardiopulmonary chapter conditions 6', 'loss hearing note covid-19', 'neurological common approach cat practical weak br differential', 'health taiwan covid-19 system putting resiliency test br', 'detection previously fusion sars-cov-2 br 2019-ncov random panther access protocol open rapid sars-coronavirus-2 novel', 'sars-cov-2 emetine inhibit replication vitro remdesivir br homoharringtonine lopinavir', 'covid-19<br china lesson control hope', 'human 229e coronavirus identification gene polymorphism br>(aminopeptidase n/cd13 receptor br', 'child covid-19 eye meet', 'low covid-19 resource br severity setting tool scoring', 'chapter production safe food biosecurity strategies controlled backyard poultry br way 14', 'patients anesthesia coronavirus perioperative infection control management br novel', 'covid-19 system italy response medical milan emergency br outbreak', 'simple test high-throughput 19 covid fast br', 'covid-19 br endoscopy unit pathway separated patient', 'flu covid-19 learn italy act br', 'covid-19 response cancer recommendations br radiotherapy prostate', 'covid-19 exercising time wall br expert recommend', \"disease lymphocytic virus associate live syndrome sialadenitis sjögren's hepatitis chronic c br\", 'interventions early model sars-cov-2 mitigate singapore br study spread', 'pharyngitis', 'juss antimicrobial chemical aureus sinensis pro-apoptotic sgc-7901 oil leave essential toona roem effect br composition staphylococcus a. activity', 'sirc control outbreak optimal epidemic', 'health covid-19 department neck otorhinolaryngology surgery care prevention head br suggestions worker', 'case sars-cov-2 infection family cluster asymptomatic br', 'respiratory severe community-acquired infection adult care management critical br viral', 'current covid-19 afghanistan br situation', 'tocilizumab possible covid-19<br osteonecrosis opportunity interleukin-6 br inhibitor receptor therapeutic patient correlation jaw', 'covid-19 woman infection risk pregnant br', 'fusion characterization structural hcov-229e core br', 'evolution human nl63,<br coronavirus mosaic structure thousand years', 'health application public architecture alpha project leverage br', 'detection dromedarius pancoronavirus \\ufeff1 pcr iran br camelus', 'factor covid-19 infection risk ace2 overexpression br', 'covid-19 mundial emergencia una salud de pública br', 'respiratory severe clinical fever vis-à-vis onset syndrome features acute laboratory br', 'society tomography covid-19 pandemic amidst computed br cardiac guidance cardiovascular', 'covid-19 clinical comparative pneumonia feature br study', 'br>‘host ’ coronavirus spike sars-cov mers-cov,<br determine feature bat-to-human jump', 'nelfinavir coronavirus inhibit inhibitor replication sars-associated br hiv protease', 'coronavirus china infection control emerge preparedness br measure novel proactive', 'current prophylactic chapter treat therapeutics approach pneumonia 17 br', 'integrative covid-19 consideration pandemic br', 'containment health community public outbreak coronavirus br>(2019-ncov social pivotal br measure isolation distance old-style quarantine role novel', 'covid-19 pandemic ophthalmologists preparedness br', 'innervation syndrome acute rtx resiniferatoxin respiratory prognosis improve afferent disease advance pulmonary state propose br patient outcome poor covid-19 review role distress', 'covid-19 chest disease-19 coronavirus finding update br ct', 'coronavirus 3rd 2019-ncov century update br outbreak novel 21st', 'health covid-19 mental china br service epidemic online rethinking', 'protective tests personal environment sars-cov-2 room infection infant isolation equipment br', 'channel coronavirus e form cation-selective sars ion br protein', 'cell dendritic murine response coronavirus interferon infection plasmacytoid sars br', 'covid-19 option challenge br treatment reality', 'evidence severe clinical covid-19 patients antiviral benefit rapid infection clearance azithromycin br combination hydroxychloroquine', 'respiratory discovery fusion coronavirus middle east syndrome inhibitor structure-based br', 'global covid-19 access vaccine ensuring', 'genomic identification coronavirus sars-cov-2 hotspot br novel hyper-variable', 'assessment community chapter services br dispensing pharmacy extended medication 18', 'virus scv 2,6-bis-arylmethyloxy-5-hydroxychromones coronavirus antiviral hepatitis c hcv sars-associated br activity', 'respiratory mers-cov emergence coronavirus middle east syndrome br', 'disease-2019 manifestation disease case coronavirus retrospective severity 73 br analysis ct', 'covid-19 woman pregnant br central america', 'pharyngeal covid-19 patients feces conversion br samples sars-cov-2–positive sputum', '1 epidemic coronavirus deadly education begin infection dental maintaining care br outbreak viral specialist', 'disease global health coronavirus 2019<br>(covid-19)—an emerge threat outbreak', 'respiratory learn severe coronavirus lessons syndrome acute br outbreak epidemic', 'adenoviruses gastroenteritis countries enteric rotaviruses br infantile', 'covid-19 virus pandemic lessons learned br', 'mutant crystallographic human 229e coronavirus crystallization 15 x-ray nonstructural br protein preliminary analysis', 'disease health covid-19 coronavirus 16 –the jth transport br editorial implication', 'open-label covid-19 control favipiravir experimental br study treatment', 'covid-19 search develope review india narrative chloroquine systematic special country diabetes br hydroxychloroquine treatment reference', 'factor seropositivity virus herd associate transmissible 1989–1990 gastroenteritis demographic management br swine', 'covid-19<br oncology radiation service singapore navigating perspective br outbreak challenge', 'discrimination covid-19<br racism response', 'disease considerations 2019 triage patients pandemic coronavirus /scai statement referred (covid-19)<br structural heart br intervention consensus acc', 'covid-19 wuhan care major br outbreak radiotherapy', 'taiwan covid-19 response br initial rapid outbreak experience proactive', 'covid-19 clinical chest patients characteristics china infected features jiangsu br ct high-resolution', 'health chapter needs underutilized food ancient species 9 fruits ingredients:<br nutraceuticals br alternative functional', 'injury covid-19 multi-organ br treatment comorbidities', 'hand disease factor detection influence severe molecular mouth child foot mild assay br', 'covid-19 pandemic physician gi preventive strategy br', 'phylogeny viruses', 'respiratory obstetric guideline severe neonate mother 2009 syndrome bear probable acute no.<br>225 sars management suspect br patient april', 'influence covid-19 cird-f china br spread', 'lvad severe covid-19<br durable ards cytokine support imperfect patient storm', 'review disease-2019<br>(covid-19 coronavirus', 'human 229e nucleocapsid coronavirus domain carboxyl terminal br protein oligomerization', 'covid-19 staff common emotional medical impact br', '2019 case nepal coronavirus \\ufeff1 novel', 'respiratory factor coronavirus middle east incidence syndrome br climate', 'covid-19<br pandemic care maintaining hiv', 'covid-19 pandemic transplantation donation organ dilemma br', 'respiratory progress,<br china opportunities challenges medicine', 'clinical positive case china retrospective sars-cov-2 wuhan center infection characteristic laboratory confirm single br analysis', '13 system chapter gastrointestinal br disorders', 'covid-19 system prevent respond approach br', 'human cell 229e epithelial coronavirus l132 involvement mapk erk infection chloroquine p38 lung br inhibition', 'coronavirus fear outbreak:<br resuscitation perform novel cardiopulmonary', 'signature severe community covid-19 br infection lymphopenic pneumonia acquire', 'covid-19 ’ coronavirus neck cancer care impact head br patient', 'health mental coronavirus br>(2019-ncov china novel', 'covid-19 pandemic ms therapy disease-modifying br', 'covid-19 pandemic research relevant br schizophrenia', 'expression active tumour feline cloning necrosis biologically characterization br factor-α', 'covid-19<br chest infection reliable rt-pcr suspect patient alternative ct', '44 paramyxovi abstract response receptor modulation rus immunological induce br β-adrenergic change', 'health chapter tourism crises 7', 'context covid-19 safe br examination clean perform position equipment wfumb statement ultrasound', 'covid-19 case china neonatal infection br', 'palliative inform practice covid-19<br response pandemic review rapid care hospice service br role epidemic', 'health covid-19 community uk response programme br national worker', 'covid-19 coronary artery dissection br patient spontaneous', '2019 covid-19 patients pulmonary coronavirus cancer pathology pneumonia early-phase lung br novel', 'br>2019-ncov environment stressed fear destruction infected causality suspected chaotic india:<br mass', 'covid-19 ethical practice pandemic', 'highlights guideline frontline covid-19 china advice medicine br traditional expert national chinese', 'tumour granulosa cell adrenal', 'posterior oropharyngeal response sars-cov-2 serum infection saliva cohort sample observational viral load br profile study temporal antibody', 'detection 2020 positive case hospital china sars-cov-2 wuhan infection rt-pcr jan br 4880 rate feb', 'sud sars-unique coronavirus domain ” sars “ oligo(g)-binding br protein', 'interaction involve sars-cov br ace2 s motif protein functional', 'long sars-cov-2 time child adult br shed stool', 'covid-19 society chest pandemic statement patient imaging multinational management fleischner br role consensus', \"disease gut parkinson's microbiota br implications\", 'diseases chapter reemerging emerging br viral 8', 'respiratory epitope severe virus coronavirus identification br>(2019-ncov syndrome potential acute type br cross-protective', 'respiratory prophylactic small interfering severe br syndrome progress potential acute date therapeutic rnas', 'covid-19 nigeria lesson recent contain br outbreak epidemic', 'disease 2019 systemic pandemic coronavirus (covid-19)<br immunomodulatory therapies br', 'niclosamide therapeutic antiviral potential spectrum broad br agent', 'respiratory epidemiological mers-cov datum coronavirus middle east br syndrome cluster source open retrospective analysis epidemic', 'early coronavirus syndrome acute survival oxygenation respiratory pooled disease (ards)<br br poor 2019 (covid-19):<br membrane distress analysis extracorporeal', 'global simulation-based analysis case supply coronavirus br>(covid-19/sars-cov-2 impact predicting br outbreak chain epidemic', 'covid-19 parenting time', 'disease emerging pandemie sars – und', 'disease rna contamination hospital italy sars-cov-2 northern lack environmental infectious tertiary br referral', 'covid-19 care dementia', 'disease 2019 covid-19 clinical italy case coronavirus spain \\ufeff1 cluster import feature br bolivia', 'aids human 229e coronavirus pneumonia colombia hcov-229e fatal rsv – related br patient', 'serum concentration patient infection sepsis high br procalcitonin', 'traffic domestic international coronavirus br (covid-19)<br association outbreak air', 'disease 2019 art covid-19 coronavirus war era ” “ br', 'empower covid-19 hospital china internet br fight', 'chapter collection donation blood 11', 'human monoclonal ferret coronavirus infection prophylaxis sars br antibody', '3clpro discovery sars-cov-2 plant structural basis † anti-covid-19 drug br medicinal', 'global physiotherapy early impact br covid19 reflection implications', 'visual 2019 detection reverse coronavirus sars-cov-2 br isothermal loop-mediated assay rapid transcription novel amplification', 'assessment covid-19 pandemic insight br situation analysis', 'covid-19 pandemic chloroquine know clinician br hydroxychloroquine', 'marqueurs biologiques des d’évolution du bronchiolites un de nourrisson asthme gravité br initiale aiguës vers', 'prepare psychiatrist era post-covid-19 – br', 'covid-19 population china movement control year br mass', 'disease health public centers regulatory response affair roles control preparedness contribution prevention emergency br pharmacist', 'reproductive 12 system chapter', 'disease-2019 covid-19 prevent hospital effective coronavirus strategy br outbreak', 'covid-19 eastern mediterranean saudi therapeutic strategies arabia prevention br region', 'diagnose treat coronavirus originate china wuhan responsible pneumonia infection measures br outbreak novel', 'nucleocapsid coronavirus br activation pathway transduction sars signal protein ap-1', 'covid-19 real-time algorithm mortality cause prediction information base br patient estimation', 'respiratory severe lessons syndrome infection control acute sars br implications', 'br>(covid-19 coronavirus research factors environmental imperative transmission br role novel', 'respiratory severe patients syndrome replication nasopharynx acute viral br associated diarrhea', 'covid-19 smoke difference predisposition br patient sex', 'domestic international model originate china wuhan br nowcasting 2019-ncov potential forecast outbreak study spread', 'covid-19 practice medical burn suggestion br outbreak experience', 'plasma sars-cov-2 critically patient infection br convalescent ill treatment', '2019 discovery resource coronavirus br>(sars-cov-2 medicine drug br traditional novel chinese', 'covid-19 clinical case 25 review retrospective center medical record wuhan china characteristic death single br', 'covid-19 role pandemic neck cancer team virtual multidisciplinary head management br patient meeting', 'disease workflow hospital protection coronavirus hubei cancer wuhan china 2019<br>(covid-19 procedures br outbreak experience radiotherapy', 'fear sars-cov-2 datum versus', 'acid icu nucleic non-icu comparisons sars-cov-2 time sample conversion br patient different', 'lancet infectious emerge threat commission preparedness br diseases epidemic', 'cleavage br>2019-ncov coronavirus spike clade cov absent site contain furin-like glycoprotein br', 'improving evidence based bronchiolitis care', 'covid-19 chest pictorial disease-19 coronavirus review x-ray portable br', 'health covid-19 disruption month outbreak china life live work:<br adult satisfaction br unprecedented distress work', 'mannheimia interaction br>(pasteurella haemolytica vivo leukocyte infection herpesvirus-1 bovine ex effect experimental br leukotoxin bhv-1 cattle', 'covid-19<br prevent department operational strategies singapore sars radiology br experience spread', 'virus recombination emergence event reject result 2019-ncov hypothesis full-genome evolutionary br recent novel analysis corona', 'respiratory severe covid-19 syndrome acute br distress treatment', 'covid-19 impend department pandemic overwhelm emergency br storm', 'college covid-19<br student china psychological impact epidemic', 'covid-19 unfounded medication cannabidiol sars-cov-2 claim pandemic potential risk prophylaxis versus br', 'respiratory coronavirus middle east br>(mers-cov traveler syndrome prevention', 'respiratory virus surveillance emerge br', 'b season consecutive child like-illness outpatient br cohort adolescent influenza', 'disease 2019 coronavirus severity estimates model-based br analysis', 'respiratory virus porcine response coronavirus transmissible inoculation gastroenteritis immune challenge br pig cellular primary', '3clpro coronavirus cis-cleavage br characterization vitro basis sars screen anti-sars drug trans- protease activity', 'disease 2019 model coronavirus evolving hubei province china descriptive outside transmission dynamic br study epidemiology', 'passengers aedes dengue,<br salmonella anopheles 2019-ncov aircraft zika board include br', 'transgenic human vivo br aminopeptidase (cd13)<br vitro mouse cells infect coronavirus-229e n', 'tough covid-19 br iran battle sanction', 'covid-19 rna mean doe load br viral', 'covid-19 infection risk diabetes br patient hypertension mellitus increase', 'feline pale br shade pink blood transfusion', 'practice infection 2003 control impact sars br outbreak', 'ameliorate injury critically therapy patient covid-19-infected br cardiac ill anti-oxidative', 'injury clinical br>2019-ncov link biochemical lung infect viral load br patient index', 'learn covid-19 doctor coronavirus lesson protector 10 protect br fight', 'datum covid-19<br model spatial determining effect panel', 'gastrointestinal cat disorders', 'long-term covid-19 familial cluster br patient study glucocorticoid', 'severe immunodeficiency associate leukemia acute lymphoblastic br treatment', 'covid-19 sendai pandemic framework building biological hazard br resilience implication', 'covid-19 carrier infection delivery cluster asymptomatic br familial', 'human cell wild-type coronavirus endosomal cell-surface tmprss2 cathepsin br prefer entry', 'health covid-19 mental outbreak china br service online', 'human hcov-oc43 immunoperoxidase indirect hcov-229e assay br coronaviruses titration', 'virus 3 carboxyterminal difference syndrome respiratory portion reproductive isolate american antigenic encode frame porcine read open br viral european prrsv', 'lesson covid-19 pregnancy early', 'respiratory severe syndrome acute sars', 'research nano covid-19', 'covid-19<br performance laudable professionalism br outbreak fight epidemic nurse', 'covid-19 pandemic handling oncological br set', 'pharmaceutical covid-19 pandemic china recommendations care perspective provide br service guidance', 'recurrence rna covid-19 positive case sars-cov-2 br', 'covid-19 link child transmission br chain', 'covid-19<br clinical patients areas high-altitude imaging feature analysis data', 'covid-19<br safe pandemic problem scope br laparoscopy considered', 'interferon-α antiviral characterization infection vitro effect coronoavirus br sars-like', 'disease 2019 covid-19 ’ coronavirus internet chinese things-aided diagnosis br expert treatment consensus', 'taiwan covid-19 clinical anti-sars-cov-2 case course macau br return dynamic igg pneumonia', 'covid-19 dpp4 play diabetes br role inhibition', 'severe serum concentration marked digoxin decline br episode diarrhea', 'geometric coronavirus approach base br phylogeny', 'neurons mycobacterium sulfolipid-1<br nociceptive induces cough activates tuberculosis', 'injury evidence covid-19 end-stage failure 2019-ncov strong myocardial heart br', 'adapt basic covid-19<br guideline pandemic life considering support resuscitation br challenge', 'function spike sars-cov-2 structure glycoprotein br antigenicity', 'covid-19 pandemic dental care provision br guidelines', 'modelling approach individual-based transmission healthcare dynamic br associated study infections', 'covid-19 looming infection threat act collectively fast africa br', 'pathogenesis covid-19 molecular immune diagnosis br', 'covid-19 history anti-lessons', 'members covid-19 pandemic team room precautions operating br', 'disease human resource supply coronavirus respond br>2019 management emergency br epidemic nurse', 'acid fold superfamily br amino catalytic serine nucleophile near br>(chymo)trypsin-like base universal nbczone three-dimensional construction protease', 'protective personal consideration covid-19 early coronavirus lesson impact equipment br outbreak behavioral ppe', 'taiwan covid-19 community department buffer handle area infection potential emergency br', 'commentary health global world 2019 covid-19 organization review coronavirus declare ” “ emergency br novel', 'health public hospital shelter respond fangcang concept emergency br novel', 'telemedicine covid-19 era', 'eggs inembryonated propagation isolation br coronaviruses', 'covid-19 international pandemic cancer therapy radiation breast br guidelines', 'covid-19 maintain model cancer center academic singapore care segregated-team br outbreak', 'covid-19 coronavirus ade receive br', 'datum covid-19 china wuhan traveller-derived estimate bias quantify observational br prevalence', 'covid-19 guidance mfm', 'current covid-19 january 2020 response review period march br indonesia analysis', 'stock covid-19 market virus contagious death return impact infectious diseases:<br', 'health covid-19 mental swan pandemic ’ ‘ e-health point care black br turn', 'interaction system database management quality br', '2019 changes coronavirus finding pneumonia 2019-ncov br patient novel ct', 'tocilizumab covid-19 finding pneumonia favorable br patient change treatment ct', 'nucleocapsid coronavirus property c-terminal localization nuclear/nucleolar sars br protein', 'double covid-19<br triage pandemic home cancer care ” “ protocol patient', 'disease manifestation chest diagnostic coronavirus value area 2019<br>(covid-19 imaging xiaogan br ct', 'covid-19 variation china wuhan br death effects humidity temperature', 'respiratory severe virus cell spike vero-e6<br syndrome acute sars infect cleave br protein', 'covid-19 learn limiting lesson japan -<br cruise ship spread', 'supply primer vaccine policy demand', 'health application cdc updated isolation care br facilities guidelines', 'health covid-19 mental aging science knowledge bridge br service', 'covid-19<br patients residents care dermatology', 'cardiology ventilation covid-19 response pandemic reacquainting br mechanical', 'taiwan covid-19 community hospital pandemic strategies battle fighting preventive br', 'incubation covid-19 stage period transmission cluster terminal br familial', '2019 2020 data-driven domestic coronavirus china transportation br 2019-ncov correlational association outbreak novel train', 'disease covid-19 statistical case coronavirus china investigating dynamic technique br novel', 'covid-19<br medicine traditional treatment chinese', 'respiratory mers-cov coronavirus middle east focus syndrome br', 'respiratory severe 89 syndrome acute sars', 'covid-19 pandemic urgent dental care br patient', 'respiratory covid-19 infection support br patient', 'global covid-19 mortality potential – br', '2019 manifestation disease clinical coronavirus city china wenzhou characteristic multi-center zhejiang,<br br>(covid-19):a br novel study image', 'covid-19 suitable baricitinib authors – br reply treatment', 'disease 2019 covid-19 involvement coronavirus till hepatic gastrointestinal know br', 'interaction 2 design sars-cov spike peptide enzyme biological angiotensin-converting br protein novel inhibitory activity', 'covid-19 airway staff kong hong management emergency br safety', 'evidence covid-19 interaction virus mechanisms distribution host tissue proposed neurotropic targeting – br cns', 'mers-cov target antiviral replication hcov-229e genome binase viral strategy br novel', 'plasmid 6 recombinant', 'tocilizumab severe covid-19 interleukin-6 release mortality syndrome receptor cytokine antagonist crs reduce br key (il-6r)<br', 'mycoplasma posterior infección diseminada una neuroftalmológicas como desarrollo complicación de pneumonia por aguda y encefalitis br manifestaciones', 'injury covid-19 liver management br challenge', '2 renin-angiotensin coronavirus receptor enzyme sars angiotensin-converting br functional system?:<br', 'exacerbations detection system compliance symptom patient-reported diaries smartphone-based information daily br copd', 'covid-19 clinical pandemic br operations dermatology strategic', 'global imminent coronavirus strategies threat practical covid-19—the br novel', 'covid-19 pandemic br midst disorder opioid epidemic', 'possible covid-19<br hyperglycemia infection pathophysiologic mechanism novel', 'infections:<br mers-cov respiratory emerging viral influenza', 'covid-19 community infodemic pandemic br dissemination rapid scholarly engagement combat cardiovascular', 'nucleocapsid coronavirus multimerization sars br protein analysis', 'disease bronchitis market virus negative br infectious live bird newcastle avian backyard ivory-coast commercial prevalence farm influenza', 'covid-19 phylogenetic patient infection source clarifying br role analysis', 'covid-19 surveillance response singapore investigation cluster br measure implication', 'livelihood india life 19 strategies threat covid br combination combat', '2<br syndrome relationship postweaning titre euthanased pig lymph histology healthy multisystemic circovirus antigen british node porcine 375 sick waste br antibody score 113<br farm', 'acid nucleic domain proteins swapping folding 3.8 br protein', 'covid-19 pandemic ophthalmologist perspective br', 'detection pancoronavirus known rt-pcr assay br coronaviruses', 'synthesis diagnostic novo de template development pcr sars assay br', 'disease treat prevent early coronavirus intravenous vitamin 2019<br>(covid-19 c dose high br', 'respiratory covid-19 caused patients comparison hospitalized h1n1 syndrome acute br distress', 'great covid-19 mankind mutated future risk foretells br', 'diagnostic challenge', 'covid-19 community oncology preparedness africa br', 'testing 79 vaccines regulation', 'covid-19 coronavirus br patient safety epidemic', 'disease aminoquinolines covid-19 coronavirus br>2019 chloroquine br hydroxychloroquine', 'plan br>2019 coronavirus intensive neonatal contingency care unit management br outbreak novel', 'department plan oncology 2019-ncov radiation switzerland amid contingency br outbreak', 'respiratory review pneumonia medicine non-bacterial viral br infections', 'disease 2019 covid-19 evidence coronavirus meta-analysis patient troponin br cardiac', 'replicon gfp-expressing discovery drug sars-cov high-throughput assay br', 'cross-reactivity virus sars-cov spike sars-cov-2 characterization immune glycoprotein br entry', 'child covid-19 virus know', 'covid-19 zhuhai china complex management emergency br experience', 'covid-19 relate closely mers sars br', 'line covid-19 silver pandemic fellow lens look gastroenterology br', 'covid-19 manifestations oral gastrointestinal potential transmission – fecal br', 'health disease killer chapter cell localization natural br migration', 'low pulmonary efficacy plasminogen multicenter controlled trial acute thromboembolism dose randomized,<br recombinant activator br tissue-type safety treatment', '54 kitten fade chapter', 'covid-19 reconsider short production pandemic food supply relevance br chain local', 'disease coronavirus evaluation thin-section features 2019<br>(covid-19 imaging ct', 'disease application 2019<br non-isolated hospital coronavirus area control general management prevention br refine epidemic', 'constraint covid-19 shorten resource pandemic cancer center approach defer comprehensive breast states br radiotherapy treatment united --', 'covid-19 department br examination infection prevention radiology radiological experience', 'early coronavirus infection time rt-pcr diagnosis sars real br', 'possible covid-19 therapeutic option remdesivir br', 'sars-cov-2 br infection transmission rapid ferrets', 'outbreak italy course ibd sars-cov-2 northern uneventful br patient', 'frontline br>2019-ncov early lesson outbreak', 'covid-19 department pandemic medical infection control br image', \"2019 case coronavirus china br yan'an atypical novel\", 'replicon application function analysis coronavirus non-infectious sars screen drug br protein viral construction', 'covid-19 consciousness preparedness br climate change', 'brief line coronavirus 2019-ncov perspective br', 'covid-19 epidemic cancer diagnosis treatment br patient procedure expert interventional consensus', 'reaction study human real-time chain assays coronavirus thailand reverse-transcription comprehensive polymerase br infections rural', 'blocked cell depends sars-cov-2 inhibitor tmprss2 proven ace2 br clinically protease entry', 'covid-19 program cleveland clinic akron general residency br experience urology', 'scale detection human 229e coronavirus nasal rt-pcr assay br study specimen hybridization', 'twitch chapter tremor 39 cat', 'inside system human renin-angiotensin sars-cov-2 flaw immune unexpected br reveal', 'health covid-19 public', 'taiwan criterium covid-19 evolving br epidemic', 'covid-19 korean response case emergency br outbreak', 'commentary covid-19 diabetes', 'europe datum clinical covid-19 case virological \\ufeff1 series br', 'covid-19 italy pandemic ageism br decision-making', 'covid-19 clinical china shanghai progression br patient', '2020 pandemic coronavirus deadly china 2003 sars br novel epidemic', 'clinical br>2019 coronavirus br characteristic type infect association patient novel ct', 'respiratory il-8 clinical severe patients load,<br syndrome acute relationship viral progression br (il)—6 ribavirin interleukin temporal', 'chapter cell 25 biology ace2 functions regulation br physiological', 'coronavirus 2019-ncov inhibitor medicine potential approve m br clinically protease', 'considerations fda products stem medicine cell-based 73 br regulatory', 'covid-19 predictor china hardest-hit br areas difference gender matt prevalence outbreak ptss', 'opportunity urban preparedness setting br epidemic challenge', 'incubation disease covid-19 confirmed application reported br>2019 coronavirus period cases publicly br estimation', 'global covid-19 coronavirus wuhan control br novel challenge', 'research cyberpsychology covid-19', 'human coronavirus non-immunosuppressive a-dependent alisporivir inhibit cyclosporine a-derivatives replication include br nl63 cyclophilin', 'covid-19 purification br therapy critically complication potential cytokine reduce effect late blood ill storm', 'university epidemiological human virus molecular hospital 3 spain catalonia 2013–2015 type tertiary br study parainfluenza', 'covid-19 2020 crt', 'disease cord neuroanatomic cat diagnosis spinal br specific paralyze', 'human 229e coronavirus activation infection br monocyte', 'broad-spectrum picornaviruses corona- silvestrol antiviral inhibitor eif4a br activity', 'disease 2019 cell advance patients adherence coronavirus period (covid-19)<br inhibitor carcinoma hedgehog basal management br treatment sonic', 'animals production meat |<br infectious diseases', 'predict spike host sars-cov-2 infection recognition ace2 mammalian range ace2<br br protein optimize', 'disease covid-19 cardiovascular', 'survey departments covid-19 italian pandemic medical oncology nationwide reorganization br', 'bigger world cats microbiota intestinal thought dogs br', 'covid-19 interleukin-6 biomarker potential progression br', 'concern covid-19 positive sars-cov-2 arouse discharge regard standard present br patient turn', 'programs tissue br decreasing transplantable latitude regulation increasing', 'targets sars-cov-2 br approach candidate responses immune predict bioinformatic homology sequence', 'covid-19 unmasking brugada infection syndrome br', 'covid-19 practice epidemic oncological surgery strategy br digestive', 'human br>(bcov molecular relate coronavirus oc43 comparative closely different bovine (hcov-oc43),<br evolutionary br epidemiology reveal pattern', '2019 woman case preterm coronavirus delivery pregnant br novel', 'global response jigsaw piece miss research 19 covid cohesive amidst br', 'covid-19 conundrum ace2 diabetes br mellitus', 'virus-specific cell hematopoietic standard stem transplantation t time allogeneic care br', 'disease veterinary covid-19 active public health surveillance coronavirus time random adapting protocol base real br – methodology', 'respiratory chapter arabian coronavirus middle east 4 syndrome infection emerge peninsula br', 'pandemic life 19 covid effects daily', 'sclerosis multiple', 'function human production 229e orf4a coronavirus viroporin br protein viral regulate', 'disease non-alcoholic covid-19 live nafld br patient preliminary analysis implication fatty', 'brescia patients italy pandemic sars-cov-2 (covid-19)<br kidney transplant management dialysis br', 'disease covid-19 br close-up cardiovascular', 'health 2019 disease mental staff coronavirus perception medical wuhan cross-sectional psychological care impact br outbreak novel study nurse', 'health context covid-19 datum security international regulations 182 capacity country br outbreak annual analysis', 'disease current br>(covid-19 coronavirus dental journal view', 'covid-19<br case pandemic selection donor heart study', 'akt apoptosis cell sars-cov-infected br e6 vero pathway importance signal', 'elicit systemic coronavirus subcutaneously humoral inject uv-inactivated sars mouse vaccine br immunity', 'neutralization response coronavirus br activity sars individual protein antibody', 'evolution sars-cov-2 diversity genetic', 'respiratory detection human children one-year colorado br coronaviruses study infections', 'anaesthetist coronavirus know br outbreak', '103 osteonecrosis chapter', 'health covid-19 mental outbreak old china adult br service', 'estimating fatality covid-19 case rate', 'virology research chapter 34', 'covid-19 close faraway infection rheumatoid arthritis:<br', 'originating coronavirus china 2019-ncov divergence genome br composition novel', 'covid-19 clinical middle-aged comparison young elderly feature br patient', 'capable acid interaction nucleocapsid coronavirus amino 209 domain c-terminal sars self-association br protein', 'respiratory great covid-19 patients symptom transmission risk br', 'coronavirus strain coronaviridae hsr1 sars-associated br', 'disease emerge zoonotic br paradigm coronaviruses', 'covid-19 swim cancer tide era br patient', 'covid-19 fight chloroquine weapon available br hydroxychloroquine', 'viral membranes', 'respiratory human virus coronavirus br nl63', 'covid-19 tokyo 2020 summer games olympic br outbreak implication', 'disease br>(new coronavirus emotional 2019-ncov impact', 'study clinical hospital case china cancer retrospective wuhan characteristic br patient covid-19-infected', 'age production first-lactation dairy milk dutch first-calving br farm', 'manifestation innate cytopathic virus-modulated effect br immunity', 'human cell bst2/cd317 counteract coronavirus tether br surface infection br>229e virion productive', '2019 reporting coronavirus reproduction numbers br novel growth epidemic (2019-ncov)<br', 'coronavirus novel emerge', 'respiratory severe inactivation coronavirus sars-cov syndrome acute induce br', 'recombination emergence coronavirus 3 group br', 'factor apoptosis cell nucleocapsid coronavirus actin sars reorganization cos-1<br induce br protein growth absence', 'prime illness gilt clinical respiratory porcine neonate prcv coronavirus increased lactogenic immunity tgev survival litter reduce br rate', 'cleavage cell nucleocapsid caspases coronavirus infection protein effector sars br type-specific', 'competencies 2 effective protection programs create core br', 'covid-19 clinical review meta-analysis systematic laboratory feature br image', 'gastrointestinal system chapter 4', 'ocular surface 2019-ncov transmission ignore br', 'persistent negative sars-cov-2 finding infect asymptomatic br patient ct', 'behavior health dairy calf social effects br contact level', 'interstitial review infection lung br role diseases', 'echocardiography ase 2019 outbreak patients protection coronavirus statement providers br service novel', 'disease global covid-19 association resource coronavirus br>2019 mortality status incidence country healthcare daily br index economic epidemiology cumulative', 'sars-cov proteomics br study bioinformatical evolution', 'dependent rna molecular sars-cov-2 sofosbuvir,<br galidesivir remdesivir tenofovir rdrp polymerase br dock ribavirin study', 'o s,-trimethyl doe status lethal effect damage cause acute phosphorodithioate lung s protect br germ-free', 'respiratory severe syndrome acute imaging br>(sars', 'evidence sars-cov-2 infection gastrointestinal br', 'detection real-time transcription-pcr reverse sars-cov evaluation specificity sensitivity br assay quantitative', '7)/mas chapter pulmonary emerging target br>2/angiotensin-(1 receptor axis enzyme 38 pharmacological angiotensin-converting br diseases', 'support nutrition time sars-cov-2<br>(covid-19', 'disease 2019 covid-19 clinical coronavirus newborn characteristic infant child br novel', 'prevent inhalation airborne efficacy practice contaminant mask dental br face', 'covid-19 active center outpacing br transfusion transmission blood role', 'disease 2019 assessing patients coronavirus infectivity br (covid-19)<br tears shedding viral', 'duration sars-cov lessons neutralize sars-cov-2 serum infection br antibody', 'interaction learn model coronavirus br antiviral act deep drug-target predicting available drug commercially br>(sars-cov-2 novel', 'chapter 61 cat eye cloudy', 'respiratory system infection vitamin c immune br', 'rt-lamp reverse assays sars-cov-2 isothermal development loop-mediated targeting br transcription amplification', 'covid-19 global rheumatology time', 'covid-19 coming br considering prevalence schizophrenia decades', 'cleavage rna coronavirus recognition endoribonuclease sars br', 'urgently illness covid-19 patients psychological chronic physical care br outbreak integrate', 'mers-cov respiratory learn sars-cov sars-cov-2 load br viral specimen', 'covid-19 department coronavirus know radiology br outbreak', 'covid-19 patients cancer oncology clinics radiation u.s. impact br', 'covid-19 model china social wuhan mix control reduce effect strategy br outcome study epidemic', 'native illness covid-19 immunosuppressed clinical-therapeutic proposal staging br states', 'practice hospital kong precautions ophthalmic acute hong major sars br outbreak experience', 'respiratory severe protection syndrome acute sars br', 'coronavirus sars pigs susceptibility br chickens', 'disease covid-19 in-hospital associate kidney death br patient', 'pneumonia covid-19 ct teach', 'respiratory epidemiological severe genetic syndrome acute br analysis', 'covid-19 unusual symptom present gi', 'covid-19 pandemic br usa expect', 'injury disease severe clinical 2019<br 1 patients characteristics coronavirus myocardial br novel', 'synthesis virus prudently sars-cov-2 engineer conduct br', 'respiratory severe outbreak coronavirus development syndrome pathogenesis:<br replication acute sars vaccine br recent implications challenge', 'respiratory severe played coronavirus br syndrome t acute responses immune – cells vγ9vδ2 anti role', 'wisely covid-19 choose cancer br patient key', 'covid-19 practice closure coronavirus review rapid systematic management include br outbreak school', 'covid-19 biologic psoriasis interrupt era br', 'coronavirus morphological associate infant property biological mouse br diarrhea', 'covid-19 woman br pregnancy infection general healthcare association outcome worker', 'epidemic br 2019-ncov control', 'covid-19 ethical social-distancing scientific basis br intervention', 'covid-19 precaution surgery additional br epidemic', 'codehop-based human coronavirus collection nasopharyngeal family-wide primer identify br novel specimen', 'coronavirus strain origin date sars', 'respiratory severe detection rna health-care syndrome-associated coronavirus nasopharyngeal acute workers br', 'disease 2019 tomography analysis stratify coronavirus severity compute br quantitative', 'sars-cov identification development inhibitor ace2 potent critical br determinant entry', 'sars-cov-2 follow-up infection asymptomatic br patient', 'covid-19 control relax extend distance br measure', 'disease 36<br epidemiological clinical 2019 covid-19 coronavirus china child observational feature br cohort study zhejiang', 'possible severe phosphodiesterase lesson inhibitor 5<br type role covid19 infections?<br treatment urology', 'disease 2019 severe covid-19 coronavirus meta-analysis associate infection thrombocytopenia br', 'evidence covid-19 3clpro clinical br trial inhibitor potential ongoing option available therapeutic', 'human italy coronavirus circulate phylogenetic br nl63 analysis', 'estimating fatality covid-19 case rate', 'disease infectious 15 microbiology', 'disease (covid-19):<br clinical coronavirus 19 dental care implications', 'respiratory 5′<br 2 porcine virus replacement reproductive syndrome activity type heterologous allow br untranslated preservation functional fully region', '2019 reply basic early numb coronavirus china 2020:<br 2019-ncov reproduction growth dhungana base br outbreak novel exponential estimation', 'covid-19 know dialysis units br', 'pathogenesis infection:<br covid-19 diarrhea prevention management epidemiology', 'disease course coronavirus value wuhan br outside asymptomatic pneumonia patient novel image ct', 'outbreak update 2019-ncov', 'br>2019-ncov reanalysis intermediate insertions spike host similarity structure genome refutes br protein snakes hiv-1 sequence unique', 'msk covid-19 review working rapid personnel ally heath br outbreak recommendation', 'diseases 134 biology viral viruses', 'coronavirus pneumonia novel', 'respiratory severe find hypothetical surface enterocytes br intestinal structural syndrome acute pneumocytes sars coronaviral protein', 'covid-19 international microbiota donor urgent suggestion transplant update expert panel br outbreak faecal screening', 'case sars-cov-2 br index scotland', 'covid-19 home mitigate child confinement effect br outbreak', 'system detection early participatory design surveillance coronavirus br>(2019-ncov approach importance prevention implement br novel', 'respiratory covid-19 clinical cell epidemic stem syndrome infection acute hint mesenchymal h7n9 br induced distress study treatment influenza', 'haematology covid-19 department plan oncology paediatric management br strategic', 'dermatologist covid-19 pandemic skin know br', 'official guideline cancer sars-cov-2 infection french protect br patient', 'clinical br>2019 coronavirus china wuhan infect feature patient novel', 'numb india sars-cov-2 prediction 5–6 death br week', 'nutritional individual guidance sars-cov-2 statement espen infection practical management br expert', 'virus march ambulatory management rapid marseille,<br respiratory 31st diagnosis suspect disease january hospital case present snapshot br viral covid-19 2020 france 1st infectious referral', 'serodiagnosis expression purification cloning coronavirus nucleocapsid sars sars-associated br protein sequence', 'covid-19 sars-cov-2 inherit arrhythmia syndrome br', 'elicit epitope response hypothetical patient humoral structural variable protein sars br specific', 'covid-19 pandemic medical status cross-sectional psychological workforce br study', 'clinical hospitalize rhinovirus infection adult relevance br patient', '7)/mas chapter ace2/ang-(1 genetic animal 22 axis models br alteration', 'birds detection chicken pheasant turkey parrot rt-pcr avian br coronaviruses galliform', 'local rcp think physician act br role national', 'chapter 4 bartonellosis', 'health covid-19 consideration mental quarantine child br', 'covid-19 hospital hope：role life br cabin ark facing', 'health respiratory disease covid-19 policies hospital protection coronavirus protect br worker', 'tcm coronavirus sars-cov-2 novel infection advantage treatment br attention situation pay', '2019 active recombination coronavirus undergo br novel', 'n95 br 2019-ncov respirator transmission association', '1 coronavirus -19 review meta-analysis pregnancy infection covid mers spectrum systematic br>(sars br outcome', 'concern covid-19 live cause br little', 'incubation covid-19 clinical undergo period infection characteristic surgery br patient outcome', 'covid-19 big challenges data gis', 'lactation expression cow gene endometrium pregnancy holstein estrous day 17 effects br cycle', 'conquer virus understand sars-cov devastate emerge br quickly', 'disaster italy pandemic br cause covid death hospitalization term unexpected 19<br', 'modelling covid-19 datum transmission br intervention', 'disease severe pulmonary coronavirus associate 2019<br>(covid-19 chronic obstructive br', 'interaction covid-19 mean pathology-urology br', 'coronavirus 9 variable non-structural modes br protein oligomerization', 'disease coronavirus prognosis severity biomarker 2019<br>(covid-19 saa br distinguish', 'introduction chapter 1', 'transport covid-19 outbreak neonatal', 'covid-19 statistic space-time surveillance evaluate detecting br emerge scan cluster prospective rapid united states', 'west covid-19 africa pandemic', 'characterisation bind virus genomic br>2019 coronavirus origin receptor implication br novel epidemiology', 'stress dairy male gammulin mortality cold serum evaluation formula supplement calve protein br>(transport protein-based br arrival growth morbidity', 'health union public chapter policies 25 innovation horizon 2020 european strategy br', '2019 disease urgently coronavirus br (covid-19)<br glucose timely management blood outbreak novel', 'disease 2019 covid-19 congenital coronavirus focus burden heart br cardiovascular', 'containment lesson interrupting transmission singapore covid-19:<br effort', 'disease international coronavirus burden infection potential 2019<br>(covid-19 dissemination iran br estimation', 'disease 2019 course gene coronavirus target test sars-cov-2 rt-pcr dynamic br patient change process', 'covid-19 system wastewater mitigate transmission br plumb', 'sars-cov-2-related coronaviruses harbor br pangolins', 'covid-19<br active inpatients surveillance cases information technology suspected', 'procedure coronavirus recommendations novel pneumonia resuscitation strategy br cardiopulmonary', 'induction virus sars-cov ifn-α replication coordinate br -γ absence', 'respiratory shadow middle east ebola syndrome br', 'resistance sars-cov-2 compounds oil essential investigation garlic br', 'covid-19 active old adult support br measure community-dwelling', 'epidemiological conference molecular surveillance throughput era marker update immem-10 high br microbial sequence', 'limit health fragile system southern help sars-cov-2 hemisphere winter pneumococcal program damage potential country enhance br vaccination influenza', 'respiratory severe cross-reactivity human 229e oc43 coronavirus coronaviruses syndrome acute antigenic br associated', 'guideline br cat avian h5n1 prevention management abcd influenza', 'obstetric clinical covid-19 single-centre china retrospective descriptive neonatal pregnant wuhan,<br feature br patient outcome study', 'covid-19 failure clinical landscape br heart statement trials collaboratory', 'health strategy covid-19 public mitigation rapidly escalate br intervention canada', 'covid-19 clinical pandemic surgery br annotation orthopaedic trauma', '2019 coronavirus sars-cov-2 chloroquine br novel', 'respond sars virus', 'ventilation hospital design general computational fluid ward dynamic br rethinking', 'respiratory covid-19 control rehabilitation elderly randomize br patient study', 'china status br infection management nosocomial solution', 'disease demyelinating murine coronavirus infection virus-induced br paradigm', 'covid-19 society responding perspectives gastroenterology br chinese', 'survey epidemiological clinical 2019<br characteristics coronavirus china recipients wuhan descriptive transplant heart br outbreak', 'cure covid-19 positive result sars-cov-2 br patient sputum', 'possible involvement coronavirus sars-cov-2 oral transmission enteric – br faecal', 'covid-19 italian reproductive lesson medical br experience', 'coronavirus period pneumonia shanghai crisis psychological br outbreak experience intervention', 'poor pandemic coronavirus br risk quarantine novel', 'wing coronavirus br>(2019-ncov travellers novel', '2019 disease covid-19 overlook coronavirus symptom br patient novel digestive', 'agent inactivation coronavirus inanimate surface biocidal br persistence', 'association deaminase nucleocapsid coronavirus br apobec3 g cytidine protein', 'errores aciertos la de salud las pública crisis en españa y gestión br', 'antibiotic possible disease patients inflammatory br>(covid-19 shock cause coronavirus-19 diagnosed septic br consumption inappropriate storm', 'external diagnostic coronavirus sars-new assurance quality br antibody', 'recombination coronavirus pneumonia hku1 phylogenetic br patient novel analysis', 'market guangdong susceptible virus china province live poultry avian br worker influenza swine', 'covid-19 taking control right measure', 'palliative frontline time care covid-19:<br reflections', 'covid-19 plasma therapy potential br convalescent', 'covid-19 microlaryngobronchoscopy case pandemic surgical paediatric practical insight perform br otolaryngology', 'health violate covid-19 international regulations br outbreak', 'epidemiological human hospitalize coronavirus descriptive infection kong hong six-year br patient study', 'health covid-19 case workers risk care br', 'covid-19 syndrome cytokine immunosuppression br consider storm', 'discovery clinical coronavirus diagnostics br novel', 'utilize transgenic antigen-expressing cell presenter prototype virus sars-cov-2 immune adjuvant vaccine strategy br novel cellular decoy', 'human pathogens tuning animal models:<br studying humanized mouse fine', 'covid-19 italy france china br forecast analysis spread', 'disease covid-19 coronavirus primer physician emergency br', 'forward molecular safe sars-cov-2 microbiota donor test transplant br stool faecal screening way', 'coronavirus astroviruses novel bat', 'crisis medication shortages covid-19<br', 'warfare disease chapter br 22 biological infectious bioterrorism', 'virus en y niño asma el', 'possible covid-19 pandemic irradiation:<br method respirator reuse ultraviolet facilitate br germicidal disinfection', 'human receptor-binding hcov-emc coronavirus neutralize domain s critical predict br protein novel', 'health covid-19 system strain ecuador edge dengue care country br latin pushing co-epidemics america', 'wireless smartphone-enabled covid-19<br otoscope-assisted telemedicine br outbreak online', 'suggest covid-19<br gene br patient severity ace2 interferon-regulated susceptibility dysregulation lupus epigenetic increase', 'reactivation 1 experimental response mucosal reinfection herpesvirus serum calve isotype-specific bovine secretion br antibody', 'health covid-19<br mental epidemic iranian', 'covid-19<br mental exercise quarantine old focus therapy physical consequence special br fight', 'chapter 3 problem areas specific', 'covid-19 review finding br typical diagnosis pneumonia ct differential', 'health affect covid-19 mental student international care br outbreak chinese', 'hospital coronavirus infection impromptu preparing speech prevention br novel', '2019 disease coronavirus (covid-19)<br hemodialysis pneumonia patient', 'covid-19 mental illness:<br challenges vulnerabilities', '81 covid-19 china finding wuhan br pneumonia descriptive radiological patient study', 'bundling:<br covid-19 traffic global interrupting control transmission prevention enhance implement br implications effort', '2019 disease br>(covid-19 outbreak- coronavirus emergence time infection zoonotic strategy br impede week consider', 'fatality case comparison cross-country br rates covid-19/sars-cov-2', 'mers-cov covid-19 kingdom saudi shadows arabia br', 'disease case coronavirus br>2019 korea pediatric', 'resolution impediments bats lessons rhinolophid hipposiderid overcome br', 'coronavirus bird eye novel view', 'disease 2019 covid-19 individuals sleep january coronavirus china social capital self-isolated quality days br>2020 br outbreak 14', '2019 coronavirus pandemics br novel crown jewel', 'covid-19 clinical pneumonitis manifesting syndrome hypersensitivity br', 'covid-19 kcdc initial risk assessments korea br outbreak phase', 'efficient system community safe center massive covid-19:<br drive-through br outbreak screening', 'severe coronavirus false-negative cases syndrome acute chain ct respiratory diagnosis results role 2 deep-learning-based polymerase br reaction real-time reverse-transcriptase insights', 'personal coronavirus pneumonia knowledge br novel', 'respiratory coronavirus middle east syndrome child br', 'severe coronavirus 2<br syndrome infection acute outcomes respiratory clinical course cohort preliminary study patients 28 br covid-19 korean', 'disease 2019 covid-19 january sleep patients treating staff coronavirus 2020 social medical february china support effects quality br', 'application lopinavir/ritonavir coronavirus korea monitored rt-pcr tertiary disease caused case transmission pneumonia br patient index treatment 2019 covid-19 response quantitative', 'emigration covid-19 population distribution china wuhan br correlation epidemic', 'experience prepare sichuan coronavirus china intensive province infection br>2019–2020 care unit br novel epidemic', 'covid-19 anesthesia coronavirus recommendations infection suspect br patient', 'survey covid-19 epidemic:<br nationwide psychological policy br distress implication chinese recommendation', 'suggest quarantine coronavirus upgraded cases isolation korea br outbreak novel', 'evidence treat covid-19 inhalation ether support br chloroform', 'disease 2019 pandemic coronavirus br advice diagnosis spinal standardized diseases treatment', 'disease covid-19 coronavirus china cause know zoonotic br novel', 'early future sars-cov 2019-ncov outbreak:<br prediction epidemics similarities br trends', 'fatality case coronavirus caution estimate (2019-ncov):<br word 2019-novel rate', 'health covid-19 mental south perspectives psychological amid korea br outbreak intervention', 'kinetics patients sars-cov-2 infection load korea br viral', 'outbreak overview covid-19', 'respiratory clinical coronavirus non-invasive pneumonia infection transmission support reduction risk br patient novel efficacy', '2019 clinical case coronavirus (sars-cov-2)<br finding wuhan china retrospective group outside infect series br patient novel', 'severe human coronavirus identification pneumonia descriptive cause br novel study', '2019 turkey coronavirus infection threat control perspective br novel', 'disease 2019 experience community out-of-hospital patients coronavirus center mild symptoms single korea br cohort treatment', 'covid-19 clinical recommendations br institute l. irccs ” “ management infectious national diseases spallanzani', 'respiratory detection real-time clinical evaluation pcr multiplex specimens assay br viruses', 'respiratory severe leaf-nosed virus nigeria identification coronavirus-like syndrome acute br bat', '2 molecular therapeutic sars-cov-2 target receptor potential enzyme ace2 mechanism angiotensin-converting br', '2019 disease implementation coronavirus time support oxygenation indications,<br membrane br novel extracorporeal', 'tomographic coronavirus cases findings 2019:<br computed pneumonia outbreak novel', 'countermeasures integrative covid-19 cancer therapy challenges br epidemic', 'efficient emc human highlights betacoronavirus potential replication epithelium zoonotic br novel primary', '2019 respiratory severe coronavirus exhale china non-invasive syndrome acute transmission support br experience air awareness', '2019 case coronavirus wuhan pneumonia infection control measures imported prevention china:<br korea br novel implication', 'making emerge potential ” “ vaccine br solution biodefense demand', 'single-cell suggest datum rna 2 impairment patient kidney 2019-ncov enzyme infect angiotensin-converting br role sequence', 'disease epidemiological clinical 74 covid-19 case coronavirus-infected br>2019 virological characteristic gastrointestinal symptom br', 'disease 2019 factor hospitalize coronavirus associate novel br patient outcome analysis', 'covid-19 emergent strategies br phase', 'clinical hospital case coronavirus hubei province characteristic tertiary br novel']\n"
     ]
    }
   ],
   "source": [
    "list_title = df_covid['processed_title'].to_list()\n",
    "print(list_title)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "list_both = list_abstract + list_title"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "def give_count_word(word):\n",
    "    count = 0\n",
    "    for text in list_both:\n",
    "        splitstring = text.split()\n",
    "        for x in splitstring:\n",
    "            if x.lower() == word.lower():\n",
    "                count = count + 1\n",
    "    print(count)\n",
    "    return count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 1635 entries, 1632 to 35874\n",
      "Data columns (total 11 columns):\n",
      "paper_id              1635 non-null object\n",
      "doi                   1635 non-null object\n",
      "abstract              1635 non-null object\n",
      "body_text             1635 non-null object\n",
      "authors               1635 non-null object\n",
      "title                 1635 non-null object\n",
      "journal               1635 non-null object\n",
      "abstract_summary      1635 non-null object\n",
      "language              1635 non-null object\n",
      "processed_abstract    1635 non-null object\n",
      "processed_title       1635 non-null object\n",
      "dtypes: object(11)\n",
      "memory usage: 153.3+ KB\n"
     ]
    }
   ],
   "source": [
    "df_covid.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "404\n",
      "395\n",
      "15\n",
      "7\n",
      "63\n",
      "10\n",
      "18\n",
      "30\n",
      "83\n",
      "8\n",
      "33\n",
      "56\n",
      "35\n",
      "81\n",
      "0\n",
      "0\n",
      "64\n",
      "0\n",
      "6\n",
      "15\n",
      "0\n",
      "0\n",
      "123\n",
      "44\n",
      "20\n",
      "155\n",
      "84\n",
      "21\n",
      "1\n",
      "4\n",
      "27\n",
      "43\n",
      "0\n",
      "6\n",
      "53\n",
      "17\n",
      "1\n",
      "95\n",
      "90\n",
      "1\n",
      "39\n",
      "96\n",
      "0\n",
      "0\n",
      "75\n",
      "3\n",
      "17\n",
      "1155\n",
      "4\n",
      "150\n",
      "80\n",
      "17\n",
      "65\n",
      "18\n",
      "67\n",
      "13\n",
      "0\n",
      "20\n",
      "182\n",
      "56\n",
      "3\n",
      "0\n",
      "3\n",
      "161\n",
      "101\n",
      "3\n",
      "52\n",
      "18\n",
      "0\n",
      "101\n",
      "36\n",
      "23\n",
      "6\n",
      "69\n",
      "26\n",
      "52\n",
      "32\n",
      "36\n",
      "32\n",
      "63\n",
      "29\n",
      "26\n",
      "60\n",
      "24\n",
      "59\n",
      "45\n",
      "216\n",
      "2\n",
      "3\n",
      "25\n",
      "13\n",
      "14\n",
      "0\n",
      "27\n",
      "22\n",
      "16\n",
      "9\n",
      "27\n",
      "1\n",
      "7\n",
      "92\n",
      "21\n",
      "250\n",
      "13\n",
      "118\n",
      "33\n",
      "0\n",
      "4\n",
      "9\n",
      "2\n",
      "4\n",
      "0\n",
      "0\n",
      "1\n",
      "0\n",
      "121\n",
      "88\n",
      "115\n",
      "159\n",
      "289\n",
      "320\n",
      "0\n",
      "114\n",
      "3\n",
      "169\n",
      "71\n",
      "6\n",
      "183\n",
      "81\n",
      "3\n",
      "3\n",
      "13\n",
      "28\n",
      "38\n",
      "541\n",
      "6\n",
      "8\n",
      "37\n",
      "11\n",
      "24\n",
      "33\n",
      "48\n",
      "30\n",
      "34\n",
      "18\n",
      "46\n",
      "27\n",
      "24\n",
      "10\n",
      "1\n",
      "126\n",
      "17\n",
      "107\n",
      "65\n",
      "123\n",
      "9\n",
      "46\n",
      "30\n",
      "24\n",
      "54\n",
      "10\n",
      "1\n",
      "12\n",
      "126\n",
      "79\n",
      "19\n",
      "3\n",
      "8\n",
      "264\n",
      "286\n",
      "12\n",
      "99\n",
      "349\n",
      "129\n",
      "26\n",
      "1\n",
      "13\n",
      "75\n",
      "6\n",
      "31\n",
      "98\n",
      "4\n",
      "1\n",
      "2\n",
      "134\n",
      "14\n",
      "115\n",
      "201\n",
      "21\n",
      "39\n",
      "52\n",
      "24\n",
      "242\n",
      "59\n",
      "82\n",
      "15\n",
      "37\n",
      "3\n",
      "45\n",
      "1\n",
      "41\n",
      "0\n",
      "9\n",
      "15\n",
      "86\n",
      "79\n",
      "0\n",
      "158\n",
      "131\n",
      "5\n",
      "[404, 395, 15, 7, 63, 10, 18, 30, 83, 8, 33, 56, 35, 81, 0, 0, 64, 0, 6, 15, 0, 0, 123, 44, 20, 155, 84, 21, 1, 4, 27, 43, 0, 6, 53, 17, 1, 95, 90, 1, 39, 96, 0, 0, 75, 3, 17, 1155, 4, 150, 80, 17, 65, 18, 67, 13, 0, 20, 182, 56, 3, 0, 3, 161, 101, 3, 52, 18, 0, 101, 36, 23, 6, 69, 26, 52, 32, 36, 32, 63, 29, 26, 60, 24, 59, 45, 216, 2, 3, 25, 13, 14, 0, 27, 22, 16, 9, 27, 1, 7, 92, 21, 250, 13, 118, 33, 0, 4, 9, 2, 4, 0, 0, 1, 0, 121, 88, 115, 159, 289, 320, 0, 114, 3, 169, 71, 6, 183, 81, 3, 3, 13, 28, 38, 541, 6, 8, 37, 11, 24, 33, 48, 30, 34, 18, 46, 27, 24, 10, 1, 126, 17, 107, 65, 123, 9, 46, 30, 24, 54, 10, 1, 12, 126, 79, 19, 3, 8, 264, 286, 12, 99, 349, 129, 26, 1, 13, 75, 6, 31, 98, 4, 1, 2, 134, 14, 115, 201, 21, 39, 52, 24, 242, 59, 82, 15, 37, 3, 45, 1, 41, 0, 9, 15, 86, 79, 0, 158, 131, 5]\n"
     ]
    }
   ],
   "source": [
    "count_list_freq = []\n",
    "for word in keywords:\n",
    "    count_of_word = give_count_word(word)\n",
    "    count_list_freq.append(count_of_word)\n",
    "print(count_list_freq)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1155\n"
     ]
    }
   ],
   "source": [
    "print(max(count_list_freq))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [],
   "source": [
    "dictionary_of_words_freq = dict(zip(keywords,count_list_freq))\n",
    "import operator\n",
    "sorted_d_freq = dict(sorted(dictionary_of_words_freq.items(), key=operator.itemgetter(1)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'serosurveys': 0, 'tap': 0, 'roadmap': 0, 'intentional': 0, 'non-profit': 0, 'bed-side': 0, 'surveillance/detection': 0, 'hoc': 0, 'denominator': 0, 'drift': 0, 'tradeoff': 0, 'holistic': 0, 'analytics': 0, 'naturally-occurring': 0, 'accelerator': 0, 'tester': 0, 'crispr': 0, 'reagent': 0, 'demographics': 0, 'companion': 1, 'execution': 1, 'ad': 1, 'streamline': 1, 'accessibility': 1, 'lock': 1, 'migrate': 1, 'separation': 1, 'elisas': 1, 'instrument': 1, 'inclusive': 2, 'longitudinal': 2, 'latency': 2, 'expertise': 3, 'coalition': 3, 'heavily': 3, 'spillover': 3, 'recruitment': 3, 'ethical': 3, 'organism': 3, 'point-of-care': 3, 'leverage': 3, 'private': 3, 'entity': 4, 'force': 4, 'legal': 4, 'coordination': 4, 'innovation': 4, 'scheme': 5, 'traffic': 6, 'accuracy': 6, 'sector': 6, 'academic': 6, 'mitigation': 6, 'marker': 6, 'wildlife': 7, 'couple': 7, 'occupational': 8, 'device': 8, 'genomics': 8, 'demographic': 9, 'farm': 9, 'mitigate': 9, 'capability': 9, 'operational': 10, 'regulatory': 10, 'bioinformatics': 10, 'track': 11, 'immediate': 12, 'distinguish': 12, 'convalescent': 13, 'official': 13, 'platform': 13, 'sufficient': 13, 'commercial': 13, 'aid': 14, 'diagnostics': 14, 'environment': 15, 'variant': 15, 'extent': 15, 'domestic': 15, 'barrier': 16, 'environmental': 17, 'scale': 17, 'technology': 17, 'experiment': 17, 'opportunity': 18, 'avoid': 18, 'mass': 18, 'widespread': 18, 'employ': 19, 'food': 20, 'recommendation': 20, 'biological': 21, 'start': 21, 'evolutionary': 21, 'neutralize': 22, 'market': 23, 'load': 24, 'supply': 24, 'efficacy': 24, 'specificity': 24, 'particular': 24, 'university': 25, 'mutation': 26, 'preparedness': 26, 'communication': 26, 'purpose': 27, 'advance': 27, 'protocol': 27, 'guidance': 27, 'policy': 28, 'capacity': 29, 'define': 30, 'issue': 30, 'cytokine': 30, 'quickly': 31, 'record': 32, 'explore': 32, 'swab': 33, 'allow': 33, 'state': 33, 'progression': 34, 'enhance': 35, 'recognize': 36, 'pcr': 36, 'exist': 37, 'effort': 37, 'evolution': 38, 'term': 39, 'asymptomatic': 39, 'diagnostic': 41, 'local': 43, 'help': 44, 'share': 45, 'guideline': 45, 'national': 46, 'area': 46, 'ongoing': 48, 'intervention': 52, 'exposure': 52, 'predict': 52, 'genetic': 53, 'therapeutic': 54, 'screen': 56, 'practice': 56, 'improve': 59, 'influenza': 59, 'critical': 60, 'surveillance': 63, 'rapidly': 63, 'bat': 64, 'mechanism': 65, 'future': 65, 'collect': 67, 'design': 69, 'species': 71, 'region': 75, 'impact': 75, 'understand': 79, 'method': 79, 'determine': 80, 'rapid': 81, 'information': 81, 'antibody': 82, 'approach': 83, 'laboratory': 84, 'target': 86, 'specific': 88, 'support': 90, 'current': 92, 'sample': 95, 'assay': 96, 'detection': 98, 'factor': 99, 'genome': 101, 'possible': 101, 'detect': 107, 'host': 114, 'sequence': 115, 'development': 115, 'effect': 118, 'measure': 121, 'develope': 123, 'important': 123, 'public': 126, 'early': 126, 'model': 129, 'role': 131, 'test': 134, 'response': 150, 'associate': 155, 'provide': 158, 'increase': 159, 'risk': 161, 'time': 169, 'datum': 182, 'potential': 183, 'transmission': 201, 'epidemic': 216, 'viral': 242, 'fund': 250, 'include': 264, 'source': 286, 'health': 289, 'clinical': 320, 'human': 349, 'virus': 395, 'severe': 404, 'disease': 541, 'covid-19': 1155}\n"
     ]
    }
   ],
   "source": [
    "print(sorted_d_freq)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'count_list_freq' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-11-c34fe6e64c27>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[0mnew_keywords\u001b[0m\u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      2\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mrange\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkeywords\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 3\u001b[1;33m     \u001b[1;32mif\u001b[0m \u001b[0mcount_list_freq\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m<\u001b[0m \u001b[1;36m100\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      4\u001b[0m         \u001b[0mnew_keywords\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkeywords\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      5\u001b[0m \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mnew_keywords\u001b[0m\u001b[1;33m,\u001b[0m\u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mnew_keywords\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mNameError\u001b[0m: name 'count_list_freq' is not defined"
     ]
    }
   ],
   "source": [
    "new_keywords= []\n",
    "for i in range(len(keywords)):\n",
    "    if count_list_freq[i]< 100:\n",
    "        new_keywords.append(keywords[i])\n",
    "print(new_keywords,len(new_keywords))\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_keywords = ['environment', 'wildlife', 'surveillance', 'operational', 'opportunity', 'define', 'approach', 'occupational', 'swab', 'screen', 'enhance', 'rapid', 'serosurveys', 'tap', 'bat', 'roadmap', 'traffic', 'variant', 'intentional', 'non-profit', 'help', 'food', 'laboratory', 'biological', 'companion', 'entity', 'purpose', 'local', 'bed-side', 'accuracy', 'genetic', 'environmental', 'execution', 'sample', 'support', 'ad', 'term', 'assay', 'surveillance/detection', 'hoc', 'region', 'expertise', 'scale', 'force', 'determine', 'technology', 'mechanism', 'avoid', 'collect', 'convalescent', 'denominator', 'recommendation', 'practice', 'coalition', 'drift', 'heavily', 'spillover', 'intervention', 'mass', 'tradeoff', 'recognize', 'market', 'sector', 'design', 'mutation', 'exposure', 'record', 'pcr', 'explore', 'rapidly', 'capacity', 'preparedness', 'critical', 'load', 'improve', 'share', 'inclusive', 'recruitment', 'university', 'official', 'aid', 'holistic', 'advance', 'neutralize', 'barrier', 'demographic', 'protocol', 'streamline', 'couple', 'current', 'start', 'platform', 'allow', 'analytics', 'legal', 'farm', 'longitudinal', 'coordination', 'naturally-occurring', 'accelerator', 'accessibility', 'tester', 'specific', 'crispr', 'ethical', 'species', 'academic', 'information', 'organism', 'point-of-care', 'sufficient', 'policy', 'evolution', 'mitigation', 'device', 'exist', 'track', 'supply', 'state', 'ongoing', 'issue', 'progression', 'widespread', 'national', 'guidance', 'efficacy', 'regulatory', 'lock', 'experiment', 'future', 'mitigate', 'area', 'cytokine', 'specificity', 'therapeutic', 'bioinformatics', 'migrate', 'immediate', 'understand', 'employ', 'leverage', 'genomics', 'distinguish', 'factor', 'communication', 'separation', 'commercial', 'impact', 'marker', 'quickly', 'detection', 'innovation', 'elisas', 'latency', 'diagnostics', 'evolutionary', 'asymptomatic', 'predict', 'particular', 'influenza', 'antibody', 'extent', 'effort', 'private', 'guideline', 'instrument', 'diagnostic', 'reagent', 'capability', 'domestic', 'target', 'method', 'demographics', 'scheme']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "After filtering, number of papers related to tasks and subtasks: 1164\n"
     ]
    }
   ],
   "source": [
    "# Create a filter with 'False' values\n",
    "index_list =  list(df_covid.index.values) \n",
    "filter = pd.Series([False] * len(index_list))\n",
    "filter.index = index_list\n",
    "  \n",
    "# Update the filter using the synonym list, checking if a synonym appears in the title or the abstract of a paper\n",
    "for s in new_keywords:\n",
    "    # Check if a synonym is in title or abstract\n",
    "    filter = filter | df_covid.processed_abstract.str.lower().str.contains(s) | df_covid.processed_title.str.lower().str.contains(s)\n",
    "\n",
    "# Filter out papers in metadata dataframe using the above filter\n",
    "df_covid = df_covid[filter]\n",
    "\n",
    "# Sanity check\n",
    "print(\"After filtering, number of papers related to tasks and subtasks:\", len(df_covid))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>authors</th>\n",
       "      <th>title</th>\n",
       "      <th>journal</th>\n",
       "      <th>abstract_summary</th>\n",
       "      <th>language</th>\n",
       "      <th>processed_abstract</th>\n",
       "      <th>processed_title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1663</td>\n",
       "      <td>01213aa45eeb8088eea6f64614ccc066e2321f73</td>\n",
       "      <td>10.1371/journal.pone.0230548</td>\n",
       "      <td>Radiologic characteristics of 2019 novel coron...</td>\n",
       "      <td>In December, 2019, a series of pneumonia cases...</td>\n",
       "      <td>Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,&lt;...</td>\n",
       "      <td>Association of radiologic findings with&lt;br&gt;mo...</td>\n",
       "      <td>PLoS One</td>\n",
       "      <td>Radiologic characteristics of 2019 novel&lt;br&gt;c...</td>\n",
       "      <td>en</td>\n",
       "      <td>radiologic characteristic 2019 novel coronavir...</td>\n",
       "      <td>association radiologic finding br mortality pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1671</td>\n",
       "      <td>0146de390eb6bdb814a5bd33459ce2c74176a72d</td>\n",
       "      <td>10.1186/s13643-020-01343-4</td>\n",
       "      <td>Background: A new type of coronavirus, novel c...</td>\n",
       "      <td>Recently, a new type of coronavirus was identi...</td>\n",
       "      <td>Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...</td>\n",
       "      <td>Traditional Chinese herbal medicine for&lt;br&gt;tr...</td>\n",
       "      <td>Syst Rev</td>\n",
       "      <td>Background: A new type of coronavirus, novel&lt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>background type coronavirus novel coronavirus ...</td>\n",
       "      <td>traditional chinese herbal medicine br treat n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1679</td>\n",
       "      <td>018269476cd191365d6b8bed046078aea07c8c01</td>\n",
       "      <td>10.1186/s40249-020-00640-3</td>\n",
       "      <td>Background: As reported by the World Health Or...</td>\n",
       "      <td>On 31 December 2019, the World Health Organiza...</td>\n",
       "      <td>Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...</td>\n",
       "      <td>A mathematical model for simulating the&lt;br&gt;ph...</td>\n",
       "      <td>Infectious Diseases of Poverty</td>\n",
       "      <td>Background: As reported by the World Health&lt;b...</td>\n",
       "      <td>en</td>\n",
       "      <td>background world health organization novel cor...</td>\n",
       "      <td>mathematical model simulate br phase-based tra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1693</td>\n",
       "      <td>021144f6c1945b9bff9ea9e4b04b24dcf53330b4</td>\n",
       "      <td>10.3390/v8030055</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a memb...</td>\n",
       "      <td>Coronaviruses are enveloped, single-stranded, ...</td>\n",
       "      <td>Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...</td>\n",
       "      <td>Identification and Comparison of Receptor&lt;br&gt;...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a&lt;br&gt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>porcine epidemic diarrhea virus pedv member al...</td>\n",
       "      <td>identification comparison receptor br binding ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1807</td>\n",
       "      <td>05192151667b1bb4e3405de11f6e4ae2f844e7c5</td>\n",
       "      <td>10.3390/v11010059</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been regard...</td>\n",
       "      <td>Before the first outbreak of severe acute resp...</td>\n",
       "      <td>Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...</td>\n",
       "      <td>From SARS to MERS, Thrusting Coronaviruses&lt;br...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been&lt;br&gt;re...</td>\n",
       "      <td>en</td>\n",
       "      <td>coronaviruses covs regard relatively harmless ...</td>\n",
       "      <td>sars mers thrusting coronaviruses br spotlight</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      paper_id                           doi  \\\n",
       "1663  01213aa45eeb8088eea6f64614ccc066e2321f73  10.1371/journal.pone.0230548   \n",
       "1671  0146de390eb6bdb814a5bd33459ce2c74176a72d    10.1186/s13643-020-01343-4   \n",
       "1679  018269476cd191365d6b8bed046078aea07c8c01    10.1186/s40249-020-00640-3   \n",
       "1693  021144f6c1945b9bff9ea9e4b04b24dcf53330b4              10.3390/v8030055   \n",
       "1807  05192151667b1bb4e3405de11f6e4ae2f844e7c5             10.3390/v11010059   \n",
       "\n",
       "                                               abstract  \\\n",
       "1663  Radiologic characteristics of 2019 novel coron...   \n",
       "1671  Background: A new type of coronavirus, novel c...   \n",
       "1679  Background: As reported by the World Health Or...   \n",
       "1693  Porcine epidemic diarrhea virus (PEDV), a memb...   \n",
       "1807  Coronaviruses (CoVs) have formerly been regard...   \n",
       "\n",
       "                                              body_text  \\\n",
       "1663  In December, 2019, a series of pneumonia cases...   \n",
       "1671  Recently, a new type of coronavirus was identi...   \n",
       "1679  On 31 December 2019, the World Health Organiza...   \n",
       "1693  Coronaviruses are enveloped, single-stranded, ...   \n",
       "1807  Before the first outbreak of severe acute resp...   \n",
       "\n",
       "                                                authors  \\\n",
       "1663   Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,<...   \n",
       "1671   Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...   \n",
       "1679   Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...   \n",
       "1693   Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...   \n",
       "1807   Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...   \n",
       "\n",
       "                                                  title  \\\n",
       "1663   Association of radiologic findings with<br>mo...   \n",
       "1671   Traditional Chinese herbal medicine for<br>tr...   \n",
       "1679   A mathematical model for simulating the<br>ph...   \n",
       "1693   Identification and Comparison of Receptor<br>...   \n",
       "1807   From SARS to MERS, Thrusting Coronaviruses<br...   \n",
       "\n",
       "                             journal  \\\n",
       "1663                        PLoS One   \n",
       "1671                        Syst Rev   \n",
       "1679  Infectious Diseases of Poverty   \n",
       "1693                         Viruses   \n",
       "1807                         Viruses   \n",
       "\n",
       "                                       abstract_summary language  \\\n",
       "1663   Radiologic characteristics of 2019 novel<br>c...       en   \n",
       "1671   Background: A new type of coronavirus, novel<...       en   \n",
       "1679   Background: As reported by the World Health<b...       en   \n",
       "1693   Porcine epidemic diarrhea virus (PEDV), a<br>...       en   \n",
       "1807   Coronaviruses (CoVs) have formerly been<br>re...       en   \n",
       "\n",
       "                                     processed_abstract  \\\n",
       "1663  radiologic characteristic 2019 novel coronavir...   \n",
       "1671  background type coronavirus novel coronavirus ...   \n",
       "1679  background world health organization novel cor...   \n",
       "1693  porcine epidemic diarrhea virus pedv member al...   \n",
       "1807  coronaviruses covs regard relatively harmless ...   \n",
       "\n",
       "                                        processed_title  \n",
       "1663  association radiologic finding br mortality pa...  \n",
       "1671  traditional chinese herbal medicine br treat n...  \n",
       "1679  mathematical model simulate br phase-based tra...  \n",
       "1693  identification comparison receptor br binding ...  \n",
       "1807     sars mers thrusting coronaviruses br spotlight  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "#creating a bag of words\n",
    "list_of_processed_abstracts = df_covid[\"processed_abstract\"].to_list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "bag_of_words = []\n",
    "for each in list_of_processed_abstracts:\n",
    "    each_list = each.split()\n",
    "    bag_of_words = bag_of_words + each_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "bag_of_words = list(set(bag_of_words))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "14652\n"
     ]
    }
   ],
   "source": [
    "print(len(bag_of_words))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True\n"
     ]
    }
   ],
   "source": [
    "str = \"radiologic characteristic 2019 novel coronavir\"\n",
    "print(\"novel\" in str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "def vectorization(proc_abstract):\n",
    "    vector = np. zeros((len(bag_of_words)), dtype=int)\n",
    "    for i in range(len(bag_of_words)):\n",
    "        if bag_of_words[i] in proc_abstract:\n",
    "            vector[i] = vector[i] + 1\n",
    "    return vector"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1164/1164 [00:26<00:00, 43.13it/s]\n"
     ]
    }
   ],
   "source": [
    "df_covid[\"feature_vectors\"] = df_covid[\"processed_abstract\"].progress_apply(vectorization)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>authors</th>\n",
       "      <th>title</th>\n",
       "      <th>journal</th>\n",
       "      <th>abstract_summary</th>\n",
       "      <th>language</th>\n",
       "      <th>processed_abstract</th>\n",
       "      <th>processed_title</th>\n",
       "      <th>feature_vectors</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1663</td>\n",
       "      <td>01213aa45eeb8088eea6f64614ccc066e2321f73</td>\n",
       "      <td>10.1371/journal.pone.0230548</td>\n",
       "      <td>Radiologic characteristics of 2019 novel coron...</td>\n",
       "      <td>In December, 2019, a series of pneumonia cases...</td>\n",
       "      <td>Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,&lt;...</td>\n",
       "      <td>Association of radiologic findings with&lt;br&gt;mo...</td>\n",
       "      <td>PLoS One</td>\n",
       "      <td>Radiologic characteristics of 2019 novel&lt;br&gt;c...</td>\n",
       "      <td>en</td>\n",
       "      <td>radiologic characteristic 2019 novel coronavir...</td>\n",
       "      <td>association radiologic finding br mortality pa...</td>\n",
       "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1671</td>\n",
       "      <td>0146de390eb6bdb814a5bd33459ce2c74176a72d</td>\n",
       "      <td>10.1186/s13643-020-01343-4</td>\n",
       "      <td>Background: A new type of coronavirus, novel c...</td>\n",
       "      <td>Recently, a new type of coronavirus was identi...</td>\n",
       "      <td>Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...</td>\n",
       "      <td>Traditional Chinese herbal medicine for&lt;br&gt;tr...</td>\n",
       "      <td>Syst Rev</td>\n",
       "      <td>Background: A new type of coronavirus, novel&lt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>background type coronavirus novel coronavirus ...</td>\n",
       "      <td>traditional chinese herbal medicine br treat n...</td>\n",
       "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1679</td>\n",
       "      <td>018269476cd191365d6b8bed046078aea07c8c01</td>\n",
       "      <td>10.1186/s40249-020-00640-3</td>\n",
       "      <td>Background: As reported by the World Health Or...</td>\n",
       "      <td>On 31 December 2019, the World Health Organiza...</td>\n",
       "      <td>Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...</td>\n",
       "      <td>A mathematical model for simulating the&lt;br&gt;ph...</td>\n",
       "      <td>Infectious Diseases of Poverty</td>\n",
       "      <td>Background: As reported by the World Health&lt;b...</td>\n",
       "      <td>en</td>\n",
       "      <td>background world health organization novel cor...</td>\n",
       "      <td>mathematical model simulate br phase-based tra...</td>\n",
       "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1693</td>\n",
       "      <td>021144f6c1945b9bff9ea9e4b04b24dcf53330b4</td>\n",
       "      <td>10.3390/v8030055</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a memb...</td>\n",
       "      <td>Coronaviruses are enveloped, single-stranded, ...</td>\n",
       "      <td>Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...</td>\n",
       "      <td>Identification and Comparison of Receptor&lt;br&gt;...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a&lt;br&gt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>porcine epidemic diarrhea virus pedv member al...</td>\n",
       "      <td>identification comparison receptor br binding ...</td>\n",
       "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1807</td>\n",
       "      <td>05192151667b1bb4e3405de11f6e4ae2f844e7c5</td>\n",
       "      <td>10.3390/v11010059</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been regard...</td>\n",
       "      <td>Before the first outbreak of severe acute resp...</td>\n",
       "      <td>Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...</td>\n",
       "      <td>From SARS to MERS, Thrusting Coronaviruses&lt;br...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been&lt;br&gt;re...</td>\n",
       "      <td>en</td>\n",
       "      <td>coronaviruses covs regard relatively harmless ...</td>\n",
       "      <td>sars mers thrusting coronaviruses br spotlight</td>\n",
       "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      paper_id                           doi  \\\n",
       "1663  01213aa45eeb8088eea6f64614ccc066e2321f73  10.1371/journal.pone.0230548   \n",
       "1671  0146de390eb6bdb814a5bd33459ce2c74176a72d    10.1186/s13643-020-01343-4   \n",
       "1679  018269476cd191365d6b8bed046078aea07c8c01    10.1186/s40249-020-00640-3   \n",
       "1693  021144f6c1945b9bff9ea9e4b04b24dcf53330b4              10.3390/v8030055   \n",
       "1807  05192151667b1bb4e3405de11f6e4ae2f844e7c5             10.3390/v11010059   \n",
       "\n",
       "                                               abstract  \\\n",
       "1663  Radiologic characteristics of 2019 novel coron...   \n",
       "1671  Background: A new type of coronavirus, novel c...   \n",
       "1679  Background: As reported by the World Health Or...   \n",
       "1693  Porcine epidemic diarrhea virus (PEDV), a memb...   \n",
       "1807  Coronaviruses (CoVs) have formerly been regard...   \n",
       "\n",
       "                                              body_text  \\\n",
       "1663  In December, 2019, a series of pneumonia cases...   \n",
       "1671  Recently, a new type of coronavirus was identi...   \n",
       "1679  On 31 December 2019, the World Health Organiza...   \n",
       "1693  Coronaviruses are enveloped, single-stranded, ...   \n",
       "1807  Before the first outbreak of severe acute resp...   \n",
       "\n",
       "                                                authors  \\\n",
       "1663   Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,<...   \n",
       "1671   Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...   \n",
       "1679   Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...   \n",
       "1693   Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...   \n",
       "1807   Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...   \n",
       "\n",
       "                                                  title  \\\n",
       "1663   Association of radiologic findings with<br>mo...   \n",
       "1671   Traditional Chinese herbal medicine for<br>tr...   \n",
       "1679   A mathematical model for simulating the<br>ph...   \n",
       "1693   Identification and Comparison of Receptor<br>...   \n",
       "1807   From SARS to MERS, Thrusting Coronaviruses<br...   \n",
       "\n",
       "                             journal  \\\n",
       "1663                        PLoS One   \n",
       "1671                        Syst Rev   \n",
       "1679  Infectious Diseases of Poverty   \n",
       "1693                         Viruses   \n",
       "1807                         Viruses   \n",
       "\n",
       "                                       abstract_summary language  \\\n",
       "1663   Radiologic characteristics of 2019 novel<br>c...       en   \n",
       "1671   Background: A new type of coronavirus, novel<...       en   \n",
       "1679   Background: As reported by the World Health<b...       en   \n",
       "1693   Porcine epidemic diarrhea virus (PEDV), a<br>...       en   \n",
       "1807   Coronaviruses (CoVs) have formerly been<br>re...       en   \n",
       "\n",
       "                                     processed_abstract  \\\n",
       "1663  radiologic characteristic 2019 novel coronavir...   \n",
       "1671  background type coronavirus novel coronavirus ...   \n",
       "1679  background world health organization novel cor...   \n",
       "1693  porcine epidemic diarrhea virus pedv member al...   \n",
       "1807  coronaviruses covs regard relatively harmless ...   \n",
       "\n",
       "                                        processed_title  \\\n",
       "1663  association radiologic finding br mortality pa...   \n",
       "1671  traditional chinese herbal medicine br treat n...   \n",
       "1679  mathematical model simulate br phase-based tra...   \n",
       "1693  identification comparison receptor br binding ...   \n",
       "1807     sars mers thrusting coronaviruses br spotlight   \n",
       "\n",
       "                                        feature_vectors  \n",
       "1663  [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...  \n",
       "1671  [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...  \n",
       "1679  [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...  \n",
       "1693  [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...  \n",
       "1807  [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1663    [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...\n",
       "Name: feature_vectors, dtype: object"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid['feature_vectors'][0:1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "query = \"How widespread current exposure is to be able to make immediate policy recommendations on mitigation measures. Denominators for testing and a mechanism for rapidly sharing that information, including demographics, to the extent possible. Sampling methods to determine asymptomatic disease (e.g., use of serosurveys (such as convalescent samples) and early detection of disease (e.g., use of screening of neutralizing antibodies such as ELISAs).\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "query_tokens = spacy_tokenizer(query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "query_vector = vectorization(query_tokens)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(query_vector)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1164"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df_covid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1164\n"
     ]
    }
   ],
   "source": [
    "distance_vectors = df_covid['feature_vectors'].to_list()\n",
    "print(len(distance_vectors))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "distances = []\n",
    "for vector in distance_vectors:\n",
    "    dist = np.linalg.norm(vector-query_vector)\n",
    "    distances.append(dist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1164"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(distances)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12.922847983320086"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min(distances)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32.93933818400121"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(distances)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "minpos = distances.index(min(distances))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1045"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "minpos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Submissions should be made via our electronic submission system at http://ees.elsevier.com/ thelancet/'"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.iloc[minpos]['abstract']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyError",
     "evalue": "'processed_abstract'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "\u001b[1;32m~\\Anaconda3\\lib\\site-packages\\pandas\\core\\indexes\\base.py\u001b[0m in \u001b[0;36mget_loc\u001b[1;34m(self, key, method, tolerance)\u001b[0m\n\u001b[0;32m   2896\u001b[0m             \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 2897\u001b[1;33m                 \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_engine\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   2898\u001b[0m             \u001b[1;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;31mKeyError\u001b[0m: 'processed_abstract'",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[1;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-88-f7acf6b8e605>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      4\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnumpy\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mnp\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      5\u001b[0m \u001b[0mvectoriser\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mTfidfVectorizer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 6\u001b[1;33m \u001b[0mdf_covid\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'abstractVect'\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mlist\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mvectoriser\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mfit_transform\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdf_covid\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'processed_abstract'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtoarray\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m~\\Anaconda3\\lib\\site-packages\\pandas\\core\\frame.py\u001b[0m in \u001b[0;36m__getitem__\u001b[1;34m(self, key)\u001b[0m\n\u001b[0;32m   2978\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mnlevels\u001b[0m \u001b[1;33m>\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   2979\u001b[0m                 \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_getitem_multilevel\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 2980\u001b[1;33m             \u001b[0mindexer\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   2981\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[0mis_integer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mindexer\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   2982\u001b[0m                 \u001b[0mindexer\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[0mindexer\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\Anaconda3\\lib\\site-packages\\pandas\\core\\indexes\\base.py\u001b[0m in \u001b[0;36mget_loc\u001b[1;34m(self, key, method, tolerance)\u001b[0m\n\u001b[0;32m   2897\u001b[0m                 \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_engine\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   2898\u001b[0m             \u001b[1;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 2899\u001b[1;33m                 \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_engine\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_loc\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_maybe_cast_indexer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   2900\u001b[0m         \u001b[0mindexer\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_indexer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mkey\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmethod\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mmethod\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mtolerance\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mtolerance\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   2901\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mindexer\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mndim\u001b[0m \u001b[1;33m>\u001b[0m \u001b[1;36m1\u001b[0m \u001b[1;32mor\u001b[0m \u001b[0mindexer\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msize\u001b[0m \u001b[1;33m>\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\index.pyx\u001b[0m in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mpandas\\_libs\\hashtable_class_helper.pxi\u001b[0m in \u001b[0;36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;31mKeyError\u001b[0m: 'processed_abstract'"
     ]
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "vectoriser = TfidfVectorizer()\n",
    "df_covid['abstractVect'] = list(vectoriser.fit_transform(df_covid['processed_abstract']).toarray())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>authors</th>\n",
       "      <th>title</th>\n",
       "      <th>journal</th>\n",
       "      <th>abstract_summary</th>\n",
       "      <th>language</th>\n",
       "      <th>processed_abstract</th>\n",
       "      <th>processed_title</th>\n",
       "      <th>abstractVect</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1663</td>\n",
       "      <td>01213aa45eeb8088eea6f64614ccc066e2321f73</td>\n",
       "      <td>10.1371/journal.pone.0230548</td>\n",
       "      <td>Radiologic characteristics of 2019 novel coron...</td>\n",
       "      <td>In December, 2019, a series of pneumonia cases...</td>\n",
       "      <td>Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,&lt;...</td>\n",
       "      <td>Association of radiologic findings with&lt;br&gt;mo...</td>\n",
       "      <td>PLoS One</td>\n",
       "      <td>Radiologic characteristics of 2019 novel&lt;br&gt;c...</td>\n",
       "      <td>en</td>\n",
       "      <td>radiologic characteristic 2019 novel coronavir...</td>\n",
       "      <td>association radiologic finding br mortality pa...</td>\n",
       "      <td>[0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.07153731...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1671</td>\n",
       "      <td>0146de390eb6bdb814a5bd33459ce2c74176a72d</td>\n",
       "      <td>10.1186/s13643-020-01343-4</td>\n",
       "      <td>Background: A new type of coronavirus, novel c...</td>\n",
       "      <td>Recently, a new type of coronavirus was identi...</td>\n",
       "      <td>Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...</td>\n",
       "      <td>Traditional Chinese herbal medicine for&lt;br&gt;tr...</td>\n",
       "      <td>Syst Rev</td>\n",
       "      <td>Background: A new type of coronavirus, novel&lt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>background type coronavirus novel coronavirus ...</td>\n",
       "      <td>traditional chinese herbal medicine br treat n...</td>\n",
       "      <td>[0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1679</td>\n",
       "      <td>018269476cd191365d6b8bed046078aea07c8c01</td>\n",
       "      <td>10.1186/s40249-020-00640-3</td>\n",
       "      <td>Background: As reported by the World Health Or...</td>\n",
       "      <td>On 31 December 2019, the World Health Organiza...</td>\n",
       "      <td>Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...</td>\n",
       "      <td>A mathematical model for simulating the&lt;br&gt;ph...</td>\n",
       "      <td>Infectious Diseases of Poverty</td>\n",
       "      <td>Background: As reported by the World Health&lt;b...</td>\n",
       "      <td>en</td>\n",
       "      <td>background world health organization novel cor...</td>\n",
       "      <td>mathematical model simulate br phase-based tra...</td>\n",
       "      <td>[0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1693</td>\n",
       "      <td>021144f6c1945b9bff9ea9e4b04b24dcf53330b4</td>\n",
       "      <td>10.3390/v8030055</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a memb...</td>\n",
       "      <td>Coronaviruses are enveloped, single-stranded, ...</td>\n",
       "      <td>Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...</td>\n",
       "      <td>Identification and Comparison of Receptor&lt;br&gt;...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Porcine epidemic diarrhea virus (PEDV), a&lt;br&gt;...</td>\n",
       "      <td>en</td>\n",
       "      <td>porcine epidemic diarrhea virus pedv member al...</td>\n",
       "      <td>identification comparison receptor br binding ...</td>\n",
       "      <td>[0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1807</td>\n",
       "      <td>05192151667b1bb4e3405de11f6e4ae2f844e7c5</td>\n",
       "      <td>10.3390/v11010059</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been regard...</td>\n",
       "      <td>Before the first outbreak of severe acute resp...</td>\n",
       "      <td>Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...</td>\n",
       "      <td>From SARS to MERS, Thrusting Coronaviruses&lt;br...</td>\n",
       "      <td>Viruses</td>\n",
       "      <td>Coronaviruses (CoVs) have formerly been&lt;br&gt;re...</td>\n",
       "      <td>en</td>\n",
       "      <td>coronaviruses covs regard relatively harmless ...</td>\n",
       "      <td>sars mers thrusting coronaviruses br spotlight</td>\n",
       "      <td>[0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      paper_id                           doi  \\\n",
       "1663  01213aa45eeb8088eea6f64614ccc066e2321f73  10.1371/journal.pone.0230548   \n",
       "1671  0146de390eb6bdb814a5bd33459ce2c74176a72d    10.1186/s13643-020-01343-4   \n",
       "1679  018269476cd191365d6b8bed046078aea07c8c01    10.1186/s40249-020-00640-3   \n",
       "1693  021144f6c1945b9bff9ea9e4b04b24dcf53330b4              10.3390/v8030055   \n",
       "1807  05192151667b1bb4e3405de11f6e4ae2f844e7c5             10.3390/v11010059   \n",
       "\n",
       "                                               abstract  \\\n",
       "1663  Radiologic characteristics of 2019 novel coron...   \n",
       "1671  Background: A new type of coronavirus, novel c...   \n",
       "1679  Background: As reported by the World Health Or...   \n",
       "1693  Porcine epidemic diarrhea virus (PEDV), a memb...   \n",
       "1807  Coronaviruses (CoVs) have formerly been regard...   \n",
       "\n",
       "                                              body_text  \\\n",
       "1663  In December, 2019, a series of pneumonia cases...   \n",
       "1671  Recently, a new type of coronavirus was identi...   \n",
       "1679  On 31 December 2019, the World Health Organiza...   \n",
       "1693  Coronaviruses are enveloped, single-stranded, ...   \n",
       "1807  Before the first outbreak of severe acute resp...   \n",
       "\n",
       "                                                authors  \\\n",
       "1663   Yuan, Mingli.  Yin, Wen.  Tao, Zhaowu.  Tan,<...   \n",
       "1671   Li, Yuxi.  Liu, Xiaobo.  Guo, Liuxue.  Li, Ju...   \n",
       "1679   Yin, Tian-Mu Chen.  Jia, Rui.  Qiu-Peng, Wang...   \n",
       "1693   Deng, Feng.  Ye, Gang.  Liu, Qianqian.  Navid...   \n",
       "1807   Song, Zhiqi.  Xu, Yanfeng.  Bao, Linlin.  Zha...   \n",
       "\n",
       "                                                  title  \\\n",
       "1663   Association of radiologic findings with<br>mo...   \n",
       "1671   Traditional Chinese herbal medicine for<br>tr...   \n",
       "1679   A mathematical model for simulating the<br>ph...   \n",
       "1693   Identification and Comparison of Receptor<br>...   \n",
       "1807   From SARS to MERS, Thrusting Coronaviruses<br...   \n",
       "\n",
       "                             journal  \\\n",
       "1663                        PLoS One   \n",
       "1671                        Syst Rev   \n",
       "1679  Infectious Diseases of Poverty   \n",
       "1693                         Viruses   \n",
       "1807                         Viruses   \n",
       "\n",
       "                                       abstract_summary language  \\\n",
       "1663   Radiologic characteristics of 2019 novel<br>c...       en   \n",
       "1671   Background: A new type of coronavirus, novel<...       en   \n",
       "1679   Background: As reported by the World Health<b...       en   \n",
       "1693   Porcine epidemic diarrhea virus (PEDV), a<br>...       en   \n",
       "1807   Coronaviruses (CoVs) have formerly been<br>re...       en   \n",
       "\n",
       "                                     processed_abstract  \\\n",
       "1663  radiologic characteristic 2019 novel coronavir...   \n",
       "1671  background type coronavirus novel coronavirus ...   \n",
       "1679  background world health organization novel cor...   \n",
       "1693  porcine epidemic diarrhea virus pedv member al...   \n",
       "1807  coronaviruses covs regard relatively harmless ...   \n",
       "\n",
       "                                        processed_title  \\\n",
       "1663  association radiologic finding br mortality pa...   \n",
       "1671  traditional chinese herbal medicine br treat n...   \n",
       "1679  mathematical model simulate br phase-based tra...   \n",
       "1693  identification comparison receptor br binding ...   \n",
       "1807     sars mers thrusting coronaviruses br spotlight   \n",
       "\n",
       "                                           abstractVect  \n",
       "1663  [0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.07153731...  \n",
       "1671  [0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...  \n",
       "1679  [0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...  \n",
       "1693  [0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...  \n",
       "1807  [0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, ...  "
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    " arr =df_covid[\"abstractVect\"][0:1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1164\n"
     ]
    }
   ],
   "source": [
    "distance_vectors = df_covid['abstractVect'].to_list()\n",
    "print(len(distance_vectors))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "query =\"How widespread current exposure is to be able to make immediate policy recommendations on mitigation measures. Denominators for testing and a mechanism for rapidly sharing that information, including demographics, to the extent possible. Sampling methods to determine asymptomatic disease (e.g., use of serosurveys (such as convalescent samples) and early detection of disease (e.g., use of screening of neutralizing antibodies such as ELISAs).\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "query_vector = vectoriser.transform([query]).toarray()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "query_vector0 = query_vector[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "numpy.ndarray"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(query_vector0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12136"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(query_vector0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12136"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(distance_vectors[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "distances = []\n",
    "for vector in distance_vectors:\n",
    "    dist = np.linalg.norm(vector-query_vector)\n",
    "    distances.append(dist) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1.4142135623730954"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(distances)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12.922847983320086"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min(distances)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "minpos = distances.index(min(distances))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1045"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "minpos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "' Mitigate the effects of home confinement on<br>children during the COVID-19 outbreak'"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_covid.iloc[minpos]['title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
